BANQUE;NAME;GO ACCESSION;SIZE;ES;NES;NOM p-val;FDR q-val
GO BP;REGULATION OF HISTONE METHYLATION;GO:0031060;54;-0.5323279;-2.2230377;0;0.01655698
GO BP;POSITIVE REGULATION OF VIRAL GENOME REPLICATION;GO:0045070;31;-0.5850841;-2.194321;0;0.014802814
GO BP;REGULATION OF CHROMATIN ORGANIZATION;GO:1902275;149;-0.42616415;-2.1805694;0;0.01184311
GO BP;REGULATION OF AUTOPHAGY OF MITOCHONDRION;GO:1903146;37;-0.57773936;-2.1744366;0;0.010066278
GO BP;CHROMATIN DISASSEMBLY;GO:0031498;17;-0.6847989;-2.1640017;0;0.009244843
GO BP;RAC PROTEIN SIGNAL TRANSDUCTION;GO:0016601;28;-0.6155598;-2.1638932;0;0.007704036
GO BP;GOLGI VESICLE TRANSPORT;GO:0048193;314;-0.37994966;-2.1249998;0;0.01439526
GO BP;VENTRAL SPINAL CORD DEVELOPMENT;GO:0021517;22;-0.62255675;-2.1158676;0;0.014810922
GO BP;SISTER CHROMATID SEGREGATION;GO:0000819;167;-0.41263166;-2.1158545;0;0.013165263
GO BP;MITOTIC SISTER CHROMATID SEGREGATION;GO:0000070;140;-0.4269964;-2.1129527;0;0.012205484
GO BP;HISTONE H3 K9 MODIFICATION;GO:0061647;39;-0.52891624;-2.1062846;0;0.012176445
GO BP;COVALENT CHROMATIN MODIFICATION;GO:0016569;380;-0.36685908;-2.0826385;0;0.016004343
GO BP;MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS;GO:1902850;123;-0.4178985;-2.0806828;0;0.015134564
GO BP;REGULATION OF HISTONE H3 K9 METHYLATION;GO:0051570;18;-0.64238316;-2.0618348;0;0.018120902
GO BP;MITOTIC SPINDLE ORGANIZATION;GO:0007052;99;-0.42796692;-2.0549614;0;0.01864636
GO BP;RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM;GO:0006890;78;-0.45450774;-2.0473187;0;0.018884221
GO BP;REGULATION OF CHROMOSOME ORGANIZATION;GO:0033044;293;-0.36859065;-2.0434072;0;0.018678196
GO BP;REGULATION OF HISTONE MODIFICATION;GO:0031056;113;-0.4218137;-2.0428267;0;0.017708005
GO BP;PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER;GO:1905508;32;-0.5421883;-2.0236332;0;0.022588432
GO BP;HISTONE H3 K9 METHYLATION;GO:0051567;30;-0.5555423;-2.0185182;0.001748252;0.022702342
GO BP;HISTONE H3 DEACETYLATION;GO:0070932;18;-0.6363906;-2.008035;0;0.024105774
GO BP;HISTONE METHYLATION;GO:0016571;113;-0.4113219;-1.9993593;0;0.026779404
GO BP;MEMBRANE DOCKING;GO:0022406;168;-0.38730446;-1.9965401;0;0.026488645
GO BP;DNA GEOMETRIC CHANGE;GO:0032392;107;-0.41035214;-1.9879507;0;0.028449854
GO BP;NCRNA EXPORT FROM NUCLEUS;GO:0097064;36;-0.51655006;-1.9814537;0;0.029580623
GO BP;HISTONE H4 ACETYLATION;GO:0043967;57;-0.46847996;-1.9792416;0;0.029307378
GO BP;CYTOKINESIS;GO:0000910;134;-0.39917848;-1.9760517;0;0.02944709
GO BP;BARBED END ACTIN FILAMENT CAPPING;GO:0051016;16;-0.64283085;-1.9743277;0;0.029286114
GO BP;GOLGI ORGANIZATION;GO:0007030;113;-0.4028112;-1.9613229;0;0.032892197
GO BP;POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION;GO:1903599;18;-0.617938;-1.9601071;0;0.032230895
GO BP;RNA LOCALIZATION;GO:0006403;211;-0.3652289;-1.9581227;0;0.03210651
GO BP;MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION;GO:0031109;92;-0.41758367;-1.9570804;0;0.031251214
GO BP;CILIARY BASAL BODY PLASMA MEMBRANE DOCKING;GO:0097711;95;-0.4137387;-1.9560993;0;0.030662766
GO BP;POSITIVE REGULATION OF CYTOKINESIS;GO:0032467;25;-0.55332947;-1.9498383;0;0.032413024
GO BP;HISTONE H3 ACETYLATION;GO:0043966;50;-0.4737855;-1.9472506;0;0.03274191
GO BP;HISTONE UBIQUITINATION;GO:0016574;43;-0.4841003;-1.9428347;0;0.033312023
GO BP;CHROMOSOME SEGREGATION;GO:0007059;280;-0.35561243;-1.9418426;0;0.033020314
GO BP;REGULATION OF ORGANELLE ASSEMBLY;GO:1902115;163;-0.37754422;-1.9394486;0;0.03283597
GO BP;REGULATION OF CHROMOSOME SEGREGATION;GO:0051983;93;-0.41657877;-1.9380678;0;0.032360103
GO BP;REGULATION OF CELLULAR RESPONSE TO HEAT;GO:1900034;72;-0.43507263;-1.9361671;0;0.03228858
GO BP;REGULATION OF MITOPHAGY;GO:1901524;16;-0.62190336;-1.9340043;0;0.032252558
GO BP;ENDOTHELIAL CELL DEVELOPMENT;GO:0001885;43;-0.48744744;-1.9330494;0.001754386;0.031961035
GO BP;CYTOSKELETON DEPENDENT CYTOKINESIS;GO:0061640;83;-0.42012134;-1.9197524;0;0.0364152
GO BP;MITOTIC NUCLEAR DIVISION;GO:0140014;233;-0.3559987;-1.9196045;0;0.035613514
GO BP;REGULATION OF PROTEIN DEPOLYMERIZATION;GO:1901879;61;-0.43790254;-1.919226;0;0.035034228
GO BP;LYSOSOMAL TRANSPORT;GO:0007041;90;-0.40948552;-1.9176452;0;0.034944244
GO BP;SPINDLE ORGANIZATION;GO:0007051;153;-0.37834045;-1.9172454;0;0.034326322
GO BP;NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION;GO:0051058;46;-0.4774195;-1.9151942;0;0.03432624
GO BP;MITOTIC CYTOKINESIS;GO:0000281;65;-0.43346453;-1.9118726;0;0.035005305
GO BP;PROTEIN DNA COMPLEX DISASSEMBLY;GO:0032986;18;-0.60412526;-1.9117894;0.001834862;0.0343052
GO BP;POSITIVE REGULATION OF HISTONE METHYLATION;GO:0031062;33;-0.5081663;-1.9108912;0.001766785;0.03398212
GO BP;POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I;GO:0045943;20;-0.5853523;-1.9039509;0.005110733;0.035871785
GO BP;PROTEIN DEPOLYMERIZATION;GO:0051261;82;-0.41358733;-1.901021;0;0.036533304
GO BP;PROTEIN K63 LINKED UBIQUITINATION;GO:0070534;38;-0.4839324;-1.89755;0.001694915;0.037261076
GO BP;VIRAL RNA GENOME REPLICATION;GO:0039694;23;-0.552732;-1.8973452;0.003472222;0.036647465
GO BP;CELL DIVISION;GO:0051301;494;-0.32752758;-1.8935063;0;0.037260998
GO BP;CELL DIFFERENTIATION IN SPINAL CORD;GO:0021515;20;-0.58006626;-1.8916315;0.001692047;0.037250414
GO BP;NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY;GO:0043242;57;-0.4500138;-1.8875916;0;0.038241755
GO BP;NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION;GO:0031111;31;-0.5116927;-1.8820999;0.001655629;0.03986322
GO BP;REGULATION OF CYTOKINESIS;GO:0032465;66;-0.42604;-1.8788339;0;0.04066399
GO BP;DENDRITE MORPHOGENESIS;GO:0048813;103;-0.39020434;-1.8780404;0;0.04024863
GO BP;NEGATIVE REGULATION OF HISTONE METHYLATION;GO:0031061;17;-0.5908887;-1.8766932;0.003407155;0.03984897
GO BP;REGULATION OF CHROMATIN BINDING;GO:0035561;19;-0.5742195;-1.8732882;0.001663894;0.04083492
GO BP;MITOTIC SPINDLE ASSEMBLY;GO:0090307;52;-0.4468484;-1.8717724;0;0.040861566
GO BP;DE NOVO PROTEIN FOLDING;GO:0006458;35;-0.48240224;-1.8716961;0.003552398;0.04025113
GO BP;NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION;GO:0030835;29;-0.51452804;-1.870578;0.001736111;0.039855856
GO BP;ESTABLISHMENT OF RNA LOCALIZATION;GO:0051236;178;-0.3575133;-1.8697625;0;0.039561424
GO BP;REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY;GO:0043254;329;-0.3315261;-1.8691657;0;0.039135505
GO BP;POSITIVE REGULATION OF CHROMATIN ORGANIZATION;GO:1905269;86;-0.4054997;-1.8679912;0;0.038910866
GO BP;NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION;GO:1902904;100;-0.39331993;-1.8671207;0;0.038692255
GO BP;NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION;GO:2001251;123;-0.3826554;-1.8620245;0;0.04045005
GO BP;HISTONE DEACETYLATION;GO:0016575;64;-0.43601853;-1.8617115;0;0.040003613
GO BP;REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT;GO:0046822;90;-0.3972471;-1.8611463;0;0.039650984
GO BP;ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT;GO:0006888;168;-0.35897917;-1.8561966;0;0.041117616
GO BP;POSITIVE REGULATION OF ORGANELLE ASSEMBLY;GO:1902117;64;-0.42742023;-1.8487767;0.001697793;0.044059563
GO BP;REGULATION OF DENDRITE MORPHOGENESIS;GO:0048814;67;-0.41973975;-1.8479112;0;0.04385255
GO BP;DENDRITE DEVELOPMENT;GO:0016358;176;-0.35472083;-1.8474963;0;0.04342196
GO BP;NEUROBLAST PROLIFERATION;GO:0007405;37;-0.47707573;-1.8472023;0;0.04298614
GO BP;REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS;GO:0032434;105;-0.3841518;-1.847034;0;0.042486876
GO BP;REGULATION OF SISTER CHROMATID SEGREGATION;GO:0033045;74;-0.40517205;-1.8406459;0;0.044898305
GO BP;PEPTIDYL LYSINE TRIMETHYLATION;GO:0018023;40;-0.47081307;-1.8394122;0;0.044838298
GO BP;ACTIN FILAMENT DEPOLYMERIZATION;GO:0030042;38;-0.4704362;-1.8378334;0.001709402;0.045056578
GO BP;REGULATION OF DENDRITE DEVELOPMENT;GO:0050773;115;-0.37973037;-1.8370092;0;0.04485541
GO BP;REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I;GO:0006356;29;-0.50580066;-1.8335936;0;0.04590286
GO BP;REGULATION OF CENTRIOLE REPLICATION;GO:0046599;20;-0.55152434;-1.8327574;0.003454231;0.045682307
GO BP;NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION;GO:0051494;108;-0.3864954;-1.8322139;0;0.045469258
GO BP;PROTEIN CONTAINING COMPLEX LOCALIZATION;GO:0031503;242;-0.33562586;-1.8293805;0;0.04653921
GO BP;CHROMATIN REMODELING;GO:0006338;140;-0.37166348;-1.8293312;0;0.04606403
GO BP;REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION;GO:0031110;64;-0.41596776;-1.8290765;0;0.045693614
GO BP;POSITIVE REGULATION OF DENDRITE DEVELOPMENT;GO:1900006;61;-0.42271796;-1.8259692;0.001703578;0.04655504
GO BP;MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS;GO:0006509;31;-0.50579935;-1.8257912;0.003472222;0.046107855
GO BP;GLUCOSE CATABOLIC PROCESS;GO:0006007;31;-0.49768674;-1.825623;0;0.0456587
GO BP;AUTOPHAGY OF MITOCHONDRION;GO:0000422;65;-0.41367808;-1.8245273;0;0.045638308
GO BP;NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I;GO:0042790;17;-0.5793124;-1.8237724;0.005208334;0.045465883
GO BP;SPINDLE ASSEMBLY;GO:0051225;95;-0.38747895;-1.814988;0;0.04925804
GO BP;MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT;GO:0006851;19;-0.5609732;-1.8091404;0.005514706;0.05185261
GO BP;MRNA TRANSPORT;GO:0051028;136;-0.35799533;-1.808843;0;0.05140307
GO BP;POST GOLGI VESICLE MEDIATED TRANSPORT;GO:0006892;95;-0.37976953;-1.8085649;0;0.050975677
GO BP;POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS;GO:1901522;19;-0.5532722;-1.8072622;0.005291005;0.051141452
GO BP;MITOPHAGY;GO:0000423;21;-0.53339195;-1.80644;0.003514939;0.050925992
GO BP;NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION;GO:0035024;17;-0.5763209;-1.8061821;0.010507881;0.05050424
GO BP;HISTONE H2A UBIQUITINATION;GO:0033522;24;-0.5219177;-1.8056093;0.003418803;0.050333012
GO BP;SPINDLE LOCALIZATION;GO:0051653;42;-0.45645854;-1.801202;0;0.05222551
GO BP;MITOTIC SISTER CHROMATID COHESION;GO:0007064;22;-0.53686464;-1.8000554;0.008403362;0.052282847
GO BP;MULTICELLULAR ORGANISM GROWTH;GO:0035264;112;-0.37112463;-1.7989819;0;0.052337945
GO BP;REGULATION OF MICROTUBULE BASED PROCESS;GO:0032886;183;-0.3435965;-1.7988102;0;0.0519564
GO BP;DENDRITIC SPINE MORPHOGENESIS;GO:0060997;44;-0.4481841;-1.7977866;0.001779359;0.051958766
GO BP;NEGATIVE REGULATION OF CHROMATIN ORGANIZATION;GO:1905268;47;-0.4393777;-1.7969688;0.003430532;0.05183852
GO BP;CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT;GO:0030705;157;-0.35029417;-1.7964613;0;0.0516339
GO BP;PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS;GO:0006515;28;-0.4945526;-1.7961434;0.001818182;0.05143276
GO BP;NUCLEOTIDE EXCISION REPAIR;GO:0006289;103;-0.37987888;-1.7939142;0;0.052230623
GO BP;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY;GO:0048010;71;-0.40780306;-1.7937082;0.001642036;0.051891886
GO BP;NUCLEAR CHROMOSOME SEGREGATION;GO:0098813;225;-0.33279938;-1.7928679;0;0.051978152
GO BP;PROTEIN TARGETING TO LYSOSOME;GO:0006622;20;-0.5567815;-1.7924287;0.008880994;0.05173973
GO BP;FATTY ACYL COA METABOLIC PROCESS;GO:0035337;33;-0.48377675;-1.7919817;0.001730104;0.05151646
GO BP;BLASTOCYST FORMATION;GO:0001825;33;-0.47134984;-1.78818;0.003333333;0.05303846
GO BP;POSITIVE REGULATION OF INTRACELLULAR TRANSPORT;GO:0032388;169;-0.34889695;-1.788151;0;0.05259507
GO BP;POSITIVE REGULATION OF DENDRITE MORPHOGENESIS;GO:0050775;33;-0.48313907;-1.7854708;0.003460208;0.053581458
GO BP;POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC;GO:0045815;54;-0.42086634;-1.7838261;0;0.054116648
GO BP;ESTABLISHMENT OF ENDOTHELIAL BARRIER;GO:0061028;33;-0.47813606;-1.7832832;0.005154639;0.05395396
GO BP;REGULATION OF LONG TERM SYNAPTIC POTENTIATION;GO:1900271;26;-0.50890964;-1.7829627;0.004950495;0.053703915
GO BP;RNA EXPORT FROM NUCLEUS;GO:0006405;129;-0.35638657;-1.7815704;0;0.054078847
GO BP;NUCLEAR EXPORT;GO:0051168;184;-0.3424805;-1.7810946;0;0.053850513
GO BP;NUCLEAR TRANSPORT;GO:0051169;296;-0.3194893;-1.7808442;0;0.05355046
GO BP;ACTIVATION OF GTPASE ACTIVITY;GO:0090630;71;-0.39806598;-1.7807337;0;0.053169504
GO BP;REGULATION OF MICROTUBULE POLYMERIZATION;GO:0031113;41;-0.44905788;-1.7801384;0;0.0530195
GO BP;BLASTOCYST DEVELOPMENT;GO:0001824;80;-0.39004642;-1.7799472;0;0.0526862
GO BP;PEPTIDYL LYSINE METHYLATION;GO:0018022;108;-0.3709944;-1.7792737;0.001560062;0.052653875
GO BP;ENDOMEMBRANE SYSTEM ORGANIZATION;GO:0010256;341;-0.31638354;-1.7792517;0;0.05226393
GO BP;POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE;GO:1905477;92;-0.37819237;-1.776506;0;0.05319167
GO BP;BRANCHED CHAIN AMINO ACID METABOLIC PROCESS;GO:0009081;20;-0.53526443;-1.7746866;0.003460208;0.053652942
GO BP;RNA STABILIZATION;GO:0043489;38;-0.45787695;-1.774116;0.003448276;0.05364069
GO BP;REGULATION OF CELL CYCLE G2 M PHASE TRANSITION;GO:1902749;193;-0.33785826;-1.7722678;0;0.054135688
GO BP;SPINAL CORD MOTOR NEURON DIFFERENTIATION;GO:0021522;15;-0.59552014;-1.772202;0.013422819;0.053749315
GO BP;CELL PART MORPHOGENESIS;GO:0032990;457;-0.3055127;-1.768664;0;0.055063087
GO BP;REGULATION OF CELL CYCLE PHASE TRANSITION;GO:1901987;388;-0.30922353;-1.7684892;0;0.054753684
GO BP;REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING;GO:0006349;15;-0.58541864;-1.7684789;0.005747126;0.054354023
GO BP;CELLULAR RESPONSE TO HEAT;GO:0034605;111;-0.3673781;-1.7676872;0;0.05435588
GO BP;EPITHELIAL CELL MORPHOGENESIS;GO:0003382;22;-0.5149233;-1.7671282;0.005434783;0.05429635
GO BP;POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS;GO:0061003;17;-0.5707574;-1.7665792;0.005084746;0.054179147
GO BP;ENDOPLASMIC RETICULUM ORGANIZATION;GO:0007029;48;-0.43171036;-1.7616162;0.001703578;0.05644354
GO BP;REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION;GO:0010569;38;-0.45164263;-1.7615441;0.001694915;0.056104824
GO BP;MICROTUBULE CYTOSKELETON ORGANIZATION;GO:0000226;456;-0.3048975;-1.7594236;0;0.05687907
GO BP;PROTEIN METHYLATION;GO:0006479;148;-0.34975967;-1.7574393;0;0.05756083
GO BP;REGULATION OF PROTEIN CATABOLIC PROCESS;GO:0042176;316;-0.31394032;-1.756645;0;0.057531744
GO BP;REGULATION OF DENDRITIC SPINE MORPHOGENESIS;GO:0061001;34;-0.46356642;-1.7553425;0.003231018;0.05785288
GO BP;REGULATION OF CYTOSKELETON ORGANIZATION;GO:0051493;410;-0.3041894;-1.7546065;0;0.057852603
GO BP;PLATELET MORPHOGENESIS;GO:0036344;16;-0.57646716;-1.7536465;0.008333334;0.05802126
GO BP;APICAL JUNCTION ASSEMBLY;GO:0043297;54;-0.41623205;-1.753251;0.00331675;0.057798937
GO BP;NEGATIVE REGULATION OF HISTONE MODIFICATION;GO:0031057;32;-0.4779912;-1.7515663;0.003344482;0.058377177
GO BP;REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS;GO:2000058;127;-0.3542516;-1.7495308;0;0.059008863
GO BP;MAINTENANCE OF PROTEIN LOCATION IN CELL;GO:0032507;60;-0.40332958;-1.7474716;0.001730104;0.059951615
GO BP;SYNAPSE ASSEMBLY;GO:0007416;83;-0.3801666;-1.747045;0;0.059760407
GO BP;MICROTUBULE POLYMERIZATION;GO:0046785;64;-0.4053987;-1.7463077;0;0.059803464
GO BP;NCRNA TRANSCRIPTION;GO:0098781;101;-0.36878303;-1.7454607;0.001560062;0.05992128
GO BP;NEURON PROJECTION ORGANIZATION;GO:0106027;67;-0.39673182;-1.7447816;0;0.06001487
GO BP;PEPTIDYL LYSINE MODIFICATION;GO:0018205;327;-0.3122678;-1.7443122;0;0.059844416
GO BP;MITOTIC DNA REPLICATION;GO:1902969;15;-0.57354516;-1.7442261;0.010638298;0.059518006
GO BP;POSITIVE REGULATION OF CELLULAR CATABOLIC PROCESS;GO:0031331;299;-0.31400356;-1.7440723;0;0.059210557
GO BP;SISTER CHROMATID COHESION;GO:0007062;53;-0.41628882;-1.7435395;0.005059022;0.05901844
GO BP;MRNA PROCESSING;GO:0006397;449;-0.30243233;-1.742106;0;0.059321515
GO BP;FOREBRAIN DEVELOPMENT;GO:0030900;234;-0.32402357;-1.7420282;0;0.058999192
GO BP;PROTEIN LOCALIZATION TO LYSOSOME;GO:0061462;33;-0.4617492;-1.7400687;0.003361345;0.05976377
GO BP;NEURON PROJECTION GUIDANCE;GO:0097485;167;-0.3362111;-1.7380922;0;0.060368404
GO BP;POSITIVE REGULATION OF MACROAUTOPHAGY;GO:0016239;58;-0.40243024;-1.7373282;0.003384095;0.060439847
GO BP;REGULATION OF NEUROBLAST PROLIFERATION;GO:1902692;18;-0.56384075;-1.7370752;0.010309278;0.060183536
GO BP;PEPTIDYL LYSINE ACETYLATION;GO:0018394;137;-0.34890443;-1.7365578;0;0.060056295
GO BP;CHROMOSOME SEPARATION;GO:0051304;80;-0.37684146;-1.735823;0;0.060086474
GO BP;ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II;GO:0002504;82;-0.37810203;-1.7355813;0.001612903;0.05987858
GO BP;CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY;GO:0033962;19;-0.5378194;-1.7344038;0.010452962;0.060139306
GO BP;ORGANELLE DISASSEMBLY;GO:1903008;85;-0.3742406;-1.7338333;0;0.060183033
GO BP;REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION;GO:1902903;257;-0.31747597;-1.7304904;0;0.061520148
GO BP;PROTEIN ACETYLATION;GO:0006473;162;-0.335994;-1.7297889;0;0.061554614
GO BP;NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY;GO:0000288;67;-0.3929753;-1.7293677;0.001724138;0.06142578
GO BP;REGULATION OF HISTONE H3 K4 METHYLATION;GO:0051569;23;-0.50800675;-1.7250607;0.006655574;0.063342944
GO BP;LIMBIC SYSTEM DEVELOPMENT;GO:0021761;64;-0.391533;-1.72431;0;0.06335896
GO BP;VIRAL GENOME REPLICATION;GO:0019079;86;-0.37497345;-1.7234665;0.001552795;0.063470684
GO BP;CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING;GO:0051085;26;-0.49715;-1.7232664;0.010256411;0.063187584
GO BP;DNA REPAIR;GO:0006281;481;-0.2965774;-1.7209169;0;0.06404973
GO BP;NUCLEUS LOCALIZATION;GO:0051647;22;-0.51132524;-1.7204342;0.01607143;0.063950114
GO BP;PROTEIN LOCALIZATION TO NUCLEUS;GO:0034504;213;-0.32032606;-1.7201341;0;0.0638052
GO BP;POSITIVE REGULATION OF CHROMOSOME ORGANIZATION;GO:2001252;151;-0.3379706;-1.7196954;0;0.06372077
GO BP;POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT;GO:0060999;36;-0.4479656;-1.7152559;0.009819968;0.06579862
GO BP;CYTOSOLIC TRANSPORT;GO:0016482;140;-0.34102196;-1.7128364;0;0.06706243
GO BP;HISTONE H4 K16 ACETYLATION;GO:0043984;20;-0.5315146;-1.7110264;0.007130125;0.06778261
GO BP;NEGATIVE REGULATION OF CHROMOSOME SEGREGATION;GO:0051985;40;-0.4349593;-1.7108996;0.008417509;0.06753319
GO BP;POSITIVE REGULATION OF CATABOLIC PROCESS;GO:0009896;349;-0.30392045;-1.7108994;0;0.06717205
GO BP;HISTONE MONOUBIQUITINATION;GO:0010390;28;-0.47336733;-1.7104542;0.00166113;0.06716118
GO BP;REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION;GO:0032784;45;-0.42303634;-1.7071166;0;0.069205
GO BP;RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN;GO:0035966;171;-0.33229417;-1.705808;0;0.069631375
GO BP;VACUOLAR TRANSPORT;GO:0007034;125;-0.3478548;-1.70562;0;0.06939622
GO BP;MRNA 3 END PROCESSING;GO:0031124;94;-0.3626504;-1.7050076;0.001683502;0.06944152
GO BP;RRNA TRANSCRIPTION;GO:0009303;32;-0.47033194;-1.7049611;0.019064125;0.0690999
GO BP;ADP METABOLIC PROCESS;GO:0046031;97;-0.36417952;-1.7048471;0.0015625;0.06884776
GO BP;POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION;GO:1903829;263;-0.3121602;-1.704691;0;0.06857384
GO BP;LONG CHAIN FATTY ACYL COA METABOLIC PROCESS;GO:0035336;19;-0.5213017;-1.7003907;0.013651877;0.071098655
GO BP;REGULATION OF GENE EXPRESSION EPIGENETIC;GO:0040029;280;-0.30797157;-1.6997292;0;0.071025796
GO BP;SPINAL CORD DEVELOPMENT;GO:0021510;55;-0.39825478;-1.6970108;0.001642036;0.07248907
GO BP;REGULATION OF INTRACELLULAR PROTEIN TRANSPORT;GO:0033157;185;-0.32660407;-1.6969436;0.001536098;0.07216046
GO BP;POSITIVE REGULATION OF DNA REPAIR;GO:0045739;51;-0.40515563;-1.6967218;0.008319467;0.07193669
GO BP;POSITIVE REGULATION OF ORGANELLE ORGANIZATION;GO:0010638;497;-0.29033953;-1.6955308;0;0.07229107
GO BP;REGULATION OF CENTROSOME CYCLE;GO:0046605;53;-0.40724978;-1.6951442;0.004830918;0.07216157
GO BP;CYTOKINETIC PROCESS;GO:0032506;38;-0.42871618;-1.6936594;0.010256411;0.072809204
GO BP;PROTEIN IMPORT;GO:0017038;153;-0.33279675;-1.6926922;0;0.07302083
GO BP;MAINTENANCE OF LOCATION IN CELL;GO:0051651;77;-0.3753904;-1.6887966;0.00499168;0.07509753
GO BP;RESPONSE TO NERVE GROWTH FACTOR;GO:1990089;41;-0.42821452;-1.6865486;0.01655629;0.076252386
GO BP;HISTONE H2A ACETYLATION;GO:0043968;16;-0.5422917;-1.6862983;0.012006861;0.07608999
GO BP;REGULATION OF MACROAUTOPHAGY;GO:0016241;151;-0.33085752;-1.6851698;0;0.07632602
GO BP;REGULATION OF CYCLASE ACTIVITY;GO:0031279;15;-0.5604571;-1.6845515;0.018835617;0.07627269
GO BP;MEMBRANE PROTEIN PROTEOLYSIS;GO:0033619;43;-0.42370766;-1.6829753;0.001633987;0.07685731
GO BP;SYNAPSE ORGANIZATION;GO:0050808;243;-0.31062487;-1.6818464;0;0.077234514
GO BP;REGULATION OF CELLULAR PROTEIN LOCALIZATION;GO:1903827;425;-0.2948817;-1.6816128;0;0.07702081
GO BP;MICROTUBULE DEPOLYMERIZATION;GO:0007019;35;-0.44162345;-1.6815416;0.003355705;0.07670351
GO BP;ACTIN FILAMENT BASED MOVEMENT;GO:0030048;91;-0.36321047;-1.6815374;0.001577287;0.076345086
GO BP;SUPRAMOLECULAR FIBER ORGANIZATION;GO:0097435;486;-0.28909755;-1.6795387;0;0.0772134
GO BP;POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS;GO:2000060;79;-0.3672547;-1.6788821;0.004854369;0.07734271
GO BP;CELL CYCLE G2 M PHASE TRANSITION;GO:0044839;243;-0.30692685;-1.6788374;0;0.07701868
GO BP;MRNA EXPORT FROM NUCLEUS;GO:0006406;104;-0.35118127;-1.677336;0.001615509;0.07753971
GO BP;PROTEIN ACYLATION;GO:0043543;200;-0.31780863;-1.676916;0;0.07746171
GO BP;REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS;GO:0061136;155;-0.32655895;-1.6743271;0;0.078887895
GO BP;SKELETAL MUSCLE TISSUE REGENERATION;GO:0043403;26;-0.48062348;-1.6737524;0.003584229;0.078868106
GO BP;POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS;GO:1903364;120;-0.34044427;-1.6736974;0.001612903;0.07855017
GO BP;POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT;GO:0051962;332;-0.2985783;-1.6734248;0;0.07837246
GO BP;POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS;GO:0045732;179;-0.31971803;-1.6733241;0;0.078085564
GO BP;MICROTUBULE ORGANIZING CENTER ORGANIZATION;GO:0031023;121;-0.3387705;-1.6720971;0;0.07851268
GO BP;NEURAL TUBE FORMATION;GO:0001841;93;-0.35914245;-1.6705401;0;0.07923954
GO BP;MUSCLE FILAMENT SLIDING;GO:0030049;23;-0.4876736;-1.6701555;0.017452007;0.079177424
GO BP;TUBE CLOSURE;GO:0060606;80;-0.36718675;-1.6684316;0.003246753;0.079795025
GO BP;RECEPTOR METABOLIC PROCESS;GO:0043112;130;-0.33497304;-1.6684246;0.004545454;0.07945175
GO BP;NEURON MIGRATION;GO:0001764;96;-0.35383803;-1.6681383;0.001594896;0.07932752
GO BP;POSITIVE REGULATION OF NEURON DIFFERENTIATION;GO:0045666;245;-0.30850056;-1.6664184;0;0.080167755
GO BP;REGULATION OF INTRACELLULAR TRANSPORT;GO:0032386;276;-0.30427718;-1.6648386;0;0.08088915
GO BP;RESPONSE TO HEAT;GO:0009408;138;-0.3300113;-1.6645879;0;0.08072934
GO BP;CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION;GO:0048667;386;-0.29131508;-1.6639837;0;0.08083001
GO BP;MORPHOGENESIS OF AN EPITHELIAL SHEET;GO:0002011;46;-0.4102282;-1.6627989;0.010362694;0.08140339
GO BP;DENDRITIC SPINE DEVELOPMENT;GO:0060996;77;-0.37158927;-1.6626558;0.008196721;0.0811687
GO BP;POSITIVE REGULATION OF MUSCLE HYPERTROPHY;GO:0014742;21;-0.49107072;-1.6615329;0.019332161;0.08162
GO BP;EPITHELIAL TUBE FORMATION;GO:0072175;104;-0.3537581;-1.6596841;0;0.082558006
GO BP;RNA POLYADENYLATION;GO:0043631;44;-0.40773702;-1.6590877;0.010016695;0.082603246
GO BP;REGULATION OF PROTEIN IMPORT;GO:1904589;47;-0.40482134;-1.6590128;0.001636661;0.08228881
GO BP;POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY;GO:0031334;182;-0.31898323;-1.6586075;0;0.08224723
GO BP;NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS;GO:2000378;41;-0.4236341;-1.6585444;0.014827018;0.08194179
GO BP;MACROMOLECULE METHYLATION;GO:0043414;255;-0.3047843;-1.657468;0;0.08233087
GO BP;VIRAL LIFE CYCLE;GO:0019058;244;-0.30657852;-1.6568922;0;0.08239641
GO BP;NUCLEOBASE CONTAINING COMPOUND TRANSPORT;GO:0015931;213;-0.31113586;-1.6556172;0;0.08288165
GO BP;PYRUVATE METABOLIC PROCESS;GO:0006090;120;-0.33614722;-1.6554499;0.001620746;0.08267023
GO BP;REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER;GO:0034243;27;-0.45955595;-1.6548017;0.013745705;0.08275727
GO BP;RETROGRADE AXONAL TRANSPORT;GO:0008090;15;-0.5345447;-1.6543206;0.026785715;0.08272878
GO BP;CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS;GO:0071378;16;-0.5424897;-1.6541659;0.016423358;0.08252481
GO BP;REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS;GO:1903362;211;-0.3083187;-1.6513783;0;0.084003486
GO BP;ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY;GO:0007163;174;-0.31909558;-1.6512704;0.001508296;0.08375839
GO BP;TUBE FORMATION;GO:0035148;112;-0.34301677;-1.64809;0.003081664;0.08575081
GO BP;GOLGI TO PLASMA MEMBRANE TRANSPORT;GO:0006893;57;-0.38664275;-1.6467943;0.01010101;0.086360365
GO BP;ESTABLISHMENT OF CELL POLARITY;GO:0030010;115;-0.336574;-1.646327;0;0.08635179
GO BP;HIPPO SIGNALING;GO:0035329;37;-0.42366648;-1.6460643;0.00862069;0.08622078
GO BP;MICROTUBULE BASED MOVEMENT;GO:0007018;217;-0.31032032;-1.6454931;0;0.08630087
GO BP;REGULATION OF DNA REPAIR;GO:0006282;98;-0.34817654;-1.6446842;0;0.086606435
GO BP;DNA REPLICATION;GO:0006260;242;-0.29927936;-1.6446093;0;0.08631236
GO BP;CELL CELL JUNCTION ASSEMBLY;GO:0007043;90;-0.35165784;-1.6418846;0.001689189;0.08796397
GO BP;ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE;GO:0030968;105;-0.34175873;-1.6418179;0.003159558;0.08765753
GO BP;CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN;GO:0035967;140;-0.3249743;-1.6417077;0;0.08741717
GO BP;METHYLATION DEPENDENT CHROMATIN SILENCING;GO:0006346;17;-0.5267832;-1.6410668;0.026446281;0.08754838
GO BP;CELL CYCLE CHECKPOINT;GO:0000075;198;-0.31284297;-1.6399986;0.00147929;0.08798531
GO BP;CHROMOSOME LOCALIZATION;GO:0050000;68;-0.37003613;-1.6389546;0.008264462;0.08845968
GO BP;REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS;GO:1900180;94;-0.34744975;-1.6387634;0.006299213;0.088268876
GO BP;POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT;GO:0090316;126;-0.33116108;-1.6385063;0.003194888;0.08812826
GO BP;RECEPTOR CATABOLIC PROCESS;GO:0032801;34;-0.433258;-1.6369145;0.011725294;0.08883618
GO BP;REGULATION OF TOR SIGNALING;GO:0032006;80;-0.36055207;-1.6346664;0.003389831;0.09021139
GO BP;ESTABLISHMENT OF ORGANELLE LOCALIZATION;GO:0051656;337;-0.2898604;-1.6346284;0;0.089902505
GO BP;HISTONE H3 K4 METHYLATION;GO:0051568;47;-0.39796278;-1.6343445;0.015280136;0.08981501
GO BP;NAD METABOLIC PROCESS;GO:0019674;42;-0.41500136;-1.6340467;0.014925373;0.08974639
GO BP;POSITIVE REGULATION OF CELL DEVELOPMENT;GO:0010720;351;-0.2871063;-1.6325077;0;0.09050502
GO BP;POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY;GO:1904377;49;-0.3964435;-1.6319346;0.008361204;0.09058969
GO BP;PALLIUM DEVELOPMENT;GO:0021543;115;-0.33945274;-1.631791;0.004680187;0.09036677
GO BP;REGULATION OF MRNA POLYADENYLATION;GO:1900363;17;-0.51823837;-1.6311077;0.034358047;0.09058016
GO BP;REGULATION OF POSTSYNAPSE ORGANIZATION;GO:0099175;66;-0.3720082;-1.6307496;0.003278689;0.090530895
GO BP;REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE;GO:1905475;140;-0.32739022;-1.6291897;0;0.0913195
GO BP;CYTOPLASMIC MICROTUBULE ORGANIZATION;GO:0031122;45;-0.40618145;-1.6266509;0.012903226;0.09281061
GO BP;NEGATIVE REGULATION OF ORGANELLE ORGANIZATION;GO:0010639;308;-0.29243714;-1.6266004;0;0.09251187
GO BP;MICROTUBULE NUCLEATION;GO:0007020;24;-0.46753228;-1.6264169;0.019197207;0.09233348
GO BP;ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS;GO:0009067;19;-0.5008707;-1.6263549;0.02846975;0.09202175
GO BP;PROTEIN TRANSPORT ALONG MICROTUBULE;GO:0098840;61;-0.3811113;-1.6261021;0.006339144;0.09196769
GO BP;VACUOLE ORGANIZATION;GO:0007033;143;-0.3240356;-1.6259943;0;0.09171421
GO BP;PROTEIN LOCALIZATION TO CYTOSKELETON;GO:0044380;56;-0.3791498;-1.6245844;0.010309278;0.0924595
GO BP;NADH METABOLIC PROCESS;GO:0006734;35;-0.42264265;-1.6236761;0.010204081;0.09291253
GO BP;PODOSOME ASSEMBLY;GO:0071800;16;-0.53352076;-1.6216654;0.03663004;0.0941837
GO BP;NEUTRAL LIPID BIOSYNTHETIC PROCESS;GO:0046460;29;-0.44664204;-1.6210808;0.018518519;0.09427736
GO BP;NEURAL PRECURSOR CELL PROLIFERATION;GO:0061351;97;-0.3478777;-1.6209284;0.0015625;0.09406943
GO BP;NADPH REGENERATION;GO:0006740;15;-0.5316585;-1.61919;0.026086956;0.095100276
GO BP;NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS;GO:0033866;63;-0.37641996;-1.6182882;0.003246753;0.09548245
GO BP;ATP DEPENDENT CHROMATIN REMODELING;GO:0043044;75;-0.35649973;-1.6182861;0.008264462;0.09515434
GO BP;REGULATION OF CHROMOSOME SEPARATION;GO:1905818;56;-0.38101003;-1.6179427;0.009803922;0.09507555
GO BP;REGULATION OF CELL MORPHOGENESIS;GO:0022604;354;-0.2870692;-1.615548;0;0.09652023
GO BP;PROTEIN SUMOYLATION;GO:0016925;69;-0.36059353;-1.6148614;0.00931677;0.09680365
GO BP;DOUBLE STRAND BREAK REPAIR;GO:0006302;213;-0.3033224;-1.614446;0;0.096755646
GO BP;POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME;GO:0048026;16;-0.5268282;-1.6137295;0.023026315;0.09694512
GO BP;MICROTUBULE BASED TRANSPORT;GO:0099111;155;-0.31839263;-1.613417;0;0.096849896
GO BP;REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY;GO:0050803;138;-0.32249218;-1.6116949;0;0.09772439
GO BP;POSITIVE REGULATION OF DNA METABOLIC PROCESS;GO:0051054;152;-0.31438196;-1.6107436;0;0.0981382
GO BP;POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS;GO:0044089;385;-0.28288662;-1.6079397;0;0.10012237
GO BP;POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT;GO:0010976;200;-0.30550605;-1.6077185;0;0.09996655
GO BP;DNA METHYLATION OR DEMETHYLATION;#N/A;72;-0.360222;-1.6068463;0.00617284;0.10032579
GO BP;REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS;#N/A;15;-0.5381073;-1.6058489;0.028419184;0.100639306
GO BP;POSITIVE REGULATION OF MRNA METABOLIC PROCESS;#N/A;64;-0.36778894;-1.6038346;0.016583748;0.101838976
GO BP;METHYLATION;GO:0032259;295;-0.28874335;-1.6037692;0.001430615;0.10154794
GO BP;REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III;GO:0006359;18;-0.4966772;-1.6034158;0.020833334;0.10149838
GO BP;POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL;#N/A;109;-0.3314404;-1.6015664;0.003159558;0.10261302
GO BP;CELL CELL JUNCTION ORGANIZATION;GO:0045216;133;-0.3227564;-1.5995607;0.00152207;0.10378111
GO BP;REGULATION OF DOUBLE STRAND BREAK REPAIR;GO:2000779;62;-0.3722214;-1.5993841;0.013582343;0.10362176
GO BP;NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT;#N/A;17;-0.511784;-1.5976951;0.02417962;0.10468556
GO BP;RECOMBINATIONAL REPAIR;GO:0000725;119;-0.32667956;-1.5976465;0.001569859;0.104387
GO BP;LYTIC VACUOLE ORGANIZATION;#N/A;54;-0.38759732;-1.5948901;0.011904762;0.106282294
GO BP;REGULATION OF MICROTUBULE DEPOLYMERIZATION;GO:0031114;26;-0.45897245;-1.5939944;0.018272426;0.10671074
GO BP;DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION;GO:0006271;17;-0.5106736;-1.5939238;0.02636204;0.10643148
GO BP;REGULATION OF CELL SHAPE;GO:0008360;117;-0.32515877;-1.591703;0.001589825;0.10788393
GO BP;CORONARY VASCULATURE DEVELOPMENT;GO:0060976;36;-0.41961178;-1.5917022;0.015384615;0.10754623
GO BP;DNA DEALKYLATION;#N/A;24;-0.45866176;-1.5907422;0.029462738;0.10808469
GO BP;REGULATION OF VESICLE FUSION;GO:0031338;21;-0.46708235;-1.5898657;0.035714287;0.108496815
GO BP;EPHRIN RECEPTOR SIGNALING PATHWAY;GO:0048013;71;-0.36066192;-1.5895779;0.010050251;0.10844661
GO BP;POSITIVE REGULATION OF MITOTIC CELL CYCLE;GO:0045931;127;-0.32120064;-1.5884675;0.004807693;0.10906933
GO BP;RNA SPLICING VIA TRANSESTERIFICATION REACTIONS;GO:0000375;310;-0.2853422;-1.5883664;0;0.108803384
GO BP;TELENCEPHALON DEVELOPMENT;GO:0021537;160;-0.30752203;-1.5881271;0.003025719;0.10868593
GO BP;ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME;#N/A;27;-0.44766378;-1.587553;0.027874565;0.108856514
GO BP;REGULATION OF AUTOPHAGY;GO:0010506;266;-0.28930283;-1.5853196;0.001481482;0.11038672
GO BP;NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE;#N/A;34;-0.41689557;-1.5848436;0.024752475;0.110458225
GO BP;REGULATION OF DENDRITIC SPINE DEVELOPMENT;GO:0060998;60;-0.36694914;-1.5839574;0.011456628;0.11095889
GO BP;DEMETHYLATION;GO:0070988;46;-0.38617802;-1.5835861;0.014876033;0.11095892
GO BP;RESPONSE TO AMINO ACID STARVATION;#N/A;43;-0.3904841;-1.5831271;0.006441224;0.111032866
GO BP;PROTEASOMAL PROTEIN CATABOLIC PROCESS;GO:0010498;414;-0.27728635;-1.5827855;0;0.110997446
GO BP;NEGATIVE REGULATION OF PROTEIN POLYMERIZATION;GO:0032272;54;-0.37511656;-1.5818887;0.015228426;0.11142911
GO BP;PROTEIN DESTABILIZATION;GO:0031648;43;-0.39287922;-1.5811524;0.02443281;0.111775294
GO BP;CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION;GO:0021953;96;-0.3310398;-1.5798578;0.007874016;0.11251241
GO BP;METAPHASE ANAPHASE TRANSITION OF CELL CYCLE;#N/A;52;-0.38045648;-1.5787404;0.02341137;0.1130662
GO BP;MAINTENANCE OF CELL NUMBER;#N/A;136;-0.31727308;-1.578678;0;0.11278486
GO BP;AXON DEVELOPMENT;GO:0061564;337;-0.27954632;-1.5784401;0;0.112621784
GO BP;PROTEIN TARGETING TO VACUOLE;GO:0006623;37;-0.41050678;-1.5768889;0.016155088;0.1136759
GO BP;GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE;GO:0061615;24;-0.46705568;-1.576363;0.015706806;0.11383739
GO BP;METAPHASE PLATE CONGRESSION;GO:0051310;54;-0.37547952;-1.5744466;0.011705685;0.11520728
GO BP;SNRNA METABOLIC PROCESS;GO:0016073;33;-0.42492747;-1.5735421;0.024647888;0.11572331
GO BP;DNA CONFORMATION CHANGE;GO:0071103;261;-0.2868716;-1.5725365;0.001485884;0.11621478
GO BP;REGULATION OF NEURON PROJECTION DEVELOPMENT;GO:0010975;346;-0.27711737;-1.5724;0;0.11604793
GO BP;RESPONSE TO MISFOLDED PROTEIN;GO:0051788;24;-0.46490154;-1.57162;0.012068966;0.1163116
GO BP;RECEPTOR BIOSYNTHETIC PROCESS;#N/A;16;-0.50759107;-1.5714105;0.039426524;0.11614472
GO BP;INTESTINAL ABSORPTION;GO:0050892;24;-0.4553862;-1.5710216;0.02389706;0.11614155
GO BP;PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL;GO:0070646;242;-0.29162315;-1.570964;0.001455604;0.11586989
GO BP;CHROMATIN ASSEMBLY OR DISASSEMBLY;GO:0006333;144;-0.31322166;-1.5709327;0.00317965;0.115572706
GO BP;DNA MODIFICATION;GO:0006304;93;-0.33516654;-1.57057;0.0032;0.115550555
GO BP;STRESS GRANULE ASSEMBLY;GO:0034063;19;-0.48698953;-1.5699588;0.027118644;0.11579294
GO BP;EPITHELIAL CELL DEVELOPMENT;GO:0002064;141;-0.3097469;-1.5696574;0.001547988;0.1156914
GO BP;LOCALIZATION WITHIN MEMBRANE;GO:0051668;61;-0.36384115;-1.5694193;0.015050167;0.11550965
GO BP;DENDRITIC CELL DIFFERENTIATION;GO:0097028;16;-0.5053983;-1.5693576;0.044802867;0.11522457
GO BP;DNA INTEGRITY CHECKPOINT;#N/A;145;-0.31076723;-1.5679474;0.001582279;0.11608798
GO BP;POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION;#N/A;117;-0.3210592;-1.5659746;0.004846527;0.117374614
GO BP;REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY;GO:0043244;88;-0.33937964;-1.5658673;0.004815409;0.11712308
GO BP;POSTSYNAPTIC MEMBRANE ORGANIZATION;GO:0001941;23;-0.44421566;-1.5652077;0.042881645;0.11729997
GO BP;FATTY ACYL COA BIOSYNTHETIC PROCESS;#N/A;27;-0.43839782;-1.5638752;0.029259896;0.11808798
GO BP;RESPONSE TO PLATELET DERIVED GROWTH FACTOR;GO:0036119;18;-0.49305564;-1.5638107;0.024875622;0.11782372
GO BP;PURINE NUCLEOSIDE METABOLIC PROCESS;GO:0042278;52;-0.36846507;-1.5638059;0.01650165;0.1175045
GO BP;IMPORT INTO NUCLEUS;GO:0051170;128;-0.3167439;-1.5615287;0.0016;0.119043134
GO BP;POSITIVE REGULATION OF AXON EXTENSION;GO:0045773;36;-0.40242618;-1.5611311;0.018900344;0.119090565
GO BP;REGULATION OF NEURON DIFFERENTIATION;GO:0045664;428;-0.27184546;-1.561012;0;0.11882643
GO BP;POSITIVE REGULATION OF MRNA PROCESSING;#N/A;26;-0.43834648;-1.5609446;0.025510205;0.118560396
GO BP;REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION;GO:0010769;214;-0.2920501;-1.559683;0.001485884;0.11934364
GO BP;RAS PROTEIN SIGNAL TRANSDUCTION;GO:0007265;341;-0.2766655;-1.5593115;0;0.11937961
GO BP;POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS;GO:0045723;15;-0.522373;-1.5588185;0.047957372;0.119597554
GO BP;MONOSACCHARIDE CATABOLIC PROCESS;#N/A;55;-0.36879185;-1.555707;0.020373514;0.12190872
GO BP;ORGANELLE FISSION;GO:0048285;369;-0.27562767;-1.555436;0;0.12176006
GO BP;REGULATION OF GLIOGENESIS;GO:0014013;66;-0.3540318;-1.5542688;0.015;0.12251279
GO BP;POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION;GO:0033138;63;-0.35735178;-1.554107;0.013289036;0.122309074
GO BP;POSTSYNAPSE ORGANIZATION;GO:0099173;112;-0.31959826;-1.5538375;0.006525286;0.12224113
GO BP;STEM CELL PROLIFERATION;GO:0072089;75;-0.34233746;-1.5537068;0.011182109;0.122048296
GO BP;ENDOCYTIC RECYCLING;GO:0032456;41;-0.39482853;-1.5523567;0.020654045;0.12289458
GO BP;TOR SIGNALING;GO:0031929;98;-0.33221346;-1.5517082;0.004746835;0.12308935
GO BP;PROTEIN K48 LINKED DEUBIQUITINATION;GO:0071108;30;-0.41673094;-1.551172;0.030874785;0.12327911
GO BP;POSITIVE REGULATION OF TOR SIGNALING;GO:0032008;29;-0.43018776;-1.5502621;0.02617801;0.12374654
GO BP;DNA DEMETHYLATION;GO:0080111;18;-0.49151492;-1.5501568;0.037996545;0.12351212
GO BP;ACTIN FILAMENT ORGANIZATION;GO:0007015;287;-0.28445137;-1.5495961;0;0.12371323
GO BP;POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT;GO:0010828;29;-0.4259383;-1.5495456;0.027027028;0.1234268
GO BP;ANTIGEN PROCESSING AND PRESENTATION;GO:0019882;165;-0.30370837;-1.5489132;0;0.12362878
GO BP;RESPONSE TO INTERLEUKIN 4;GO:0070670;23;-0.45357424;-1.5483706;0.033898305;0.123826854
GO BP;REGULATION OF CHROMATIN SILENCING;GO:0031935;31;-0.4244839;-1.54637;0.038194444;0.12533163
GO BP;VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE;#N/A;85;-0.33240607;-1.5462058;0.006410257;0.12515579
GO BP;PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION;#N/A;228;-0.2888965;-1.5458071;0.00295858;0.12523086
GO BP;INCLUSION BODY ASSEMBLY;GO:0070841;19;-0.48110718;-1.5456088;0.03898305;0.12510544
GO BP;DEVELOPMENTAL GROWTH;GO:0048589;439;-0.2700952;-1.545488;0;0.12486044
GO BP;RNA SPLICING;GO:0008380;388;-0.27400917;-1.5434042;0;0.12656811
GO BP;ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE;GO:0072666;42;-0.38755202;-1.5433202;0.014446228;0.12631157
GO BP;THIOESTER BIOSYNTHETIC PROCESS;#N/A;49;-0.37110823;-1.5432358;0.017452007;0.12606242
GO BP;MITOTIC CELL CYCLE CHECKPOINT;GO:0007093;149;-0.3073383;-1.542716;0.001574803;0.12618116
GO BP;REGULATION OF CENTROSOME DUPLICATION;GO:0010824;40;-0.3989122;-1.5426767;0.01980198;0.12590915
GO BP;PROTEIN DEMETHYLATION;GO:0006482;25;-0.45083404;-1.5409507;0.03898305;0.12718637
GO BP;RESPONSE TO EPIDERMAL GROWTH FACTOR;GO:0070849;40;-0.3886835;-1.5401794;0.024561403;0.12756397
GO BP;HISTONE H2A MONOUBIQUITINATION;GO:0035518;17;-0.5029007;-1.5398129;0.034234233;0.12758851
GO BP;NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING;#N/A;30;-0.41749457;-1.538869;0.029850746;0.12813902
GO BP;MORPHOGENESIS OF EMBRYONIC EPITHELIUM;GO:0016331;112;-0.31781662;-1.5385517;0.004815409;0.12808482
GO BP;CELLULAR EXTRAVASATION;GO:0045123;30;-0.41991714;-1.5384605;0.028764805;0.12786008
GO BP;REGULATION OF PROTEIN EXPORT FROM NUCLEUS;GO:0046825;35;-0.3937491;-1.537091;0.029209621;0.128894
GO BP;NEURONAL STEM CELL POPULATION MAINTENANCE;GO:0097150;19;-0.46800026;-1.5358734;0.03958692;0.12970708
GO BP;TOOTH MINERALIZATION;GO:0034505;15;-0.5058489;-1.533245;0.04659498;0.13188991
GO BP;AXO DENDRITIC TRANSPORT;GO:0008088;56;-0.3583754;-1.5322685;0.018581081;0.13255782
GO BP;CORTICAL CYTOSKELETON ORGANIZATION;GO:0030865;43;-0.37945575;-1.5321908;0.024;0.13230704
GO BP;IN UTERO EMBRYONIC DEVELOPMENT;GO:0001701;299;-0.27652797;-1.5321665;0;0.13201326
GO BP;PROTEIN LOCALIZATION TO VACUOLE;GO:0072665;56;-0.3637886;-1.5320687;0.022108844;0.13180329
GO BP;POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION;GO:1902751;28;-0.4225383;-1.5320055;0.024475524;0.1315386
GO BP;AMYLOID BETA CLEARANCE;GO:0097242;24;-0.4436732;-1.5307616;0.02529511;0.13239454
GO BP;CELL JUNCTION ASSEMBLY;GO:0034329;181;-0.29334584;-1.530543;0.001557632;0.13229896
GO BP;NEGATIVE REGULATION OF AUTOPHAGY;GO:0010507;62;-0.35414568;-1.529563;0.019900497;0.13289386
GO BP;CIRCADIAN REGULATION OF GENE EXPRESSION;GO:0032922;49;-0.37289533;-1.5286967;0.019966722;0.13353577
GO BP;NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS;GO:0032435;31;-0.4125469;-1.5282782;0.023608768;0.13362442
GO BP;ACTOMYOSIN STRUCTURE ORGANIZATION;GO:0031032;141;-0.30348957;-1.527026;0.00462963;0.13447545
GO BP;POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT;GO:0046824;56;-0.35876706;-1.526264;0.014900662;0.13485996
GO BP;MYOBLAST FUSION;GO:0007520;20;-0.46095553;-1.5260774;0.035472974;0.13469961
GO BP;RNA 3 END PROCESSING;#N/A;132;-0.31052452;-1.5238163;0.006069803;0.13664798
GO BP;CENTRIOLE ASSEMBLY;GO:0098534;35;-0.3999158;-1.5236951;0.032040473;0.1364554
GO BP;NEUROMUSCULAR JUNCTION DEVELOPMENT;GO:0007528;36;-0.4033055;-1.5234536;0.025996534;0.13637781
GO BP;POSITIVE REGULATION OF CELL CYCLE PROCESS;GO:0090068;230;-0.28317824;-1.5226969;0.00149925;0.13680176
GO BP;POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS;GO:1903052;101;-0.31899574;-1.5220548;0.017515924;0.13717817
GO BP;EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING;GO:0009792;470;-0.261125;-1.5214622;0;0.13739446
GO BP;LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL;#N/A;15;-0.5071852;-1.5211468;0.032986112;0.13737236
GO BP;POSITIVE REGULATION OF GTPASE ACTIVITY;GO:0043547;285;-0.2771287;-1.520742;0;0.13743137
GO BP;EPIBOLY;#N/A;27;-0.42674962;-1.520598;0.034246575;0.13726468
GO BP;FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY;GO:0008543;75;-0.3371806;-1.5204581;0.011608624;0.1370906
GO BP;DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS;GO:0060560;159;-0.2945927;-1.5202805;0.005788712;0.13695654
GO BP;POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION;GO:0045648;24;-0.43865916;-1.519287;0.039426524;0.13773122
GO BP;KINETOCHORE ASSEMBLY;GO:0051382;16;-0.4919881;-1.5189215;0.04570384;0.13773668
GO BP;CELL JUNCTION ORGANIZATION;#N/A;217;-0.28577825;-1.5188322;0.004531722;0.13749658
GO BP;RECEPTOR LOCALIZATION TO SYNAPSE;GO:0097120;36;-0.39389205;-1.5185491;0.04363002;0.13744894
GO BP;REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION;GO:0046578;181;-0.29102436;-1.5185206;0;0.13716651
GO BP;LIPID DROPLET ORGANIZATION;GO:0034389;16;-0.4936517;-1.5181376;0.0460177;0.13719775
GO BP;POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION;GO:1901989;81;-0.3285065;-1.5153028;0.01633987;0.13967465
GO BP;REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION;GO:0051056;257;-0.2802354;-1.5147078;0.001461988;0.13987483
GO BP;NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY;GO:0045744;22;-0.4504806;-1.5141165;0.05045045;0.14006855
GO BP;HIPPOCAMPUS DEVELOPMENT;GO:0021766;52;-0.36597174;-1.5137316;0.021311475;0.14019668
GO BP;MACROMOLECULE DEACYLATION;#N/A;87;-0.32455018;-1.5113523;0.009630819;0.14225383
GO BP;REGULATION OF SPINDLE ORGANIZATION;#N/A;37;-0.39778337;-1.5079093;0.03508772;0.14537217
GO BP;REGULATION OF PROTEIN TARGETING TO MEMBRANE;#N/A;27;-0.41977388;-1.5075451;0.047933884;0.14545357
GO BP;NUCLEUS ORGANIZATION;GO:0006997;104;-0.31512848;-1.5072913;0.00456621;0.14539212
GO BP;REGULATION OF PROTEIN POLYMERIZATION;#N/A;161;-0.29337958;-1.5067979;0.006060606;0.14563055
GO BP;REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS;GO:0042304;36;-0.39678124;-1.5065109;0.042402826;0.14559838
GO BP;CELL PROLIFERATION IN FOREBRAIN;GO:0021846;18;-0.46645695;-1.5052165;0.057894737;0.14661075
GO BP;REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY;GO:0060765;23;-0.43488878;-1.5046296;0.04007286;0.14687414
GO BP;POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION;GO:0032743;19;-0.46393815;-1.5035683;0.049382716;0.14770812
GO BP;CENTROSOME DUPLICATION;GO:0051298;62;-0.343026;-1.5025346;0.011128776;0.14844039
GO BP;CELL CYCLE G1 S PHASE TRANSITION;GO:0044843;219;-0.2801708;-1.5022815;0.00591716;0.1483839
GO BP;REGULATION OF ACTIN FILAMENT BASED PROCESS;GO:0032970;276;-0.27307144;-1.5020878;0.001510574;0.14826083
GO BP;TIGHT JUNCTION ORGANIZATION;GO:0120193;51;-0.35681012;-1.5014129;0.03076923;0.1486477
GO BP;GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT;GO:0043001;38;-0.38308436;-1.5012554;0.033444814;0.14845799
GO BP;INTERSTRAND CROSS LINK REPAIR;GO:0036297;50;-0.3639159;-1.5010921;0.019639935;0.14833769
GO BP;CELLULAR RESPONSE TO UV;GO:0034644;66;-0.34302315;-1.5006226;0.023140496;0.1484687
GO BP;REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR;GO:1901796;161;-0.28830546;-1.4991342;0.006289308;0.14967823
GO BP;NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT;GO:0046426;15;-0.49444;-1.4982826;0.059352517;0.15025552
GO BP;NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT;GO:1904893;15;-0.49444;-1.4974066;0.05818182;0.15081209
GO BP;EYE PHOTORECEPTOR CELL DEVELOPMENT;GO:0042462;18;-0.466944;-1.4972893;0.04467354;0.15059146
GO BP;POSITIVE REGULATION OF CELL CYCLE;GO:0045787;298;-0.27266943;-1.4968507;0.001470588;0.15069897
GO BP;POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION;#N/A;28;-0.42106503;-1.4964701;0.04537205;0.15078205
GO BP;NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS;#N/A;195;-0.28400177;-1.4964148;0;0.15053192
GO BP;SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION;GO:0007264;431;-0.25870562;-1.4953116;0;0.15152235
GO BP;LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS;GO:0035338;15;-0.4978085;-1.4949019;0.052083332;0.15163374
GO BP;MICROTUBULE ORGANIZING CENTER LOCALIZATION;#N/A;28;-0.41527826;-1.4944526;0.042031523;0.15171434
GO BP;REGULATION OF ACTIN FILAMENT ORGANIZATION;GO:0110053;185;-0.28222305;-1.4940492;0.005925926;0.15181486
GO BP;SOMATIC STEM CELL DIVISION;GO:0048103;18;-0.4695842;-1.4932297;0.05479452;0.15234658
GO BP;REGULATION OF MRNA PROCESSING;GO:0050684;122;-0.30529398;-1.4928361;0.01674277;0.15244038
GO BP;MAINTENANCE OF PROTEIN LOCATION;GO:0045185;87;-0.3242399;-1.4920722;0.014469453;0.15301189
GO BP;POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE;GO:0090314;23;-0.43227673;-1.4914486;0.04812834;0.15336423
GO BP;VENTRICULAR SYSTEM DEVELOPMENT;GO:0021591;21;-0.44209766;-1.4906651;0.0352349;0.15385382
GO BP;LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS;#N/A;20;-0.45096403;-1.4897729;0.05087719;0.15442576
GO BP;REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY;GO:1902175;22;-0.4473466;-1.4893953;0.048648648;0.15454467
GO BP;POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL;GO:0051281;16;-0.49667853;-1.4886804;0.05172414;0.15506722
GO BP;NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS;#N/A;124;-0.30258867;-1.4880008;0.001577287;0.1554562
GO BP;POST EMBRYONIC DEVELOPMENT;GO:0009791;71;-0.33529472;-1.487956;0.02310231;0.15516342
GO BP;REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL;GO:0010522;50;-0.3633209;-1.4878354;0.023178808;0.15498951
GO BP;TOXIN TRANSPORT;GO:1901998;33;-0.392314;-1.4874071;0.037037037;0.15509729
GO BP;CILIUM ORGANIZATION;GO:0044782;312;-0.26954722;-1.4872571;0;0.15492474
GO BP;RESPONSE TO TEMPERATURE STIMULUS;GO:0009266;176;-0.28293252;-1.4870157;0.013392857;0.15487519
GO BP;NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS;GO:0036475;19;-0.46357888;-1.4864908;0.060822897;0.15518253
GO BP;AMINO ACID ACTIVATION;#N/A;45;-0.3658606;-1.4863969;0.033333335;0.15498607
GO BP;ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION;GO:0040001;31;-0.3992271;-1.4854107;0.042031523;0.1556592
GO BP;REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY;#N/A;89;-0.31800157;-1.4848157;0.012678289;0.15596013
GO BP;POSITIVE REGULATION OF MRNA CATABOLIC PROCESS;GO:0061014;40;-0.38364613;-1.4846828;0.040885862;0.15577824
GO BP;ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN;GO:0048002;144;-0.2969697;-1.4830658;0.007800312;0.15726933
GO BP;RESPONSE TO GROWTH HORMONE;GO:0060416;23;-0.42763913;-1.4827458;0.049833886;0.15731649
GO BP;RESPONSE TO MITOCHONDRIAL DEPOLARISATION;GO:0098780;19;-0.44901136;-1.482536;0.07005254;0.15722401
GO BP;PROTEIN LOCALIZATION TO CELL PERIPHERY;#N/A;254;-0.27134734;-1.482531;0.003030303;0.1569109
GO BP;ANDROGEN RECEPTOR SIGNALING PATHWAY;GO:0030521;51;-0.35983026;-1.4823605;0.038800705;0.15679936
GO BP;PROTEIN POLYMERIZATION;GO:0051258;208;-0.2773538;-1.4818252;0.001506024;0.15711178
GO BP;SELECTIVE AUTOPHAGY;GO:0061912;45;-0.37289295;-1.4818145;0.03372681;0.15679578
GO BP;RIBONUCLEOSIDE METABOLIC PROCESS;#N/A;52;-0.3519275;-1.4804797;0.028333334;0.15797244
GO BP;CEREBRAL CORTEX DEVELOPMENT;GO:0021987;84;-0.3269655;-1.4795732;0.023372287;0.1586821
GO BP;PROTEIN FOLDING;GO:0006457;180;-0.28583574;-1.4786817;0.00295421;0.15931873
GO BP;ACTIN CYTOSKELETON REORGANIZATION;GO:0031532;80;-0.3251037;-1.4768769;0.026936026;0.16110279
GO BP;PROTEOGLYCAN METABOLIC PROCESS;GO:0006029;58;-0.34595546;-1.4762357;0.028052805;0.16150413
GO BP;PROTEIN REFOLDING;GO:0042026;30;-0.40132174;-1.4760818;0.054145515;0.16134179
GO BP;DNA RECOMBINATION;GO:0006310;235;-0.27490327;-1.4751892;0;0.16205801
GO BP;NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION;GO:0030837;43;-0.37061965;-1.4747639;0.031666666;0.16225211
GO BP;DNA METHYLATION;GO:0006306;58;-0.3436669;-1.4745245;0.031719532;0.16221619
GO BP;ESTABLISHMENT OF SPINDLE ORIENTATION;GO:0051294;32;-0.3952786;-1.474444;0.03786575;0.1619727
GO BP;TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR;GO:0006283;70;-0.34093815;-1.4741279;0.029411765;0.16196355
GO BP;RESPONSE TO FIBROBLAST GROWTH FACTOR;GO:0071774;95;-0.31598017;-1.4738641;0.014705882;0.1619096
GO BP;MITOTIC CHROMOSOME CONDENSATION;GO:0007076;16;-0.48040885;-1.4737619;0.04886562;0.16172282
GO BP;INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY;GO:0035735;39;-0.3739735;-1.4731238;0.028021015;0.16209841
GO BP;NEGATIVE REGULATION OF MRNA METABOLIC PROCESS;#N/A;68;-0.33371717;-1.4730728;0.020168068;0.16182917
GO BP;NEUROTROPHIN SIGNALING PATHWAY;GO:0038179;27;-0.41582447;-1.4729668;0.048739497;0.16164629
GO BP;PROTEIN AUTOUBIQUITINATION;GO:0051865;61;-0.34257284;-1.4725373;0.036020584;0.16179094
GO BP;IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE;GO:0036498;60;-0.34085664;-1.4703065;0.02388535;0.16418996
GO BP;CHAPERONE MEDIATED PROTEIN FOLDING;GO:0061077;52;-0.35337934;-1.470086;0.022260275;0.16410601
GO BP;REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY;GO:0048169;15;-0.49053374;-1.4683651;0.06620209;0.16570301
GO BP;MITOTIC CYTOKINETIC PROCESS;GO:1902410;23;-0.43125722;-1.4683157;0.04385965;0.16542287
GO BP;NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION;GO:1902532;375;-0.2592614;-1.4682285;0;0.1652119
GO BP;INTRACELLULAR RECEPTOR SIGNALING PATHWAY;GO:0030522;203;-0.2764978;-1.4668447;0.003016591;0.16641319
GO BP;NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS;GO:0009132;123;-0.29842186;-1.4666965;0.011182109;0.16623992
GO BP;INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY;GO:0030518;102;-0.30834854;-1.4664402;0.018808777;0.16619962
GO BP;REGULATION OF VIRAL GENOME REPLICATION;GO:0045069;64;-0.34440786;-1.4657184;0.032367975;0.16668692
GO BP;REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY;GO:0030947;23;-0.4255778;-1.4651047;0.053540587;0.1670896
GO BP;REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL;GO:0051279;40;-0.37581226;-1.4638996;0.030664396;0.16805087
GO BP;NUCLEOTIDE PHOSPHORYLATION;GO:0046939;105;-0.3037014;-1.4636348;0.012519562;0.16804416
GO BP;RESPONSE TO AUDITORY STIMULUS;GO:0010996;15;-0.487743;-1.4635829;0.05903399;0.16776896
GO BP;REGULATION OF NEURON MIGRATION;GO:2001222;24;-0.42240584;-1.4630858;0.05762712;0.16805428
GO BP;REGULATION OF NUCLEAR DIVISION;#N/A;153;-0.28724736;-1.462681;0.00621118;0.16818476
GO BP;RESPONSE TO UV;GO:0009411;116;-0.30294332;-1.4622161;0.016129032;0.1683554
GO BP;TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY;GO:0070897;34;-0.38702536;-1.4616945;0.0502693;0.16862227
GO BP;REGULATION OF TELOMERE MAINTENANCE;GO:0032204;75;-0.33022478;-1.4614711;0.018404908;0.1685487
GO BP;KINETOCHORE ORGANIZATION;GO:0051383;21;-0.42574066;-1.4609615;0.05756579;0.16880842
GO BP;REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL;#N/A;189;-0.27807498;-1.4607561;0.003081664;0.16870287
GO BP;REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION;GO:2000177;56;-0.34332177;-1.4607006;0.031353135;0.16843519
GO BP;NEURON PROJECTION EXTENSION;GO:1990138;117;-0.30040345;-1.4595836;0.009756098;0.16957332
GO BP;REGULATION OF TRANSMEMBRANE TRANSPORT;#N/A;276;-0.266148;-1.4583788;0;0.17059727
GO BP;MONOCARBOXYLIC ACID METABOLIC PROCESS;GO:0032787;453;-0.25290963;-1.4569945;0.001362398;0.17196366
GO BP;RESPONSE TO ZINC ION;GO:0010043;23;-0.42733926;-1.4566026;0.04770318;0.17207782
GO BP;NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC;GO:0000291;35;-0.38055384;-1.4565529;0.04385965;0.17180161
GO BP;SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT;GO:0072395;66;-0.32418653;-1.4553784;0.02341137;0.172854
GO BP;HEAD MORPHOGENESIS;GO:0060323;30;-0.39911512;-1.4553434;0.06132879;0.17257081
GO BP;REGULATION OF LYASE ACTIVITY;#N/A;18;-0.45592928;-1.4553419;0.06481481;0.17224866
GO BP;ACTIN POLYMERIZATION OR DEPOLYMERIZATION;GO:0008154;147;-0.28767878;-1.4537332;0.01399689;0.17393933
GO BP;FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY;GO:0002431;66;-0.33401543;-1.4532882;0.019704433;0.1741283
GO BP;NEGATIVE REGULATION OF MAPK CASCADE;GO:0043409;125;-0.29325584;-1.4528826;0.024390243;0.17427403
GO BP;GLUCOSE 6 PHOSPHATE METABOLIC PROCESS;GO:0051156;20;-0.44826147;-1.45239;0.06677797;0.17453673
GO BP;CRANIAL SKELETAL SYSTEM DEVELOPMENT;GO:1904888;43;-0.36251292;-1.4510292;0.044444446;0.17588557
GO BP;REGULATION OF GTPASE ACTIVITY;GO:0043087;341;-0.25926572;-1.4502838;0;0.17649549
GO BP;REGULATION OF DEPHOSPHORYLATION;GO:0035303;164;-0.27899703;-1.449308;0.007633588;0.17732772
GO BP;RESPONSE TO ENDOPLASMIC RETICULUM STRESS;GO:0034976;243;-0.26735654;-1.448027;0.011444922;0.17857459
GO BP;CELL CYCLE DNA REPLICATION;#N/A;59;-0.3380543;-1.4478859;0.025641026;0.17845683
GO BP;POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER;GO:0032968;17;-0.46312642;-1.4456714;0.0742115;0.18099527
GO BP;VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS;#N/A;41;-0.36298767;-1.4456352;0.048172757;0.18071198
GO BP;POSITIVE REGULATION OF VIRAL LIFE CYCLE;GO:1903902;53;-0.34569064;-1.445456;0.035947714;0.18061878
GO BP;POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION;GO:0031346;284;-0.26161352;-1.445365;0.005730659;0.18038969
GO BP;SYNCYTIUM FORMATION;GO:0006949;29;-0.3974763;-1.4448452;0.050933786;0.18074872
GO BP;INTRACILIARY TRANSPORT;GO:0042073;47;-0.3567759;-1.4447409;0.03502627;0.18054584
GO BP;RESPONSE TO SALT STRESS;GO:0009651;17;-0.45633534;-1.444542;0.055077452;0.18045628
GO BP;DNA UNWINDING INVOLVED IN DNA REPLICATION;GO:0006268;15;-0.47850066;-1.4430885;0.08289242;0.18193121
GO BP;REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY;GO:0032878;23;-0.42253298;-1.4428998;0.0625;0.18188259
GO BP;RAB PROTEIN SIGNAL TRANSDUCTION;GO:0032482;60;-0.3361759;-1.4421365;0.04118616;0.18248577
GO BP;MACROAUTOPHAGY;GO:0016236;260;-0.26454526;-1.4415874;0.009188362;0.18284158
GO BP;NEGATIVE REGULATION OF CELL CYCLE PROCESS;#N/A;276;-0.26301947;-1.4414704;0.002994012;0.1826692
GO BP;INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY;GO:0048009;21;-0.42676973;-1.4406644;0.05944056;0.18332598
GO BP;NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION;#N/A;205;-0.2719773;-1.4402614;0.016296295;0.18343745
GO BP;POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH;GO:0040018;17;-0.464206;-1.4401431;0.07706093;0.18325423
GO BP;POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS;GO:2001022;80;-0.3173861;-1.4400519;0.023217248;0.1830507
GO BP;REGULATION OF PROTEIN ACETYLATION;#N/A;54;-0.3479037;-1.4362996;0.03284072;0.18734555
GO BP;MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE;#N/A;34;-0.37088722;-1.4362638;0.054237287;0.18703577
GO BP;ARTERY DEVELOPMENT;GO:0060840;61;-0.33257565;-1.4359348;0.02698145;0.18708093
GO BP;DEVELOPMENTAL CELL GROWTH;GO:0048588;152;-0.2841997;-1.4357864;0.01754386;0.18691216
GO BP;CARBOHYDRATE CATABOLIC PROCESS;GO:0016052;157;-0.2804878;-1.4352586;0.012345679;0.18724929
GO BP;PROTEIN POLYUBIQUITINATION;GO:0000209;262;-0.26077566;-1.4345813;0.007407407;0.18779112
GO BP;DNA DOUBLE STRAND BREAK PROCESSING;GO:0000729;22;-0.42385545;-1.434557;0.057894737;0.18747492
GO BP;POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS;GO:0045923;22;-0.41991165;-1.4344738;0.062836625;0.18725634
GO BP;RENAL FILTRATION;GO:0097205;15;-0.47459444;-1.4329383;0.07650273;0.18892509
GO BP;COENZYME BIOSYNTHETIC PROCESS;#N/A;124;-0.28851032;-1.4323965;0.0192;0.18927297
GO BP;REGULATION OF MRNA METABOLIC PROCESS;#N/A;273;-0.25784433;-1.4321203;0.001468429;0.18930027
GO BP;POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS;GO:0046827;20;-0.43273723;-1.4318051;0.08483755;0.189348
GO BP;POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR;GO:2000781;25;-0.40756643;-1.4316812;0.07649254;0.18915689
GO BP;ACTIN FILAMENT BUNDLE ORGANIZATION;GO:0061572;120;-0.2960149;-1.4316158;0.02183406;0.18892314
GO BP;REGULATION OF DNA REPLICATION;GO:0006275;90;-0.31028572;-1.430263;0.032733224;0.19022153
GO BP;POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL;GO:0010524;21;-0.4332979;-1.429995;0.07553957;0.1901998
GO BP;PROCESS UTILIZING AUTOPHAGIC MECHANISM;#N/A;411;-0.25052887;-1.4297211;0.001388889;0.19018601
GO BP;NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS;GO:1901799;47;-0.35314885;-1.4286163;0.052013423;0.19114113
GO BP;REGULATION OF MRNA 3 END PROCESSING;#N/A;28;-0.39643544;-1.4285716;0.07917384;0.19087888
GO BP;REGULATION OF SISTER CHROMATID COHESION;GO:0007063;22;-0.4178177;-1.4279149;0.08695652;0.1913791
GO BP;REGULATION OF MRNA CATABOLIC PROCESS;#N/A;165;-0.27646062;-1.4277428;0.01993865;0.19126733
GO BP;NUCLEAR ENVELOPE REASSEMBLY;GO:0031468;17;-0.46017876;-1.4272878;0.076241136;0.19149832
GO BP;REGULATION OF PROTEIN OLIGOMERIZATION;#N/A;22;-0.42527497;-1.4263529;0.05604203;0.19240142
GO BP;NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE;#N/A;36;-0.36933693;-1.4259443;0.045302015;0.19256097
GO BP;RESPONSE TO IONIZING RADIATION;GO:0010212;125;-0.29161263;-1.4255092;0.010920437;0.19270864
GO BP;ENDOSOME TO LYSOSOME TRANSPORT;GO:0008333;48;-0.35125723;-1.4253738;0.062184874;0.19254035
GO BP;REGULATION OF STEM CELL PROLIFERATION;GO:0072091;43;-0.35418782;-1.4248654;0.04326123;0.19287343
GO BP;RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS;#N/A;41;-0.3607816;-1.4240991;0.05087719;0.19354348
GO BP;POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION;GO:0010822;95;-0.2997589;-1.4235667;0.024390243;0.19393273
GO BP;NEGATIVE REGULATION OF CATABOLIC PROCESS;GO:0009895;231;-0.26532772;-1.4226911;0.004316547;0.1947107
GO BP;TRANSCRIPTION BY RNA POLYMERASE I;GO:0006360;59;-0.33562157;-1.4224652;0.043551087;0.19469923
GO BP;GLIAL CELL MIGRATION;GO:0008347;34;-0.37411654;-1.4211657;0.06185567;0.19600494
GO BP;BLASTOCYST GROWTH;GO:0001832;17;-0.46104434;-1.4205346;0.0884808;0.1965699
GO BP;REGULATION OF CELL PROJECTION ORGANIZATION;GO:0031344;491;-0.24399164;-1.4205247;0.00135318;0.19624123
GO BP;PROTEIN MONOUBIQUITINATION;GO:0006513;66;-0.3223681;-1.420502;0.031719532;0.19593373
GO BP;MITOTIC METAPHASE PLATE CONGRESSION;GO:0007080;42;-0.3557086;-1.4203023;0.049913943;0.19586296
GO BP;LAMELLIPODIUM MORPHOGENESIS;GO:0072673;15;-0.46060547;-1.4201505;0.087114334;0.19570467
GO BP;INTRA GOLGI VESICLE MEDIATED TRANSPORT;GO:0006891;28;-0.39277586;-1.4194696;0.075134166;0.19626212
GO BP;REGULATION OF DNA METABOLIC PROCESS;#N/A;276;-0.2588386;-1.4189832;0.004261364;0.19654688
GO BP;POSITIVE REGULATION OF DEVELOPMENTAL GROWTH;GO:0048639;108;-0.2922443;-1.4185679;0.022580646;0.19676512
GO BP;REGULATION OF PROTEIN HOMODIMERIZATION ACTIVITY;#N/A;15;-0.4643248;-1.4183859;0.09913044;0.19668756
GO BP;RRNA MODIFICATION;GO:0000154;33;-0.38256896;-1.4181252;0.067880794;0.19669285
GO BP;AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS;GO:0042987;38;-0.3615354;-1.4180473;0.055462185;0.19647366
GO BP;REGULATION OF CELL CYCLE G1 S PHASE TRANSITION;GO:1902806;138;-0.28556627;-1.4173766;0.024615385;0.19699295
GO BP;PEROXISOMAL MEMBRANE TRANSPORT;#N/A;16;-0.4570691;-1.4170039;0.07205624;0.19715177
GO BP;CLATHRIN COAT ASSEMBLY;GO:0048268;15;-0.48002523;-1.4167664;0.07992895;0.19717802
GO BP;DNA DEPENDENT DNA REPLICATION;GO:0006261;136;-0.2845756;-1.4163411;0.017080745;0.19743547
GO BP;TISSUE MIGRATION;#N/A;206;-0.2677187;-1.4161423;0.00625;0.197344
GO BP;CELLULAR RESPONSE TO AMINO ACID STIMULUS;GO:0071230;55;-0.32949442;-1.4151391;0.06013746;0.19829436
GO BP;POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE;GO:1900087;31;-0.38047093;-1.4145688;0.056140352;0.19876339
GO BP;REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC;GO:0032228;15;-0.46348178;-1.4131244;0.09549549;0.2003613
GO BP;REGULATION OF NEURONAL SYNAPTIC PLASTICITY;GO:0048168;28;-0.3914404;-1.4130899;0.0754717;0.20007698
GO BP;REGULATION OF CELL DIVISION;GO:0051302;113;-0.29126644;-1.413003;0.029874213;0.19986974
GO BP;ENDOSOME ORGANIZATION;GO:0007032;71;-0.31662753;-1.4119207;0.04707792;0.20093034
GO BP;POSITIVE REGULATION OF AUTOPHAGY;GO:0010508;103;-0.30136716;-1.4117286;0.04;0.20084468
GO BP;SENSORY SYSTEM DEVELOPMENT;GO:0048880;230;-0.2624959;-1.4099861;0.004418262;0.20282029
GO BP;POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION;GO:0010575;18;-0.43477267;-1.4096377;0.09671533;0.20294358
GO BP;REGULATION OF ERYTHROCYTE DIFFERENTIATION;GO:0045646;35;-0.3741005;-1.409306;0.07224959;0.20303008
GO BP;DOPAMINERGIC NEURON DIFFERENTIATION;GO:0071542;19;-0.42816666;-1.408613;0.092819616;0.20365104
GO BP;RETROGRADE TRANSPORT ENDOSOME TO GOLGI;GO:0042147;73;-0.31437132;-1.4069756;0.040677965;0.20546804
GO BP;SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR;GO:0072331;235;-0.2583954;-1.4068792;0.013254787;0.20527923
GO BP;RESPONSE TO INTERFERON GAMMA;GO:0034341;104;-0.2939778;-1.4066784;0.032310177;0.20523661
GO BP;SERTOLI CELL DIFFERENTIATION;GO:0060008;15;-0.47098342;-1.4057264;0.08084358;0.20620164
GO BP;MULTI ORGANISM LOCALIZATION;#N/A;53;-0.33803442;-1.4056132;0.053140096;0.20600624
GO BP;REGULATION OF FATTY ACID METABOLIC PROCESS;GO:0019217;65;-0.32175985;-1.4055338;0.042975206;0.2057703
GO BP;PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY;GO:0048008;47;-0.34378165;-1.4042119;0.051666666;0.20721495
GO BP;POSITIVE REGULATION OF GLIOGENESIS;GO:0014015;38;-0.36179864;-1.4038976;0.07067138;0.20729306
GO BP;CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION;#N/A;93;-0.29667497;-1.403163;0.038961038;0.20792148
GO BP;REGULATION OF ION TRANSMEMBRANE TRANSPORT;GO:0034765;218;-0.2620492;-1.4021006;0.004418262;0.20900077
GO BP;REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY;GO:2000810;18;-0.44432515;-1.4020175;0.06405694;0.20878449
GO BP;REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE;GO:1900101;23;-0.41327485;-1.4019028;0.07706422;0.2086008
GO BP;NEURAL TUBE DEVELOPMENT;GO:0021915;132;-0.28312403;-1.4010719;0.031045752;0.20939621
GO BP;ESTABLISHMENT OF LOCALIZATION IN CELL;GO:0051649;392;-0.24748385;-1.4006354;0.004195804;0.20969364
GO BP;ENDOSOMAL TRANSPORT;GO:0016197;200;-0.26696128;-1.4004476;0.017883755;0.20957923
GO BP;REGULATION OF NUCLEOTIDE METABOLIC PROCESS;#N/A;85;-0.30758867;-1.4000899;0.038034864;0.20973328
GO BP;POSITIVE REGULATION OF CELL DIVISION;GO:0051781;48;-0.34420347;-1.3995054;0.05612245;0.21026176
GO BP;BETA CATENIN TCF COMPLEX ASSEMBLY;#N/A;27;-0.38851687;-1.3993604;0.07890223;0.21012352
GO BP;REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT;GO:0010827;53;-0.33197454;-1.3991009;0.06779661;0.21013382
GO BP;MEMBRANE BIOGENESIS;GO:0044091;27;-0.39060342;-1.3986639;0.087030716;0.21040674
GO BP;REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY;GO:0032231;72;-0.31471416;-1.3972877;0.043624163;0.21200329
GO BP;REGULATION OF PEPTIDYL LYSINE ACETYLATION;#N/A;44;-0.34836942;-1.3971573;0.06878307;0.21184912
GO BP;VESICLE TARGETING;GO:0006903;80;-0.30434996;-1.3971034;0.0288;0.21158987
GO BP;REGULATION OF GLIAL CELL DIFFERENTIATION;#N/A;36;-0.36502218;-1.3961897;0.052542374;0.21249795
GO BP;NEGATIVE REGULATION OF DNA REPLICATION;GO:0008156;30;-0.37908396;-1.3960658;0.0713073;0.21237692
GO BP;RESPONSE TO RADIATION;GO:0009314;314;-0.24832733;-1.3955529;0.009957326;0.21269843
GO BP;NEGATIVE REGULATION OF MITOTIC CELL CYCLE;GO:0045930;262;-0.25159886;-1.3944596;0.007256894;0.21394448
GO BP;POSITIVE REGULATION OF TRANSLATIONAL INITIATION;GO:0045948;21;-0.41606694;-1.393583;0.09123435;0.21485314
GO BP;ANATOMICAL STRUCTURE MATURATION;#N/A;100;-0.29544556;-1.3931699;0.037459284;0.21510805
GO BP;DOSAGE COMPENSATION;GO:0007549;18;-0.43668866;-1.3913685;0.08506945;0.2173043
GO BP;POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT;#N/A;105;-0.2904539;-1.3898013;0.03257329;0.21922454
GO BP;POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION;GO:1902808;39;-0.35506925;-1.3890814;0.07401033;0.21997207
GO BP;POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION;GO:0032786;30;-0.37655914;-1.3884208;0.07236842;0.22059347
GO BP;ENDODERM DEVELOPMENT;GO:0007492;56;-0.32866028;-1.3878407;0.052810904;0.2211035
GO BP;REGULATION OF DNA METHYLATION;GO:0044030;21;-0.41869453;-1.3855977;0.088541664;0.22392792
GO BP;ADIPOSE TISSUE DEVELOPMENT;GO:0060612;31;-0.3727169;-1.3851489;0.08571429;0.22423428
GO BP;AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS;GO:0042982;52;-0.32655707;-1.3847228;0.069846675;0.22445253
GO BP;HISTONE H4 K5 ACETYLATION;GO:0043981;16;-0.4409063;-1.3837339;0.096885815;0.22556613
GO BP;REGULATION OF AXONOGENESIS;GO:0050770;126;-0.28032136;-1.3824581;0.042789225;0.22700882
GO BP;NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY;GO:0031333;100;-0.29611897;-1.3824191;0.041322313;0.2267261
GO BP;REGULATION OF CELL MATRIX ADHESION;GO:0001952;82;-0.3077549;-1.3822781;0.047393367;0.22657776
GO BP;PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II;#N/A;32;-0.36459577;-1.3821789;0.079566;0.2263918
GO BP;LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE;#N/A;20;-0.41518116;-1.3821408;0.10564663;0.22610073
GO BP;VISUAL BEHAVIOR;GO:0007632;28;-0.38154814;-1.3814459;0.09122203;0.22671175
GO BP;REGULATION OF RESPONSE TO OXIDATIVE STRESS;GO:1902882;63;-0.32340693;-1.3814169;0.07108239;0.22640806
GO BP;GOLGI VESICLE BUDDING;GO:0048194;69;-0.3138813;-1.3792987;0.041736227;0.22912298
GO BP;FACE DEVELOPMENT;GO:0060324;39;-0.3593479;-1.3789434;0.08305648;0.22927915
GO BP;VESICLE DOCKING;GO:0048278;55;-0.33299527;-1.3789225;0.060913704;0.22895887
GO BP;3 UTR MEDIATED MRNA STABILIZATION;#N/A;16;-0.45502543;-1.3784658;0.100682594;0.22925597
GO BP;NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS;GO:0042177;106;-0.2910864;-1.3777943;0.036858976;0.22983517
GO BP;REPLICATION FORK PROCESSING;GO:0031297;31;-0.3765515;-1.3776937;0.08916084;0.22963804
GO BP;GENETIC IMPRINTING;GO:0071514;23;-0.4076663;-1.3750424;0.0929432;0.23308936
GO BP;CELL PROJECTION ASSEMBLY;GO:0030031;455;-0.23689069;-1.3749832;0.009681881;0.2328278
GO BP;REGULATION OF RESPONSE TO INTERFERON GAMMA;GO:0060330;16;-0.449565;-1.3749024;0.11130742;0.2326056
GO BP;RESPONSE TO ANTINEOPLASTIC AGENT;#N/A;75;-0.30515563;-1.3734406;0.0464716;0.23438649
GO BP;SNARE COMPLEX ASSEMBLY;GO:0035493;17;-0.43963525;-1.3733793;0.10409556;0.23414697
GO BP;PHOTORECEPTOR CELL DEVELOPMENT;GO:0042461;24;-0.40099502;-1.3726304;0.121317156;0.23485045
GO BP;CHROMOSOME CONDENSATION;GO:0030261;36;-0.35628742;-1.3720652;0.08;0.23534061
GO BP;DNA STRAND ELONGATION;GO:0022616;24;-0.394306;-1.3720003;0.093959734;0.23508823
GO BP;REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION;GO:2000142;27;-0.38377976;-1.3703905;0.098827474;0.23715176
GO BP;ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY;GO:0061339;17;-0.43565625;-1.3693649;0.091065295;0.2383452
GO BP;REGULATION OF CELL SIZE;GO:0008361;133;-0.27322417;-1.3687085;0.02488336;0.23896533
GO BP;BODY MORPHOGENESIS;GO:0010171;41;-0.34949064;-1.368283;0.07583774;0.23923519
GO BP;POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY;GO:0010592;16;-0.44293177;-1.3679616;0.10834814;0.23936243
GO BP;CELLULAR RESPONSE TO ALCOHOL;#N/A;52;-0.33298725;-1.3664857;0.078464106;0.2412396
GO BP;REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS;#N/A;16;-0.44260937;-1.3652568;0.10142349;0.24269462
GO BP;EMBRYONIC CRANIAL SKELETON MORPHOGENESIS;GO:0048701;29;-0.37644872;-1.3649223;0.10387324;0.24280332
GO BP;NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY;GO:0048011;21;-0.4077073;-1.3645996;0.114035085;0.24293676
GO BP;REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH;#N/A;46;-0.3387587;-1.3636955;0.06521739;0.24386948
GO BP;AXON EXTENSION;GO:0048675;92;-0.28775123;-1.3627748;0.061461795;0.24484862
GO BP;REGULATION OF MUSCLE CELL DIFFERENTIATION;GO:0051147;98;-0.29018894;-1.3622715;0.037398376;0.24527325
GO BP;RNA MODIFICATION;GO:0009451;136;-0.27310506;-1.3622525;0.03645008;0.2449494
GO BP;REGULATION OF DNA RECOMBINATION;GO:0000018;79;-0.29855308;-1.3620774;0.06514658;0.24486859
GO BP;HISTONE H3 K4 TRIMETHYLATION;GO:0080182;16;-0.43500113;-1.3615589;0.12414966;0.24531275
GO BP;REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES;GO:1901031;24;-0.39537203;-1.3615125;0.10106383;0.24503829
GO BP;POSITIVE REGULATION OF JUN KINASE ACTIVITY;GO:0043507;53;-0.3223427;-1.360678;0.07258064;0.24595965
GO BP;NEGATIVE REGULATION OF ATP METABOLIC PROCESS;#N/A;18;-0.42131445;-1.3600742;0.116071425;0.24661687
GO BP;RESPONSE TO GROWTH FACTOR;GO:0070848;492;-0.2323424;-1.3596623;0.001412429;0.24692193
GO BP;NUCLEOTIDE EXCISION REPAIR DNA INCISION 3 TO LESION;#N/A;21;-0.40757033;-1.3595831;0.09380531;0.24669458
GO BP;NATURAL KILLER CELL MEDIATED IMMUNITY;#N/A;22;-0.3993773;-1.3588928;0.1033275;0.24746929
GO BP;REPRODUCTIVE SYSTEM DEVELOPMENT;GO:0061458;297;-0.24538435;-1.3588312;0.008810572;0.24718702
GO BP;PEPTIDYL SERINE MODIFICATION;#N/A;228;-0.25236478;-1.358351;0.017910447;0.24759589
GO BP;GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS;#N/A;35;-0.35686612;-1.3582104;0.08967851;0.24745199
GO BP;REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER;#N/A;20;-0.41404453;-1.358103;0.11681416;0.24727939
GO BP;REGULATION OF ATP METABOLIC PROCESS;GO:1903578;96;-0.2856427;-1.3579187;0.041533545;0.24720491
GO BP;VESICLE DOCKING INVOLVED IN EXOCYTOSIS;GO:0006904;38;-0.346141;-1.357918;0.08460237;0.24685276
GO BP;ASTROCYTE DIFFERENTIATION;GO:0048708;40;-0.349006;-1.3573855;0.08580858;0.24730211
GO BP;NEGATIVE REGULATION OF MAP KINASE ACTIVITY;GO:0043407;55;-0.32438728;-1.3570976;0.090756305;0.24737626
GO BP;NON MOTILE CILIUM ASSEMBLY;GO:1905515;49;-0.333969;-1.3568455;0.07692308;0.2474014
GO BP;REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION;GO:0033135;88;-0.29465732;-1.3565567;0.044481054;0.24746117
GO BP;NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION;GO:0000715;22;-0.40527457;-1.3558257;0.12169312;0.24818271
GO BP;ORGANELLE FUSION;GO:0048284;100;-0.28554052;-1.3557526;0.040849674;0.24792926
GO BP;RECEPTOR CLUSTERING;GO:0043113;37;-0.3584155;-1.355549;0.10745234;0.2479053
GO BP;MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS;#N/A;154;-0.26838386;-1.3546684;0.025437202;0.24893251
GO BP;GENE SILENCING;GO:0016458;230;-0.25143343;-1.354267;0.016491754;0.24918815
GO BP;POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION;GO:2000179;30;-0.36739442;-1.3527483;0.09240924;0.2512514
GO BP;POSITIVE REGULATION OF TELOMERE MAINTENANCE;GO:0032206;46;-0.33562487;-1.3524408;0.093023255;0.25138915
GO BP;POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS;GO:1900078;17;-0.4284599;-1.3524001;0.13787085;0.2511099
GO BP;ORGANELLE TRANSPORT ALONG MICROTUBULE;GO:0072384;72;-0.30029517;-1.3518163;0.067434214;0.25160486
GO BP;PROTEIN LOCALIZATION TO GOLGI APPARATUS;GO:0034067;24;-0.3893213;-1.3509554;0.10732538;0.252651
GO BP;NEGATIVE REGULATION OF RNA CATABOLIC PROCESS;GO:1902369;48;-0.32739082;-1.3498486;0.073529415;0.25393713
GO BP;REGULATION OF CILIUM ASSEMBLY;GO:1902017;46;-0.3338188;-1.3497765;0.08173077;0.25371343
GO BP;MRNA SPLICE SITE SELECTION;GO:0006376;28;-0.3776328;-1.34751;0.098615915;0.25692618
GO BP;PROTEIN LOCALIZATION TO PLASMA MEMBRANE;GO:0072659;217;-0.25426173;-1.347388;0.01923077;0.25678343
GO BP;REGULATION OF PHOSPHATASE ACTIVITY;GO:0010921;135;-0.26593357;-1.3468077;0.029366305;0.25721297
GO BP;REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY;GO:0050856;26;-0.383979;-1.3465606;0.114285715;0.2572949
GO BP;NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION;GO:2000104;18;-0.4235426;-1.3460718;0.12820514;0.25778016
GO BP;NEGATIVE REGULATION OF DEPHOSPHORYLATION;GO:0035305;86;-0.2953839;-1.3454671;0.06446541;0.25839487
GO BP;MODIFICATION OF POSTSYNAPTIC STRUCTURE;GO:0099010;16;-0.4465505;-1.3444984;0.14335664;0.25956735
GO BP;REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT;#N/A;15;-0.44221833;-1.3442792;0.11481482;0.25953433
GO BP;POSITIVE REGULATION OF CELL GROWTH;GO:0030307;118;-0.2763244;-1.3435861;0.047244094;0.26032862
GO BP;G1 DNA DAMAGE CHECKPOINT;#N/A;59;-0.31837544;-1.3429549;0.0765391;0.2609249
GO BP;CELL FATE SPECIFICATION;GO:0001708;39;-0.35306767;-1.3420169;0.087478556;0.26206484
GO BP;REGULATION OF DNA DEPENDENT DNA REPLICATION;GO:0090329;43;-0.3412763;-1.3419806;0.09259259;0.2617612
GO BP;NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS;#N/A;450;-0.23070487;-1.3393317;0.008163265;0.26552013
GO BP;POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION;GO:0035307;32;-0.36674127;-1.3391577;0.10858144;0.2654681
GO BP;EYE MORPHOGENESIS;GO:0048592;92;-0.28862175;-1.3384567;0.06260032;0.26618925
GO BP;PURINE CONTAINING COMPOUND METABOLIC PROCESS;#N/A;353;-0.2373592;-1.3382267;0.015580736;0.26614383
GO BP;NUCLEOBASE BIOSYNTHETIC PROCESS;#N/A;17;-0.43022248;-1.3382137;0.14310345;0.26579612
GO BP;MITOTIC RECOMBINATION;GO:0006312;20;-0.4175744;-1.337648;0.14086956;0.26629767
GO BP;NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION;GO:1902807;88;-0.28718176;-1.3373864;0.055045873;0.26636076
GO BP;REGULATION OF VACUOLE ORGANIZATION;GO:0044088;42;-0.3382319;-1.3363178;0.09965636;0.26772338
GO BP;REGULATION OF CATION TRANSMEMBRANE TRANSPORT;GO:1904062;170;-0.25857595;-1.336242;0.04636785;0.2675051
GO BP;HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE;GO:0048873;18;-0.42503196;-1.3360527;0.12429378;0.26747823
GO BP;RESPONSE TO GAMMA RADIATION;GO:0010332;50;-0.32142752;-1.3353012;0.091388404;0.2683449
GO BP;CELLULAR CARBOHYDRATE CATABOLIC PROCESS;#N/A;36;-0.34493607;-1.3348998;0.08680555;0.26860705
GO BP;EPITHELIAL TUBE MORPHOGENESIS;GO:0060562;224;-0.25010076;-1.3347242;0.01923077;0.26850736
GO BP;ENDODERM FORMATION;GO:0001706;40;-0.3338994;-1.3344246;0.08347245;0.268622
GO BP;VESICLE ORGANIZATION;GO:0016050;268;-0.24223574;-1.334316;0.01510574;0.2684442
GO BP;RIBOSE PHOSPHATE METABOLIC PROCESS;GO:0019693;330;-0.23598333;-1.3336958;0.014858841;0.26907915
GO BP;RESPONSE TO OSMOTIC STRESS;GO:0006970;62;-0.30343083;-1.3333892;0.08082409;0.26925182
GO BP;ACTIN MEDIATED CELL CONTRACTION;GO:0070252;71;-0.30359226;-1.3331102;0.06589786;0.26932612
GO BP;NEGATIVE REGULATION OF MRNA PROCESSING;#N/A;29;-0.37072414;-1.3329747;0.114583336;0.26916942
GO BP;PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS;#N/A;32;-0.36045146;-1.3329691;0.11442786;0.2688169
GO BP;CELLULAR RESPONSE TO LIGHT STIMULUS;GO:0071482;84;-0.2935797;-1.3320463;0.05892256;0.26997307
GO BP;NUCLEOSOME ORGANIZATION;GO:0034728;139;-0.26511014;-1.3315462;0.03767661;0.27045667
GO BP;LATE ENDOSOME TO VACUOLE TRANSPORT;GO:0045324;16;-0.42357713;-1.3315407;0.12006861;0.27011
GO BP;AUTOPHAGOSOME ORGANIZATION;GO:1905037;84;-0.28748247;-1.3309362;0.06331169;0.27070385
GO BP;GLYCOGEN BIOSYNTHETIC PROCESS;GO:0005978;36;-0.3560147;-1.3303959;0.09353741;0.27124447
GO BP;ENDOPLASMIC RETICULUM MANNOSE TRIMMING;#N/A;16;-0.42619643;-1.329744;0.118965514;0.2719355
GO BP;REGULATION OF SYNAPSE ASSEMBLY;GO:0051963;46;-0.32610244;-1.3292445;0.10350584;0.27236494
GO BP;POLYSACCHARIDE CATABOLIC PROCESS;#N/A;19;-0.4120563;-1.3286386;0.11187608;0.2729714
GO BP;POSITIVE REGULATION OF VIRAL PROCESS;GO:0048524;96;-0.2821553;-1.3284976;0.048076924;0.2728519
GO BP;REGULATION OF STEM CELL POPULATION MAINTENANCE;GO:2000036;26;-0.3722928;-1.3274167;0.097087376;0.2742943
GO BP;NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT;#N/A;192;-0.25339052;-1.327222;0.03196347;0.27430868
GO BP;CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS;GO:0071375;228;-0.24597442;-1.3271694;0.029498525;0.27404675
GO BP;PROTEIN K11 LINKED UBIQUITINATION;GO:0070979;26;-0.38118455;-1.3270718;0.12937063;0.27384594
GO BP;CELLULAR POLYSACCHARIDE CATABOLIC PROCESS;#N/A;19;-0.4120563;-1.3270209;0.11743772;0.27359778
GO BP;DNA TEMPLATED TRANSCRIPTION ELONGATION;GO:0006354;101;-0.28104758;-1.3269631;0.06603774;0.27334368
GO BP;SNRNA TRANSCRIPTION;GO:0009301;68;-0.30612883;-1.3261827;0.0738255;0.27428108
GO BP;BRAIN MORPHOGENESIS;GO:0048854;19;-0.41024682;-1.3261645;0.11797753;0.2739559
GO BP;POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION;#N/A;17;-0.42602646;-1.3261498;0.13539967;0.27362075
GO BP;REGULATION OF DNA DAMAGE CHECKPOINT;GO:2000001;16;-0.42632753;-1.3251688;0.13504274;0.27485627
GO BP;PIGMENT BIOSYNTHETIC PROCESS;#N/A;43;-0.33315048;-1.324454;0.09490334;0.2757352
GO BP;AMEBOIDAL TYPE CELL MIGRATION;GO:0001667;273;-0.23971272;-1.321891;0.018895349;0.27975485
GO BP;CELLULAR RESPONSE TO INSULIN STIMULUS;GO:0032869;170;-0.2557764;-1.3215109;0.034700315;0.28004152
GO BP;NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS;GO:2000059;42;-0.3324503;-1.3214983;0.091388404;0.27969912
GO BP;POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS;#N/A;15;-0.43988207;-1.3211224;0.15384616;0.27999753
GO BP;CELLULAR RESPONSE TO STARVATION;GO:0009267;122;-0.26891783;-1.320653;0.058536585;0.2804448
GO BP;CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND;GO:0071407;387;-0.23078707;-1.3206238;0.019033674;0.28012592
GO BP;N TERMINAL PROTEIN AMINO ACID ACETYLATION;GO:0006474;15;-0.44410896;-1.3201255;0.13284133;0.28060624
GO BP;REGULATION OF PROTEOLYSIS;GO:0030162;493;-0.22575529;-1.3197124;0.0056899;0.28091562
GO BP;NUCLEOTIDE EXCISION REPAIR DNA INCISION;GO:0033683;38;-0.3404687;-1.3195668;0.12520868;0.2807919
GO BP;REGULATION OF SPINDLE ASSEMBLY;GO:0090169;25;-0.3776728;-1.3188508;0.125;0.28164214
GO BP;NEURON RECOGNITION;GO:0008038;28;-0.36997482;-1.3179533;0.121783875;0.2827235
GO BP;PROTEIN LOCALIZATION TO CHROMOSOME;GO:0034502;81;-0.28993157;-1.3176448;0.07528642;0.28289637
GO BP;CELLULAR RESPONSE TO NITROGEN COMPOUND;#N/A;453;-0.22714141;-1.3166777;0.009549796;0.28415897
GO BP;CELL GROWTH;#N/A;331;-0.23460148;-1.3149916;0.021961933;0.28677085
GO BP;INTERLEUKIN 2 PRODUCTION;GO:0032623;39;-0.3371135;-1.3133614;0.09747899;0.2892958
GO BP;ORGANELLE MEMBRANE FUSION;#N/A;80;-0.28655323;-1.3125976;0.08858603;0.2902501
GO BP;LABYRINTHINE LAYER MORPHOGENESIS;GO:0060713;15;-0.429445;-1.3117849;0.14003591;0.2913287
GO BP;MITOTIC DNA INTEGRITY CHECKPOINT;GO:0044774;96;-0.28063354;-1.3103598;0.07177814;0.29348075
GO BP;REGULATION OF EXTENT OF CELL GROWTH;#N/A;82;-0.28834838;-1.3100299;0.0732899;0.29367578
GO BP;CARDIAC MYOFIBRIL ASSEMBLY;GO:0055003;16;-0.42659554;-1.3099979;0.15018316;0.29335067
GO BP;LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS;GO:0042759;15;-0.43288898;-1.3096735;0.11413044;0.29356515
GO BP;MRNA CIS SPLICING VIA SPLICEOSOME;GO:0045292;29;-0.35990736;-1.3087083;0.12802768;0.29484257
GO BP;ACTIN FILAMENT POLYMERIZATION;GO:0030041;129;-0.26450163;-1.3073255;0.05263158;0.29687858
GO BP;NEGATIVE REGULATION OF NUCLEAR DIVISION;#N/A;48;-0.31705406;-1.306828;0.11072665;0.29736626
GO BP;REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY;GO:2000649;35;-0.34471604;-1.3067601;0.1295972;0.29713058
GO BP;REGULATION OF CELLULAR COMPONENT SIZE;#N/A;268;-0.23765089;-1.3058788;0.029069768;0.29834485
GO BP;SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE;GO:0042770;118;-0.26608855;-1.3056631;0.064615384;0.29837045
GO BP;STEROID HORMONE MEDIATED SIGNALING PATHWAY;GO:0043401;135;-0.26221833;-1.3048979;0.06836248;0.2994151
GO BP;DIENCEPHALON DEVELOPMENT;GO:0021536;27;-0.37384832;-1.3047332;0.14134276;0.29935375
GO BP;POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION;GO:2000758;25;-0.3741609;-1.3047198;0.11774744;0.29899585
GO BP;POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY;GO:2001238;35;-0.33723992;-1.3046576;0.11764706;0.29873934
GO BP;MAMMARY GLAND EPITHELIUM DEVELOPMENT;GO:0061180;47;-0.3166199;-1.3045423;0.10099338;0.298575
GO BP;NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION;GO:2000042;16;-0.4190682;-1.3039063;0.14261168;0.29936346
GO BP;MULTICELLULAR ORGANISMAL MOVEMENT;#N/A;30;-0.35431924;-1.3027115;0.13712375;0.3011056
GO BP;NEGATIVE REGULATION OF HYDROLASE ACTIVITY;GO:0051346;278;-0.23660143;-1.3025423;0.019005848;0.30104324
GO BP;POSITIVE REGULATION OF CHROMOSOME SEGREGATION;GO:0051984;27;-0.3678046;-1.3024029;0.13993174;0.30094737
GO BP;POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION;GO:0043536;40;-0.33445475;-1.3023318;0.1220339;0.30071852
GO BP;SYNAPTIC TRANSMISSION GABAERGIC;GO:0051932;24;-0.37641224;-1.3023208;0.14756945;0.30036098
GO BP;MIDBODY ABSCISSION;GO:0061952;17;-0.41565394;-1.3022739;0.14414415;0.30008784
GO BP;NON RECOMBINATIONAL REPAIR;GO:0000726;79;-0.28606045;-1.302077;0.07827476;0.30005774
GO BP;REGULATION OF MAP KINASE ACTIVITY;GO:0043405;240;-0.23881255;-1.3017923;0.03402367;0.3002278
GO BP;REGULATION OF MUSCLE HYPERTROPHY;#N/A;43;-0.32968834;-1.3015517;0.11308562;0.30030048
GO BP;TELOMERASE RNA LOCALIZATION;#N/A;19;-0.40734047;-1.3012106;0.1454219;0.30051532
GO BP;VESICLE LOCALIZATION;GO:0051648;170;-0.25431386;-1.300861;0.04945904;0.30077836
GO BP;POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS;GO:0036003;22;-0.39286155;-1.3008277;0.13013698;0.30048183
GO BP;VASCULOGENESIS;GO:0001570;52;-0.31426793;-1.3000642;0.118530884;0.30150792
GO BP;POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION;#N/A;17;-0.40872633;-1.2999904;0.13440861;0.30126962
GO BP;NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC;GO:0045814;99;-0.27659282;-1.2999722;0.0752;0.30091736
GO BP;REGULATION OF RUFFLE ASSEMBLY;GO:1900027;24;-0.3841697;-1.2998109;0.13965517;0.30084336
GO BP;NEGATIVE REGULATION OF TOR SIGNALING;GO:0032007;37;-0.3414409;-1.2991214;0.12690355;0.30169642
GO BP;REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE;GO:1903076;74;-0.28899208;-1.2975382;0.07755776;0.30409983
GO BP;TELENCEPHALON GLIAL CELL MIGRATION;#N/A;16;-0.42633206;-1.2971708;0.14492753;0.30437374
GO BP;INTERMEDIATE FILAMENT BASED PROCESS;GO:0045103;36;-0.33538407;-1.2971648;0.11480865;0.30401385
GO BP;REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE;GO:1902473;18;-0.4068988;-1.2963173;0.12456141;0.30504942
GO BP;ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE;GO:0008608;30;-0.3549514;-1.2959772;0.12392427;0.30531973
GO BP;REGULATION OF MUSCLE ADAPTATION;#N/A;60;-0.29914233;-1.2944796;0.102649;0.30757666
GO BP;POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS;GO:2000573;57;-0.30790773;-1.294468;0.103270225;0.3072263
GO BP;REGULATION OF JUN KINASE ACTIVITY;GO:0043506;61;-0.30022022;-1.2936136;0.08361775;0.3084593
GO BP;ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS;#N/A;40;-0.32723677;-1.2935249;0.12479201;0.3082825
GO BP;ASTROCYTE DEVELOPMENT;GO:0014002;22;-0.38509288;-1.2926638;0.14507772;0.3094478
GO BP;NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS;GO:1900181;19;-0.39561814;-1.291369;0.16838488;0.3114423
GO BP;PROTEIN LOCALIZATION TO CILIUM;GO:0061512;45;-0.31519806;-1.291333;0.11986301;0.31112766
GO BP;POSITIVE REGULATION OF PROTEIN ACETYLATION;GO:1901985;33;-0.35127828;-1.2906321;0.1450512;0.31206945
GO BP;FATTY ACID BIOSYNTHETIC PROCESS;GO:0006633;106;-0.27101675;-1.2899418;0.06549521;0.31295925
GO BP;POSITIVE REGULATION OF CILIUM ASSEMBLY;GO:0045724;21;-0.3838022;-1.2898357;0.14920071;0.31276324
GO BP;DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY;#N/A;39;-0.33325636;-1.2892827;0.12227806;0.31339929
GO BP;EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT;#N/A;24;-0.37774083;-1.2889779;0.14309764;0.3136027
GO BP;MUSCLE CELL CELLULAR HOMEOSTASIS;GO:0046716;16;-0.42790234;-1.288829;0.16550523;0.31350976
GO BP;REGULATION OF PROTEIN DEPHOSPHORYLATION;GO:0035304;110;-0.26707727;-1.2884728;0.08252427;0.31374964
GO BP;REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY;GO:0071900;383;-0.2261219;-1.2877613;0.024965325;0.31468743
GO BP;ERBB SIGNALING PATHWAY;GO:0038127;115;-0.26401362;-1.2872436;0.06451613;0.31526184
GO BP;MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS;GO:0051457;20;-0.39124587;-1.2863365;0.15275311;0.31652126
GO BP;RNA CAPPING;#N/A;33;-0.3402988;-1.2853307;0.14359862;0.31791666
GO BP;NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS;#N/A;17;-0.40229315;-1.2849859;0.15853658;0.31813043
GO BP;POSITIVE REGULATION OF LOCOMOTION;GO:0040017;385;-0.22456329;-1.2844864;0.030726258;0.31869015
GO BP;T CELL MIGRATION;GO:0072678;35;-0.3393875;-1.2843812;0.13448276;0.31850222
GO BP;NEGATIVE REGULATION OF ORGANELLE ASSEMBLY;#N/A;34;-0.3444115;-1.2841481;0.14867257;0.31855702
GO BP;REGULATION OF AUTOPHAGOSOME ASSEMBLY;GO:2000785;35;-0.3351893;-1.2837625;0.13930348;0.31893435
GO BP;CENTROMERE COMPLEX ASSEMBLY;GO:0034508;49;-0.3108455;-1.283168;0.12880144;0.3195997
GO BP;REGULATION OF OSTEOCLAST DIFFERENTIATION;GO:0045670;31;-0.34796217;-1.2828528;0.13181019;0.31980535
GO BP;RUFFLE ORGANIZATION;GO:0031529;41;-0.32029822;-1.2827401;0.12755102;0.3196396
GO BP;GLIOGENESIS;GO:0042063;171;-0.25112537;-1.2824128;0.055384614;0.31984678
GO BP;MYOFIBRIL ASSEMBLY;GO:0030239;40;-0.32978266;-1.2816296;0.11604095;0.32093024
GO BP;CAMERA TYPE EYE MORPHOGENESIS;GO:0048593;75;-0.28231868;-1.2816218;0.10837439;0.3205656
GO BP;RNA METHYLATION;GO:0001510;70;-0.28977603;-1.2814485;0.10851419;0.32046682
GO BP;POSITIVE REGULATION OF GROWTH;GO:0045927;172;-0.24554339;-1.2810206;0.041925468;0.3208549
GO BP;REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY;GO:0061097;56;-0.30348194;-1.2806901;0.11111111;0.32109633
GO BP;CARDIOVASCULAR SYSTEM DEVELOPMENT;#N/A;470;-0.21895361;-1.2789911;0.016759777;0.32386687
GO BP;MICROVILLUS ORGANIZATION;GO:0032528;19;-0.39632446;-1.277896;0.15384616;0.32552564
GO BP;TRIGLYCERIDE METABOLIC PROCESS;GO:0006641;66;-0.29372332;-1.2767859;0.1;0.3272332
GO BP;POSITIVE REGULATION OF STEM CELL PROLIFERATION;GO:2000648;26;-0.3580953;-1.276389;0.14535902;0.32758692
GO BP;TAXIS;#N/A;341;-0.22664405;-1.2762594;0.031073445;0.32748538
GO BP;POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS;GO:1900182;63;-0.29318354;-1.2758585;0.12392427;0.32786107
GO BP;TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER;GO:0006368;74;-0.28627038;-1.2756529;0.11580595;0.3278387
GO BP;MAINTENANCE OF LOCATION;#N/A;231;-0.2381443;-1.2752787;0.037593983;0.3281185
GO BP;REGULATION OF RNA SPLICING;GO:0043484;118;-0.26153398;-1.2747087;0.08292683;0.3288116
GO BP;RESPONSE TO INSULIN;GO:0032868;204;-0.24065739;-1.2742419;0.075642966;0.32923517
GO BP;PROTEIN DEGLYCOSYLATION;GO:0006517;26;-0.36180827;-1.2735428;0.14336284;0.3301773
GO BP;NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY;GO:1902176;15;-0.41903543;-1.2726252;0.17217392;0.33152255
GO BP;EMBRYONIC AXIS SPECIFICATION;GO:0000578;21;-0.38127583;-1.272321;0.1368421;0.33177227
GO BP;TISSUE REGENERATION;GO:0042246;46;-0.3079335;-1.272095;0.13301282;0.33181307
GO BP;COFACTOR CATABOLIC PROCESS;#N/A;35;-0.33395648;-1.2720226;0.1462185;0.33157504
GO BP;POSITIVE REGULATION OF AXONOGENESIS;GO:0050772;61;-0.29578987;-1.2719563;0.116838485;0.33129433
GO BP;CELLULAR RESPONSE TO PEPTIDE;GO:1901653;268;-0.23031819;-1.271924;0.03692762;0.33097628
GO BP;POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION;GO:0050679;119;-0.2618186;-1.2717553;0.09006211;0.3308972
GO BP;ER NUCLEUS SIGNALING PATHWAY;GO:0006984;39;-0.3272831;-1.2717099;0.1375839;0.3306141
GO BP;POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION;GO:0045840;39;-0.32727063;-1.2708627;0.14285715;0.3318149
GO BP;NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS;GO:1903363;72;-0.28431615;-1.2700398;0.1152;0.3330147
GO BP;EMBRYONIC PATTERN SPECIFICATION;GO:0009880;39;-0.32231882;-1.2699362;0.1401384;0.3328336
GO BP;REGULATION OF CARBOHYDRATE CATABOLIC PROCESS;#N/A;68;-0.28896177;-1.2693404;0.10440457;0.33358306
GO BP;DNA TEMPLATED TRANSCRIPTION INITIATION;GO:0006352;199;-0.23976772;-1.2672415;0.06376361;0.33708298
GO BP;POSITIVE REGULATION OF TRANSFERASE ACTIVITY;#N/A;474;-0.21752208;-1.2667155;0.019337017;0.33776462
GO BP;DORSAL VENTRAL PATTERN FORMATION;GO:0009953;48;-0.3131469;-1.2663586;0.14451827;0.33811015
GO BP;CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION;GO:0034629;20;-0.38118538;-1.2660228;0.17801048;0.3383861
GO BP;BONE CELL DEVELOPMENT;#N/A;23;-0.37207755;-1.2658335;0.16206262;0.3383854
GO BP;RNA DESTABILIZATION;GO:0050779;28;-0.34914988;-1.2658117;0.14141414;0.3380423
GO BP;CELLULAR GLUCAN METABOLIC PROCESS;#N/A;58;-0.29235864;-1.2658063;0.1318328;0.3376665
GO BP;FATTY ACID METABOLIC PROCESS;GO:0006631;263;-0.23239018;-1.2657902;0.0601173;0.33732092
GO BP;RESPONSE TO LIGHT STIMULUS;GO:0009416;208;-0.23805656;-1.2653397;0.056835636;0.3378081
GO BP;HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS;GO:0030201;23;-0.37899557;-1.2651156;0.15817223;0.33792225
GO BP;ORGANIC ACID BIOSYNTHETIC PROCESS;#N/A;240;-0.23557642;-1.2643483;0.07153502;0.3390389
GO BP;RRNA METHYLATION;GO:0031167;23;-0.36295447;-1.2642103;0.16393442;0.33891436
GO BP;CYTOPLASMIC SEQUESTERING OF PROTEIN;GO:0051220;22;-0.36625895;-1.2630119;0.17094018;0.34096494
GO BP;PROTEIN DEMANNOSYLATION;#N/A;18;-0.40644798;-1.2609556;0.18962432;0.3446115
GO BP;IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY;GO:0002768;244;-0.23276421;-1.2609012;0.04287902;0.34433493
GO BP;HORMONE MEDIATED SIGNALING PATHWAY;GO:0009755;155;-0.24767011;-1.2608628;0.07954545;0.34403118
GO BP;REGULATION OF SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM;#N/A;164;-0.2438795;-1.2601572;0.0770416;0.3451019
GO BP;PROTEIN LOCALIZATION TO CHROMATIN;GO:0071168;27;-0.3500705;-1.2597653;0.15436241;0.34547058
GO BP;PROTEIN LOCALIZATION TO SYNAPSE;GO:0035418;51;-0.30511212;-1.2593007;0.1524288;0.34595767
GO BP;MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS;GO:0031293;17;-0.40346533;-1.2592719;0.18165137;0.345626
GO BP;TEMPERATURE HOMEOSTASIS;GO:0001659;110;-0.25864008;-1.2591227;0.08527132;0.34552705
GO BP;MYELOID LEUKOCYTE ACTIVATION;#N/A;417;-0.22026081;-1.2585286;0.03547067;0.34631678
GO BP;LENS FIBER CELL DIFFERENTIATION;GO:0070306;17;-0.3954998;-1.2585123;0.16955018;0.34596348
GO BP;NEGATIVE REGULATION OF PROTEIN ACETYLATION;GO:1901984;15;-0.41564074;-1.2582319;0.17010309;0.34609556
GO BP;NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS;GO:0090305;248;-0.23272163;-1.258095;0.057692308;0.3459737
GO BP;SULFUR COMPOUND CATABOLIC PROCESS;#N/A;38;-0.32550317;-1.2580509;0.13986014;0.3456886
GO BP;MORPHOGENESIS OF AN EPITHELIUM;GO:0002009;380;-0.21867603;-1.2575111;0.026760563;0.3463756
GO BP;REGULATION OF CELL JUNCTION ASSEMBLY;GO:1901888;68;-0.28457406;-1.2571015;0.121753246;0.34686148
GO BP;REGULATION OF CELLULAR AMIDE METABOLIC PROCESS;#N/A;342;-0.22429806;-1.2569219;0.04539007;0.34679398
GO BP;REGULATION OF PROTEIN BINDING;GO:0043393;161;-0.24695446;-1.2569014;0.088721804;0.3464467
GO BP;EMBRYONIC SKELETAL SYSTEM DEVELOPMENT;GO:0048706;70;-0.28305852;-1.2559024;0.13614263;0.34801602
GO BP;POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION;GO:1904951;301;-0.22603449;-1.2557379;0.046676096;0.34796175
GO BP;GAMETE GENERATION;GO:0007276;418;-0.2188961;-1.2557088;0.036775105;0.34764427
GO BP;PLASMA MEMBRANE TUBULATION;GO:0097320;17;-0.40585688;-1.2551587;0.17465754;0.34829152
GO BP;POLARIZED EPITHELIAL CELL DIFFERENTIATION;GO:0030859;15;-0.41213593;-1.254256;0.16787003;0.34977594
GO BP;ZINC ION TRANSPORT;GO:0006829;20;-0.38256004;-1.2542427;0.17926186;0.3494266
GO BP;REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS;GO:1902991;28;-0.3516394;-1.2541225;0.15972222;0.34927142
GO BP;REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY;GO:0043666;92;-0.2708838;-1.2537549;0.11378205;0.349595
GO BP;CALCIUM ION TRANSMEMBRANE TRANSPORT;GO:0070588;173;-0.24068868;-1.2523397;0.076219514;0.35196415
GO BP;GLUCOSE IMPORT;GO:0046323;47;-0.30702427;-1.252043;0.1412151;0.35214236
GO BP;DNA PACKAGING;GO:0006323;156;-0.24528621;-1.2519847;0.08411215;0.35186273
GO BP;DIVALENT INORGANIC CATION TRANSPORT;#N/A;263;-0.22963361;-1.2518026;0.053731345;0.3518292
GO BP;WOUND HEALING;GO:0042060;357;-0.21977556;-1.250661;0.038961038;0.35372677
GO BP;NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY;GO:2001243;80;-0.27333686;-1.2506186;0.097402595;0.35344404
GO BP;MOTOR NEURON AXON GUIDANCE;GO:0008045;20;-0.38438597;-1.2506113;0.17605634;0.3530837
GO BP;TRANSCRIPTION BY RNA POLYMERASE III;GO:0006383;47;-0.30790827;-1.2502396;0.14217253;0.3534224
GO BP;CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS;#N/A;21;-0.37928137;-1.2497419;0.18827708;0.35405022
GO BP;REGULATION OF PROTEIN TARGETING;#N/A;64;-0.28810826;-1.2492548;0.11815068;0.35462874
GO BP;RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC;GO:0090503;39;-0.31762707;-1.2485569;0.14983165;0.35562307
GO BP;PRESYNAPSE ORGANIZATION;GO:0099172;18;-0.39082444;-1.2480178;0.18412162;0.35635877
GO BP;POSITIVE REGULATION OF KINASE ACTIVITY;GO:0033674;412;-0.21883151;-1.2473161;0.036516853;0.357454
GO BP;ARTERY MORPHOGENESIS;GO:0048844;42;-0.3099176;-1.2468137;0.1578073;0.35803
GO BP;NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL;#N/A;68;-0.28120914;-1.2468086;0.11675127;0.3576475
GO BP;POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION;GO:0001938;55;-0.29511708;-1.2467679;0.13957597;0.35734686
GO BP;POSITIVE REGULATION OF TRANSPORTER ACTIVITY;GO:0032411;59;-0.29318106;-1.2467234;0.14705883;0.3570483
GO BP;NEUTRAL LIPID METABOLIC PROCESS;GO:0006638;83;-0.27417478;-1.2465062;0.13106796;0.3571286
GO BP;REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS;GO:0099072;46;-0.31029525;-1.2464905;0.1579832;0.35677406
GO BP;CELL SUBSTRATE ADHESION;GO:0031589;240;-0.23015878;-1.2464;0.07122093;0.35657838
GO BP;GLIAL CELL DEVELOPMENT;GO:0021782;69;-0.2832216;-1.2463171;0.14566284;0.35636103
GO BP;POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY;GO:0071902;245;-0.23047492;-1.2457693;0.08417997;0.35711488
GO BP;REGULATION OF ANION TRANSMEMBRANE TRANSPORT;#N/A;18;-0.39405525;-1.245727;0.17086332;0.3568301
GO BP;EMBRYONIC APPENDAGE MORPHOGENESIS;#N/A;85;-0.26916134;-1.2446188;0.12248062;0.3587165
GO BP;REGULATION OF MYOTUBE DIFFERENTIATION;GO:0010830;26;-0.3585281;-1.2446164;0.17953321;0.35834748
GO BP;REGULATION OF COFACTOR METABOLIC PROCESS;#N/A;28;-0.34022573;-1.2445011;0.17553191;0.35819393
GO BP;COFACTOR BIOSYNTHETIC PROCESS;#N/A;192;-0.2371038;-1.2441123;0.06708268;0.35859206
GO BP;BLOOD VESSEL ENDOTHELIAL CELL MIGRATION;GO:0043534;80;-0.27212813;-1.2434753;0.12026359;0.35954863
GO BP;TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER;GO:0006361;34;-0.32846525;-1.2434243;0.15979381;0.35926148
GO BP;RESPONSE TO HYPEROXIA;#N/A;17;-0.39733493;-1.243384;0.18374558;0.3589723
GO BP;RECEPTOR RECYCLING;GO:0001881;28;-0.35549298;-1.243326;0.1897436;0.35871163
GO BP;CONTRACTILE ACTIN FILAMENT BUNDLE ASSEMBLY;GO:0030038;76;-0.27412006;-1.2432272;0.12390925;0.3585271
GO BP;DORSAL VENTRAL NEURAL TUBE PATTERNING;GO:0021904;19;-0.3895085;-1.2428212;0.19478261;0.3589694
GO BP;PEROXISOMAL TRANSPORT;#N/A;61;-0.28684393;-1.2421844;0.14043993;0.35983878
GO BP;NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS;#N/A;58;-0.28592223;-1.2415653;0.12913907;0.36072856
GO BP;DENDRITE EXTENSION;GO:0097484;19;-0.38808632;-1.2405204;0.19746377;0.36246878
GO BP;DNA BIOSYNTHETIC PROCESS;GO:0071897;161;-0.24075899;-1.2399231;0.09612403;0.36328056
GO BP;POSITIVE REGULATION OF RNA SPLICING;GO:0033120;28;-0.3416792;-1.2393109;0.15753424;0.36415485
GO BP;NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT;GO:0032387;41;-0.31255257;-1.2391096;0.155;0.36414394
GO BP;MITOCHONDRIAL FUSION;GO:0008053;20;-0.3831929;-1.2388916;0.2064057;0.36421996
GO BP;POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY;GO:0061098;33;-0.3287645;-1.2382108;0.18696398;0.3652152
GO BP;NEGATIVE REGULATION OF ION TRANSPORT;GO:0043271;73;-0.27425689;-1.2382016;0.1266892;0.36486065
GO BP;PROTEIN LOCALIZATION TO ENDOSOME;GO:0036010;24;-0.36506313;-1.2378249;0.18739353;0.36522794
GO BP;NEGATIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS;GO:1903051;60;-0.29044613;-1.237398;0.14082278;0.3657201
GO BP;NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS;#N/A;419;-0.21349019;-1.2362621;0.036723163;0.36772904
GO BP;TRICARBOXYLIC ACID CYCLE;GO:0006099;33;-0.3268282;-1.2360411;0.16020235;0.3677757
GO BP;MUSCLE CONTRACTION;GO:0006936;193;-0.2336248;-1.2353112;0.07606973;0.36892456
GO BP;MEIOTIC CELL CYCLE;GO:0051321;184;-0.2392565;-1.234551;0.0927357;0.37011817
GO BP;REGULATION OF MULTICELLULAR ORGANISM GROWTH;GO:0040014;41;-0.31593013;-1.2337162;0.17235772;0.37142208
GO BP;CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS;#N/A;73;-0.27472466;-1.2336612;0.1300813;0.37114015
GO BP;INTRASPECIES INTERACTION BETWEEN ORGANISMS;#N/A;24;-0.3491618;-1.2336268;0.17931035;0.37082076
GO BP;REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY;GO:0033143;62;-0.2854761;-1.2333721;0.14927769;0.370967
GO BP;REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY;#N/A;17;-0.39673358;-1.2329042;0.20725389;0.37149912
GO BP;NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS;#N/A;486;-0.20998725;-1.2325904;0.04702628;0.37176955
GO BP;INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS;GO:0008631;36;-0.32052636;-1.2325846;0.18043844;0.37139353
GO BP;INTRACELLULAR PROTEIN TRANSMEMBRANE TRANSPORT;GO:0065002;45;-0.30802038;-1.2325506;0.16695653;0.37108028
GO BP;NEGATIVE REGULATION OF GTPASE ACTIVITY;GO:0034260;38;-0.31569323;-1.2324984;0.1629393;0.3707993
GO BP;EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS;GO:0048704;49;-0.305514;-1.2321883;0.1736111;0.37106064
GO BP;CELL CELL SIGNALING BY WNT;GO:0198738;385;-0.21617134;-1.2321419;0.040389974;0.37077403
GO BP;POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY;GO:0034123;16;-0.40303883;-1.2317451;0.21903051;0.3712121
GO BP;RESPONSE TO PEPTIDE HORMONE;GO:0043434;302;-0.22285043;-1.2309867;0.073573574;0.37240443
GO BP;REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY;GO:0043467;129;-0.24728037;-1.2298082;0.11341853;0.37439272
GO BP;NEGATIVE REGULATION OF GLIOGENESIS;#N/A;24;-0.35428917;-1.2290357;0.20959148;0.37559187
GO BP;CELLULAR RESPONSE TO HORMONE STIMULUS;GO:0032870;463;-0.21180342;-1.2289522;0.04359673;0.3753985
GO BP;REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE;#N/A;21;-0.36076015;-1.2289207;0.20304568;0.37507764
GO BP;REGULATION OF VIRAL LIFE CYCLE;#N/A;102;-0.25681484;-1.228905;0.12933753;0.3747266
GO BP;CELL DEATH IN RESPONSE TO OXIDATIVE STRESS;GO:0036473;61;-0.285158;-1.2282298;0.15033785;0.37584868
GO BP;TISSUE MORPHOGENESIS;GO:0048729;449;-0.21349716;-1.2273924;0.036986303;0.37725115
GO BP;NUCLEOSIDE METABOLIC PROCESS;GO:0009116;81;-0.2683671;-1.2273905;0.13301282;0.37687132
GO BP;DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION;#N/A;48;-0.29934266;-1.2271146;0.14745763;0.37704116
GO BP;MYELOID LEUKOCYTE MEDIATED IMMUNITY;#N/A;376;-0.2138934;-1.2269342;0.042735044;0.37702313
GO BP;COLLATERAL SPROUTING;GO:0048668;21;-0.36589205;-1.2262866;0.19405594;0.3778803
GO BP;CELL FATE COMMITMENT;GO:0045165;124;-0.25055367;-1.2262517;0.1221865;0.37757772
GO BP;GLOMERULUS DEVELOPMENT;GO:0032835;35;-0.32102272;-1.2262498;0.18592964;0.37720072
GO BP;PROTEIN K48 LINKED UBIQUITINATION;GO:0070936;50;-0.297712;-1.2257127;0.18135594;0.37792462
GO BP;GASTRULATION WITH MOUTH FORMING SECOND;GO:0001702;24;-0.35338122;-1.2254317;0.2043919;0.37809706
GO BP;COPII COATED VESICLE BUDDING;GO:0090114;61;-0.28463015;-1.2252421;0.15599343;0.37816826
GO BP;HEART DEVELOPMENT;GO:0007507;399;-0.21348716;-1.2251619;0.044630405;0.3779942
GO BP;POSTSYNAPTIC SPECIALIZATION ORGANIZATION;#N/A;16;-0.40165544;-1.2243941;0.19786096;0.37916654
GO BP;CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS;#N/A;27;-0.34741822;-1.2243211;0.20871143;0.3789288
GO BP;PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY;GO:0007205;15;-0.40436754;-1.224264;0.21651377;0.37865275
GO BP;POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT;GO:0034767;74;-0.27353862;-1.2235236;0.14862682;0.37980264
GO BP;PEPTIDYL TYROSINE AUTOPHOSPHORYLATION;GO:0038083;23;-0.35931206;-1.2234621;0.19430485;0.37955076
GO BP;VESICLE CARLOADING;#N/A;19;-0.37584612;-1.2233914;0.20613287;0.37931734
GO BP;GLIAL CELL DIFFERENTIATION;GO:0010001;124;-0.24950694;-1.2226592;0.117263846;0.38053346
GO BP;REGULATION OF PROTEIN STABILITY;GO:0031647;242;-0.22668931;-1.222345;0.08912387;0.3807654
GO BP;HETEROCHROMATIN ORGANIZATION;GO:0070828;15;-0.39875564;-1.2222443;0.20707071;0.3805694
GO BP;REGULATION OF WNT SIGNALING PATHWAY;GO:0030111;272;-0.22245175;-1.2219715;0.07860262;0.3807772
GO BP;REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS;GO:2001020;183;-0.23364528;-1.2218843;0.09305761;0.3805834
GO BP;REGULATION OF CALCIUM ION TRANSPORT;GO:0051924;124;-0.24599037;-1.221749;0.12903225;0.38046217
GO BP;CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE;#N/A;458;-0.20965646;-1.2216234;0.03217158;0.38034973
GO BP;LONG CHAIN FATTY ACID METABOLIC PROCESS;GO:0001676;66;-0.27681792;-1.2210351;0.14006515;0.381191
GO BP;NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS;#N/A;220;-0.22732435;-1.2210318;0.08380682;0.38082096
GO BP;REGULATION OF TRANSLATIONAL FIDELITY;GO:0006450;17;-0.38305363;-1.2209952;0.21981981;0.38051933
GO BP;FC RECEPTOR SIGNALING PATHWAY;GO:0038093;143;-0.24230869;-1.2197413;0.11128776;0.38271013
GO BP;RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS;GO:0009156;26;-0.349797;-1.2186639;0.18524872;0.38452482
GO BP;CELL MATRIX ADHESION;GO:0007160;150;-0.24072628;-1.2182982;0.11937985;0.38495633
GO BP;CARBOHYDRATE TRANSPORT;GO:0008643;99;-0.2573784;-1.2180263;0.13964687;0.38511837
GO BP;EPITHELIAL CELL DIFFERENTIATION;GO:0030855;392;-0.21311001;-1.2173984;0.06779661;0.38597697
GO BP;RESPONSE TO INORGANIC SUBSTANCE;GO:0010035;370;-0.21409713;-1.2171475;0.06896552;0.38610822
GO BP;MALE SEX DIFFERENTIATION;GO:0046661;109;-0.25651062;-1.2169518;0.1465798;0.38612396
GO BP;SEXUAL REPRODUCTION;GO:0019953;489;-0.21033926;-1.2164444;0.05172414;0.38681838
GO BP;REGULATION OF RESPONSE TO DRUG;GO:2001023;46;-0.30002093;-1.2162406;0.16637781;0.38686395
GO BP;PEROXISOME ORGANIZATION;GO:0007031;70;-0.27065542;-1.2162002;0.15544872;0.3865608
GO BP;NEGATIVE REGULATION OF PROTEOLYSIS;GO:0045861;209;-0.22729182;-1.2158476;0.09270517;0.38690948
GO BP;GLAND DEVELOPMENT;GO:0048732;292;-0.22035642;-1.2158451;0.073913045;0.386534
GO BP;CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT;GO:0021954;47;-0.2890116;-1.2156806;0.16150081;0.38651493
GO BP;POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY;#N/A;22;-0.36595267;-1.2151664;0.21164021;0.3871595
GO BP;POSITIVE REGULATION OF PHOSPHATASE ACTIVITY;GO:0010922;22;-0.36135;-1.2145295;0.21602787;0.3880778
GO BP;POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION;GO:1902745;24;-0.353741;-1.2144197;0.19512194;0.38793302
GO BP;PROTEIN TRANSMEMBRANE TRANSPORT;GO:0071806;52;-0.29034868;-1.2143018;0.17391305;0.38780227
GO BP;CELLULAR COMPONENT DISASSEMBLY;#N/A;435;-0.20956452;-1.2141696;0.05907173;0.38774517
GO BP;POSITIVE REGULATION OF PROTEIN IMPORT;GO:1904591;33;-0.32320938;-1.2139841;0.18353345;0.38775632
GO BP;APPENDAGE MORPHOGENESIS;#N/A;101;-0.25391284;-1.2132525;0.12732919;0.38893157
GO BP;LUNG MORPHOGENESIS;GO:0060425;33;-0.32593617;-1.21308;0.19765495;0.38893786
GO BP;POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION;GO:0010634;108;-0.2507986;-1.2126943;0.12852664;0.38933465
GO BP;REGULATION OF CELLULAR RESPONSE TO DRUG;GO:2001038;22;-0.35956767;-1.2119616;0.209009;0.3904244
GO BP;CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS;GO:0006921;27;-0.3477485;-1.2098123;0.21985815;0.39458257
GO BP;REGULATION OF POTASSIUM ION TRANSPORT;GO:0043266;40;-0.30492544;-1.2095859;0.19117647;0.39469188
GO BP;CELLULAR RESPONSE TO STEROID HORMONE STIMULUS;GO:0071383;175;-0.23375094;-1.209583;0.09953344;0.39431274
GO BP;NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS;GO:1902883;34;-0.32131758;-1.2094078;0.17152104;0.39434597
GO BP;POTASSIUM ION TRANSPORT;GO:0006813;86;-0.26022664;-1.207759;0.15284553;0.3974456
GO BP;LONG TERM SYNAPTIC POTENTIATION;GO:0060291;46;-0.29626608;-1.207523;0.18367347;0.3975371
GO BP;GLIAL CELL ACTIVATION;#N/A;26;-0.34258345;-1.2072339;0.21891418;0.39782494
GO BP;REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL;#N/A;22;-0.3592849;-1.2069706;0.20959148;0.3980351
GO BP;POSITIVE REGULATION OF CELL MATRIX ADHESION;GO:0001954;37;-0.31212834;-1.2066466;0.17529215;0.39839464
GO BP;APPENDAGE DEVELOPMENT;#N/A;120;-0.24921757;-1.2062244;0.12844037;0.39891815
GO BP;POSTREPLICATION REPAIR;GO:0006301;48;-0.28944662;-1.2059509;0.17986798;0.39910793
GO BP;AXIS SPECIFICATION;GO:0009798;60;-0.27889585;-1.2055094;0.1744;0.39973095
GO BP;ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE;GO:0006086;16;-0.39239714;-1.2038739;0.23392858;0.4028151
GO BP;POSITIVE REGULATION OF BMP SIGNALING PATHWAY;GO:0030513;25;-0.34634396;-1.203586;0.19789842;0.40304303
GO BP;REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY;GO:0010803;40;-0.30704054;-1.2028335;0.19584055;0.40430164
GO BP;EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY;GO:0007173;97;-0.25401068;-1.2020519;0.14983714;0.4055358
GO BP;MAMMARY GLAND DEVELOPMENT;GO:0030879;98;-0.25336552;-1.2020164;0.14626391;0.40523338
GO BP;REGULATION OF LYMPHOCYTE MIGRATION;GO:2000401;33;-0.31483698;-1.2019799;0.18954249;0.40491703
GO BP;REGULATION OF ANATOMICAL STRUCTURE SIZE;#N/A;328;-0.21387568;-1.2008667;0.09288824;0.4069553
GO BP;NEGATIVE REGULATION OF CELL MATRIX ADHESION;GO:0001953;27;-0.33412412;-1.2006186;0.20987654;0.4071032
GO BP;TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING;GO:0010833;74;-0.26620242;-1.2000272;0.17515923;0.4079811
GO BP;MUSCLE SYSTEM PROCESS;GO:0003012;254;-0.22072785;-1.1996766;0.09730539;0.40835625
GO BP;REGULATION OF DNA BIOSYNTHETIC PROCESS;GO:2000278;90;-0.26168618;-1.1987611;0.17147435;0.40991065
GO BP;REGULATION OF T CELL DIFFERENTIATION;GO:0045580;76;-0.2639487;-1.1984166;0.16721854;0.41029164
GO BP;NOTCH SIGNALING PATHWAY;GO:0007219;125;-0.24303097;-1.1983287;0.1505216;0.41009223
GO BP;EMBRYONIC MORPHOGENESIS;GO:0048598;387;-0.20963477;-1.1981773;0.07092199;0.41000473
GO BP;GTP METABOLIC PROCESS;GO:0046039;21;-0.3605958;-1.1976714;0.23445825;0.4107305
GO BP;RESPONSE TO PEPTIDE;#N/A;353;-0.21115774;-1.1973946;0.08183079;0.4109348
GO BP;GLYCOSYL COMPOUND METABOLIC PROCESS;#N/A;94;-0.25438136;-1.1970983;0.17694806;0.41122887
GO BP;CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION;GO:0021799;20;-0.35601485;-1.1969424;0.22404371;0.41120705
GO BP;NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY;GO:0033144;28;-0.3367928;-1.195668;0.21146953;0.4135967
GO BP;PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION;GO:0070198;29;-0.32936004;-1.1955552;0.22719449;0.41346848
GO BP;ENDOTHELIAL CELL MIGRATION;GO:0043542;140;-0.2371974;-1.1947855;0.1446541;0.414733
GO BP;REGULATION OF ION TRANSPORT;GO:0043269;321;-0.21266448;-1.1938192;0.09859155;0.4164329
GO BP;NEGATIVE REGULATION OF MACROAUTOPHAGY;GO:0016242;31;-0.31995696;-1.1926466;0.21342513;0.4186249
GO BP;RESPONSE TO ALCOHOL;GO:0097305;141;-0.23726411;-1.1922518;0.14593698;0.41911033
GO BP;PROTEIN K63 LINKED DEUBIQUITINATION;GO:0070536;28;-0.33536395;-1.1918156;0.22146508;0.41969427
GO BP;RECEPTOR MEDIATED ENDOCYTOSIS;GO:0006898;171;-0.2303123;-1.1916968;0.12998523;0.41955894
GO BP;ENERGY RESERVE METABOLIC PROCESS;GO:0006112;61;-0.27270606;-1.1910412;0.19303797;0.4206009
GO BP;CANONICAL WNT SIGNALING PATHWAY;GO:0060070;241;-0.22072984;-1.1909908;0.12244898;0.42030665
GO BP;POSITIVE REGULATION OF PROTEOLYSIS;GO:0045862;265;-0.21673821;-1.190681;0.11046512;0.42056987
GO BP;RESPONSE TO X RAY;GO:0010165;29;-0.329347;-1.1897743;0.21960072;0.42219415
GO BP;POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS;GO:0120162;65;-0.26851314;-1.1891072;0.16343042;0.42327937
GO BP;REGULATION OF METAL ION TRANSPORT;#N/A;195;-0.2236631;-1.188346;0.113354035;0.42458677
GO BP;CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT;GO:0072111;15;-0.39837822;-1.1878456;0.23411979;0.42528006
GO BP;PLASMA MEMBRANE ORGANIZATION;GO:0007009;70;-0.2650347;-1.1877816;0.19663866;0.42503697
GO BP;EYE PHOTORECEPTOR CELL DIFFERENTIATION;GO:0001754;25;-0.33913624;-1.1875432;0.2353952;0.42514804
GO BP;TORC1 SIGNALING;GO:0038202;37;-0.30578992;-1.186589;0.22016807;0.42687583
GO BP;REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION;#N/A;70;-0.26820287;-1.186309;0.17412935;0.4270554
GO BP;MICROTUBULE ANCHORING;GO:0034453;24;-0.3389743;-1.1851139;0.24172185;0.42932132
GO BP;REGULATION OF LEUKOCYTE DEGRANULATION;#N/A;29;-0.33058795;-1.1851104;0.21107267;0.4289303
GO BP;CARDIAC VENTRICLE MORPHOGENESIS;GO:0003208;49;-0.28861088;-1.1850624;0.19833334;0.42862147
GO BP;REGULATION OF KERATINOCYTE PROLIFERATION;GO:0010837;22;-0.34335485;-1.1850578;0.22563177;0.42823297
GO BP;ZINC ION HOMEOSTASIS;GO:0055069;21;-0.35762838;-1.1843632;0.21964286;0.4293884
GO BP;REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY;GO:1901016;24;-0.34523317;-1.1842402;0.2072072;0.4292356
GO BP;AMYLOID BETA METABOLIC PROCESS;GO:0050435;38;-0.30783328;-1.1840872;0.20767888;0.42917004
GO BP;UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY;GO:0043162;20;-0.3608068;-1.1838062;0.24394463;0.42942536
GO BP;LYMPHOCYTE COSTIMULATION;#N/A;29;-0.3295061;-1.1836747;0.23239437;0.42932138
GO BP;PLACENTA DEVELOPMENT;GO:0001890;114;-0.24285589;-1.183177;0.17218544;0.43010455
GO BP;BLOOD VESSEL MORPHOGENESIS;GO:0048514;375;-0.20860134;-1.183134;0.09762901;0.4298048
GO BP;POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY;GO:2000651;15;-0.3826438;-1.1814591;0.24027073;0.43310744
GO BP;LYMPHOCYTE MIGRATION;GO:0072676;48;-0.28459904;-1.181148;0.1967742;0.43343544
GO BP;MITOCHONDRIAL CALCIUM ION HOMEOSTASIS;GO:0051560;19;-0.36493695;-1.1808594;0.25309736;0.4336639
GO BP;NEGATIVE REGULATION OF PHOSPHORYLATION;GO:0042326;333;-0.21008049;-1.1803412;0.09809663;0.43445376
GO BP;ECTODERM DEVELOPMENT;GO:0007398;15;-0.3929388;-1.1798584;0.26024956;0.43518183
GO BP;VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION;GO:0010573;23;-0.3414747;-1.1791168;0.22702703;0.43640026
GO BP;REGULATION OF CELL SUBSTRATE ADHESION;GO:0010810;150;-0.2323914;-1.1790252;0.15197569;0.436206
GO BP;CELL SUBSTRATE JUNCTION ORGANIZATION;#N/A;77;-0.2596877;-1.1790212;0.18941979;0.4358223
GO BP;LACTATION;GO:0007595;35;-0.31107616;-1.1788944;0.21640489;0.43569878
GO BP;PIGMENT METABOLIC PROCESS;#N/A;50;-0.28557104;-1.1787714;0.2017094;0.43559718
GO BP;ENDOTHELIAL CELL PROLIFERATION;GO:0001935;84;-0.2562873;-1.1786928;0.18211383;0.43535653
GO BP;POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION;GO:0051495;169;-0.22801296;-1.1786171;0.15981735;0.43513113
GO BP;REGULATION OF VIRAL TRANSCRIPTION;GO:0046782;56;-0.27968398;-1.1777039;0.23050848;0.43684423
GO BP;REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING;GO:1904356;57;-0.2760792;-1.1775856;0.20727848;0.4367436
GO BP;TRANSCYTOSIS;GO:0045056;17;-0.3778614;-1.1759309;0.2637931;0.44020808
GO BP;CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING;#N/A;427;-0.2045071;-1.175754;0.09598854;0.4402127
GO BP;PROTEIN LOCALIZATION TO CELL SURFACE;GO:0034394;46;-0.29214844;-1.1756887;0.21702838;0.43998492
GO BP;REGULATION OF CELL CYCLE CHECKPOINT;#N/A;30;-0.32659623;-1.1752486;0.24070796;0.44061008
GO BP;REGULATION OF DEVELOPMENTAL GROWTH;GO:0048638;212;-0.22230732;-1.1743048;0.13157895;0.44237977
GO BP;PROTEIN DEPHOSPHORYLATION;GO:0006470;250;-0.21602608;-1.1742342;0.12987013;0.44214025
GO BP;CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT;GO:0021680;20;-0.3593878;-1.1739894;0.25394046;0.44226474
GO BP;PERIPHERAL NERVOUS SYSTEM DEVELOPMENT;GO:0007422;43;-0.29002652;-1.1739367;0.19800332;0.44198662
GO BP;RHO PROTEIN SIGNAL TRANSDUCTION;GO:0007266;150;-0.23143862;-1.1737232;0.15246637;0.44207233
GO BP;REGULATION OF SYNAPTIC VESICLE RECYCLING;#N/A;19;-0.3656074;-1.1735158;0.25823224;0.4421445
GO BP;REGULATION OF MITOCHONDRION ORGANIZATION;GO:0010821;149;-0.22943906;-1.1731676;0.16438356;0.44254377
GO BP;ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE;GO:0061951;55;-0.27921495;-1.173152;0.20166667;0.44218382
GO BP;RESPONSE TO TRANSFORMING GROWTH FACTOR BETA;GO:0071559;170;-0.22448732;-1.173014;0.13375796;0.44212052
GO BP;HINDBRAIN MORPHOGENESIS;GO:0021575;30;-0.31932902;-1.1728816;0.24028268;0.4420516
GO BP;NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT;#N/A;19;-0.35981146;-1.1724392;0.23716815;0.44261009
GO BP;SEX DIFFERENTIATION;GO:0007548;170;-0.22954482;-1.1722704;0.15905511;0.4425936
GO BP;ZINC ION TRANSMEMBRANE TRANSPORT;GO:0071577;17;-0.3715746;-1.1719483;0.24680074;0.4429585
GO BP;PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS;#N/A;158;-0.22847672;-1.1717734;0.15757576;0.44296896
GO BP;HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS;GO:0015012;17;-0.37645945;-1.1715606;0.22019868;0.4430991
GO BP;POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION;GO:0051057;46;-0.28742066;-1.1715512;0.22129783;0.4427372
GO BP;REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE;GO:0000083;24;-0.33770412;-1.1712712;0.23951049;0.44298872
GO BP;RESPONSE TO HEPATOCYTE GROWTH FACTOR;#N/A;15;-0.38024145;-1.1708057;0.22912966;0.44367823
GO BP;RESPONSE TO AMMONIUM ION;#N/A;88;-0.25298628;-1.1708056;0.17335473;0.44328633
GO BP;ADAPTIVE THERMOGENESIS;GO:1990845;106;-0.24795847;-1.1706346;0.17806041;0.4432837
GO BP;REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS;#N/A;26;-0.33164963;-1.1704574;0.23471074;0.44328567
GO BP;THIOESTER METABOLIC PROCESS;#N/A;86;-0.25615698;-1.1695142;0.19386107;0.44500178
GO BP;NEUROTRANSMITTER RECEPTOR TRANSPORT;#N/A;31;-0.31290418;-1.1689131;0.2460177;0.44597775
GO BP;REGULATION OF MAPK CASCADE;GO:0043408;470;-0.20122303;-1.1679499;0.09973046;0.44787034
GO BP;PITUITARY GLAND DEVELOPMENT;GO:0021983;15;-0.38890022;-1.1674575;0.27106228;0.4486228
GO BP;QUINONE METABOLIC PROCESS;#N/A;19;-0.3629865;-1.1674312;0.2672414;0.4482798
GO BP;REGULATION OF GROWTH;GO:0040008;446;-0.20270073;-1.1673394;0.0941337;0.44810098
GO BP;LEUKOCYTE CELL CELL ADHESION;GO:0007159;179;-0.22598602;-1.166828;0.17125382;0.44892082
GO BP;AMYLOID BETA FORMATION;GO:0034205;28;-0.32350597;-1.1666114;0.2301038;0.4490108
GO BP;T CELL DIFFERENTIATION;GO:0030217;131;-0.23715505;-1.1664006;0.16692914;0.44909355
GO BP;RESPONSE TO STARVATION;GO:0042594;147;-0.22927286;-1.1661497;0.15739268;0.44931746
GO BP;REGULATION OF HISTONE DEACETYLATION;GO:0031063;22;-0.34657088;-1.1661484;0.26737967;0.44892815
GO BP;CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS;GO:0021955;23;-0.34474152;-1.1659691;0.24615385;0.4489453
GO BP;COENZYME METABOLIC PROCESS;#N/A;209;-0.21930426;-1.1656015;0.13757396;0.4493544
GO BP;NEGATIVE REGULATION OF JNK CASCADE;GO:0046329;27;-0.3327147;-1.1650047;0.2555746;0.45030063
GO BP;COGNITION;GO:0050890;160;-0.22788379;-1.1648884;0.16666667;0.45019737
GO BP;ENDOTHELIUM DEVELOPMENT;GO:0003158;83;-0.25372064;-1.1648378;0.19651347;0.44992623
GO BP;CARBOHYDRATE METABOLIC PROCESS;GO:0005975;444;-0.2018311;-1.1646792;0.10533515;0.449892
GO BP;REGULATION OF REGULATED SECRETORY PATHWAY;GO:1903305;93;-0.248212;-1.1645124;0.1908397;0.4499059
GO BP;CELL CYCLE ARREST;GO:0007050;185;-0.22451681;-1.1644772;0.15933232;0.4496007
GO BP;REGULATION OF BINDING;GO:0051098;276;-0.21220264;-1.1642804;0.13922156;0.44966304
GO BP;MOLTING CYCLE PROCESS;#N/A;56;-0.272393;-1.1640136;0.221519;0.44985905
GO BP;PROTEIN ADP RIBOSYLATION;GO:0006471;30;-0.32051763;-1.163909;0.23979592;0.44970262
GO BP;NEGATIVE REGULATION OF PEPTIDASE ACTIVITY;GO:0010466;133;-0.23519474;-1.1634234;0.1856;0.4503874
GO BP;REGULATION OF CARBOHYDRATE METABOLIC PROCESS;#N/A;148;-0.22946769;-1.1628135;0.1726283;0.45137212
GO BP;SPLICEOSOMAL COMPLEX ASSEMBLY;GO:0000245;52;-0.2773814;-1.1625506;0.22073579;0.45157638
GO BP;REGULATION OF TRIGLYCERIDE METABOLIC PROCESS;GO:0090207;26;-0.33224976;-1.1620241;0.25084174;0.45239538
GO BP;GLUTAMINE METABOLIC PROCESS;GO:0006541;18;-0.36860874;-1.1603702;0.2770035;0.45574865
GO BP;REGULATION OF ALPHA BETA T CELL DIFFERENTIATION;#N/A;37;-0.29787365;-1.1596013;0.22934233;0.45715728
GO BP;CARDIAC CHAMBER DEVELOPMENT;#N/A;125;-0.23562679;-1.1594164;0.17767295;0.45721188
GO BP;EMBRYONIC PLACENTA DEVELOPMENT;GO:0001892;69;-0.2606933;-1.158586;0.20574163;0.45877212
GO BP;GLUCOSE METABOLIC PROCESS;GO:0006006;161;-0.22867143;-1.1580491;0.1745283;0.45964977
GO BP;LYMPHOCYTE DIFFERENTIATION;GO:0030098;192;-0.21923707;-1.1579925;0.16613925;0.45938158
GO BP;ACETYL COA BIOSYNTHETIC PROCESS;GO:0006085;22;-0.34620792;-1.1573384;0.24955437;0.46054515
GO BP;SNRNA PROCESSING;GO:0016180;24;-0.33152038;-1.1572105;0.27425373;0.4604621
GO BP;NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT;GO:0090317;32;-0.31238952;-1.1570822;0.25524476;0.46039012
GO BP;POSITIVE REGULATION OF POTASSIUM ION TRANSPORT;GO:0043268;18;-0.3615462;-1.1565092;0.26223776;0.46136245
GO BP;REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS;GO:1905897;74;-0.2578054;-1.1557912;0.22222222;0.46258718
GO BP;MRNA TRANSCRIPTION;GO:0009299;20;-0.35226464;-1.1557196;0.27758008;0.46236217
GO BP;NEGATIVE REGULATION OF PROTEIN BINDING;GO:0032091;64;-0.2622847;-1.1556666;0.22061191;0.46209496
GO BP;REGULATION OF TRANSPORTER ACTIVITY;#N/A;146;-0.2308555;-1.1555842;0.18224299;0.46187913
GO BP;MEIOTIC CELL CYCLE PROCESS;#N/A;139;-0.23039718;-1.155424;0.19384615;0.46185982
GO BP;REGULATION OF MRNA SPLICING VIA SPLICEOSOME;GO:0048024;86;-0.24800263;-1.1554103;0.2070626;0.46149713
GO BP;MRNA MODIFICATION;GO:0016556;20;-0.35242224;-1.1549306;0.2701252;0.46221095
GO BP;NEGATIVE REGULATION OF CELL DEVELOPMENT;GO:0010721;206;-0.21942686;-1.1546092;0.16369048;0.4625054
GO BP;EXOCYTIC PROCESS;#N/A;62;-0.26883674;-1.1540586;0.22968198;0.46342346
GO BP;REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY;GO:0040036;20;-0.35081524;-1.1538894;0.2668919;0.46342778
GO BP;CALCINEURIN MEDIATED SIGNALING;GO:0097720;35;-0.303793;-1.1533165;0.24747474;0.46438894
GO BP;MODIFICATION OF SYNAPTIC STRUCTURE;GO:0099563;21;-0.34598434;-1.1530281;0.26643598;0.46466804
GO BP;CEREBELLAR CORTEX DEVELOPMENT;GO:0021695;34;-0.31210107;-1.1529864;0.23920266;0.46436715
GO BP;NEURON DEATH;GO:0070997;244;-0.211498;-1.152986;0.13777778;0.46397495
GO BP;ESTABLISHMENT OR MAINTENANCE OF CYTOSKELETON POLARITY;#N/A;15;-0.37198707;-1.1528211;0.26923078;0.46395683
GO BP;HYDROGEN PEROXIDE METABOLIC PROCESS;GO:0042743;30;-0.31950626;-1.1521379;0.2614035;0.46523014
GO BP;ORGANOPHOSPHATE BIOSYNTHETIC PROCESS;#N/A;470;-0.1983407;-1.1517442;0.109266944;0.46577257
GO BP;TRANSLESION SYNTHESIS;GO:0019985;38;-0.29657444;-1.1516362;0.25344828;0.46563157
GO BP;MULTIVESICULAR BODY ORGANIZATION;GO:0036257;30;-0.3183379;-1.1513386;0.2607204;0.46594855
GO BP;OXIDOREDUCTION COENZYME METABOLIC PROCESS;#N/A;40;-0.29350147;-1.1511787;0.25;0.46591124
GO BP;MEMBRANE FUSION;GO:0061025;111;-0.2376093;-1.1510345;0.2030981;0.46586475
GO BP;VESICLE BUDDING FROM MEMBRANE;GO:0006900;89;-0.24829169;-1.1509184;0.2032258;0.46574208
GO BP;ERAD PATHWAY;GO:0036503;89;-0.24901427;-1.1502975;0.2111293;0.4666988
GO BP;RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS;GO:0046390;152;-0.22384305;-1.1495979;0.19379845;0.4679234
GO BP;NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS;#N/A;110;-0.23765478;-1.1492953;0.20487805;0.46825272
GO BP;NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS;GO:0009124;35;-0.30457044;-1.1492413;0.2300885;0.46798384
GO BP;POSITIVE REGULATION OF EXOCYTOSIS;GO:0045921;64;-0.2679945;-1.148699;0.21895425;0.46887398
GO BP;OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS;GO:0006490;17;-0.36810115;-1.1486776;0.26943943;0.46852404
GO BP;CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT;GO:0061005;29;-0.31271622;-1.1485155;0.23893805;0.46853605
GO BP;DEPHOSPHORYLATION;GO:0016311;374;-0.20214523;-1.148508;0.13571429;0.46815747
GO BP;VESICLE CYTOSKELETAL TRAFFICKING;GO:0099518;47;-0.2815141;-1.1484544;0.25324675;0.46787712
GO BP;SENSORY ORGAN DEVELOPMENT;GO:0007423;325;-0.20444456;-1.1480311;0.14327486;0.46853444
GO BP;POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II;GO:1902895;22;-0.34448302;-1.1479957;0.26101694;0.46823144
GO BP;NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS;GO:1903573;36;-0.30097312;-1.147393;0.26363635;0.469302
GO BP;EMBRYONIC DIGIT MORPHOGENESIS;GO:0042733;45;-0.28348133;-1.1471766;0.2600671;0.46942022
GO BP;MEIOTIC CHROMOSOME SEPARATION;GO:0051307;19;-0.35939533;-1.1467967;0.27438018;0.46990556
GO BP;NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT;GO:0010977;108;-0.23747425;-1.1464727;0.2224;0.47028664
GO BP;SCHWANN CELL DEVELOPMENT;GO:0014044;22;-0.34439644;-1.1461362;0.2785235;0.47072986
GO BP;ANGIOGENESIS INVOLVED IN WOUND HEALING;GO:0060055;15;-0.3747485;-1.1460339;0.2833935;0.47057235
GO BP;FOCAL ADHESION ASSEMBLY;GO:0048041;64;-0.26332843;-1.1458174;0.26588628;0.47068128
GO BP;PORE COMPLEX ASSEMBLY;GO:0046931;17;-0.35884827;-1.1455301;0.26711187;0.47099137
GO BP;REGULATION OF TRANSLATIONAL INITIATION;GO:0006446;67;-0.2601177;-1.1449842;0.25762713;0.47190875
GO BP;SMALL MOLECULE CATABOLIC PROCESS;#N/A;329;-0.20498061;-1.143972;0.13402061;0.47382715
GO BP;REGULATION OF CIRCADIAN RHYTHM;GO:0042752;81;-0.24940386;-1.1434674;0.22455573;0.47463515
GO BP;RETINA DEVELOPMENT IN CAMERA TYPE EYE;GO:0060041;93;-0.2438315;-1.1428374;0.21550387;0.47576487
GO BP;T CELL RECEPTOR SIGNALING PATHWAY;GO:0050852;132;-0.22994918;-1.1425353;0.20093457;0.47606722
GO BP;REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT;GO:1901379;36;-0.30363384;-1.1423614;0.26132405;0.47607338
GO BP;INSULIN RECEPTOR SIGNALING PATHWAY;GO:0008286;109;-0.23694368;-1.1423556;0.24012639;0.47569513
GO BP;CELLULAR RESPONSE TO ACID CHEMICAL;#N/A;131;-0.23237899;-1.1404579;0.20941558;0.4797778
GO BP;B CELL DIFFERENTIATION;GO:0030183;77;-0.25163332;-1.140367;0.25203252;0.47960606
GO BP;MULTICELLULAR ORGANISM AGING;GO:0010259;25;-0.32532576;-1.140235;0.2716263;0.47951132
GO BP;PROTEIN LOCALIZATION TO KINETOCHORE;GO:0034501;17;-0.359152;-1.1402316;0.27845883;0.47912562
GO BP;DNA SYNTHESIS INVOLVED IN DNA REPAIR;GO:0000731;46;-0.28312337;-1.1401287;0.2547332;0.4789627
GO BP;HYPEROSMOTIC RESPONSE;GO:0006972;20;-0.34574386;-1.1398169;0.29238755;0.4793477
GO BP;POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION;GO:0045687;23;-0.32937932;-1.1398095;0.275;0.47897568
GO BP;RESPONSE TO MANGANESE ION;GO:0010042;15;-0.38411567;-1.1396885;0.2869875;0.47888565
GO BP;POSITIVE REGULATION OF PROTEIN BINDING;GO:0032092;74;-0.25359195;-1.1392108;0.24161074;0.4796237
GO BP;CARDIAC VENTRICLE DEVELOPMENT;GO:0003231;92;-0.24481438;-1.138895;0.22006473;0.47999212
GO BP;WALKING BEHAVIOR;GO:0090659;18;-0.35251892;-1.1388283;0.27572817;0.47976443
GO BP;POSITIVE REGULATION OF WNT SIGNALING PATHWAY;GO:0030177;143;-0.22707072;-1.1384522;0.22289157;0.48026675
GO BP;REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT;GO:1902305;42;-0.28751013;-1.138319;0.25615764;0.48020628
GO BP;ANTERIOR POSTERIOR AXIS SPECIFICATION;GO:0009948;32;-0.30984938;-1.1376845;0.25043178;0.48134658
GO BP;POSITIVE REGULATION OF VASCULATURE DEVELOPMENT;#N/A;107;-0.23707028;-1.1370407;0.22439024;0.48245248
GO BP;ASYMMETRIC CELL DIVISION;GO:0008356;15;-0.38289723;-1.1370252;0.28869566;0.48209992
GO BP;INTERACTION WITH HOST;#N/A;153;-0.22597301;-1.1369386;0.21337579;0.4819031
GO BP;MUSCLE STRUCTURE DEVELOPMENT;GO:0061061;398;-0.19904722;-1.1369171;0.14958449;0.48156574
GO BP;POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY;GO:0051091;166;-0.22106193;-1.1367931;0.20268257;0.481455
GO BP;CELLULAR RESPONSE TO RADIATION;GO:0071478;135;-0.22868267;-1.1366432;0.19805194;0.48140612
GO BP;NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION;GO:0010801;16;-0.36450395;-1.136565;0.30265486;0.48119444
GO BP;CIRCADIAN RHYTHM;GO:0007623;141;-0.22526932;-1.1363082;0.20528771;0.481416
GO BP;REGULATION OF HAIR CYCLE;GO:0042634;20;-0.35040873;-1.135979;0.27580371;0.48180094
GO BP;PROTEIN AUTOPHOSPHORYLATION;GO:0046777;175;-0.22222349;-1.1358788;0.18779343;0.48166198
GO BP;CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT;GO:0060706;23;-0.33133546;-1.1356342;0.28892735;0.48184985
GO BP;REGULATION OF PROTEIN SUMOYLATION;GO:0033233;17;-0.37443912;-1.1351047;0.29307282;0.48269385
GO BP;EPITHELIAL TO MESENCHYMAL TRANSITION;GO:0001837;94;-0.24217476;-1.1349676;0.23655914;0.48263893
GO BP;PROTEIN CONTAINING COMPLEX DISASSEMBLY;GO:0032984;269;-0.2078242;-1.1343092;0.17359051;0.48380488
GO BP;NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE;GO:0045824;27;-0.3168711;-1.1342565;0.2652705;0.48353934
GO BP;REGULATION OF METALLOPEPTIDASE ACTIVITY;GO:1905048;16;-0.38018;-1.1335908;0.30418944;0.48468563
GO BP;MITOCHONDRIAL RNA PROCESSING;GO:0000963;16;-0.37647188;-1.1334502;0.30341113;0.48464942
GO BP;VENTRICULAR SEPTUM DEVELOPMENT;GO:0003281;55;-0.26870844;-1.1334296;0.25460637;0.48430818
GO BP;POSITIVE REGULATION OF ATP METABOLIC PROCESS;GO:1903580;30;-0.31170127;-1.1331922;0.270073;0.48451266
GO BP;REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE;GO:2000008;29;-0.3132316;-1.1331525;0.26666668;0.48422688
GO BP;LEARNING;GO:0007612;76;-0.25056905;-1.1323372;0.25293133;0.4857682
GO BP;REGULATION OF PROTEIN AUTOPHOSPHORYLATION;GO:0031952;32;-0.30814344;-1.1322843;0.29787233;0.48550537
GO BP;POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION;GO:0045639;56;-0.26473176;-1.1321756;0.2801358;0.48537642
GO BP;PHOSPHOLIPID BIOSYNTHETIC PROCESS;GO:0008654;219;-0.21087164;-1.1318866;0.20726173;0.48566404
GO BP;REGULATION OF AMYLOID BETA FORMATION;GO:1902003;22;-0.3331958;-1.1318774;0.29913044;0.4852984
GO BP;RESPONSE TO ANESTHETIC;GO:0072347;38;-0.29053938;-1.1316943;0.26863086;0.48539203
GO BP;POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY;#N/A;70;-0.25010747;-1.1304935;0.24114671;0.48773497
GO BP;RUFFLE ASSEMBLY;GO:0097178;35;-0.3011933;-1.1304609;0.2717949;0.4874297
GO BP;REGULATION OF EPITHELIAL CELL DIFFERENTIATION;GO:0030856;82;-0.24670921;-1.1302363;0.25081968;0.48753926
GO BP;CELLULAR RESPONSE TO CHEMICAL STRESS;#N/A;257;-0.20702294;-1.1296747;0.19724771;0.48844424
GO BP;RESPONSE TO GLUCAGON;GO:0033762;21;-0.34347808;-1.1295459;0.30105633;0.48838872
GO BP;REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY;#N/A;36;-0.29087797;-1.1282411;0.27302632;0.49113414
GO BP;EXTRACELLULAR VESICLE BIOGENESIS;GO:0140112;19;-0.3413724;-1.1277741;0.2867012;0.4918305
GO BP;REGULATION OF LAMELLIPODIUM ASSEMBLY;GO:0010591;23;-0.33163267;-1.1276667;0.30286738;0.49171975
GO BP;REGULATION OF LIPOPROTEIN LIPASE ACTIVITY;#N/A;15;-0.3704121;-1.1275613;0.29152542;0.49161518
GO BP;MOLTING CYCLE;#N/A;67;-0.2571467;-1.1268938;0.2689211;0.49280897
GO BP;LYSOSOME LOCALIZATION;GO:0032418;55;-0.26786402;-1.1263491;0.27331188;0.49375018
GO BP;REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT;GO:1903169;78;-0.24806456;-1.126079;0.25528455;0.4939917
GO BP;NUCLEAR ENVELOPE ORGANIZATION;GO:0006998;44;-0.28391555;-1.1259723;0.26166666;0.49384773
GO BP;NEGATIVE REGULATION OF DNA METABOLIC PROCESS;#N/A;94;-0.2431146;-1.1251984;0.24635333;0.49533367
GO BP;MALE GAMETE GENERATION;GO:0048232;327;-0.20070487;-1.1242051;0.17841727;0.49733832
GO BP;DEVELOPMENTAL MATURATION;#N/A;164;-0.21890494;-1.124058;0.2238806;0.49731585
GO BP;POSITIVE REGULATION OF DNA BINDING;GO:0043388;42;-0.28209314;-1.1240486;0.29577464;0.49694994
GO BP;MULTI ORGANISM BEHAVIOR;#N/A;31;-0.3014102;-1.123458;0.29038113;0.49796268
GO BP;NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION;GO:2000178;18;-0.3551408;-1.1231036;0.32310468;0.4983552
GO BP;REGULATION OF MUSCLE SYSTEM PROCESS;GO:0090257;140;-0.22292393;-1.123054;0.21815287;0.49808627
GO BP;2 OXOGLUTARATE METABOLIC PROCESS;GO:0006103;16;-0.3677553;-1.1229311;0.3121693;0.49799183
GO BP;DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR;GO:0030330;97;-0.23644377;-1.1223098;0.23439878;0.49912426
GO BP;MAMMARY GLAND DUCT MORPHOGENESIS;GO:0060603;19;-0.3499332;-1.1222153;0.30824372;0.49898046
GO BP;CARDIAC SEPTUM DEVELOPMENT;GO:0003279;85;-0.2439605;-1.1219058;0.25;0.49932274
GO BP;RECEPTOR SIGNALING PATHWAY VIA STAT;#N/A;74;-0.24986309;-1.1214614;0.2534722;0.4999976
GO BP;HOMEOSTASIS OF NUMBER OF CELLS;GO:0048872;175;-0.21859568;-1.1211886;0.22798742;0.50026083
GO BP;GLYCEROLIPID BIOSYNTHETIC PROCESS;#N/A;202;-0.21283305;-1.1211362;0.2;0.5000199
GO BP;POSITIVE REGULATION OF CELL ADHESION;GO:0045785;247;-0.20654061;-1.1210405;0.19331396;0.49985048
GO BP;SOMITE DEVELOPMENT;GO:0061053;51;-0.27007672;-1.1206735;0.26885247;0.50032485
GO BP;UROGENITAL SYSTEM DEVELOPMENT;GO:0001655;219;-0.20918497;-1.1202822;0.18942732;0.5008836
GO BP;DIACYLGLYCEROL METABOLIC PROCESS;GO:0046339;16;-0.3676861;-1.1202781;0.3097826;0.5005079
GO BP;REGULATION OF EPITHELIAL CELL MIGRATION;GO:0010632;161;-0.21832395;-1.1200451;0.22565688;0.50067425
GO BP;INTRACELLULAR STEROL TRANSPORT;GO:0032366;21;-0.33784416;-1.1198388;0.30152673;0.5007412
GO BP;FEMALE PREGNANCY;GO:0007565;119;-0.2306869;-1.1196398;0.2325228;0.5008465
GO BP;SOMITOGENESIS;GO:0001756;37;-0.285378;-1.1193761;0.26943004;0.501102
GO BP;AGING;GO:0007568;229;-0.2066581;-1.1185981;0.21810089;0.50262916
GO BP;VIRAL BUDDING VIA HOST ESCRT COMPLEX;GO:0039702;20;-0.34043318;-1.1179736;0.3200692;0.50374585
GO BP;CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS;GO:0071322;100;-0.23933776;-1.1179271;0.24605678;0.50347316
GO BP;INTEGRIN MEDIATED SIGNALING PATHWAY;GO:0007229;73;-0.2524682;-1.117158;0.26968175;0.50496644
GO BP;MEMBRANE INVAGINATION;GO:0010324;44;-0.2763589;-1.1168242;0.28819445;0.5053639
GO BP;PEPTIDYL THREONINE MODIFICATION;#N/A;95;-0.23902799;-1.1168;0.2532258;0.5050393
GO BP;RHYTHMIC PROCESS;GO:0048511;194;-0.21070533;-1.1165731;0.21837349;0.5051784
GO BP;LEUKOCYTE MEDIATED IMMUNITY;GO:0002443;478;-0.19249326;-1.1160696;0.18104668;0.50603664
GO BP;MATURATION OF SSU RRNA;GO:0030490;46;-0.27300522;-1.1159523;0.29146537;0.5059293
GO BP;NEGATIVE REGULATION OF CHROMATIN SILENCING;GO:0031936;15;-0.36904794;-1.115643;0.29924244;0.5062773
GO BP;UBIQUITIN DEPENDENT ERAD PATHWAY;GO:0030433;70;-0.25188154;-1.1155833;0.273906;0.5060297
GO BP;POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS;#N/A;25;-0.31834173;-1.115524;0.30927834;0.5057799
GO BP;BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS;GO:0060444;16;-0.36608163;-1.1144772;0.35081375;0.50793016
GO BP;GASTRULATION;GO:0007369;133;-0.22428462;-1.1139501;0.25281805;0.5088636
GO BP;POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY;GO:0090263;114;-0.22670639;-1.1136711;0.24603175;0.5091086
GO BP;REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION;GO:0035023;105;-0.233052;-1.1135433;0.25379938;0.5090175
GO BP;OSTEOCLAST DIFFERENTIATION;GO:0030316;56;-0.26504442;-1.113489;0.281198;0.5087584
GO BP;REGULATION OF EXOCYTOSIS;GO:0017157;141;-0.2236005;-1.1132891;0.23831071;0.5088681
GO BP;CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE;GO:0036474;19;-0.34189746;-1.1128719;0.28596187;0.50950384
GO BP;REGULATION OF MACROPHAGE ACTIVATION;GO:0043030;27;-0.31081206;-1.1124742;0.31727573;0.5100743
GO BP;RETINOIC ACID RECEPTOR SIGNALING PATHWAY;GO:0048384;21;-0.3387312;-1.1124592;0.3041237;0.50972635
GO BP;EMBRYONIC CAMERA TYPE EYE DEVELOPMENT;GO:0031076;22;-0.33108038;-1.1122183;0.3265306;0.50989425
GO BP;MITOCHONDRION LOCALIZATION;GO:0051646;38;-0.28560483;-1.1118805;0.30956239;0.5103264
GO BP;REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY;GO:2001242;135;-0.2226738;-1.1113445;0.2456964;0.511205
GO BP;MYELOID CELL DIFFERENTIATION;GO:0030099;284;-0.20238262;-1.1107067;0.20754717;0.51229197
GO BP;POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION;GO:0051149;53;-0.2656398;-1.1106042;0.3;0.5121417
GO BP;REGULATION OF CELL ADHESION;GO:0030155;430;-0.19342571;-1.1100359;0.18398876;0.5130782
GO BP;HISTONE H3 K27 METHYLATION;GO:0070734;18;-0.35108697;-1.1100318;0.29502574;0.5126987
GO BP;POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY;GO:1901890;24;-0.32615098;-1.1094608;0.30823117;0.5136989
GO BP;POSITIVE REGULATION OF NEURON DEATH;GO:1901216;75;-0.24810407;-1.1086454;0.29579833;0.51531833
GO BP;CELLULAR AMINO ACID CATABOLIC PROCESS;GO:0009063;95;-0.23876803;-1.1075585;0.26393443;0.51756
GO BP;REGULATION OF VESICLE MEDIATED TRANSPORT;GO:0060627;374;-0.19536598;-1.1065779;0.20630373;0.51957273
GO BP;REGULATION OF APOPTOTIC SIGNALING PATHWAY;#N/A;313;-0.19799566;-1.106525;0.20592384;0.5193213
GO BP;POSITIVE REGULATION OF DNA RECOMBINATION;GO:0045911;28;-0.30412838;-1.1062062;0.3088737;0.5197478
GO BP;RECEPTOR INTERNALIZATION;GO:0031623;64;-0.25478697;-1.1058706;0.2885572;0.5201561
GO BP;BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE;GO:0048754;88;-0.23603858;-1.1058397;0.2617886;0.5198502
GO BP;AORTA DEVELOPMENT;GO:0035904;40;-0.2819195;-1.1048495;0.3229508;0.52191347
GO BP;CELL CELL ADHESION;GO:0098609;449;-0.19021964;-1.1044078;0.19662921;0.52261
GO BP;REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS;GO:2000377;121;-0.22408077;-1.1042504;0.24920128;0.52259713
GO BP;RESPONSE TO AMYLOID BETA;GO:1904645;25;-0.31765482;-1.1041538;0.32142857;0.52245134
GO BP;POSITIVE REGULATION OF INSULIN SECRETION;GO:0032024;47;-0.26932147;-1.1038007;0.31028667;0.52291596
GO BP;STEM CELL DIVISION;GO:0017145;32;-0.2890583;-1.1034214;0.3;0.5234513
GO BP;CARBOHYDRATE TRANSMEMBRANE TRANSPORT;GO:0034219;77;-0.2433161;-1.1031526;0.29588607;0.5237289
GO BP;NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING;GO:1904357;25;-0.31639925;-1.1022918;0.31958762;0.5254923
GO BP;LYMPHOCYTE ACTIVATION;GO:0046649;376;-0.19286485;-1.1019309;0.19783197;0.52599174
GO BP;T CELL DIFFERENTIATION IN THYMUS;GO:0033077;42;-0.27651548;-1.1013017;0.2901024;0.52709967
GO BP;PSEUDOURIDINE SYNTHESIS;GO:0001522;17;-0.35816646;-1.1011388;0.3216783;0.5270898
GO BP;RESPONSE TO STEROL;#N/A;22;-0.32587487;-1.1010734;0.31323284;0.52685016
GO BP;STRIATED MUSCLE CELL DIFFERENTIATION;GO:0051146;167;-0.21103221;-1.1009874;0.23574731;0.5267089
GO BP;FATTY ACID DERIVATIVE METABOLIC PROCESS;#N/A;97;-0.2335898;-1.1007886;0.29329172;0.52683043
GO BP;T CELL ACTIVATION;GO:0042110;253;-0.2017766;-1.0997143;0.23303835;0.5290435
GO BP;RESPONSE TO FLUID SHEAR STRESS;GO:0034405;27;-0.30876806;-1.0990419;0.31698775;0.530358
GO BP;RESPONSE TO WOUNDING;GO:0009611;429;-0.19018312;-1.0987649;0.19645293;0.53063685
GO BP;POSITIVE REGULATION OF NUCLEAR DIVISION;#N/A;46;-0.2753129;-1.09876;0.3277027;0.5302588
GO BP;REGULATION OF EPIDERMIS DEVELOPMENT;GO:0045682;57;-0.25753355;-1.0984592;0.3117932;0.5305848
GO BP;REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION;GO:0051153;59;-0.25726002;-1.0979624;0.29354838;0.53146154
GO BP;REGULATION OF SYNAPTIC PLASTICITY;GO:0048167;102;-0.22882463;-1.0976825;0.272578;0.5317498
GO BP;REGULATION OF CELL SUBSTRATE JUNCTION ASSEMBLY;#N/A;47;-0.26642644;-1.0974507;0.3148148;0.53197306
GO BP;B CELL HOMEOSTASIS;GO:0001782;20;-0.33511806;-1.096907;0.32761577;0.5329583
GO BP;ALPHA AMINO ACID BIOSYNTHETIC PROCESS;#N/A;52;-0.26247913;-1.0965347;0.30995107;0.5334893
GO BP;PROTEIN PALMITOYLATION;GO:0018345;29;-0.29431367;-1.0963981;0.31932774;0.53344464
GO BP;REGULATION OF ACTIN CYTOSKELETON REORGANIZATION;GO:2000249;28;-0.3099143;-1.0958335;0.33105803;0.53445125
GO BP;CELLULAR RESPONSE TO CALCIUM ION;GO:0071277;47;-0.26746702;-1.0957693;0.31239936;0.534231
GO BP;REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY;GO:0051090;279;-0.19830476;-1.0953462;0.24783862;0.53486973
GO BP;ADULT BEHAVIOR;GO:0030534;74;-0.24533004;-1.0944604;0.28064516;0.5366586
GO BP;POLYSACCHARIDE BIOSYNTHETIC PROCESS;GO:0000271;56;-0.25725564;-1.094235;0.31078905;0.5367748
GO BP;INOSITOL PHOSPHATE MEDIATED SIGNALING;GO:0048016;39;-0.27763504;-1.0936699;0.31141868;0.5378169
GO BP;NEGATIVE REGULATION OF KINASE ACTIVITY;GO:0033673;192;-0.20799655;-1.0934614;0.26397514;0.53795004
GO BP;OOCYTE DIFFERENTIATION;GO:0009994;27;-0.30792934;-1.0934546;0.33910036;0.5375723
GO BP;COENZYME A METABOLIC PROCESS;GO:0015936;15;-0.36277226;-1.0934074;0.3357271;0.5372889
GO BP;NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION;GO:0031345;129;-0.22069569;-1.0927867;0.29027113;0.538431
GO BP;RNA DEPENDENT DNA BIOSYNTHETIC PROCESS;GO:0006278;67;-0.24884526;-1.0926852;0.29508197;0.53825355
GO BP;MITOCHONDRIAL GENOME MAINTENANCE;GO:0000002;20;-0.33217946;-1.0926666;0.32715008;0.5379062
GO BP;ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE;GO:0072594;475;-0.18783659;-1.0925231;0.22222222;0.5378868
GO BP;RESPONSE TO NUTRIENT;GO:0007584;149;-0.21542636;-1.0925062;0.28477904;0.53753525
GO BP;BASEMENT MEMBRANE ORGANIZATION;GO:0071711;23;-0.3193974;-1.0924454;0.3286219;0.53730774
GO BP;POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION;#N/A;150;-0.21705918;-1.0920738;0.27740863;0.53786236
GO BP;RESPONSE TO TYPE I INTERFERON;GO:0034340;56;-0.260004;-1.0917361;0.32258064;0.5382848
GO BP;HEME BIOSYNTHETIC PROCESS;GO:0006783;21;-0.3286455;-1.090808;0.33557048;0.5402703
GO BP;UBIQUINONE METABOLIC PROCESS;GO:0006743;16;-0.35390204;-1.0901763;0.34519574;0.541368
GO BP;FAT SOLUBLE VITAMIN METABOLIC PROCESS;#N/A;20;-0.3309732;-1.0899233;0.33391917;0.5416235
GO BP;POSITIVE REGULATION OF MAP KINASE ACTIVITY;GO:0043406;184;-0.20667927;-1.089095;0.24441132;0.5432451
GO BP;RIG I SIGNALING PATHWAY;GO:0039529;15;-0.36047614;-1.0889573;0.36624774;0.54321027
GO BP;ENDOTHELIAL CELL CHEMOTAXIS;GO:0035767;15;-0.36481112;-1.0889388;0.35636362;0.5428595
GO BP;CARDIAC CELL DEVELOPMENT;GO:0055006;54;-0.2582626;-1.0886307;0.32597622;0.54323196
GO BP;INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY;#N/A;80;-0.24037583;-1.0878799;0.3028846;0.54467857
GO BP;REGULATION OF KIDNEY DEVELOPMENT;#N/A;29;-0.3000428;-1.0878694;0.3368984;0.544312
GO BP;REGULATION OF TRANS SYNAPTIC SIGNALING;#N/A;244;-0.20203914;-1.087744;0.2748538;0.5442467
GO BP;POSITIVE REGULATION OF SYNAPTIC TRANSMISSION;GO:0050806;85;-0.23018597;-1.0873395;0.29103214;0.5448678
GO BP;REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY;GO:1900449;27;-0.30393627;-1.0872502;0.3545611;0.5447153
GO BP;REGULATION OF COLLATERAL SPROUTING;GO:0048670;15;-0.35883984;-1.0866882;0.35929203;0.5457509
GO BP;REGULATION OF MAST CELL ACTIVATION;GO:0033003;24;-0.32080564;-1.0864111;0.342246;0.54606265
GO BP;POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY;GO:1903307;34;-0.28842723;-1.0856628;0.32124352;0.5475747
GO BP;CYTOSOLIC CALCIUM ION TRANSPORT;#N/A;100;-0.22878888;-1.0844624;0.30333334;0.5502115
GO BP;STEROL METABOLIC PROCESS;GO:0016125;120;-0.22137363;-1.083794;0.30254778;0.5515039
GO BP;REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION;GO:0045601;19;-0.33699924;-1.0833441;0.3532423;0.55224717
GO BP;REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN;GO:0033628;33;-0.28896302;-1.0828514;0.33626762;0.5531285
GO BP;FORMATION OF PRIMARY GERM LAYER;GO:0001704;82;-0.23590071;-1.0828121;0.30595812;0.55282027
GO BP;POSITIVE REGULATION OF ERBB SIGNALING PATHWAY;GO:1901186;23;-0.31673506;-1.0826068;0.3512545;0.55296606
GO BP;MUSCLE CELL DIFFERENTIATION;GO:0042692;222;-0.20092195;-1.0824195;0.27083334;0.55305964
GO BP;HINDBRAIN DEVELOPMENT;GO:0030902;90;-0.22983883;-1.081886;0.33385336;0.55402744
GO BP;POSITIVE REGULATION OF BINDING;GO:0051099;138;-0.21474998;-1.0817806;0.2961832;0.5538908
GO BP;NEGATIVE REGULATION OF ANION TRANSPORT;#N/A;15;-0.36243913;-1.0817207;0.35017422;0.5536171
GO BP;CHROMATIN ASSEMBLY;GO:0031497;123;-0.22035436;-1.0813576;0.30650154;0.55413485
GO BP;NEGATIVE REGULATION OF DNA REPAIR;#N/A;28;-0.30236733;-1.0813462;0.35438597;0.55376667
GO BP;INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY;GO:0030520;42;-0.27034485;-1.0812098;0.35945484;0.55371594
GO BP;NEURAL TUBE PATTERNING;GO:0021532;29;-0.3000279;-1.0807328;0.3381555;0.55452025
GO BP;SENSORY ORGAN MORPHOGENESIS;#N/A;146;-0.21152249;-1.0792934;0.28661418;0.5577661
GO BP;ALPHA BETA T CELL DIFFERENTIATION;GO:0046632;55;-0.25584516;-1.0792274;0.3294893;0.55751777
GO BP;EMBRYONIC EYE MORPHOGENESIS;GO:0048048;19;-0.3393036;-1.078912;0.35273972;0.5579361
GO BP;NATURAL KILLER CELL ACTIVATION;GO:0030101;34;-0.2851647;-1.0784668;0.35628226;0.5586706
GO BP;NEGATIVE REGULATION OF TRANSPORTER ACTIVITY;GO:0032410;41;-0.2709732;-1.0781872;0.32879046;0.5589663
GO BP;NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT;GO:0034763;67;-0.24458495;-1.0778278;0.31907895;0.559518
GO BP;POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION;GO:0032735;18;-0.3353109;-1.0775344;0.3430127;0.55985874
GO BP;NEGATIVE REGULATION OF TELOMERE MAINTENANCE;GO:0032205;33;-0.2928411;-1.0771506;0.35272726;0.5603803
GO BP;REGULATION OF GENE SILENCING;#N/A;129;-0.217329;-1.0765592;0.30407524;0.5615314
GO BP;REGULATION OF PROTEIN DEACETYLATION;GO:0090311;34;-0.28867245;-1.0765499;0.3423729;0.56116325
GO BP;NECROTIC CELL DEATH;GO:0070265;39;-0.28304556;-1.076135;0.33901194;0.5618403
GO BP;PHOSPHATIDIC ACID METABOLIC PROCESS;GO:0046473;29;-0.29780287;-1.075999;0.35852373;0.56175756
GO BP;REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS;#N/A;181;-0.20416008;-1.0757991;0.3062787;0.56188816
GO BP;REGULATION OF CELL CYCLE ARREST;GO:0071156;82;-0.2348455;-1.0757748;0.32189542;0.561542
GO BP;POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT;#N/A;23;-0.31454572;-1.0746799;0.36363637;0.5638569
GO BP;REGULATION OF VASCULATURE DEVELOPMENT;GO:1901342;198;-0.20471482;-1.0743507;0.2876304;0.56427765
GO BP;POST TRANSLATIONAL PROTEIN MODIFICATION;GO:0043687;285;-0.19420257;-1.0739992;0.29839882;0.5648011
GO BP;DNA CATABOLIC PROCESS;GO:0006308;32;-0.28413266;-1.0734644;0.3626943;0.56580114
GO BP;GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR;#N/A;25;-0.30349582;-1.0730985;0.34117648;0.566303
GO BP;INTERFERON BETA PRODUCTION;GO:0032608;40;-0.27044567;-1.0723892;0.3608769;0.56771034
GO BP;MEMBRANE RAFT ORGANIZATION;GO:0031579;16;-0.35114935;-1.0722404;0.38376385;0.5676912
GO BP;REGULATION OF T CELL MIGRATION;GO:2000404;25;-0.3094294;-1.0719471;0.36013985;0.5680145
GO BP;ORGANIC ACID CATABOLIC PROCESS;#N/A;212;-0.2037063;-1.0717221;0.2962963;0.5681957
GO BP;POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS;#N/A;17;-0.34603032;-1.07145;0.35334477;0.5684958
GO BP;REGULATION OF LIPID CATABOLIC PROCESS;GO:0050994;35;-0.2815395;-1.0713134;0.3523316;0.56844133
GO BP;POSITIVE REGULATION OF PROTEIN POLYMERIZATION;GO:0032273;96;-0.22658792;-1.071281;0.31962025;0.56813216
GO BP;NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS;GO:0009226;21;-0.32282013;-1.0704476;0.3653846;0.56987876
GO BP;POSITIVE REGULATION OF DEPHOSPHORYLATION;GO:0035306;42;-0.27023074;-1.0703174;0.35614035;0.5698146
GO BP;FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS;#N/A;64;-0.24412927;-1.0696492;0.34210527;0.57111025
GO BP;MONOSACCHARIDE BIOSYNTHETIC PROCESS;#N/A;74;-0.2376458;-1.0683975;0.34248787;0.57389945
GO BP;RESPONSE TO ANTIBIOTIC;GO:0046677;217;-0.20149364;-1.068268;0.31428573;0.5738178
GO BP;RESPONSE TO MURAMYL DIPEPTIDE;GO:0032495;15;-0.35651866;-1.0680995;0.38018018;0.5738764
GO BP;ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY;#N/A;37;-0.2804706;-1.0678616;0.3529412;0.5740622
GO BP;POLYSACCHARIDE METABOLIC PROCESS;#N/A;80;-0.23556176;-1.0678264;0.3305509;0.5737458
GO BP;SYNAPTIC SIGNALING;GO:0099536;366;-0.18791793;-1.0677888;0.27510917;0.57343394
GO BP;RENAL SYSTEM DEVELOPMENT;#N/A;193;-0.20395516;-1.0668857;0.3122172;0.57529926
GO BP;EMBRYONIC ORGAN DEVELOPMENT;GO:0048568;272;-0.19535273;-1.0668308;0.30465445;0.5750599
GO BP;CARDIAC MUSCLE CELL DIFFERENTIATION;GO:0055007;78;-0.23424652;-1.0664512;0.3232;0.5756564
GO BP;PATTERN SPECIFICATION PROCESS;GO:0007389;247;-0.19558387;-1.0657732;0.30422124;0.5769747
GO BP;BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS;GO:0001569;18;-0.32882774;-1.0656015;0.37230214;0.57699996
GO BP;REGULATION OF MYELINATION;GO:0031641;29;-0.28954268;-1.0654585;0.36624774;0.57698923
GO BP;NEUROTRANSMITTER UPTAKE;GO:0001504;23;-0.31439012;-1.0652223;0.3714789;0.5772129
GO BP;DOPAMINE RECEPTOR SIGNALING PATHWAY;GO:0007212;20;-0.32085636;-1.0650679;0.3766892;0.57721275
GO BP;REGULATION OF RECEPTOR RECYCLING;GO:0001919;20;-0.32196766;-1.0650558;0.36166668;0.5768419
GO BP;BASE EXCISION REPAIR;GO:0006284;41;-0.2719595;-1.0648221;0.34871796;0.577067
GO BP;NEGATIVE REGULATION OF DENDRITE DEVELOPMENT;GO:2000171;21;-0.3219154;-1.0645473;0.37017545;0.57739776
GO BP;ENDOCYTOSIS;GO:0006897;382;-0.1869425;-1.0641779;0.28939828;0.5780244
GO BP;MORPHOGENESIS OF A BRANCHING STRUCTURE;GO:0001763;117;-0.21831764;-1.0640409;0.33868378;0.5779793
GO BP;RESPONSE TO COCAINE;GO:0042220;27;-0.30047134;-1.0638496;0.37985864;0.5781084
GO BP;NEUROMUSCULAR PROCESS CONTROLLING BALANCE;GO:0050885;30;-0.29048553;-1.0622091;0.38602328;0.5819652
GO BP;MUSCLE HYPERTROPHY;GO:0014896;61;-0.24793306;-1.062049;0.34710744;0.581943
GO BP;VIRAL BUDDING;GO:0046755;24;-0.3153515;-1.0619527;0.3717728;0.58177394
GO BP;RESPONSE TO INTERLEUKIN 7;#N/A;31;-0.29031575;-1.0619367;0.3618881;0.5814096
GO BP;TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER;GO:0006367;149;-0.2095754;-1.0617115;0.3328125;0.58157367
GO BP;NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY;#N/A;28;-0.29468688;-1.0616922;0.37954938;0.58122694
GO BP;MEGAKARYOCYTE DIFFERENTIATION;GO:0030219;68;-0.23878102;-1.0616305;0.35955057;0.5809788
GO BP;ENDOCRINE PROCESS;#N/A;37;-0.27647617;-1.0614371;0.3644068;0.58110625
GO BP;JNK CASCADE;GO:0007254;150;-0.20899628;-1.061163;0.3317152;0.58140934
GO BP;PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING;GO:0014065;95;-0.22518975;-1.0609746;0.3535032;0.5815007
GO BP;IMPORT INTO CELL;#N/A;465;-0.18208079;-1.0600238;0.2926491;0.5835071
GO BP;PROTEIN LOCALIZATION TO MEMBRANE;GO:0072657;493;-0.18283863;-1.0596818;0.28765264;0.5839506
GO BP;REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY;GO:2001236;109;-0.22013725;-1.0591389;0.35573772;0.5849616
GO BP;DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE;GO:0042769;36;-0.27701277;-1.0590833;0.37456447;0.58471984
GO BP;FEMALE GAMETE GENERATION;GO:0007292;85;-0.23027696;-1.0587585;0.32013202;0.58512443
GO BP;REGULATION OF T HELPER CELL DIFFERENTIATION;#N/A;16;-0.34840268;-1.058142;0.38475177;0.5862847
GO BP;REGULATION OF CALCINEURIN MEDIATED SIGNALING;GO:0106056;27;-0.30165327;-1.0579206;0.39491525;0.5864545
GO BP;NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY;GO:2001234;176;-0.20362699;-1.057781;0.3152338;0.5863945
GO BP;INTRACELLULAR LIPID TRANSPORT;#N/A;39;-0.26931658;-1.0573535;0.37353435;0.58710724
GO BP;NEGATIVE REGULATION OF NEURON DIFFERENTIATION;GO:0045665;140;-0.2096965;-1.0571421;0.32647058;0.587272
GO BP;BEHAVIOR;GO:0007610;313;-0.1880992;-1.0569286;0.32326284;0.587424
GO BP;METENCEPHALON DEVELOPMENT;GO:0022037;71;-0.23885825;-1.0564296;0.3403909;0.58827895
GO BP;NON CANONICAL WNT SIGNALING PATHWAY;GO:0035567;116;-0.21689789;-1.0560151;0.3546875;0.5888765
GO BP;CELL RECOGNITION;GO:0008037;67;-0.23594442;-1.055861;0.35016286;0.5888793
GO BP;RESPONSE TO OXYGEN LEVELS;#N/A;288;-0.19078386;-1.0557171;0.2980333;0.5888245
GO BP;CARBOHYDRATE DERIVATIVE TRANSPORT;#N/A;60;-0.24264614;-1.0554944;0.37688443;0.58897865
GO BP;LIPID LOCALIZATION;GO:0010876;255;-0.19441116;-1.0548736;0.33848315;0.5901517
GO BP;DETERMINATION OF HEART LEFT RIGHT ASYMMETRY;GO:0061371;48;-0.25791156;-1.0548588;0.36573312;0.5897923
GO BP;POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION;GO:0030858;28;-0.29563436;-1.0542891;0.3913793;0.5908596
GO BP;RESPONSE TO METAL ION;GO:0010038;238;-0.19594747;-1.0542314;0.32868218;0.59060293
GO BP;THYMUS DEVELOPMENT;GO:0048538;31;-0.2825912;-1.0533038;0.37889272;0.5925928
GO BP;POSITIVE REGULATION OF JNK CASCADE;GO:0046330;95;-0.22335988;-1.0529407;0.38724726;0.59312606
GO BP;ERK1 AND ERK2 CASCADE;GO:0070371;177;-0.20316064;-1.0528396;0.33282673;0.5929879
GO BP;RESPONSE TO INTERLEUKIN 6;GO:0070741;24;-0.31264186;-1.0526594;0.38235295;0.59305596
GO BP;PLATELET DEGRANULATION;GO:0002576;84;-0.22778994;-1.0515964;0.3536184;0.59536254
GO BP;DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS;GO:0009200;15;-0.35321164;-1.0515361;0.40884957;0.5951191
GO BP;MONOSACCHARIDE METABOLIC PROCESS;GO:0005996;215;-0.19732949;-1.0513667;0.3402367;0.5951885
GO BP;NEGATIVE REGULATION OF CELL MOTILITY;GO:2000146;176;-0.20091558;-1.0512009;0.3474962;0.59523547
GO BP;POSITIVE REGULATION OF CELL CYCLE ARREST;GO:0071158;66;-0.23767687;-1.0508761;0.3401015;0.5956764
GO BP;LIPID PHOSPHORYLATION;GO:0046834;49;-0.25018623;-1.050452;0.35332254;0.5963515
GO BP;ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE;GO:0070200;18;-0.32997644;-1.0500851;0.40687162;0.596835
GO BP;PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS;#N/A;22;-0.31298053;-1.0496898;0.40206185;0.59742004
GO BP;RESPONSE TO OXIDATIVE STRESS;GO:0006979;334;-0.18531093;-1.0496496;0.34005764;0.5971331
GO BP;REGULATION OF ACTIN NUCLEATION;GO:0051125;21;-0.31725013;-1.0489074;0.37800688;0.5986416
GO BP;PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS;GO:0006656;36;-0.272031;-1.0481495;0.3888889;0.6001404
GO BP;NEGATIVE REGULATION OF RESPONSE TO DRUG;#N/A;16;-0.34204048;-1.0478842;0.39311594;0.60039234
GO BP;NEGATIVE REGULATION OF CELL DIFFERENTIATION;GO:0045596;427;-0.18422593;-1.0476377;0.3122421;0.6006334
GO BP;POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION;GO:0010595;74;-0.23410068;-1.0476013;0.36885247;0.60032326
GO BP;VERY LONG CHAIN FATTY ACID METABOLIC PROCESS;GO:0000038;24;-0.30467716;-1.0475855;0.37417218;0.59996605
GO BP;PHOTORECEPTOR CELL DIFFERENTIATION;#N/A;32;-0.28197873;-1.0474377;0.38488576;0.59995687
GO BP;NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY;GO:2000117;63;-0.24031548;-1.046589;0.37520662;0.60165626
GO BP;REGULATION OF PEPTIDASE ACTIVITY;GO:0052547;268;-0.19093812;-1.0462512;0.33734939;0.60215116
GO BP;TELOMERE ORGANIZATION;GO:0032200;153;-0.20487702;-1.044606;0.36307693;0.60609066
GO BP;REGULATION OF RESPONSE TO CYTOKINE STIMULUS;#N/A;115;-0.2127942;-1.0442411;0.35980552;0.6066365
GO BP;SCHWANN CELL DIFFERENTIATION;GO:0014037;28;-0.28756112;-1.043991;0.40034366;0.6069205
GO BP;NEGATIVE REGULATION OF BINDING;#N/A;109;-0.21635379;-1.0436393;0.36193448;0.607394
GO BP;UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS;GO:0006636;38;-0.26440483;-1.0428404;0.39514732;0.6090931
GO BP;HOMOLOGOUS RECOMBINATION;GO:0035825;44;-0.26178753;-1.0422829;0.38793105;0.6101117
GO BP;CONNECTIVE TISSUE DEVELOPMENT;GO:0061448;155;-0.20479764;-1.0420958;0.3832061;0.6101724
GO BP;POSITIVE REGULATION OF VIRAL TRANSCRIPTION;GO:0050434;39;-0.26986426;-1.0418949;0.39527026;0.6103051
GO BP;CELLULAR RESPONSE TO STEROL;GO:0036315;16;-0.33959812;-1.041721;0.3859964;0.61032665
GO BP;ROOF OF MOUTH DEVELOPMENT;GO:0060021;62;-0.24019332;-1.040328;0.38844302;0.6134628
GO BP;DIGESTIVE SYSTEM PROCESS;#N/A;44;-0.25941488;-1.0399578;0.4067227;0.6140514
GO BP;TRNA MODIFICATION;GO:0006400;75;-0.23091754;-1.0391351;0.40464345;0.6158444
GO BP;REGULATION OF ACTIN FILAMENT BASED MOVEMENT;#N/A;30;-0.2865144;-1.038376;0.39652175;0.61743206
GO BP;POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS;#N/A;35;-0.27438426;-1.0383172;0.3946037;0.6171736
GO BP;EPITHELIAL CELL APOPTOTIC PROCESS;GO:1904019;69;-0.23344167;-1.038217;0.3762712;0.6170083
GO BP;INTERACTION WITH SYMBIONT;GO:0051702;52;-0.24587151;-1.0377756;0.4091653;0.6177584
GO BP;NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION;GO:0010812;47;-0.2533998;-1.0365069;0.37710437;0.62059766
GO BP;ACTIVATION OF PROTEIN KINASE ACTIVITY;GO:0032147;241;-0.19188368;-1.0360382;0.371134;0.6214163
GO BP;MYELOID CELL HOMEOSTASIS;GO:0002262;113;-0.21651986;-1.0359099;0.384127;0.62134176
GO BP;NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT;#N/A;52;-0.24761038;-1.0358391;0.40468228;0.6211053
GO BP;MUSCLE ADAPTATION;#N/A;74;-0.22764488;-1.0352502;0.39765102;0.62222266
GO BP;POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS;GO:0060760;33;-0.28036883;-1.0350804;0.38045377;0.6222388
GO BP;REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS;#N/A;25;-0.29758558;-1.03464;0.40207973;0.62295943
GO BP;MRNA CLEAVAGE;GO:0006379;21;-0.31487727;-1.0342871;0.41725352;0.6234451
GO BP;REGULATION OF SYNAPTIC VESICLE CYCLE;GO:0098693;65;-0.23574422;-1.0342067;0.3786078;0.6232596
GO BP;GOLGI TO ENDOSOME TRANSPORT;GO:0006895;16;-0.33877513;-1.033547;0.42777777;0.62456024
GO BP;GLYCEROPHOSPHOLIPID METABOLIC PROCESS;GO:0006650;252;-0.18983914;-1.0334103;0.37941176;0.62449783
GO BP;REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND;GO:2001239;25;-0.29194677;-1.033403;0.4130809;0.62410325
GO BP;CARDIOCYTE DIFFERENTIATION;GO:0035051;99;-0.216075;-1.032987;0.38258165;0.6247717
GO BP;CELLULAR RESPONSE TO OSMOTIC STRESS;GO:0071470;31;-0.2772471;-1.0328771;0.39750445;0.6246304
GO BP;HEART MORPHOGENESIS;GO:0003007;177;-0.19775228;-1.0322187;0.3876652;0.62597483
GO BP;POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION;GO:2000144;20;-0.31841907;-1.0321438;0.41408935;0.6257696
GO BP;REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC;GO:0051966;28;-0.27817056;-1.0316969;0.39518902;0.62656045
GO BP;RESPONSE TO AMINO ACID;GO:0043200;90;-0.22387062;-1.0315764;0.41887417;0.62646455
GO BP;GENITALIA DEVELOPMENT;GO:0048806;30;-0.2796431;-1.0314232;0.40202704;0.62646276
GO BP;ESTROGEN METABOLIC PROCESS;GO:0008210;16;-0.33876482;-1.0313042;0.4078712;0.62635285
GO BP;EXIT FROM MITOSIS;GO:0010458;26;-0.2935872;-1.0311831;0.41935483;0.62627655
GO BP;POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION;GO:0043923;16;-0.33402613;-1.0310506;0.41391942;0.6262313
GO BP;NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE;GO:1902230;26;-0.29228985;-1.030616;0.4302926;0.62700576
GO BP;POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT;#N/A;18;-0.3175625;-1.0302091;0.4235501;0.6276709
GO BP;DNA REPLICATION INITIATION;GO:0006270;34;-0.27185714;-1.0300972;0.4100346;0.6275455
GO BP;SPECIFICATION OF SYMMETRY;#N/A;90;-0.21862997;-1.0294915;0.3804878;0.6287399
GO BP;POSITIVE REGULATION OF INTERFERON BETA PRODUCTION;GO:0032728;25;-0.29733738;-1.0294809;0.4290429;0.62835723
GO BP;MULTI MULTICELLULAR ORGANISM PROCESS;#N/A;130;-0.20562811;-1.0291622;0.38569206;0.6288066
GO BP;NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS;#N/A;37;-0.26824403;-1.0279119;0.4030612;0.63164926
GO BP;NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION;GO:2000737;19;-0.31749108;-1.0271231;0.41493055;0.63329715
GO BP;FORELIMB MORPHOGENESIS;GO:0035136;24;-0.2966517;-1.0270323;0.40917107;0.6331188
GO BP;FATTY ACID CATABOLIC PROCESS;GO:0009062;84;-0.2219852;-1.0264555;0.37990582;0.6342309
GO BP;REGULATION OF ATPASE ACTIVITY;GO:0043462;71;-0.2297264;-1.0258541;0.40589198;0.6353325
GO BP;RESPONSE TO ETHANOL;GO:0045471;77;-0.22775118;-1.025656;0.39434275;0.6354492
GO BP;MODIFICATION OF MORPHOLOGY OR PHYSIOLOGY OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION;#N/A;79;-0.22414105;-1.0254055;0.41558442;0.6357146
GO BP;RESPONSE TO HYDROGEN PEROXIDE;GO:0042542;104;-0.2151032;-1.0252541;0.40549272;0.6356613
GO BP;REGULATION OF BMP SIGNALING PATHWAY;GO:0030510;59;-0.24053289;-1.0251586;0.41919193;0.6355131
GO BP;TYPE I INTERFERON PRODUCTION;GO:0032606;103;-0.21419282;-1.024919;0.41102362;0.6357345
GO BP;INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY;#N/A;20;-0.31521168;-1.024172;0.41625208;0.637268
GO BP;NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY;GO:1902236;16;-0.33400708;-1.0239497;0.4225352;0.6374366
GO BP;BODY FLUID SECRETION;GO:0007589;58;-0.23853406;-1.0234987;0.42087543;0.63820964
GO BP;INTERFERON ALPHA PRODUCTION;GO:0032607;20;-0.31022096;-1.0233601;0.4341637;0.63818866
GO BP;NUCLEOBASE METABOLIC PROCESS;#N/A;31;-0.2772615;-1.0231856;0.41707718;0.63821554
GO BP;NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION;GO:0033137;19;-0.31446263;-1.0224937;0.44041452;0.6396584
GO BP;IMMUNE RESPONSE REGULATING SIGNALING PATHWAY;GO:0002764;357;-0.18166856;-1.0215868;0.3913649;0.64161325
GO BP;INTERFERON GAMMA MEDIATED SIGNALING PATHWAY;GO:0060333;48;-0.2505949;-1.021162;0.42372882;0.64226913
GO BP;NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION;GO:1905208;15;-0.33361727;-1.0206809;0.44070795;0.64309514
GO BP;CALCIUM ION REGULATED EXOCYTOSIS;GO:0017156;42;-0.25712162;-1.0203155;0.4206081;0.6436363
GO BP;ENSHEATHMENT OF NEURONS;#N/A;95;-0.21992229;-1.0202993;0.4308426;0.64326656
GO BP;REGULATION OF ESTABLISHMENT OF PLANAR POLARITY;GO:0090175;91;-0.21645726;-1.0202581;0.431962;0.64296395
GO BP;METAL ION TRANSPORT;GO:0030001;475;-0.1737751;-1.0199786;0.3880597;0.64326906
GO BP;CELLULAR RESPONSE TO INORGANIC SUBSTANCE;GO:0071241;141;-0.20544538;-1.0196121;0.39502332;0.6438166
GO BP;POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING;GO:1900026;33;-0.27110225;-1.0195352;0.41196012;0.64361537
GO BP;REGULATION OF ENDOTHELIAL CELL MIGRATION;GO:0010594;112;-0.210715;-1.0193499;0.4305136;0.6436764
GO BP;CELLULAR RESPONSE TO DSRNA;GO:0071359;17;-0.33161777;-1.0191568;0.4355717;0.64379287
GO BP;CYTOKINE PRODUCTION;GO:0001816;449;-0.17637107;-1.0180179;0.40830946;0.6464047
GO BP;RESPONSE TO EXTRACELLULAR STIMULUS;GO:0009991;357;-0.17999949;-1.0178834;0.3860947;0.64634734
GO BP;INTEGRIN ACTIVATION;GO:0033622;16;-0.33167806;-1.0174605;0.44483364;0.64706206
GO BP;REGULATION OF CELLULAR RESPIRATION;GO:0043457;26;-0.2772504;-1.0172698;0.40939596;0.6471526
GO BP;RESPONSE TO INCREASED OXYGEN LEVELS;#N/A;24;-0.30166954;-1.0167453;0.4337979;0.648148
GO BP;EMBRYONIC ORGAN MORPHOGENESIS;GO:0048562;171;-0.19570251;-1.0166107;0.4309816;0.64809746
GO BP;CELLULAR RESPONSE TO ABIOTIC STIMULUS;#N/A;230;-0.18628114;-1.0165448;0.41149774;0.64785993
GO BP;NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS;GO:2001021;69;-0.22746964;-1.0162295;0.432;0.6482641
GO BP;INACTIVATION OF MAPK ACTIVITY;GO:0000188;21;-0.3058333;-1.0160294;0.43229166;0.6483796
GO BP;CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS;GO:0031668;195;-0.19469361;-1.015969;0.4234375;0.64813346
GO BP;NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION;GO:0035308;51;-0.24616602;-1.0157567;0.43387097;0.6483147
GO BP;COLLAGEN METABOLIC PROCESS;GO:0032963;66;-0.23272538;-1.0151275;0.43348983;0.6495005
GO BP;NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION;GO:0048147;21;-0.3134915;-1.0148644;0.44324324;0.6498013
GO BP;REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION;GO:0060390;20;-0.30854493;-1.0148392;0.40963855;0.6494619
GO BP;POSITIVE REGULATION OF CELL SUBSTRATE ADHESION;GO:0010811;87;-0.21883507;-1.0143735;0.42439026;0.65026397
GO BP;REGULATION OF FATTY ACID OXIDATION;GO:0046320;23;-0.29615957;-1.014319;0.43154246;0.649994
GO BP;NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS;GO:1903427;22;-0.29947555;-1.0140394;0.4356261;0.65030587
GO BP;EMBRYONIC DIGESTIVE TRACT DEVELOPMENT;GO:0048566;18;-0.32146883;-1.0136693;0.44122967;0.65090257
GO BP;RESPONSE TO STEROID HORMONE;GO:0048545;257;-0.18488444;-1.0133492;0.4052478;0.65128976
GO BP;REGULATION OF LYMPHOCYTE DIFFERENTIATION;GO:0045619;93;-0.2192283;-1.0130577;0.43429488;0.6516165
GO BP;ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS;GO:0032469;19;-0.31256327;-1.0119631;0.42909092;0.6540481
GO BP;POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY;GO:2000273;18;-0.31054688;-1.0116463;0.45132744;0.65447277
GO BP;CELLULAR GLUCOSE HOMEOSTASIS;GO:0001678;104;-0.21237147;-1.0116156;0.4357262;0.65413654
GO BP;COLLAGEN BIOSYNTHETIC PROCESS;GO:0032964;32;-0.2720794;-1.0109609;0.42556918;0.65554065
GO BP;LONG TERM MEMORY;GO:0007616;18;-0.31936976;-1.0101777;0.46543002;0.6571576
GO BP;REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE;#N/A;34;-0.2699443;-1.0099286;0.44033614;0.65739197
GO BP;REGULATION OF SUPEROXIDE METABOLIC PROCESS;#N/A;23;-0.29854938;-1.009669;0.46755406;0.6576573
GO BP;GLYCEROPHOSPHOLIPID CATABOLIC PROCESS;GO:0046475;17;-0.32236174;-1.0095581;0.4332061;0.65754336
GO BP;MODULATION BY VIRUS OF HOST CELLULAR PROCESS;#N/A;16;-0.32123402;-1.0093691;0.4637931;0.65766275
GO BP;CELLULAR CARBOHYDRATE METABOLIC PROCESS;GO:0044262;209;-0.18859385;-1.0090705;0.44576523;0.65803754
GO BP;POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION;#N/A;32;-0.26948428;-1.0086387;0.43645486;0.6587585
GO BP;SODIUM ION TRANSMEMBRANE TRANSPORT;GO:0035725;81;-0.22207609;-1.0083511;0.45;0.6591078
GO BP;POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS;GO:1903020;16;-0.32912928;-1.0080479;0.41709402;0.65952003
GO BP;REGULATION OF KERATINOCYTE DIFFERENTIATION;GO:0045616;28;-0.28096673;-1.0077151;0.42808798;0.65996855
GO BP;DEOXYRIBONUCLEOTIDE METABOLIC PROCESS;#N/A;31;-0.27103147;-1.0071207;0.4519573;0.66109866
GO BP;NEGATIVE REGULATION OF TRANSFERASE ACTIVITY;#N/A;218;-0.1881822;-1.0070504;0.43740574;0.6608711
GO BP;VESICLE TARGETING TO FROM OR WITHIN GOLGI;GO:0048199;63;-0.23024815;-1.0070367;0.45261437;0.66049194
GO BP;MAMMARY GLAND MORPHOGENESIS;GO:0060443;27;-0.28632268;-1.0068358;0.4234079;0.66059273
GO BP;ALPHA AMINO ACID CATABOLIC PROCESS;#N/A;78;-0.22412214;-1.0063232;0.40759075;0.6614988
GO BP;REGULATION OF MEIOTIC CELL CYCLE;GO:0051445;34;-0.26623392;-1.0047871;0.46771377;0.6651361
GO BP;POSITIVE REGULATION OF TELOMERASE ACTIVITY;GO:0051973;32;-0.27408475;-1.0042912;0.44483364;0.66604716
GO BP;TRNA METABOLIC PROCESS;GO:0006399;165;-0.19542524;-1.0042212;0.4330357;0.66583496
GO BP;EPITHELIAL CELL PROLIFERATION;GO:0050673;254;-0.18550591;-1.0040296;0.43589744;0.6659206
GO BP;REGULATION OF EPIDERMAL CELL DIFFERENTIATION;GO:0045604;41;-0.2536735;-1.0039114;0.43856657;0.66582716
GO BP;NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING;GO:0043124;32;-0.26678646;-1.0037355;0.4430605;0.6658858
GO BP;T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE;GO:0002292;33;-0.2696321;-1.0031182;0.4440678;0.6671469
GO BP;NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION;GO:1902750;88;-0.21684325;-1.0028017;0.43879172;0.6675841
GO BP;POSITIVE REGULATION OF CATION CHANNEL ACTIVITY;GO:2001259;25;-0.28747758;-1.0026721;0.43485618;0.66750985
GO BP;FEEDING BEHAVIOR;GO:0007631;33;-0.26604706;-1.0024539;0.4522613;0.6676815
GO BP;REGULATION OF OLIGODENDROCYTE DIFFERENTIATION;GO:0048713;21;-0.30069208;-1.0023584;0.44755244;0.66751885
GO BP;REGULATION OF MULTI ORGANISM PROCESS;#N/A;498;-0.17023082;-1.0022645;0.44230768;0.66733974
GO BP;PYRIDINE NUCLEOTIDE METABOLIC PROCESS;#N/A;24;-0.28921223;-1.0018677;0.45422536;0.667955
GO BP;CELLULAR RESPONSE TO DRUG;GO:0035690;262;-0.1827157;-1.0017328;0.4505988;0.66791195
GO BP;MONOAMINE TRANSPORT;GO:0015844;33;-0.26726955;-1.001635;0.44524238;0.66774046
GO BP;DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS;GO:0045137;139;-0.19958383;-1.0012006;0.46036586;0.66847897
GO BP;REGIONALIZATION;GO:0003002;185;-0.1922165;-1.0011331;0.45101088;0.66823953
GO BP;NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION;GO:0051148;35;-0.26489696;-1.0011157;0.4562937;0.6678749
GO BP;ERYTHROCYTE HOMEOSTASIS;GO:0034101;96;-0.21382372;-1.0010829;0.4649266;0.6675509
GO BP;REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS;GO:2000300;42;-0.2486158;-0.99996096;0.45379537;0.6701394
GO BP;RESPONSE TO REACTIVE OXYGEN SPECIES;GO:0000302;161;-0.19424695;-0.99990475;0.44548288;0.6698774
GO BP;REGULATION OF STRIATED MUSCLE CONTRACTION;GO:0006942;54;-0.24050447;-0.99989355;0.4688027;0.66950184
GO BP;REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY;GO:0010640;17;-0.31726006;-0.9997866;0.47636363;0.66937476
GO BP;INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS;GO:0002437;24;-0.2845113;-0.9989468;0.4658494;0.6712199
GO BP;PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS;#N/A;17;-0.31645268;-0.9983226;0.4562607;0.6724643
GO BP;INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE;GO:0008630;89;-0.21299313;-0.9983007;0.4528302;0.6721113
GO BP;G2 DNA DAMAGE CHECKPOINT;#N/A;27;-0.28312445;-0.9980318;0.44423792;0.6723906
GO BP;RESPONSE TO LEUKEMIA INHIBITORY FACTOR;GO:1990823;79;-0.22161862;-0.9979561;0.49093905;0.672194
GO BP;SMOOTH MUSCLE CELL APOPTOTIC PROCESS;#N/A;16;-0.32779685;-0.9951832;0.47652173;0.6791405
GO BP;PHAGOCYTOSIS;GO:0006909;165;-0.19557244;-0.9950316;0.44954127;0.679115
GO BP;NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION;GO:0045671;15;-0.33070278;-0.99490845;0.43889844;0.6790331
GO BP;NEGATIVE REGULATION OF LOCOMOTION;GO:0040013;212;-0.18763524;-0.9945032;0.47323942;0.6796746
GO BP;PROTEIN HOMOOLIGOMERIZATION;GO:0051260;209;-0.1879856;-0.99406004;0.4617737;0.6805154
GO BP;CELLULAR KETONE METABOLIC PROCESS;GO:0042180;173;-0.1914234;-0.9938879;0.48031497;0.6805498
GO BP;LEUKOCYTE DIFFERENTIATION;GO:0002521;289;-0.18024799;-0.9937488;0.48051947;0.6804909
GO BP;COFACTOR METABOLIC PROCESS;#N/A;332;-0.17691147;-0.9935853;0.47954866;0.68053126
GO BP;ASSOCIATIVE LEARNING;GO:0008306;39;-0.25353643;-0.9930118;0.4661017;0.6815882
GO BP;CARDIAC MUSCLE TISSUE MORPHOGENESIS;GO:0055008;42;-0.25211683;-0.9928875;0.44901314;0.68151104
GO BP;REGULATION OF MEMBRANE DEPOLARIZATION;GO:0003254;28;-0.27233297;-0.99245954;0.45884413;0.6822486
GO BP;MISMATCH REPAIR;GO:0006298;30;-0.27021173;-0.99042284;0.47108844;0.6871947
GO BP;REGULATION OF CELL PROJECTION ASSEMBLY;GO:0060491;143;-0.19814312;-0.9894862;0.47086614;0.6892893
GO BP;POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS;#N/A;126;-0.20165114;-0.9893561;0.47919875;0.6891931
GO BP;PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS;#N/A;29;-0.27382985;-0.9891921;0.47027972;0.68921566
GO BP;CLEAVAGE INVOLVED IN RRNA PROCESSING;GO:0000469;21;-0.29941198;-0.98915726;0.4754386;0.68889195
GO BP;POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS;GO:0035774;22;-0.29275075;-0.98889554;0.48432055;0.6891939
GO BP;EMBRYO IMPLANTATION;GO:0007566;39;-0.25104907;-0.9887414;0.47803164;0.6891702
GO BP;CATION TRANSMEMBRANE TRANSPORT;GO:0098655;474;-0.17038187;-0.98857427;0.492517;0.6891956
GO BP;REGULATION OF T CELL ACTIVATION;GO:0050863;173;-0.19179499;-0.98782223;0.46637428;0.6907232
GO BP;PHOSPHATIDYLINOSITOL PHOSPHORYLATION;GO:0046854;41;-0.250008;-0.98781526;0.48873484;0.6903249
GO BP;RESPONSE TO HYDROPEROXIDE;GO:0033194;16;-0.32083446;-0.9877775;0.48404256;0.69001204
GO BP;NEGATIVE REGULATION OF DNA RECOMBINATION;GO:0045910;36;-0.25594133;-0.98738843;0.45797598;0.69065386
GO BP;REGULATION OF MORPHOGENESIS OF AN EPITHELIUM;#N/A;130;-0.2023075;-0.9869844;0.48382127;0.6912926
GO BP;REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY;GO:0008277;65;-0.22095667;-0.9865595;0.5048387;0.6920083
GO BP;POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY;GO:0051092;102;-0.20895934;-0.9864057;0.48346457;0.69200176
GO BP;SKELETAL SYSTEM MORPHOGENESIS;GO:0048705;142;-0.19714312;-0.9862351;0.4832;0.69201016
GO BP;REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE;GO:0070302;168;-0.19124013;-0.98622906;0.48356807;0.6916155
GO BP;POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM;GO:1905332;21;-0.2909424;-0.9854514;0.47197106;0.6932527
GO BP;PURINE NUCLEOBASE METABOLIC PROCESS;GO:0006144;19;-0.30205917;-0.9854414;0.46086955;0.6928656
GO BP;CELL ADHESION MEDIATED BY INTEGRIN;GO:0033627;48;-0.24366848;-0.98515344;0.45854485;0.69318235
GO BP;NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION;GO:0030857;26;-0.28241035;-0.98481363;0.46503496;0.69365597
GO BP;APOPTOTIC SIGNALING PATHWAY;GO:0097190;462;-0.16924527;-0.9839896;0.4972973;0.6954289
GO BP;REGULATION OF LIPID METABOLIC PROCESS;GO:0019216;287;-0.177338;-0.9837492;0.48895434;0.6956791
GO BP;CALCIUM ION IMPORT;GO:0070509;37;-0.2592431;-0.9835799;0.49140894;0.6956994
GO BP;EXTRACELLULAR TRANSPORT;GO:0006858;20;-0.29700184;-0.9826541;0.47560975;0.6976911
GO BP;REGULATION OF CELL CELL ADHESION;GO:0022407;238;-0.17984518;-0.9824789;0.49160305;0.69772774
GO BP;INTRINSIC APOPTOTIC SIGNALING PATHWAY;GO:0097193;239;-0.18273847;-0.98175544;0.5234604;0.6991498
GO BP;HISTONE EXCHANGE;GO:0043486;48;-0.23787047;-0.9814695;0.48154092;0.6994343
GO BP;SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS;#N/A;50;-0.23867339;-0.9814394;0.48966613;0.6990908
GO BP;MACROPHAGE ACTIVATION;GO:0042116;47;-0.24148402;-0.9813255;0.47775948;0.69900244
GO BP;PHOSPHOLIPID METABOLIC PROCESS;GO:0006644;333;-0.17430934;-0.9813129;0.48179272;0.6986162
GO BP;SMOOTHENED SIGNALING PATHWAY;GO:0007224;109;-0.2037718;-0.98065543;0.4909091;0.69993603
GO BP;RESPONSE TO CAMP;GO:0051591;61;-0.22600119;-0.980119;0.46365106;0.70094866
GO BP;REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS;GO:1900076;51;-0.23252352;-0.9800128;0.4825291;0.700803
GO BP;REGULATION OF CALCIUM ION IMPORT;GO:0090279;17;-0.30923718;-0.9791751;0.48880598;0.7025676
GO BP;MYELIN MAINTENANCE;GO:0043217;15;-0.3281699;-0.9790308;0.48951048;0.7025158
GO BP;GLYCEROLIPID METABOLIC PROCESS;GO:0046486;306;-0.17647596;-0.9789293;0.5179856;0.70235926
GO BP;LIPID CATABOLIC PROCESS;GO:0016042;226;-0.18279009;-0.9789103;0.5072674;0.7019908
GO BP;HEPATICOBILIARY SYSTEM DEVELOPMENT;#N/A;109;-0.20195742;-0.97870535;0.48939642;0.70210975
GO BP;CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY;GO:0002753;48;-0.240663;-0.97868764;0.4729064;0.70173943
GO BP;MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL;GO:0098815;22;-0.29015163;-0.9786334;0.49053356;0.70146483
GO BP;NUCLEOSIDE CATABOLIC PROCESS;#N/A;19;-0.30271778;-0.97862625;0.49655172;0.7010713
GO BP;NEGATIVE REGULATION OF GROWTH;GO:0045926;160;-0.19015841;-0.9780303;0.5086614;0.7023042
GO BP;RESPONSE TO CALCIUM ION;GO:0051592;89;-0.211344;-0.9778924;0.47847682;0.7022526
GO BP;ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS;GO:0031145;73;-0.2197317;-0.97768074;0.5;0.70237494
GO BP;EMBRYONIC PLACENTA MORPHOGENESIS;GO:0060669;20;-0.2974715;-0.977473;0.5;0.70250624
GO BP;TISSUE REMODELING;GO:0048771;99;-0.20612893;-0.9774426;0.5016077;0.70217305
GO BP;VIRION ASSEMBLY;GO:0019068;37;-0.24746004;-0.97657067;0.47317073;0.70398784
GO BP;NCRNA METABOLIC PROCESS;#N/A;420;-0.17068516;-0.97636354;0.5487316;0.7040937
GO BP;NADP METABOLIC PROCESS;GO:0006739;29;-0.26889715;-0.97636306;0.4892916;0.7036808
GO BP;NEGATIVE REGULATION OF MULTI ORGANISM PROCESS;#N/A;129;-0.19897588;-0.9760975;0.5016026;0.7039806
GO BP;DIGESTIVE TRACT MORPHOGENESIS;GO:0048546;29;-0.26393187;-0.9759038;0.50344825;0.70407367
GO BP;REGULATION OF SMALL MOLECULE METABOLIC PROCESS;#N/A;313;-0.17387123;-0.9758452;0.5477528;0.7038058
GO BP;NEGATIVE REGULATION OF CELL ADHESION;GO:0007162;174;-0.1879966;-0.9757334;0.52160954;0.7036786
GO BP;T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE;GO:0002286;49;-0.2381702;-0.97529215;0.4800638;0.70437807
GO BP;MORPHOGENESIS OF A POLARIZED EPITHELIUM;GO:0001738;116;-0.20026562;-0.9750867;0.5048387;0.70451754
GO BP;POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS;#N/A;22;-0.29323554;-0.9749552;0.48996654;0.70442694
GO BP;POSITIVE REGULATION OF ION TRANSPORT;GO:0043270;131;-0.19901541;-0.97495174;0.53291535;0.7040195
GO BP;NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY;GO:0061099;19;-0.3032591;-0.9747539;0.49376115;0.70413244
GO BP;REGULATION OF ALPHA BETA T CELL ACTIVATION;#N/A;51;-0.23199311;-0.9745461;0.51282054;0.7042666
GO BP;POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY;GO:0120034;82;-0.2120397;-0.97422904;0.51931995;0.7046949
GO BP;NEGATIVE REGULATION OF MUSCLE CONTRACTION;GO:0045932;16;-0.31164855;-0.97420394;0.48703703;0.7043465
GO BP;SYNAPTIC TRANSMISSION GLUTAMATERGIC;GO:0035249;39;-0.25167677;-0.97413075;0.49758455;0.70413387
GO BP;REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION;GO:0043370;24;-0.27927938;-0.9739125;0.47887325;0.7043425
GO BP;POSITIVE REGULATION OF MULTI ORGANISM PROCESS;#N/A;366;-0.17157865;-0.9736268;0.5218618;0.70467395
GO BP;POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION;GO:1903039;116;-0.2001227;-0.97347635;0.51653546;0.70466256
GO BP;ANATOMICAL STRUCTURE HOMEOSTASIS;#N/A;300;-0.17655627;-0.97316045;0.5576369;0.7050825
GO BP;NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING;GO:0050849;18;-0.3007657;-0.97271824;0.49825174;0.7058287
GO BP;EMBRYONIC FORELIMB MORPHOGENESIS;GO:0035115;19;-0.29731432;-0.9726062;0.4904348;0.7056921
GO BP;FATTY ACID TRANSPORT;GO:0015908;62;-0.22442256;-0.972208;0.4890388;0.70632595
GO BP;POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION;GO:0010718;37;-0.24929272;-0.97198665;0.4991274;0.7065199
GO BP;REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY;#N/A;40;-0.24566191;-0.9718728;0.49322033;0.70641917
GO BP;POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS;GO:1902993;15;-0.32384577;-0.9715789;0.4764398;0.70672965
GO BP;SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA GERMLINE RECOMBINATION WITHIN A SINGLE LOCUS;#N/A;42;-0.24410541;-0.9712911;0.48911223;0.70703727
GO BP;ENDOCRINE HORMONE SECRETION;#N/A;20;-0.29933488;-0.971218;0.5034965;0.70680803
GO BP;CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES;GO:0034614;117;-0.19822446;-0.9707247;0.52012384;0.7077427
GO BP;REGULATION OF NEUROTRANSMITTER TRANSPORT;#N/A;77;-0.2144048;-0.970724;0.50651467;0.707335
GO BP;MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA;#N/A;34;-0.25707325;-0.9699018;0.47743055;0.7090643
GO BP;POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE;GO:0070374;104;-0.20107567;-0.96948636;0.50885665;0.7097868
GO BP;PROTEIN LOCALIZATION TO MICROTUBULE;GO:0035372;17;-0.30910602;-0.968992;0.4880734;0.71068794
GO BP;REGULATION OF LEUKOCYTE DIFFERENTIATION;#N/A;151;-0.1906155;-0.96823376;0.53588516;0.71224374
GO BP;G0 TO G1 TRANSITION;#N/A;42;-0.24196605;-0.9680221;0.4966216;0.71237075
GO BP;REGULATION OF FIBROBLAST MIGRATION;GO:0010762;21;-0.29801074;-0.9676916;0.4903339;0.7128184
GO BP;ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I;GO:0002474;73;-0.21424085;-0.9673276;0.5120385;0.71337104
GO BP;NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS;GO:0120163;35;-0.25594646;-0.9672317;0.48965517;0.7132088
GO BP;POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING;GO:1904358;34;-0.25354245;-0.9668111;0.5141903;0.71392083
GO BP;ACTION POTENTIAL;GO:0001508;66;-0.22141014;-0.9667705;0.50643086;0.7136106
GO BP;MAST CELL MEDIATED IMMUNITY;GO:0002448;31;-0.26505882;-0.96649617;0.5119863;0.7139335
GO BP;CEREBELLAR CORTEX MORPHOGENESIS;GO:0021696;22;-0.28067076;-0.96596694;0.48173913;0.71485543
GO BP;NEGATIVE REGULATION OF BLOOD PRESSURE;GO:0045776;17;-0.3062351;-0.9654733;0.5154827;0.71571046
GO BP;REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS;#N/A;51;-0.23544177;-0.96528596;0.49829352;0.71576035
GO BP;CELLULAR RESPONSE TO AMYLOID BETA;GO:1904646;23;-0.28536707;-0.9649492;0.5277281;0.71627194
GO BP;REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS;GO:0043620;103;-0.2036806;-0.96492195;0.5292259;0.71591574
GO BP;POSITIVE REGULATION OF SYNAPSE ASSEMBLY;GO:0051965;25;-0.27423012;-0.96467817;0.5034965;0.71610785
GO BP;ACETYL COA METABOLIC PROCESS;GO:0006084;34;-0.25767627;-0.9646191;0.52879584;0.71586114
GO BP;NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY;GO:0071901;107;-0.20008132;-0.9644359;0.55271566;0.7159281
GO BP;POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY;GO:2001235;138;-0.19383015;-0.96422535;0.54121304;0.71606374
GO BP;INORGANIC ION TRANSMEMBRANE TRANSPORT;#N/A;464;-0.16620676;-0.96415854;0.5685997;0.71581095
GO BP;POSITIVE REGULATION OF MAPK CASCADE;GO:0043410;328;-0.17176181;-0.96411854;0.5542692;0.7155004
GO BP;POSITIVE REGULATION OF CYTOKINE PRODUCTION;GO:0001819;247;-0.17719664;-0.96393204;0.60181;0.7155787
GO BP;MUSCLE CELL DEVELOPMENT;GO:0055001;105;-0.20349845;-0.9639178;0.5303266;0.71520376
GO BP;CELLULAR RESPONSE TO LIPID;GO:0071396;377;-0.17053933;-0.96386784;0.55411255;0.71491796
GO BP;RESPONSE TO CARBOHYDRATE;GO:0009743;161;-0.18780768;-0.96370226;0.5259939;0.7149542
GO BP;POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER;GO:0060261;15;-0.3236188;-0.96307415;0.49369368;0.7161692
GO BP;ACTIVATION OF MAPKK ACTIVITY;GO:0000186;45;-0.24206075;-0.96304756;0.54333335;0.7158392
GO BP;CELLULAR AMINO ACID METABOLIC PROCESS;GO:0006520;265;-0.17543423;-0.9626127;0.5466667;0.7165507
GO BP;LIPID MODIFICATION;GO:0030258;182;-0.18547675;-0.9624202;0.5515625;0.7166518
GO BP;REGULATION OF EXECUTION PHASE OF APOPTOSIS;#N/A;21;-0.29446924;-0.96236736;0.51336896;0.71637493
GO BP;SUBSTANTIA NIGRA DEVELOPMENT;GO:0021762;33;-0.2571589;-0.96217084;0.5050676;0.71647346
GO BP;NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY;GO:0045879;22;-0.28661102;-0.96181107;0.5166375;0.7170005
GO BP;MYELOID LEUKOCYTE DIFFERENTIATION;GO:0002573;123;-0.19566841;-0.9616241;0.53090334;0.7170616
GO BP;NEGATIVE REGULATION OF AXONOGENESIS;GO:0050771;45;-0.23750134;-0.9616086;0.49917355;0.7166994
GO BP;REGULATION OF ENDOCYTOSIS;GO:0030100;152;-0.18973196;-0.9614278;0.559633;0.71677434
GO BP;LIPID HOMEOSTASIS;GO:0055088;98;-0.20189826;-0.9611163;0.5418006;0.71713805
GO BP;RESPONSE TO PH;GO:0009268;21;-0.29071248;-0.96092576;0.50259066;0.71722376
GO BP;POSITIVE REGULATION OF RESPONSE TO DRUG;#N/A;15;-0.3159073;-0.96046245;0.5121951;0.71803665
GO BP;REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION;GO:0010717;62;-0.2222682;-0.9603393;0.5459098;0.7179708
GO BP;CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS;#N/A;61;-0.22127141;-0.9599958;0.51746035;0.7184545
GO BP;REGULATION OF CYTOPLASMIC TRANSPORT;#N/A;22;-0.28811395;-0.9598129;0.51473135;0.7185136
GO BP;SULFUR COMPOUND BIOSYNTHETIC PROCESS;#N/A;137;-0.19069119;-0.9597882;0.5598756;0.7181851
GO BP;STEROID METABOLIC PROCESS;GO:0008202;208;-0.18042414;-0.95909894;0.5649547;0.71954185
GO BP;POSITIVE REGULATION OF STEROL TRANSPORT;#N/A;18;-0.30143932;-0.9583999;0.5008726;0.72089344
GO BP;DNA LIGATION;GO:0006266;17;-0.31024504;-0.9581633;0.52612615;0.72109544
GO BP;SKELETAL MUSCLE CONTRACTION;GO:0003009;20;-0.2866391;-0.9578412;0.4886562;0.72149944
GO BP;PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE;GO:1903539;27;-0.27487034;-0.95773923;0.5167224;0.72132415
GO BP;TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY;GO:0007178;228;-0.17776018;-0.95761234;0.5523521;0.7212413
GO BP;GENE SILENCING BY RNA;GO:0031047;158;-0.19084735;-0.95724326;0.5434439;0.7217943
GO BP;NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY;GO:0032232;15;-0.31979796;-0.95690775;0.5046211;0.72226846
GO BP;NEGATIVE REGULATION OF BLOOD CIRCULATION;GO:1903523;20;-0.28604102;-0.9564349;0.5224416;0.72310466
GO BP;LINOLEIC ACID METABOLIC PROCESS;GO:0043651;15;-0.31141576;-0.9561242;0.5213523;0.7235242
GO BP;CELLULAR LIPID CATABOLIC PROCESS;GO:0044242;162;-0.18509336;-0.9558594;0.55640244;0.7237973
GO BP;CELLULAR RESPONSE TO CAMP;GO:0071320;31;-0.26080576;-0.95574385;0.543058;0.72368056
GO BP;MUSCLE ORGAN MORPHOGENESIS;GO:0048644;49;-0.2355212;-0.9544443;0.5058824;0.7266487
GO BP;NEGATIVE REGULATION OF VIRAL PROCESS;GO:0048525;62;-0.2200799;-0.95419204;0.54992074;0.7268958
GO BP;BONE DEVELOPMENT;GO:0060348;138;-0.18736954;-0.95276517;0.57027465;0.73014265
GO BP;FATTY ACID BETA OXIDATION;GO:0006635;62;-0.21557452;-0.9525774;0.523888;0.7302213
GO BP;NEUROINFLAMMATORY RESPONSE;GO:0150076;32;-0.25838512;-0.9522816;0.5096661;0.73058635
GO BP;SKELETAL SYSTEM DEVELOPMENT;GO:0001501;313;-0.17121477;-0.9521588;0.58504397;0.7304905
GO BP;ANTEROGRADE AXONAL TRANSPORT;GO:0008089;39;-0.24411179;-0.95165485;0.5472973;0.7313838
GO BP;REGULATION OF ORGANIC ACID TRANSPORT;#N/A;28;-0.2634175;-0.9513701;0.5128645;0.73171127
GO BP;REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS;GO:0097006;64;-0.22053324;-0.95130074;0.5555556;0.73148793
GO BP;RIBONUCLEOPROTEIN COMPLEX BIOGENESIS;#N/A;393;-0.16527559;-0.95081896;0.6344239;0.73230577
GO BP;LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE;#N/A;97;-0.20227647;-0.95028555;0.5797342;0.73323536
GO BP;SEGMENTATION;GO:0035282;53;-0.22441453;-0.95015645;0.52461797;0.73316413
GO BP;PLATELET ACTIVATION;GO:0030168;94;-0.20202012;-0.9498399;0.5651491;0.73362535
GO BP;REGULATION OF SODIUM ION TRANSPORT;GO:0002028;54;-0.22322582;-0.9497655;0.53050846;0.7333932
GO BP;RESPONSE TO TESTOSTERONE;GO:0033574;27;-0.26067954;-0.94969714;0.50987434;0.7331547
GO BP;CELLULAR DEFENSE RESPONSE;GO:0006968;15;-0.31909117;-0.94967926;0.5124792;0.7327959
GO BP;POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY;GO:0043243;25;-0.2715175;-0.94865036;0.5263158;0.7349761
GO BP;MUSCLE ORGAN DEVELOPMENT;GO:0007517;235;-0.17557523;-0.9485627;0.5824508;0.7348089
GO BP;POSITIVE REGULATION OF ENDOCYTOSIS;GO:0045807;78;-0.20951383;-0.94760746;0.5520134;0.73680794
GO BP;RNA CATABOLIC PROCESS;GO:0006401;345;-0.16842571;-0.9472569;0.61206895;0.73729056
GO BP;POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION;#N/A;47;-0.23454972;-0.9470945;0.5515464;0.73728156
GO BP;CELLULAR RESPONSE TO OXYGEN RADICAL;#N/A;16;-0.30428556;-0.94704264;0.53157896;0.7370103
GO BP;POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE;GO:1990573;21;-0.2824631;-0.94703156;0.51943463;0.7366354
GO BP;TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION;GO:0032201;25;-0.26759255;-0.94612944;0.5541958;0.73852336
GO BP;REGULATION OF MEMBRANE PERMEABILITY;GO:0090559;65;-0.21634358;-0.94557035;0.55263156;0.7395181
GO BP;CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS;#N/A;478;-0.16315381;-0.94503605;0.6283784;0.74046534
GO BP;ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION;GO:0034314;28;-0.2566609;-0.9450008;0.5482759;0.7401366
GO BP;NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY;GO:0043433;109;-0.1973602;-0.94482976;0.5716586;0.74015105
GO BP;CELLULAR RESPONSE TO GLUCOSE STARVATION;GO:0042149;35;-0.24613686;-0.94349617;0.5568562;0.7430633
GO BP;LYMPHOCYTE CHEMOTAXIS;GO:0048247;22;-0.28180486;-0.94320005;0.54210526;0.7433616
GO BP;PEPTIDYL TYROSINE DEPHOSPHORYLATION;GO:0035335;76;-0.20634617;-0.94286525;0.54501605;0.7438064
GO BP;RESPONSE TO LEAD ION;GO:0010288;19;-0.29147655;-0.9426846;0.51301116;0.74388707
GO BP;IMMUNOGLOBULIN PRODUCTION;GO:0002377;66;-0.21515283;-0.94209844;0.54468805;0.7449794
GO BP;ENTRY INTO HOST;#N/A;91;-0.20100315;-0.941911;0.57328993;0.74506295
GO BP;FATTY ACID TRANSMEMBRANE TRANSPORT;#N/A;18;-0.3011007;-0.94131273;0.5400697;0.7461766
GO BP;REGULATION OF LAMELLIPODIUM ORGANIZATION;#N/A;35;-0.24531302;-0.9409446;0.5394046;0.7467597
GO BP;REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA;GO:0061418;70;-0.2125391;-0.9408717;0.5579832;0.74653864
GO BP;POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION;#N/A;19;-0.28488338;-0.94078285;0.5363322;0.7463359
GO BP;NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION;GO:1903828;87;-0.20482393;-0.94047666;0.6012966;0.7466794
GO BP;POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING;GO:0014068;51;-0.22453932;-0.9404258;0.53630364;0.7464069
GO BP;CELLULAR RESPONSE TO OXYGEN LEVELS;GO:0071453;174;-0.18200389;-0.94038457;0.61503065;0.74611354
GO BP;INTESTINAL EPITHELIAL CELL DIFFERENTIATION;GO:0060575;15;-0.3150161;-0.940146;0.52879584;0.7462787
GO BP;PROTEIN PEPTIDYL PROLYL ISOMERIZATION;GO:0000413;33;-0.24819103;-0.94008356;0.548495;0.7460318
GO BP;POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY;#N/A;63;-0.21790537;-0.9400515;0.54833597;0.74570817
GO BP;REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING;GO:1900024;46;-0.23223887;-0.93910545;0.529517;0.74772525
GO BP;REGULATION OF HEMOPOIESIS;GO:1903706;303;-0.16922966;-0.939078;0.6383602;0.7473745
GO BP;NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY;GO:0090090;129;-0.19265692;-0.9388247;0.58084774;0.7475809
GO BP;MODIFICATION BY SYMBIONT OF HOST MORPHOLOGY OR PHYSIOLOGY;#N/A;33;-0.25031376;-0.93852276;0.55972695;0.7479371
GO BP;RESPONSE TO VITAMIN;#N/A;64;-0.2145611;-0.93827426;0.5871711;0.74816084
GO BP;RESPONSE TO DSRNA;GO:0043331;30;-0.25862262;-0.9373809;0.5598651;0.74998575
GO BP;STEROL TRANSPORT;GO:0015918;65;-0.21402228;-0.9372609;0.5512195;0.7498933
GO BP;NEGATIVE REGULATION OF T CELL DIFFERENTIATION;GO:0045581;26;-0.2656997;-0.937;0.55119455;0.7501658
GO BP;NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING;GO:0006297;22;-0.2778704;-0.93684614;0.55315316;0.7501531
GO BP;REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY;GO:0099601;33;-0.24761772;-0.9362364;0.57019067;0.75126046
GO BP;NEGATIVE REGULATION OF CELL CELL ADHESION;GO:0022408;103;-0.19558024;-0.9360888;0.57952756;0.7512245
GO BP;ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE;#N/A;17;-0.29859173;-0.93485993;0.53968257;0.7539092
GO BP;REGULATION OF MITOTIC SPINDLE ASSEMBLY;GO:1901673;19;-0.2848597;-0.933899;0.55267704;0.75588924
GO BP;REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION;GO:2000514;31;-0.25079453;-0.9338275;0.5612789;0.75566864
GO BP;REGULATION OF CYTOPLASMIC TRANSLATION;GO:2000765;25;-0.26766047;-0.93377125;0.57699114;0.7554063
GO BP;NEURON FATE COMMITMENT;GO:0048663;20;-0.28177422;-0.93360823;0.550173;0.7553932
GO BP;PEPTIDYL TYROSINE MODIFICATION;#N/A;231;-0.17277378;-0.9334418;0.6205837;0.7554172
GO BP;LIPOPROTEIN METABOLIC PROCESS;GO:0042157;104;-0.19431674;-0.93340427;0.5963149;0.75509244
GO BP;POSITIVE REGULATION OF HISTONE DEACETYLATION;GO:0031065;15;-0.30731627;-0.9325652;0.5505415;0.7567494
GO BP;NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING;#N/A;21;-0.28296894;-0.93250865;0.55;0.75648594
GO BP;POSITIVE REGULATION OF HEMOPOIESIS;#N/A;111;-0.1923741;-0.93196195;0.6072555;0.75740576
GO BP;REGULATION OF NIK NF KAPPAB SIGNALING;GO:1901222;62;-0.21774642;-0.93171304;0.59395975;0.75763535
GO BP;REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY;#N/A;151;-0.18343544;-0.9315726;0.6191176;0.75755966
GO BP;REGULATION OF GLUCOSE METABOLIC PROCESS;GO:0010906;87;-0.20049532;-0.93147016;0.5986842;0.7573869
GO BP;ODONTOGENESIS;GO:0042476;82;-0.20372263;-0.93137705;0.5806962;0.75722843
GO BP;NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY;GO:0006294;27;-0.26508972;-0.9310273;0.557265;0.7576605
GO BP;REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING;GO:0014066;81;-0.20491114;-0.9304456;0.59669423;0.75865376
GO BP;REGULATION OF MYELOID CELL DIFFERENTIATION;GO:0045637;163;-0.1818104;-0.93033975;0.6224649;0.7584984
GO BP;NEGATIVE REGULATION OF VIRAL LIFE CYCLE;#N/A;50;-0.22910872;-0.92967117;0.55537975;0.7597728
GO BP;CELL VOLUME HOMEOSTASIS;GO:0006884;20;-0.28296688;-0.92959505;0.56217164;0.75954777
GO BP;REGULATION OF DNA BINDING;GO:0051101;90;-0.19986273;-0.9294798;0.593949;0.75940996
GO BP;ADHERENS JUNCTION ORGANIZATION;GO:0034332;45;-0.22916988;-0.92916185;0.5899654;0.75979894
GO BP;REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY;GO:0060338;29;-0.24805866;-0.9289047;0.56183743;0.7600436
GO BP;ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME;GO:0000380;66;-0.21199845;-0.9286814;0.56978655;0.7602129
GO BP;CELLULAR AMINO ACID BIOSYNTHETIC PROCESS;GO:0008652;64;-0.21629955;-0.9286242;0.5882353;0.75996006
GO BP;PROGRAMMED NECROTIC CELL DEATH;GO:0097300;33;-0.25099495;-0.9285678;0.5680272;0.7597025
GO BP;INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS;GO:0035773;46;-0.22812368;-0.92801607;0.56876063;0.760659
GO BP;CELLULAR RESPONSE TO ANTIBIOTIC;GO:0071236;101;-0.1937824;-0.92758787;0.60131794;0.76128495
GO BP;PROTEIN COMPLEX OLIGOMERIZATION;GO:0051259;339;-0.16526064;-0.92748;0.68667644;0.76115084
GO BP;REGULATION OF ENDOCRINE PROCESS;#N/A;17;-0.29975474;-0.9269841;0.56842107;0.76193964
GO BP;MONOCARBOXYLIC ACID CATABOLIC PROCESS;#N/A;100;-0.19737844;-0.9267165;0.63097197;0.76219594
GO BP;SMAD PROTEIN SIGNAL TRANSDUCTION;GO:0060395;44;-0.23015901;-0.926322;0.590301;0.76279503
GO BP;RESPONSE TO CATECHOLAMINE;#N/A;48;-0.22843835;-0.926113;0.57712305;0.762898
GO BP;POSITIVE REGULATION OF ATPASE ACTIVITY;GO:0032781;52;-0.22296228;-0.9260484;0.5966667;0.7626341
GO BP;FC EPSILON RECEPTOR SIGNALING PATHWAY;GO:0038095;92;-0.19942392;-0.92599356;0.60033166;0.7623649
GO BP;STEM CELL DIFFERENTIATION;GO:0048863;173;-0.17916544;-0.9259898;0.6302003;0.761964
GO BP;MESENCHYME DEVELOPMENT;GO:0060485;172;-0.17929852;-0.92545277;0.65876776;0.7628796
GO BP;MESENCHYMAL CELL PROLIFERATION;GO:0010463;26;-0.2613333;-0.92534155;0.57789856;0.7627633
GO BP;CELLULAR RESPONSE TO AMMONIUM ION;GO:0071242;53;-0.21994855;-0.9251885;0.57615894;0.7627422
GO BP;POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY;GO:0032233;50;-0.22557661;-0.9247458;0.60281193;0.7634512
GO BP;ERROR PRONE TRANSLESION SYNTHESIS;GO:0042276;19;-0.28671187;-0.9231942;0.56193894;0.7668288
GO BP;ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY;GO:0050851;158;-0.1805269;-0.9231603;0.65898615;0.76649874
GO BP;PEPTIDE CROSS LINKING;GO:0018149;18;-0.28667372;-0.9231269;0.5503472;0.7661703
GO BP;SPHINGOLIPID BIOSYNTHETIC PROCESS;GO:0030148;84;-0.2014189;-0.9228524;0.61612904;0.7664649
GO BP;TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY;GO:0007179;134;-0.18432029;-0.92280763;0.63870966;0.76615536
GO BP;DEFENSE RESPONSE TO VIRUS;GO:0051607;150;-0.18108131;-0.92262155;0.64118564;0.76621866
GO BP;CARBOHYDRATE BIOSYNTHETIC PROCESS;GO:0016051;145;-0.18204716;-0.9221357;0.62460566;0.76701474
GO BP;COLLAGEN FIBRIL ORGANIZATION;GO:0030199;34;-0.24579877;-0.92190874;0.57843137;0.7671864
GO BP;PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION;#N/A;36;-0.24641691;-0.9218891;0.59552497;0.7668232
GO BP;PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS;GO:0006221;36;-0.23674932;-0.9216791;0.5714286;0.76693267
GO BP;PURINE CONTAINING COMPOUND CATABOLIC PROCESS;#N/A;42;-0.2301941;-0.92142963;0.57457626;0.7671471
GO BP;PEPTIDE CATABOLIC PROCESS;GO:0043171;17;-0.29294652;-0.9204089;0.5753899;0.7692608
GO BP;B CELL ACTIVATION;GO:0042113;145;-0.18164918;-0.91995513;0.62128323;0.7699111
GO BP;REGULATION OF ANIMAL ORGAN MORPHOGENESIS;#N/A;164;-0.17925254;-0.91988105;0.675;0.7696824
GO BP;REGULATION OF MEMBRANE REPOLARIZATION;GO:0060306;16;-0.29414037;-0.9198556;0.5585284;0.76933765
GO BP;VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT;GO:0003229;40;-0.2350455;-0.91960514;0.5874126;0.76953655
GO BP;ODONTOGENESIS OF DENTIN CONTAINING TOOTH;GO:0042475;53;-0.22031935;-0.91956025;0.5927152;0.76924103
GO BP;POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING;GO:1901224;45;-0.22789745;-0.91942704;0.6097561;0.76915824
GO BP;CARDIAC MUSCLE CONTRACTION;GO:0060048;80;-0.20455231;-0.91902494;0.6042003;0.769735
GO BP;MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY;GO:0060135;43;-0.23189536;-0.9189727;0.6036036;0.769457
GO BP;DNA REPLICATION CHECKPOINT;GO:0000076;15;-0.3002436;-0.91806996;0.57788944;0.7713006
GO BP;CYTOPLASMIC TRANSLATIONAL INITIATION;GO:0002183;27;-0.2538676;-0.917992;0.58115184;0.7710722
GO BP;TRANSFORMING GROWTH FACTOR BETA PRODUCTION;GO:0071604;22;-0.28104538;-0.917341;0.5685921;0.7722485
GO BP;CELLULAR RESPONSE TO TOXIC SUBSTANCE;GO:0097237;155;-0.17989548;-0.9167586;0.64760435;0.77324194
GO BP;NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS;#N/A;54;-0.21609034;-0.91666144;0.6105442;0.77307147
GO BP;VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL;GO:0086005;19;-0.2850364;-0.9165026;0.55979204;0.7730459
GO BP;REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION;GO:0050730;153;-0.18062222;-0.9159724;0.6537867;0.7739569
GO BP;NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION;GO:0008285;448;-0.15854344;-0.91571087;0.7416201;0.7741702
GO BP;FEMALE MEIOTIC NUCLEAR DIVISION;GO:0007143;24;-0.26634565;-0.915577;0.58464223;0.7740898
GO BP;SUBSTRATE ADHESION DEPENDENT CELL SPREADING;GO:0034446;81;-0.20075119;-0.9154287;0.6201299;0.7740547
GO BP;CELLULAR RESPONSE TO FLUID SHEAR STRESS;GO:0071498;15;-0.30809623;-0.9149068;0.58076227;0.7748788
GO BP;CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM;#N/A;216;-0.17042264;-0.9148912;0.68740743;0.77451247
GO BP;POSITIVE REGULATION OF CALCIUM ION TRANSPORT;GO:0051928;59;-0.21168154;-0.914881;0.5906149;0.7741298
GO BP;REGULATION OF CARDIAC MUSCLE CONTRACTION;GO:0055117;46;-0.22943364;-0.9148564;0.6028708;0.77377963
GO BP;POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE;GO:0002720;31;-0.245623;-0.91427755;0.5891089;0.77477664
GO BP;POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS;GO:0043525;45;-0.22690594;-0.9135628;0.60714287;0.7760765
GO BP;POSITIVE REGULATION OF KIDNEY DEVELOPMENT;GO:0090184;21;-0.2700433;-0.9135596;0.5626072;0.77567387
GO BP;CARDIAC MUSCLE TISSUE DEVELOPMENT;GO:0048738;139;-0.18215723;-0.912907;0.6613162;0.7768307
GO BP;POSITIVE REGULATION OF HORMONE SECRETION;GO:0046887;72;-0.2032642;-0.9127044;0.6220736;0.77692443
GO BP;UNSATURATED FATTY ACID METABOLIC PROCESS;GO:0033559;63;-0.21176484;-0.91256493;0.6169154;0.7768538
GO BP;CARBOHYDRATE HOMEOSTASIS;#N/A;161;-0.17884484;-0.91217804;0.6641791;0.77736175
GO BP;CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL;GO:0097553;76;-0.20432957;-0.9120613;0.6129542;0.777239
GO BP;REGULATION OF STEM CELL DIFFERENTIATION;GO:2000736;92;-0.19546172;-0.9115071;0.6489533;0.77817076
GO BP;PROTEIN LOCALIZATION TO NUCLEOLUS;GO:1902570;15;-0.29831472;-0.9111317;0.5794872;0.7786599
GO BP;STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE;GO:0031098;212;-0.17180978;-0.9110353;0.6737481;0.77848715
GO BP;NEPHRON DEVELOPMENT;GO:0072006;81;-0.19932082;-0.90983266;0.6356073;0.7809929
GO BP;PLASMA LIPOPROTEIN PARTICLE CLEARANCE;GO:0034381;42;-0.23072354;-0.90958565;0.6187291;0.7811786
GO BP;NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME;GO:0048025;20;-0.2750066;-0.9095022;0.5833333;0.78095
GO BP;NEGATIVE REGULATION OF WNT SIGNALING PATHWAY;GO:0030178;153;-0.17955868;-0.909472;0.6543779;0.78060097
GO BP;MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS;#N/A;23;-0.26826924;-0.9094289;0.5922166;0.78030896
GO BP;ADULT LOCOMOTORY BEHAVIOR;GO:0008344;43;-0.22507633;-0.90933275;0.600346;0.7801341
GO BP;PHOSPHATIDYLINOSITOL METABOLIC PROCESS;GO:0046488;139;-0.18086652;-0.9075423;0.6574501;0.7840328
GO BP;REGULATION OF TELOMERE CAPPING;#N/A;22;-0.26815125;-0.9073289;0.61623615;0.78413343
GO BP;HEME METABOLIC PROCESS;GO:0042168;27;-0.2592567;-0.9060068;0.5850694;0.7868515
GO BP;SECONDARY METABOLITE BIOSYNTHETIC PROCESS;#N/A;15;-0.30172762;-0.9047649;0.5904059;0.7894179
GO BP;RESPONSE TO ALKALOID;#N/A;64;-0.21100745;-0.90399456;0.63140494;0.7908646
GO BP;PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY;#N/A;16;-0.29016232;-0.9038374;0.5769231;0.7908401
GO BP;REGULATION OF EMBRYONIC DEVELOPMENT;GO:0045995;99;-0.18947549;-0.90383023;0.6512739;0.7904525
GO BP;MYOTUBE DIFFERENTIATION;GO:0014902;57;-0.2144409;-0.90381426;0.62193125;0.79008543
GO BP;KERATINOCYTE PROLIFERATION;GO:0043616;31;-0.24274944;-0.9034708;0.6061644;0.7905149
GO BP;SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS;GO:0016447;36;-0.23684207;-0.90340346;0.60306644;0.7902707
GO BP;PROTEIN EXIT FROM ENDOPLASMIC RETICULUM;GO:0032527;39;-0.23151116;-0.90337205;0.6258503;0.78994614
GO BP;POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION;GO:0032727;16;-0.29243803;-0.90306056;0.5865052;0.7902918
GO BP;NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION;#N/A;56;-0.21273604;-0.9029216;0.62308997;0.79019874
GO BP;POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION;GO:0050731;110;-0.19101802;-0.90285796;0.659375;0.78994393
GO BP;POSITIVE REGULATION OF CELL CELL ADHESION;GO:0022409;146;-0.17826955;-0.9027664;0.684127;0.789756
GO BP;REGULATION OF ERBB SIGNALING PATHWAY;GO:1901184;76;-0.1993943;-0.9027003;0.6628478;0.7895053
GO BP;PHOSPHATIDYLCHOLINE METABOLIC PROCESS;GO:0046470;61;-0.21230799;-0.9024253;0.63529414;0.7897703
GO BP;ACTIN NUCLEATION;GO:0045010;37;-0.2336572;-0.90223086;0.5952381;0.7898211
GO BP;PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE;#N/A;124;-0.18392234;-0.901993;0.7020281;0.78993636
GO BP;SULFUR AMINO ACID METABOLIC PROCESS;#N/A;30;-0.24847604;-0.9015139;0.6040609;0.7906532
GO BP;DIVALENT INORGANIC CATION HOMEOSTASIS;GO:0072507;243;-0.165875;-0.9010117;0.73568285;0.7914399
GO BP;FIBROBLAST PROLIFERATION;#N/A;61;-0.21066055;-0.90095466;0.61488676;0.79117924
GO BP;MUSCLE TISSUE DEVELOPMENT;GO:0060537;244;-0.16724986;-0.9002761;0.7278583;0.7923782
GO BP;ACTIVATION OF IMMUNE RESPONSE;GO:0002253;374;-0.15849383;-0.8995185;0.75736326;0.7937376
GO BP;MULTICELLULAR ORGANISMAL HOMEOSTASIS;GO:0048871;296;-0.16057289;-0.89864296;0.74714285;0.7954089
GO BP;SPLEEN DEVELOPMENT;GO:0048536;23;-0.26314595;-0.8966231;0.6267361;0.799643
GO BP;REGULATION OF LEUKOCYTE MEDIATED IMMUNITY;#N/A;100;-0.1892893;-0.89622945;0.6613162;0.8001926
GO BP;AUTONOMIC NERVOUS SYSTEM DEVELOPMENT;GO:0048483;24;-0.26035732;-0.8957368;0.59122807;0.8009832
GO BP;XENOBIOTIC TRANSPORT;GO:0042908;16;-0.29338974;-0.89549536;0.6145038;0.8011502
GO BP;NEUROMUSCULAR PROCESS;GO:0050905;53;-0.21675666;-0.89529574;0.64;0.8012201
GO BP;REGULATION OF BODY FLUID LEVELS;GO:0050878;309;-0.16012968;-0.8952239;0.7692308;0.80098253
GO BP;REGULATION OF RESPONSE TO BIOTIC STIMULUS;#N/A;323;-0.1607987;-0.89493895;0.7799718;0.80123
GO BP;PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY;GO:0035357;15;-0.29789776;-0.8949309;0.5929825;0.8008418
GO BP;NEURON APOPTOTIC PROCESS;GO:0051402;167;-0.17228118;-0.8949187;0.7223043;0.8004588
GO BP;NEURON MATURATION;GO:0042551;27;-0.25293317;-0.89479965;0.62842464;0.8003249
GO BP;CHONDROCYTE DIFFERENTIATION;GO:0002062;73;-0.20150189;-0.89466745;0.6584565;0.80021524
GO BP;IRON SULFUR CLUSTER ASSEMBLY;GO:0016226;20;-0.27089697;-0.89439523;0.62147886;0.8004514
GO BP;CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES;GO:0098742;104;-0.18813612;-0.8942439;0.6868045;0.800405
GO BP;REGULATION OF LIPASE ACTIVITY;#N/A;53;-0.21350156;-0.8941938;0.6743802;0.8001058
GO BP;POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION;GO:0001956;16;-0.29204783;-0.89401454;0.6155203;0.8001292
GO BP;FIBROBLAST MIGRATION;GO:0010761;30;-0.24261592;-0.8938199;0.6159052;0.8001624
GO BP;DNA TEMPLATED TRANSCRIPTION TERMINATION;GO:0006353;71;-0.2000502;-0.893307;0.65905386;0.80095315
GO BP;LIPOPROTEIN BIOSYNTHETIC PROCESS;GO:0042158;83;-0.19556187;-0.892386;0.684127;0.80267286
GO BP;MESENCHYMAL CELL DIFFERENTIATION;GO:0048762;137;-0.17930147;-0.8921674;0.7065574;0.8027626
GO BP;REGULATION OF SMOOTHENED SIGNALING PATHWAY;GO:0008589;64;-0.20464551;-0.8919536;0.6632479;0.8028361
GO BP;NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION;GO:0051154;23;-0.2598824;-0.8918884;0.6149915;0.80257994
GO BP;VESICLE MEDIATED TRANSPORT IN SYNAPSE;GO:0099003;133;-0.1784612;-0.89184874;0.69292605;0.8022626
GO BP;POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT;#N/A;38;-0.22947647;-0.89175916;0.64763457;0.80207026
GO BP;REGENERATION;#N/A;127;-0.18059012;-0.8916867;0.7083333;0.80182254
GO BP;ENDOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY;GO:0032509;25;-0.2533315;-0.8915982;0.6241722;0.80161875
GO BP;NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS;GO:0034656;32;-0.24035841;-0.8912773;0.61120546;0.8019873
GO BP;RESPONSE TO VIRUS;GO:0009615;203;-0.16929063;-0.8909132;0.7351598;0.8024181
GO BP;NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY;GO:2001237;72;-0.20353872;-0.89076686;0.6453674;0.8023344
GO BP;ORGANIC HYDROXY COMPOUND TRANSPORT;GO:0015850;127;-0.17768279;-0.89025617;0.68167704;0.80307984
GO BP;LENS DEVELOPMENT IN CAMERA TYPE EYE;GO:0002088;51;-0.21410476;-0.88973993;0.652027;0.80386597
GO BP;NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT;#N/A;76;-0.19690116;-0.8895486;0.66313934;0.8038891
GO BP;SULFUR COMPOUND METABOLIC PROCESS;GO:0006790;273;-0.16181697;-0.88921434;0.7592068;0.80422795
GO BP;INOSITOL LIPID MEDIATED SIGNALING;GO:0048017;123;-0.18233365;-0.88833535;0.71428573;0.8057842
GO BP;CELLULAR RESPONSE TO GAMMA RADIATION;GO:0071480;29;-0.24828799;-0.8882808;0.63345194;0.80550355
GO BP;CYTOKINE METABOLIC PROCESS;GO:0042107;64;-0.20426355;-0.8880389;0.65705127;0.8056764
GO BP;I KAPPAB KINASE NF KAPPAB SIGNALING;GO:0007249;196;-0.16918518;-0.88797474;0.7410296;0.805422
GO BP;NEGATIVE REGULATION OF CELL GROWTH;GO:0030308;124;-0.1822556;-0.88777715;0.68659127;0.8054655
GO BP;ALCOHOL METABOLIC PROCESS;#N/A;252;-0.16205367;-0.88753563;0.760745;0.80562454
GO BP;TRIGLYCERIDE CATABOLIC PROCESS;GO:0019433;21;-0.2649169;-0.88744676;0.6118068;0.8054055
GO BP;NEUTRAL AMINO ACID TRANSPORT;GO:0015804;24;-0.25068495;-0.88582546;0.6208696;0.80865425
GO BP;METANEPHROS DEVELOPMENT;GO:0001656;47;-0.21704733;-0.8856331;0.6639073;0.80867
GO BP;POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION;#N/A;16;-0.28757286;-0.8852719;0.6223022;0.8090911
GO BP;NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE;GO:0070373;49;-0.21512973;-0.88499105;0.6304348;0.8093274
GO BP;REGULATION OF WATER LOSS VIA SKIN;GO:0033561;18;-0.27803725;-0.8847882;0.63928574;0.80938965
GO BP;RESPONSE TO ANGIOTENSIN;GO:1990776;16;-0.2851694;-0.884559;0.5989305;0.80950457
GO BP;HEART VALVE DEVELOPMENT;GO:0003170;46;-0.21857895;-0.8834546;0.67005074;0.8116109
GO BP;PEPTIDYL CYSTEINE MODIFICATION;#N/A;35;-0.23401497;-0.8833079;0.6490909;0.8115391
GO BP;NCRNA PROCESSING;GO:0034470;341;-0.15737146;-0.8832726;0.80206794;0.81120324
GO BP;PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS;#N/A;70;-0.19725594;-0.882866;0.6622296;0.8117
GO BP;REGULATION OF THE FORCE OF HEART CONTRACTION;GO:0002026;15;-0.29203314;-0.88253874;0.6384365;0.8120287
GO BP;DIOL METABOLIC PROCESS;#N/A;18;-0.27703032;-0.8825378;0.62454873;0.8116252
GO BP;SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND;#N/A;46;-0.21502863;-0.8814199;0.669967;0.8136802
GO BP;PROTEIN STABILIZATION;GO:0050821;152;-0.17307957;-0.8811173;0.75279105;0.8139437
GO BP;REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT;#N/A;60;-0.20284732;-0.88068646;0.6694079;0.8145296
GO BP;LOCOMOTORY BEHAVIOR;GO:0007626;103;-0.1858228;-0.88045603;0.7064516;0.81462693
GO BP;REGULATION OF RECEPTOR INTERNALIZATION;GO:0002090;34;-0.23058686;-0.87999535;0.64579606;0.815266
GO BP;EXTRINSIC APOPTOTIC SIGNALING PATHWAY;GO:0097191;162;-0.1710188;-0.879452;0.75641024;0.81607825
GO BP;STEROL HOMEOSTASIS;GO:0055092;62;-0.203935;-0.87941366;0.68729097;0.81575793
GO BP;REGULATION OF NMDA RECEPTOR ACTIVITY;GO:2000310;17;-0.28166023;-0.8785301;0.6168717;0.8173362
GO BP;RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION;#N/A;174;-0.16954614;-0.8782807;0.76968795;0.8174762
GO BP;POSITIVE REGULATION OF WOUND HEALING;GO:0090303;36;-0.22465084;-0.87809384;0.6493289;0.81746995
GO BP;RENAL SYSTEM PROCESS;GO:0003014;67;-0.20228456;-0.87757224;0.6894309;0.81825465
GO BP;SOMATIC STEM CELL POPULATION MAINTENANCE;GO:0035019;59;-0.20256834;-0.877548;0.6578512;0.81790936
GO BP;MODULATION BY VIRUS OF HOST MORPHOLOGY OR PHYSIOLOGY;#N/A;26;-0.24838041;-0.87713;0.66031194;0.8184547
GO BP;GERM CELL DEVELOPMENT;GO:0007281;156;-0.17098066;-0.8763983;0.75535166;0.8196029
GO BP;REGULATION OF MICROTUBULE BASED MOVEMENT;#N/A;18;-0.27730772;-0.8763175;0.63716817;0.8193799
GO BP;REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT;GO:2000641;18;-0.27794734;-0.876273;0.63503647;0.8190738
GO BP;MODIFICATION OF MORPHOLOGY OR PHYSIOLOGY OF OTHER ORGANISM;#N/A;90;-0.18907988;-0.8761692;0.69640064;0.8188828
GO BP;REGULATION OF GASTRULATION;GO:0010470;31;-0.2372141;-0.8758463;0.65090907;0.8191975
GO BP;ENDOTHELIAL CELL APOPTOTIC PROCESS;GO:0072577;30;-0.2404599;-0.8751792;0.654321;0.8203017
GO BP;SMOOTH MUSCLE CONTRACTION;GO:0006939;52;-0.21258472;-0.8751427;0.6928214;0.8199688
GO BP;RESPONSE TO TOXIC SUBSTANCE;GO:0009636;330;-0.15761192;-0.87499624;0.8137536;0.8198903
GO BP;SPECIFICATION OF ANIMAL ORGAN IDENTITY;GO:0010092;18;-0.273569;-0.8747307;0.61480075;0.8200908
GO BP;MONONUCLEAR CELL DIFFERENTIATION;#N/A;20;-0.27099776;-0.87467504;0.62735045;0.8198157
GO BP;SYNAPTIC VESICLE EXOCYTOSIS;GO:0016079;69;-0.19979042;-0.8745611;0.71125615;0.8196501
GO BP;CELLULAR RESPONSE TO VIRUS;GO:0098586;35;-0.22760205;-0.8744911;0.6443662;0.81941366
GO BP;NEGATIVE REGULATION OF VIRAL TRANSCRIPTION;GO:0032897;20;-0.26557043;-0.8742832;0.6333907;0.81942534
GO BP;NEGATIVE REGULATION OF TRANSPORT;GO:0051051;283;-0.1586721;-0.87410325;0.80729926;0.8193985
GO BP;T CELL CYTOKINE PRODUCTION;GO:0002369;17;-0.28132036;-0.87247175;0.6320422;0.822546
GO BP;REGULATION OF ACTION POTENTIAL;GO:0098900;32;-0.23535526;-0.8723816;0.6436782;0.822339
GO BP;POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING;GO:0051897;98;-0.18423666;-0.8723815;0.7236641;0.82193446
GO BP;NEGATIVE REGULATION OF ORGAN GROWTH;GO:0046621;22;-0.26084605;-0.8720135;0.65194345;0.8223353
GO BP;REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION;#N/A;26;-0.24696861;-0.87136483;0.6465364;0.82336575
GO BP;POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS;GO:0048260;37;-0.22456671;-0.87052983;0.65776294;0.82482237
GO BP;NEGATIVE REGULATION OF ENDOCYTOSIS;GO:0045806;29;-0.24150515;-0.8702993;0.6515913;0.82492757
GO BP;RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS;#N/A;66;-0.20057759;-0.8696631;0.70896786;0.8258808
GO BP;RNA PHOSPHODIESTER BOND HYDROLYSIS;GO:0090501;123;-0.17484881;-0.8691474;0.75;0.82658213
GO BP;PERK MEDIATED UNFOLDED PROTEIN RESPONSE;GO:0036499;16;-0.28460938;-0.8691234;0.63247865;0.82623255
GO BP;PINOCYTOSIS;GO:0006907;17;-0.27395666;-0.8688786;0.61921096;0.8263237
GO BP;ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS;#N/A;17;-0.28145263;-0.86885095;0.5952381;0.8259783
GO BP;POSITIVE REGULATION OF RESPONSE TO WOUNDING;#N/A;44;-0.21557094;-0.8688017;0.69;0.8256816
GO BP;POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS;#N/A;113;-0.17717156;-0.86743873;0.731746;0.82816744
GO BP;ACIDIC AMINO ACID TRANSPORT;#N/A;37;-0.2267928;-0.8672567;0.67021275;0.8281523
GO BP;MYELOID CELL DEVELOPMENT;GO:0061515;50;-0.20872693;-0.8672204;0.68948245;0.8278166
GO BP;ATRIAL SEPTUM DEVELOPMENT;GO:0003283;15;-0.29099894;-0.86712337;0.6287744;0.8276361
GO BP;RESPONSE TO ISCHEMIA;GO:0002931;33;-0.22955741;-0.86711055;0.678508;0.82725626
GO BP;CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS;GO:1901137;488;-0.1489228;-0.8668866;0.8867925;0.8273294
GO BP;PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION;GO:0071459;21;-0.25344658;-0.8666105;0.6215278;0.8275332
GO BP;CELL CELL ADHESION MEDIATED BY CADHERIN;GO:0044331;24;-0.24633175;-0.86495185;0.64778763;0.83074325
GO BP;POSITIVE REGULATION OF LIPID CATABOLIC PROCESS;GO:0050996;15;-0.28159305;-0.8629075;0.6574871;0.8347814
GO BP;CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE;GO:0002367;61;-0.19716331;-0.86181825;0.71088433;0.8367326
GO BP;REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS;#N/A;98;-0.18533798;-0.8604372;0.73432344;0.83921313
GO BP;DIGESTIVE SYSTEM DEVELOPMENT;GO:0055123;90;-0.18665391;-0.8595676;0.72897196;0.84057504
GO BP;REGULATION OF LIPID BIOSYNTHETIC PROCESS;GO:0046890;143;-0.17129606;-0.85950845;0.7828843;0.8402944
GO BP;ALPHA AMINO ACID METABOLIC PROCESS;GO:1901605;149;-0.16931108;-0.8594618;0.771518;0.8399801
GO BP;REGULATION OF DEFENSE RESPONSE;#N/A;444;-0.14877254;-0.85771346;0.9133965;0.843273
GO BP;REGULATION OF CELLULAR KETONE METABOLIC PROCESS;GO:0010565;132;-0.17150638;-0.8573755;0.78403753;0.84356695
GO BP;PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS;GO:0006661;101;-0.18037172;-0.8569791;0.7483766;0.8439597
GO BP;REGULATION OF LIPID LOCALIZATION;#N/A;86;-0.18669179;-0.85697514;0.7432886;0.8435577
GO BP;POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION;GO:0032481;65;-0.19480188;-0.8568826;0.73656845;0.8433303
GO BP;REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING;#N/A;97;-0.1814235;-0.85625094;0.7311475;0.84424937
GO BP;REGULATION OF ANOIKIS;GO:2000209;15;-0.27627993;-0.8551295;0.6424682;0.84618133
GO BP;POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS;#N/A;19;-0.2641675;-0.8549967;0.6620209;0.84601545
GO BP;NIK NF KAPPAB SIGNALING;GO:0038061;113;-0.1786811;-0.8549449;0.771518;0.84573025
GO BP;PROTEIN LIPID COMPLEX ASSEMBLY;GO:0065005;27;-0.23455732;-0.85493386;0.67793596;0.84533995
GO BP;HISTONE DEUBIQUITINATION;GO:0016578;21;-0.25405094;-0.8540184;0.66790354;0.84682953
GO BP;REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS;#N/A;72;-0.18991351;-0.8533074;0.71590906;0.8478508
GO BP;MAST CELL ACTIVATION;GO:0045576;36;-0.22415553;-0.85184896;0.70068026;0.8504133
GO BP;EXTRACELLULAR MATRIX DISASSEMBLY;GO:0022617;53;-0.20458631;-0.8512202;0.72861844;0.8512278
GO BP;COAGULATION;#N/A;208;-0.15986826;-0.8499665;0.8206997;0.8534063
GO BP;N TERMINAL PROTEIN AMINO ACID MODIFICATION;GO:0031365;25;-0.24298337;-0.84966683;0.6786325;0.85361534
GO BP;REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION;GO:0002761;65;-0.19390549;-0.84939706;0.7363344;0.8537215
GO BP;EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS;GO:0060441;18;-0.26758847;-0.849174;0.6690909;0.8537388
GO BP;NEGATIVE REGULATION OF TORC1 SIGNALING;GO:1904262;15;-0.28339934;-0.8490714;0.6611111;0.8535252
GO BP;REGULATION OF LIPID STORAGE;GO:0010883;33;-0.22896864;-0.84865993;0.7025641;0.85392666
GO BP;RIBONUCLEOTIDE CATABOLIC PROCESS;#N/A;26;-0.24051031;-0.8484322;0.687389;0.8539716
GO BP;ORGANIC HYDROXY COMPOUND METABOLIC PROCESS;#N/A;345;-0.15085086;-0.8476942;0.87656033;0.8550623
GO BP;SYNAPTIC VESICLE RECYCLING;GO:0036465;53;-0.20065197;-0.84565276;0.73288816;0.85873055
GO BP;OUTFLOW TRACT MORPHOGENESIS;GO:0003151;52;-0.20295149;-0.84359676;0.7258883;0.86242837
GO BP;POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS;#N/A;34;-0.22328158;-0.84247077;0.7209705;0.8643276
GO BP;POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS;GO:0046889;56;-0.19834769;-0.8418158;0.7289562;0.8652269
GO BP;NEUROTRANSMITTER TRANSPORT;GO:0006836;143;-0.1661449;-0.84178233;0.7934621;0.8648651
GO BP;PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE;#N/A;30;-0.22758995;-0.8411918;0.7205624;0.8655967
GO BP;PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS;#N/A;77;-0.18649586;-0.8403676;0.7432217;0.86676085
GO BP;POSITIVE REGULATION OF IMMUNE RESPONSE;GO:0050778;460;-0.14504647;-0.8390532;0.92214763;0.86894524
GO BP;ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I;GO:0042590;57;-0.19648676;-0.83900785;0.74523395;0.868621
GO BP;CHONDROCYTE DEVELOPMENT;GO:0002063;28;-0.23544835;-0.8385576;0.7089041;0.8691415
GO BP;MOVEMENT IN ENVIRONMENT OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION;#N/A;32;-0.22536756;-0.83793986;0.70868826;0.8699163
GO BP;POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING;#N/A;24;-0.24173255;-0.83683956;0.6920415;0.87160647
GO BP;RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY;GO:0051123;21;-0.25143176;-0.83574516;0.6937394;0.87333715
GO BP;NEGATIVE REGULATION OF VIRAL GENOME REPLICATION;GO:0045071;33;-0.22412424;-0.8352669;0.72887325;0.87386614
GO BP;NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION;#N/A;66;-0.18895681;-0.8338484;0.7745572;0.8761741
GO BP;INSULIN SECRETION;GO:0030073;128;-0.17011866;-0.8336943;0.82764226;0.8760384
GO BP;REACTIVE OXYGEN SPECIES METABOLIC PROCESS;GO:0072593;175;-0.16025321;-0.8333521;0.88130563;0.8762219
GO BP;POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS;#N/A;363;-0.14777628;-0.8332346;0.9122807;0.87604105
GO BP;OOCYTE MATURATION;GO:0001556;17;-0.26288706;-0.83257;0.68545455;0.87690926
GO BP;NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT;GO:0055026;20;-0.24753052;-0.83090216;0.6993127;0.8796646
GO BP;POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS;#N/A;251;-0.15174676;-0.8302009;0.8783784;0.8805666
GO BP;PROTEOGLYCAN BIOSYNTHETIC PROCESS;GO:0030166;36;-0.21735094;-0.8297868;0.7512195;0.8809639
GO BP;CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS;#N/A;21;-0.24848679;-0.829411;0.6987952;0.8812099
GO BP;REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION;GO:0051150;21;-0.25091428;-0.82858497;0.70034844;0.8823786
GO BP;OVULATION CYCLE;GO:0042698;38;-0.21496658;-0.8279428;0.73311895;0.8831547
GO BP;ANTERIOR POSTERIOR PATTERN SPECIFICATION;GO:0009952;114;-0.17203867;-0.8267499;0.81463414;0.8849803
GO BP;POSITIVE REGULATION OF STRESS FIBER ASSEMBLY;GO:0051496;43;-0.2074379;-0.82668203;0.75643224;0.88468814
GO BP;ACTIVATION OF PROTEIN KINASE B ACTIVITY;GO:0032148;23;-0.24216738;-0.82662493;0.7137746;0.88438576
GO BP;TERMINATION OF RNA POLYMERASE II TRANSCRIPTION;GO:0006369;33;-0.21763569;-0.8258262;0.75089604;0.8855
GO BP;LEUKOCYTE MEDIATED CYTOTOXICITY;GO:0001909;45;-0.20433502;-0.82577586;0.75;0.88517195
GO BP;UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS;GO:0006047;15;-0.2733646;-0.8252617;0.69911504;0.88571286
GO BP;REGULATION OF NOTCH SIGNALING PATHWAY;GO:0008593;73;-0.18493721;-0.82467407;0.79227054;0.8863753
GO BP;POSITIVE REGULATION OF TRANSLATION;GO:0045727;104;-0.17164695;-0.8239931;0.81846637;0.8872624
GO BP;POSITIVE REGULATION OF PROTEIN DEACETYLATION;GO:0090312;18;-0.26247132;-0.8238567;0.6968641;0.88708395
GO BP;GLYCEROLIPID CATABOLIC PROCESS;#N/A;43;-0.20684224;-0.8237348;0.7433775;0.8868804
GO BP;REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY;#N/A;84;-0.18054755;-0.8231005;0.78559464;0.8876275
GO BP;TRNA METHYLATION;GO:0030488;32;-0.22032619;-0.82297945;0.75533664;0.8874095
GO BP;HEMATOPOIETIC STEM CELL DIFFERENTIATION;GO:0060218;65;-0.18636858;-0.82107955;0.7907348;0.89049363
GO BP;POSITIVE REGULATION OF SECRETION;GO:0051047;231;-0.15276867;-0.8208811;0.8977778;0.8904615
GO BP;REGULATION OF CARDIOCYTE DIFFERENTIATION;#N/A;35;-0.21468979;-0.8196302;0.7280405;0.8923354
GO BP;SECONDARY METABOLIC PROCESS;GO:0019748;31;-0.22239602;-0.8195989;0.71972317;0.891971
GO BP;REGULATION OF MESENCHYMAL CELL PROLIFERATION;GO:0010464;21;-0.24997166;-0.8194453;0.73136914;0.89184123
GO BP;FEMALE SEX DIFFERENTIATION;#N/A;69;-0.18335834;-0.8189201;0.81037277;0.89231896
GO BP;PROTEIN N LINKED GLYCOSYLATION;GO:0006487;65;-0.1871685;-0.8185544;0.78842974;0.8925593
GO BP;LABYRINTHINE LAYER DEVELOPMENT;GO:0060711;34;-0.21640624;-0.81750786;0.7607261;0.8940255
GO BP;ESTABLISHMENT OF EPITHELIAL CELL POLARITY;GO:0090162;24;-0.23818833;-0.81693935;0.73392856;0.89462674
GO BP;OLIGODENDROCYTE DEVELOPMENT;GO:0014003;25;-0.2352521;-0.8168328;0.76551723;0.89438766
GO BP;AMINO ACID IMPORT;#N/A;15;-0.27137655;-0.8158148;0.70526314;0.8957238
GO BP;REGULATION OF BEHAVIOR;GO:0050795;25;-0.22982313;-0.81540173;0.72231686;0.8959971
GO BP;CYTOKINE MEDIATED SIGNALING PATHWAY;GO:0019221;429;-0.14256427;-0.81522584;0.9625;0.89590096
GO BP;DIGESTION;GO:0007586;57;-0.19176479;-0.81431746;0.792144;0.8970679
GO BP;REGULATION OF ANION TRANSPORT;GO:0044070;50;-0.19915436;-0.81419563;0.76884425;0.8968657
GO BP;ANOIKIS;GO:0043276;24;-0.2316807;-0.8136017;0.72648084;0.89751107
GO BP;RIBOSOME BIOGENESIS;GO:0042254;275;-0.14867567;-0.8129207;0.9187228;0.8983082
GO BP;ACTIVATION OF INNATE IMMUNE RESPONSE;GO:0002218;213;-0.15320803;-0.81263524;0.9044684;0.89837474
GO BP;RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE;GO:1990126;27;-0.2263546;-0.81263036;0.74025977;0.89796126
GO BP;SYNAPTIC VESICLE PRIMING;GO:0016082;18;-0.2573859;-0.81151754;0.721943;0.8994742
GO BP;SECRETORY GRANULE ORGANIZATION;GO:0033363;25;-0.23343022;-0.81110114;0.737931;0.89977014
GO BP;NEGATIVE REGULATION OF BIOMINERALIZATION;GO:0110150;16;-0.26241538;-0.8108866;0.72758037;0.89972866
GO BP;PROSTATE GLAND DEVELOPMENT;GO:0030850;34;-0.21414845;-0.8103937;0.7513135;0.9001488
GO BP;FOAM CELL DIFFERENTIATION;#N/A;24;-0.23646283;-0.81005836;0.7477954;0.90025836
GO BP;KERATINOCYTE DIFFERENTIATION;GO:0030216;105;-0.17035033;-0.8099114;0.8504983;0.9000721
GO BP;SKELETAL MUSCLE ADAPTATION;#N/A;17;-0.25850376;-0.80840176;0.73636365;0.902236
GO BP;POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION;GO:0046638;27;-0.23298602;-0.8078745;0.7504554;0.9027228
GO BP;OLIGODENDROCYTE DIFFERENTIATION;GO:0048709;54;-0.19302666;-0.8076502;0.7861842;0.90266675
GO BP;REGULATION OF MITOCHONDRIAL FISSION;GO:0090140;20;-0.24770334;-0.8070812;0.73426574;0.9031839
GO BP;NEGATIVE REGULATION OF REPRODUCTIVE PROCESS;#N/A;33;-0.21874154;-0.8060693;0.7748227;0.9044343
GO BP;CELLULAR RESPONSE TO EXTERNAL STIMULUS;#N/A;246;-0.14951468;-0.80559236;0.9349711;0.90481955
GO BP;REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY;#N/A;26;-0.22519235;-0.8052071;0.75384617;0.905038
GO BP;TRANSITION METAL ION HOMEOSTASIS;#N/A;96;-0.1714016;-0.8047447;0.84201956;0.90540624
GO BP;POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT;GO:0045684;23;-0.2389602;-0.8038763;0.7369338;0.90645266
GO BP;REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY;GO:0033146;32;-0.21845101;-0.8036305;0.76;0.9064273
GO BP;MATURATION OF 5 8S RRNA;#N/A;26;-0.22669338;-0.80306804;0.75837743;0.9069254
GO BP;MIDBRAIN DEVELOPMENT;GO:0030901;60;-0.18312389;-0.80291736;0.8178808;0.90673697
GO BP;WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY;GO:0007223;27;-0.22511265;-0.8023172;0.75491947;0.90731335
GO BP;REGULATION OF B CELL DIFFERENTIATION;GO:0045577;20;-0.24586533;-0.80210996;0.7248677;0.9072244
GO BP;RESPONSE TO DEXAMETHASONE;GO:0071548;31;-0.21761887;-0.800892;0.78253424;0.90879655
GO BP;POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY;GO:1901030;30;-0.21708956;-0.8008429;0.7609842;0.9084595
GO BP;INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR;GO:0042771;39;-0.20552473;-0.8000792;0.77616745;0.9092991
GO BP;ANTIBIOTIC CATABOLIC PROCESS;#N/A;26;-0.23059945;-0.79998124;0.7587354;0.90902513
GO BP;ACTIVATED T CELL PROLIFERATION;GO:0050798;23;-0.23247923;-0.7997749;0.7667239;0.9089723
GO BP;NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION;GO:0002762;25;-0.23270394;-0.7997176;0.7242583;0.9086487
GO BP;RRNA METABOLIC PROCESS;GO:0016072;208;-0.15159664;-0.7979932;0.90425533;0.9109986
GO BP;LIPID STORAGE;GO:0019915;50;-0.195287;-0.79788285;0.803056;0.9107565
GO BP;WATER HOMEOSTASIS;GO:0030104;45;-0.19271101;-0.7977744;0.79268295;0.91049075
GO BP;GLIAL CELL PROLIFERATION;GO:0014009;29;-0.21932568;-0.7975674;0.7986348;0.91040206
GO BP;NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS;GO:1904036;29;-0.21616141;-0.79753494;0.77031803;0.9100396
GO BP;REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION;#N/A;59;-0.18643317;-0.79702276;0.8245315;0.9104396
GO BP;NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS;#N/A;88;-0.17297742;-0.79698527;0.8622951;0.91007626
GO BP;REGULATION OF MUSCLE ORGAN DEVELOPMENT;GO:0048634;82;-0.17385909;-0.7969366;0.8496835;0.9097477
GO BP;REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY;GO:0051438;45;-0.19610804;-0.7948115;0.8192;0.91266316
GO BP;REGULATION OF NEUROTRANSMITTER SECRETION;GO:0046928;60;-0.18584554;-0.79459125;0.8413793;0.91260356
GO BP;SPHINGOLIPID METABOLIC PROCESS;GO:0006665;123;-0.16203241;-0.7934204;0.89167976;0.914038
GO BP;REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY;GO:0034121;41;-0.19943511;-0.7932461;0.7950413;0.91388303
GO BP;TRNA WOBBLE BASE MODIFICATION;#N/A;18;-0.24683656;-0.79295516;0.75252527;0.913936
GO BP;NCRNA CATABOLIC PROCESS;#N/A;30;-0.21669157;-0.7921549;0.76731795;0.91477674
GO BP;POSITIVE REGULATION OF COAGULATION;GO:0050820;19;-0.24805532;-0.7920671;0.7718978;0.9144825
GO BP;POSITIVE REGULATION OF DEFENSE RESPONSE;#N/A;298;-0.14275046;-0.7919159;0.942029;0.91429144
GO BP;NEURAL NUCLEUS DEVELOPMENT;GO:0048857;36;-0.20831428;-0.7915085;0.8;0.91452646
GO BP;REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS;GO:0017158;27;-0.22471851;-0.7914429;0.7787934;0.91422725
GO BP;REGULATORY T CELL DIFFERENTIATION;GO:0045066;15;-0.2639712;-0.79125315;0.74204946;0.9141018
GO BP;REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING;GO:2000677;33;-0.21123812;-0.79095274;0.79029465;0.9141274
GO BP;CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS;GO:0060351;30;-0.21737058;-0.7904945;0.76988155;0.9143713
GO BP;HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION;GO:0002244;123;-0.16318196;-0.7885258;0.8685446;0.91698235
GO BP;CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR;GO:0042994;15;-0.26163697;-0.7884874;0.77112675;0.91662675
GO BP;PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS;GO:0006220;52;-0.19112481;-0.7879708;0.80438447;0.916997
GO BP;EMBRYONIC HINDLIMB MORPHOGENESIS;GO:0035116;18;-0.24803728;-0.7876664;0.7530648;0.91704464
GO BP;POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION;GO:1903955;26;-0.22046497;-0.78734607;0.7900172;0.9170755
GO BP;REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING;GO:2001032;17;-0.25576958;-0.7871081;0.75634515;0.917006
GO BP;POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING;GO:0050850;22;-0.22782327;-0.7867908;0.7889273;0.91707295
GO BP;CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS;#N/A;39;-0.19923128;-0.78672343;0.8207705;0.91676027
GO BP;PEPTIDYL ASPARAGINE MODIFICATION;#N/A;32;-0.21166763;-0.78477085;0.79801327;0.9192604
GO BP;SPLICEOSOMAL SNRNP ASSEMBLY;GO:0000387;37;-0.20359917;-0.7835955;0.80487806;0.9205928
GO BP;RESPONSE TO ESTRADIOL;GO:0032355;88;-0.17167532;-0.7835094;0.8635634;0.9202962
GO BP;INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION;GO:0060122;18;-0.24847634;-0.7832131;0.7598628;0.9203185
GO BP;TRNA PROCESSING;GO:0008033;115;-0.1596963;-0.78291225;0.88697016;0.9203521
GO BP;RESPONSE TO BRONCHODILATOR;#N/A;25;-0.22518618;-0.7826619;0.7932862;0.9202971
GO BP;CHROMATIN REMODELING AT CENTROMERE;#N/A;41;-0.20017803;-0.78148305;0.8115942;0.92161566
GO BP;VACUOLAR ACIDIFICATION;GO:0007035;20;-0.24058501;-0.78107727;0.76373625;0.9217736
GO BP;SENSORY PERCEPTION OF PAIN;GO:0019233;43;-0.1925801;-0.7801193;0.83164984;0.92273253
GO BP;NEGATIVE REGULATION OF CALCIUM ION TRANSPORT;GO:0051926;25;-0.22545795;-0.7795465;0.79533213;0.92310786
GO BP;POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY;GO:1904031;28;-0.21919991;-0.77944106;0.7848325;0.9228248
GO BP;REGULATION OF GLUCAN BIOSYNTHETIC PROCESS;#N/A;22;-0.23451458;-0.7789261;0.8017857;0.92313963
GO BP;RESPONSE TO MORPHINE;GO:0043278;15;-0.26376656;-0.7784549;0.77835953;0.9233663
GO BP;ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE;#N/A;15;-0.25868353;-0.77648723;0.77526134;0.9257719
GO BP;CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS;#N/A;139;-0.15363707;-0.7757636;0.92534995;0.9263791
GO BP;REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL;GO:0060078;61;-0.18067087;-0.7750857;0.8597663;0.926911
GO BP;EMBRYONIC HEART TUBE DEVELOPMENT;GO:0035050;58;-0.18203104;-0.7738062;0.85762143;0.92825216
GO BP;PROTEIN HYDROXYLATION;GO:0018126;23;-0.22592804;-0.773271;0.8073555;0.92854047
GO BP;MITOCHONDRIAL RNA METABOLIC PROCESS;GO:0000959;45;-0.18877631;-0.772316;0.8388704;0.9293957
GO BP;NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION;GO:0050805;36;-0.19953239;-0.77049583;0.8131488;0.93141854
GO BP;GLUCOCORTICOID METABOLIC PROCESS;GO:0008211;16;-0.25263822;-0.76845187;0.81946903;0.93381983
GO BP;MATERNAL PLACENTA DEVELOPMENT;GO:0001893;28;-0.21651112;-0.76841736;0.79897785;0.93344253
GO BP;ALCOHOL BIOSYNTHETIC PROCESS;#N/A;127;-0.15494093;-0.7678381;0.9227053;0.933817
GO BP;NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR;GO:1902254;18;-0.24235794;-0.767651;0.7694974;0.9336543
GO BP;INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE;#N/A;42;-0.19520074;-0.7673097;0.839527;0.9336985
GO BP;CEREBRAL CORTEX CELL MIGRATION;GO:0021795;30;-0.2108958;-0.76684904;0.80937;0.9338987
GO BP;TETRAPYRROLE BIOSYNTHETIC PROCESS;GO:0033014;27;-0.21387678;-0.7661661;0.8080134;0.93440276
GO BP;REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION;#N/A;34;-0.20373924;-0.7661366;0.83468395;0.9340167
GO BP;NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION;GO:2000515;15;-0.24617946;-0.7659489;0.7747899;0.9338446
GO BP;RESPONSE TO DOPAMINE;#N/A;33;-0.20490034;-0.7656451;0.82764506;0.93382543
GO BP;AMINE TRANSPORT;GO:0015837;37;-0.1989239;-0.764101;0.82430214;0.9354953
GO BP;PEPTIDYL PROLINE MODIFICATION;GO:0018208;47;-0.18705758;-0.76217806;0.85690516;0.93759197
GO BP;MYELIN ASSEMBLY;GO:0032288;16;-0.24619623;-0.76182276;0.7993311;0.9376459
GO BP;PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS;GO:0006778;31;-0.20258121;-0.7616171;0.81785715;0.937503
GO BP;OOGENESIS;GO:0048477;52;-0.18716943;-0.76107144;0.8603448;0.93781126
GO BP;GLUTAMATE SECRETION;GO:0014047;23;-0.21866001;-0.76100916;0.80212015;0.9374638
GO BP;NEGATIVE REGULATION OF EXOCYTOSIS;GO:0045920;18;-0.23081861;-0.76061666;0.7955707;0.9375619
GO BP;CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS;GO:0050650;16;-0.2502228;-0.76056737;0.78975266;0.9372032
GO BP;NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION;GO:0050732;34;-0.1976344;-0.75991416;0.84771574;0.937588
GO BP;DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS;GO:0046545;58;-0.17741089;-0.7594744;0.8812057;0.9377465
GO BP;POSITIVE REGULATION OF TISSUE REMODELING;#N/A;19;-0.23932119;-0.7576274;0.80210155;0.9395934
GO BP;GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS;#N/A;52;-0.18281579;-0.75567234;0.85809684;0.9415953
GO BP;REGULATION OF NEURON PROJECTION REGENERATION;GO:0070570;22;-0.22667615;-0.75551707;0.7859649;0.94136894
GO BP;RIBOSOMAL SMALL SUBUNIT BIOGENESIS;GO:0042274;64;-0.17334095;-0.7548549;0.8939641;0.9417968
GO BP;POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION;GO:0090277;58;-0.17620654;-0.7534439;0.89179754;0.94312197
GO BP;POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS;GO:0042108;35;-0.19694889;-0.7532702;0.8498294;0.94290495
GO BP;ACTIVIN RECEPTOR SIGNALING PATHWAY;GO:0032924;25;-0.21791768;-0.75306726;0.8117647;0.94273543
GO BP;RESPONSE TO CHEMOKINE;#N/A;24;-0.218065;-0.7526921;0.7975986;0.9427708
GO BP;COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION;#N/A;75;-0.16679242;-0.75266707;0.8950931;0.94237876
GO BP;POSITIVE REGULATION OF MEMBRANE PERMEABILITY;GO:1905710;50;-0.18151332;-0.75265056;0.8504983;0.94197816
GO BP;PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION;GO:0046856;23;-0.21739346;-0.75236654;0.82664233;0.94190234
GO BP;CATECHOLAMINE SECRETION;GO:0050432;21;-0.23073037;-0.75219524;0.80775714;0.94167536
GO BP;REGULATION OF INSULIN SECRETION;GO:0050796;109;-0.15491457;-0.7520011;0.9362364;0.9414939
GO BP;CLATHRIN DEPENDENT ENDOCYTOSIS;GO:0072583;37;-0.19602345;-0.75078654;0.8500882;0.9424689
GO BP;REGULATION OF MEGAKARYOCYTE DIFFERENTIATION;GO:0045652;58;-0.17674595;-0.75060326;0.89464885;0.9422823
GO BP;HISTONE PHOSPHORYLATION;GO:0016572;30;-0.20529288;-0.7496037;0.8122744;0.94301087
GO BP;REGULATION OF CALCIUM MEDIATED SIGNALING;GO:0050848;58;-0.17597379;-0.74836403;0.8915663;0.94397646
GO BP;TRNA WOBBLE URIDINE MODIFICATION;GO:0002098;15;-0.24867202;-0.7481166;0.8017857;0.9438359
GO BP;SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT;GO:0070296;19;-0.23423232;-0.74703395;0.8217636;0.94467306
GO BP;PHOSPHOLIPID DEPHOSPHORYLATION;GO:0046839;30;-0.20370813;-0.74584043;0.84148395;0.9456372
GO BP;MAMMARY GLAND EPITHELIAL CELL PROLIFERATION;GO:0033598;23;-0.21895395;-0.7446422;0.8277087;0.946619
GO BP;MUSCLE FIBER DEVELOPMENT;GO:0048747;38;-0.19276689;-0.7434506;0.8576271;0.9475446
GO BP;RESPONSE TO FOOD;GO:0032094;18;-0.23118263;-0.7432492;0.82099825;0.9473532
GO BP;REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION;GO:1903053;26;-0.21266764;-0.7428323;0.8313044;0.94735926
GO BP;POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE;#N/A;55;-0.17671654;-0.74279636;0.89179754;0.94698477
GO BP;POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION;GO:0030838;69;-0.16645554;-0.7419679;0.9141914;0.94750166
GO BP;PHAGOSOME ACIDIFICATION;GO:0090383;24;-0.21464972;-0.74081707;0.8392226;0.94836426
GO BP;LIVER MORPHOGENESIS;GO:0072576;16;-0.23981364;-0.73909664;0.8339483;0.9498303
GO BP;GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS;#N/A;18;-0.23422022;-0.73888767;0.8181818;0.94964844
GO BP;DRUG CATABOLIC PROCESS;GO:0042737;74;-0.1660674;-0.7386731;0.8986928;0.9494724
GO BP;REGULATION OF OXIDATIVE PHOSPHORYLATION;GO:0002082;26;-0.2061888;-0.7380701;0.8548387;0.949722
GO BP;ANIMAL ORGAN MATURATION;#N/A;15;-0.24934526;-0.73751175;0.8082902;0.94989747
GO BP;MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA;#N/A;21;-0.22193885;-0.7374335;0.85077184;0.9495738
GO BP;RESPONSE TO KETONE;#N/A;122;-0.15048975;-0.7369961;0.9483037;0.9496031
GO BP;SIGNAL TRANSDUCTION INVOLVED IN CELLULAR RESPONSE TO AMMONIUM ION;#N/A;31;-0.20030192;-0.7365318;0.8563923;0.9496799
GO BP;APOPTOTIC DNA FRAGMENTATION;GO:0006309;19;-0.23107411;-0.7362485;0.85026735;0.9495698
GO BP;PROTEIN CONTAINING COMPLEX REMODELING;#N/A;19;-0.22979654;-0.73614997;0.83152175;0.9492601
GO BP;REGULATION OF WOUND HEALING;GO:0061041;90;-0.15603223;-0.7335166;0.9269949;0.9516137
GO BP;INNERVATION;GO:0060384;17;-0.23039006;-0.73296815;0.8172232;0.95176405
GO BP;T CELL MEDIATED IMMUNITY;GO:0002456;46;-0.1796266;-0.7318656;0.8939394;0.9524789
GO BP;NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR;GO:1901797;26;-0.20818068;-0.7315325;0.8444056;0.9523971
GO BP;REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR;GO:1902253;26;-0.20689271;-0.7312311;0.8505155;0.9522878
GO BP;PROTEIN LOCALIZATION TO MITOCHONDRION;GO:0070585;121;-0.14802991;-0.7306443;0.96567863;0.9524572
GO BP;LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE;GO:0034383;29;-0.20327547;-0.7302006;0.8664383;0.9525098
GO BP;CELLULAR RESPONSE TO KETONE;#N/A;62;-0.16880737;-0.7288913;0.9076433;0.9534513
GO BP;REGULATION OF NECROTIC CELL DEATH;GO:0010939;19;-0.22408934;-0.72882867;0.859489;0.9531076
GO BP;REPRODUCTIVE BEHAVIOR;GO:0019098;16;-0.23603503;-0.72800016;0.819398;0.9535599
GO BP;REGULATION OF PHOSPHOLIPASE C ACTIVITY;#N/A;18;-0.23102927;-0.7274538;0.8475499;0.9536822
GO BP;CARDIAC ATRIUM DEVELOPMENT;#N/A;22;-0.2110229;-0.7270939;0.86096257;0.953609
GO BP;PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY;GO:0001844;24;-0.20951377;-0.7266887;0.8559322;0.9536113
GO BP;CERAMIDE CATABOLIC PROCESS;GO:0046514;17;-0.23199372;-0.72594583;0.82871974;0.9539693
GO BP;NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION;#N/A;42;-0.18229859;-0.724512;0.8936535;0.95493406
GO BP;REGULATION OF CHOLESTEROL EFFLUX;GO:0010874;19;-0.22096421;-0.72352314;0.83870965;0.95550936
GO BP;POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY;GO:0032770;16;-0.23701724;-0.7216733;0.82545453;0.9568814
GO BP;MUCOPOLYSACCHARIDE METABOLIC PROCESS;#N/A;71;-0.16171141;-0.7207641;0.9233279;0.9573387
GO BP;REGULATION OF DEFENSE RESPONSE TO VIRUS;GO:0050688;53;-0.17191932;-0.7195308;0.9078727;0.95811003
GO BP;GRANULOCYTE DIFFERENTIATION;GO:0030851;19;-0.22261432;-0.71806544;0.85141903;0.9590822
GO BP;NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS;GO:0050687;21;-0.21564959;-0.71800554;0.85079926;0.9587212
GO BP;FOREBRAIN CELL MIGRATION;GO:0021885;36;-0.18954806;-0.7175182;0.8793706;0.958764
GO BP;REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE;#N/A;17;-0.23159604;-0.7167704;0.8563923;0.95907015
GO BP;CELL AGING;GO:0007569;85;-0.15426123;-0.71666753;0.9504132;0.9587556
GO BP;MICROTUBULE BUNDLE FORMATION;GO:0001578;62;-0.16419612;-0.7153011;0.9585492;0.9595883
GO BP;POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS;#N/A;48;-0.17310208;-0.71457756;0.92047375;0.95983136
GO BP;SEMAPHORIN PLEXIN SIGNALING PATHWAY;GO:0071526;25;-0.20642765;-0.7141412;0.8691756;0.9598219
GO BP;CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS;GO:0071549;26;-0.20228401;-0.7136976;0.8639576;0.95982087
GO BP;CELL REDOX HOMEOSTASIS;GO:0045454;60;-0.1660862;-0.71263534;0.93125;0.9603779
GO BP;PROTEIN TARGETING TO MITOCHONDRION;GO:0006626;88;-0.15174128;-0.70934117;0.9631491;0.9628791
GO BP;REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY;#N/A;16;-0.23063459;-0.70911753;0.87010676;0.9626603
GO BP;POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION;GO:0051155;30;-0.19366345;-0.70808667;0.9019964;0.9631631
GO BP;STEROL BIOSYNTHETIC PROCESS;GO:0016126;68;-0.15926918;-0.7050881;0.9396411;0.9653405
GO BP;REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS;GO:0045540;41;-0.17980233;-0.7050411;0.9098787;0.96496487
GO BP;LIPID OXIDATION;GO:0034440;83;-0.15335126;-0.70292896;0.95881385;0.96632075
GO BP;REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION;GO:1901532;70;-0.15783736;-0.7022875;0.94097805;0.9664356
GO BP;RESPONSE TO AXON INJURY;GO:0048678;52;-0.1698551;-0.7013715;0.93301433;0.96676975
GO BP;NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND;#N/A;18;-0.2163687;-0.7011656;0.8568807;0.9665161
GO BP;REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY;GO:1901028;38;-0.18628824;-0.7009817;0.9064626;0.9662496
GO BP;CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC;#N/A;50;-0.17175487;-0.7008751;0.94057727;0.96591854
GO BP;POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY;#N/A;41;-0.17701837;-0.7004496;0.90547264;0.96584374
GO BP;APOPTOTIC MITOCHONDRIAL CHANGES;GO:0008637;95;-0.14864215;-0.69984555;0.953719;0.9659062
GO BP;REGULATION OF RESPONSE TO WOUNDING;GO:1903034;112;-0.14527157;-0.69979507;0.95956457;0.96554065
GO BP;REGULATION OF TRANSLATION IN RESPONSE TO STRESS;#N/A;15;-0.2323478;-0.69926584;0.8641115;0.96557844
GO BP;PHENOL CONTAINING COMPOUND METABOLIC PROCESS;GO:0018958;44;-0.17337592;-0.69849557;0.9313725;0.9657932
GO BP;MULTIVESICULAR BODY SORTING PATHWAY;GO:0071985;32;-0.18671286;-0.69832945;0.90361446;0.9655073
GO BP;TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY;GO:0033209;109;-0.14561185;-0.6973788;0.968652;0.9658542
GO BP;DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS;GO:0046386;20;-0.21691567;-0.6971887;0.88869566;0.96559465
GO BP;TRABECULA MORPHOGENESIS;GO:0061383;35;-0.18181936;-0.6971364;0.91062397;0.96521825
GO BP;DEVELOPMENTAL INDUCTION;#N/A;16;-0.22360782;-0.6970882;0.8631052;0.96484727
GO BP;MITOTIC G2 M TRANSITION CHECKPOINT;GO:0044818;27;-0.19519415;-0.6969373;0.91549295;0.9645485
GO BP;POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION;GO:0070131;17;-0.2161921;-0.69679046;0.8727915;0.9642444
GO BP;REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS;GO:1903426;53;-0.16392393;-0.6964237;0.94358975;0.9641167
GO BP;NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT;GO:1901862;32;-0.18652049;-0.695063;0.9104478;0.9647855
GO BP;CELL CELL RECOGNITION;#N/A;30;-0.18474415;-0.6950532;0.8915663;0.96437514
GO BP;TYPE B PANCREATIC CELL PROLIFERATION;GO:0044342;17;-0.21758337;-0.6923582;0.8799314;0.96603316
GO BP;CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER;#N/A;23;-0.20299141;-0.6920278;0.89376056;0.9658547
GO BP;POSITIVE REGULATION OF DNA REPLICATION;GO:0045740;31;-0.18804595;-0.69093686;0.9083045;0.9662468
GO BP;ERROR FREE TRANSLESION SYNTHESIS;GO:0070987;19;-0.21407194;-0.6896787;0.8871528;0.9667533
GO BP;NEGATIVE REGULATION OF RNA SPLICING;GO:0033119;25;-0.19656906;-0.68912864;0.90068495;0.96671987
GO BP;RESPONSE TO CORTICOSTEROID;GO:0031960;98;-0.14589924;-0.6886439;0.97133756;0.9666887
GO BP;POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY;GO:0002711;19;-0.20809367;-0.6859803;0.9019608;0.9682576
GO BP;T CELL SELECTION;GO:0045058;23;-0.1970922;-0.6853833;0.9086207;0.96824497
GO BP;MATURE B CELL DIFFERENTIATION;GO:0002335;17;-0.21674502;-0.6842214;0.86799276;0.9686658
GO BP;MITOCHONDRION MORPHOGENESIS;GO:0070584;21;-0.2043201;-0.6827077;0.88828826;0.96929514
GO BP;NEGATIVE REGULATION OF T CELL PROLIFERATION;GO:0042130;32;-0.18086077;-0.6806945;0.9254766;0.9703019
GO BP;POSTSYNAPTIC SIGNAL TRANSDUCTION;#N/A;21;-0.20423354;-0.6780138;0.90121317;0.971678
GO BP;NEGATIVE REGULATION OF TRANSLATIONAL INITIATION;GO:0045947;18;-0.21439852;-0.6761963;0.8768116;0.97249967
GO BP;DNA CATABOLIC PROCESS ENDONUCLEOLYTIC;GO:0000737;25;-0.19311114;-0.67315155;0.89597315;0.9741109
GO BP;REGULATION OF VASOCONSTRICTION;GO:0019229;22;-0.19739683;-0.6722635;0.9247863;0.97425884
GO BP;REGULATION OF AXON GUIDANCE;GO:1902667;29;-0.18471748;-0.6712253;0.92670155;0.9745149
GO BP;TRANSITION METAL ION TRANSPORT;#N/A;93;-0.14241786;-0.66995883;0.97448164;0.97491455
GO BP;REGULATION OF PROTEIN TARGETING TO MITOCHONDRION;GO:1903214;36;-0.17470326;-0.6682122;0.93504274;0.97556454
GO BP;REGULATION OF OXIDOREDUCTASE ACTIVITY;GO:0051341;63;-0.1522853;-0.6680076;0.9678511;0.97527474
GO BP;CELLULAR RESPONSE TO IONIZING RADIATION;GO:0071479;60;-0.15569445;-0.66539794;0.9621451;0.97644645
GO BP;MESENCHYME MORPHOGENESIS;#N/A;31;-0.1805813;-0.66384625;0.92808217;0.9769834
GO BP;REGULATION OF CHOLESTEROL METABOLIC PROCESS;GO:0090181;51;-0.16192275;-0.6621064;0.9639344;0.97754747
GO BP;REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY;GO:0032925;17;-0.20949808;-0.66170496;0.925859;0.9773625
GO BP;GROWTH PLATE CARTILAGE DEVELOPMENT;GO:0003417;22;-0.19861053;-0.6616489;0.91843975;0.97697866
GO BP;AMINO SUGAR METABOLIC PROCESS;#N/A;26;-0.18643051;-0.6609091;0.9302326;0.9770027
GO BP;ENTRAINMENT OF CIRCADIAN CLOCK BY PHOTOPERIOD;GO:0043153;19;-0.20413777;-0.6595103;0.90163934;0.9773605
GO BP;ANTIBIOTIC METABOLIC PROCESS;GO:0016999;66;-0.14989038;-0.6583255;0.9708904;0.9776185
GO BP;NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY;GO:0051444;16;-0.21377994;-0.65805244;0.90592337;0.97735745
GO BP;DOPAMINE TRANSPORT;GO:0015872;16;-0.21468587;-0.6580111;0.90763766;0.9769725
GO BP;PHAGOSOME MATURATION;GO:0090382;34;-0.17292039;-0.6565686;0.93955094;0.977346
GO BP;REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM;GO:0070861;21;-0.19732025;-0.6537031;0.91531533;0.9784528
GO BP;STRIATED MUSCLE CELL APOPTOTIC PROCESS;#N/A;27;-0.18626271;-0.6531401;0.9242685;0.9783439
GO BP;REGULATION OF CELL KILLING;#N/A;34;-0.17212139;-0.651601;0.96347827;0.9786989
GO BP;ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY;GO:0007193;24;-0.19024275;-0.65132636;0.91850597;0.9784297
GO BP;REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL;GO:0003044;21;-0.19242269;-0.6488076;0.92057765;0.9793334
GO BP;PROTEIN TRIMERIZATION;GO:0070206;30;-0.17259198;-0.6446084;0.9601329;0.98099136
GO BP;NEUROEPITHELIAL CELL DIFFERENTIATION;GO:0060563;35;-0.16880228;-0.64398664;0.96229506;0.98087424
GO BP;POSITIVE REGULATION OF RECEPTOR INTERNALIZATION;GO:0002092;15;-0.21487032;-0.6431925;0.919708;0.98085773
GO BP;INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR;GO:0072332;66;-0.14743954;-0.64033985;0.98248684;0.98176545
GO BP;RESPONSE TO INTERLEUKIN 12;GO:0070671;37;-0.16583811;-0.63856345;0.9680672;0.98219085
GO BP;FIBROBLAST APOPTOTIC PROCESS;GO:0044346;17;-0.20524941;-0.6378239;0.9216758;0.9821065
GO BP;MITOCHONDRIAL FISSION;GO:0000266;31;-0.17378148;-0.6340338;0.955595;0.9834134
GO BP;NUCLEOTIDE SUGAR METABOLIC PROCESS;GO:0009225;34;-0.16615032;-0.62422794;0.9560633;0.9870562
GO BP;LEFT RIGHT PATTERN FORMATION;GO:0060972;17;-0.19603054;-0.6238769;0.9469836;0.9867759
GO BP;PEPTIDYL L CYSTEINE S PALMITOYLATION;GO:0018230;18;-0.19963893;-0.6235868;0.9365352;0.98647493
GO BP;NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY;GO:0045746;31;-0.1681903;-0.6195489;0.9700997;0.987564
GO BP;RESPONSE TO LITHIUM ION;#N/A;16;-0.20191145;-0.6191312;0.9505494;0.9873082
GO BP;RESPONSE TO INTERFERON BETA;GO:0035456;19;-0.19400436;-0.61720246;0.9309091;0.9875987
GO BP;REGULATION OF ERAD PATHWAY;GO:1904292;25;-0.1748559;-0.6135098;0.97302157;0.98847884
GO BP;REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT;GO:0055024;49;-0.14995666;-0.61188334;0.982669;0.9886414
GO BP;NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY;#N/A;19;-0.19110668;-0.61185265;0.940966;0.98823774
GO BP;POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY;GO:0051353;37;-0.15618363;-0.60848004;0.96938777;0.98894787
GO BP;SERINE FAMILY AMINO ACID METABOLIC PROCESS;GO:0009069;31;-0.16575146;-0.6080914;0.9632721;0.98866653
GO BP;INTERLEUKIN 1 BETA PRODUCTION;GO:0032611;37;-0.15520357;-0.6078603;0.9745331;0.9883286
GO BP;REGULATION OF GLYCOGEN METABOLIC PROCESS;GO:0070873;27;-0.17091754;-0.60400635;0.9578207;0.9891776
GO BP;NEGATIVE REGULATION OF MUSCLE HYPERTROPHY;#N/A;21;-0.18349682;-0.6036315;0.95620435;0.98888195
GO BP;AMINOGLYCAN CATABOLIC PROCESS;#N/A;42;-0.15030739;-0.60308456;0.98417723;0.9886385
GO BP;POLYOL CATABOLIC PROCESS;#N/A;22;-0.18068537;-0.60293543;0.95126355;0.9882658
GO BP;GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS;#N/A;15;-0.19937032;-0.60183835;0.9566787;0.98817545
GO BP;NEGATIVE REGULATION OF DNA BINDING;GO:0043392;38;-0.15368383;-0.59210443;0.9758621;0.99072695
GO BP;RENAL WATER HOMEOSTASIS;GO:0003091;19;-0.18079576;-0.5850551;0.9592199;0.99219394
GO BP;DECIDUALIZATION;GO:0046697;17;-0.1889505;-0.5843601;0.9597902;0.99196
GO BP;LONG TERM SYNAPTIC DEPRESSION;GO:0060292;16;-0.18652248;-0.5790155;0.9574468;0.99287045
GO BP;NCRNA 3 END PROCESSING;#N/A;34;-0.15211377;-0.5775334;0.98122865;0.99280334
GO BP;PEPTIDYL GLUTAMIC ACID MODIFICATION;#N/A;19;-0.18023576;-0.5767363;0.95840555;0.9925739
GO BP;STEROID CATABOLIC PROCESS;GO:0006706;17;-0.17989494;-0.5724574;0.96907216;0.99313664
GO BP;SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS;GO:0031146;83;-0.1231226;-0.56575334;0.9983525;0.99404895
GO BP;SECONDARY PALATE DEVELOPMENT;GO:0062009;16;-0.1793109;-0.5595352;0.97431505;0.99484724
GO BP;NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY;GO:2001258;20;-0.17174643;-0.55889696;0.97979796;0.9945574
GO BP;SECRETION BY TISSUE;#N/A;20;-0.16582532;-0.5546931;0.9756098;0.9948771
GO BP;NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS;GO:0010664;18;-0.17312337;-0.5508088;0.97969544;0.9951109
GO BP;NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE;GO:0032211;19;-0.1657743;-0.5333997;0.9859402;0.9972333
GO BP;REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR;GO:1902165;16;-0.17111312;-0.5276645;0.9890511;0.9975142
GO BP;TOXIN METABOLIC PROCESS;GO:0009404;16;-0.16532627;-0.51376307;0.9908592;0.9985709
GO BP;REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY;GO:0050999;29;-0.14162146;-0.5124863;0.98945516;0.99827254
GO BP;FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX;GO:0001732;15;-0.1634358;-0.49950942;0.9930314;0.9989503
GO BP;REGULATION OF MONOOXYGENASE ACTIVITY;#N/A;34;-0.13080302;-0.49226114;0.99667776;0.99905
GO BP;MATURATION OF LSU RRNA;GO:0000470;21;-0.1447089;-0.47595292;0.9944853;0.9995833
GO BP;HYALURONAN METABOLIC PROCESS;GO:0030212;23;-0.14105114;-0.47589558;0.9982487;0.99917
GO BP;ALCOHOL CATABOLIC PROCESS;#N/A;35;-0.12618792;-0.47358868;0.9983389;0.9988585
GO BP;HISTONE MRNA METABOLIC PROCESS;#N/A;24;-0.13592957;-0.46620983;0.9965458;0.9987557
GO BP;REGULATION OF SUPEROXIDE ANION GENERATION;GO:0032928;16;-0.14804037;-0.4564529;0.9928315;0.99872255
GO BP;COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE;GO:0006613;92;0.54124457;2.6968336;0;0
GO BP;MITOCHONDRIAL TRANSLATIONAL TERMINATION;GO:0070126;85;0.5199127;2.5604777;0;0
GO BP;ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM;GO:0072599;105;0.47480157;2.4032695;0;0
GO BP;TRANSLATIONAL TERMINATION;GO:0006415;100;0.4532854;2.3084915;0;0.001989214
GO BP;MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY;GO:0033108;89;0.4452212;2.1733067;0;0.013249937
GO BP;PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM;GO:0070972;124;0.40410772;2.1372912;0;0.01751645
GO BP;TRANSLATIONAL ELONGATION;GO:0006414;123;0.4000058;2.1116595;0;0.020971728
GO BP;NADH DEHYDROGENASE COMPLEX ASSEMBLY;GO:0010257;60;0.4567795;2.0932028;0;0.023916442
GO BP;ATP SYNTHESIS COUPLED ELECTRON TRANSPORT;GO:0042773;85;0.4214889;2.058381;0;0.030535463
GO BP;RESPIRATORY ELECTRON TRANSPORT CHAIN;GO:0022904;101;0.41088128;2.050485;0;0.030000571
GO BP;ATP SYNTHESIS COUPLED PROTON TRANSPORT;GO:0015986;22;0.56937456;2.0170245;0.006864989;0.03735572
GO BP;REGULATION OF GRANULOCYTE CHEMOTAXIS;GO:0071622;21;0.5546409;1.9639839;0;0.058801316
GO BP;OXIDATIVE PHOSPHORYLATION;GO:0006119;126;0.36990437;1.9473006;0;0.06364424
GO BP;MITOCHONDRIAL TRANSLATION;GO:0032543;130;0.36031577;1.9363469;0;0.06530382
GO BP;ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE;GO:0061844;26;0.51140994;1.9312083;0;0.06400932
GO BP;NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY;GO:0000184;111;0.37380233;1.9304488;0;0.060457908
GO BP;SODIUM ION HOMEOSTASIS;GO:0055078;24;0.5212101;1.9137676;0;0.06651115
GO BP;ANTIMICROBIAL HUMORAL RESPONSE;GO:0019730;43;0.4364941;1.8746024;0.004950495;0.09001758
GO BP;ELECTRON TRANSPORT CHAIN;GO:0022900;154;0.34008804;1.8487589;0;0.10705832
GO BP;O GLYCAN PROCESSING;GO:0016266;35;0.446581;1.8221811;0.002493766;0.12967944
GO BP;REGULATION OF VIRAL ENTRY INTO HOST CELL;GO:0046596;20;0.52452344;1.821318;0.004672897;0.12460446
GO BP;RESPONSE TO GONADOTROPIN;#N/A;21;0.5075514;1.8041234;0.002314815;0.13727945
GO BP;GRANULOCYTE MIGRATION;GO:0097530;55;0.40208048;1.8008446;0.0025;0.13509639
GO BP;MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE;GO:0006120;49;0.39071357;1.756377;0;0.18600696
GO BP;HUMORAL IMMUNE RESPONSE;GO:0006959;92;0.33908585;1.6795722;0.002695418;0.32205817
GO BP;MITOCHONDRIAL GENE EXPRESSION;#N/A;157;0.30621514;1.669628;0;0.3315949
GO BP;PROTEIN TARGETING TO MEMBRANE;GO:0006612;163;0.3038617;1.6691653;0;0.32035294
GO BP;REGULATION OF VASCULAR PERMEABILITY;GO:0043114;20;0.47999018;1.657742;0.025462963;0.3366562
GO BP;COMPLEMENT ACTIVATION;GO:0006956;25;0.44088176;1.6571978;0.01965602;0.32640994
GO BP;TRANSLATIONAL INITIATION;GO:0006413;168;0.29788995;1.6488941;0.002881844;0.33637276
GO BP;SYNAPSIS;GO:0007129;34;0.41238645;1.6444358;0.012254902;0.3373323
GO BP;DRUG TRANSMEMBRANE TRANSPORT;GO:0006855;46;0.3860665;1.6442163;0.00968523;0.32728687
GO BP;AXONEME ASSEMBLY;GO:0035082;37;0.40606418;1.6417402;0.009478673;0.32300386
GO BP;PHOTOTRANSDUCTION VISIBLE LIGHT;GO:0007603;16;0.49287972;1.6252518;0.026548672;0.35428122
GO BP;POSITIVE REGULATION OF P38MAPK CASCADE;GO:1900745;21;0.45751354;1.6125985;0.016018307;0.37653145
GO BP;REGULATION OF NEUTROPHIL MIGRATION;GO:1902622;16;0.48904425;1.6114392;0.021097047;0.36894628
GO BP;INNER MITOCHONDRIAL MEMBRANE ORGANIZATION;GO:0007007;44;0.37878656;1.608946;0.012437811;0.3655109
GO BP;CRANIAL NERVE DEVELOPMENT;GO:0021545;24;0.43062806;1.605961;0.017777778;0.36346903
GO BP;NEUTROPHIL MIGRATION;GO:1990266;43;0.3781193;1.6001581;0.015228426;0.3685636
GO BP;HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN;GO:0002455;22;0.45142514;1.5918999;0.030092593;0.3813524
GO BP;DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION;GO:0050906;35;0.3905968;1.5909059;0.023419203;0.37434918
GO BP;ANTIBACTERIAL HUMORAL RESPONSE;GO:0019731;20;0.4683209;1.5904517;0.029850746;0.3666225
GO BP;SYNAPTONEMAL COMPLEX ORGANIZATION;GO:0070193;18;0.4797974;1.5903583;0.028235294;0.35833126
GO BP;ENTEROENDOCRINE CELL DIFFERENTIATION;GO:0035883;19;0.45408824;1.5849667;0.03409091;0.363777
GO BP;AXONEMAL DYNEIN COMPLEX ASSEMBLY;GO:0070286;17;0.47700495;1.5801171;0.033816423;0.36730215
GO BP;CYTOCHROME COMPLEX ASSEMBLY;GO:0017004;34;0.39617336;1.579227;0.021327015;0.36135888
GO BP;CRISTAE FORMATION;GO:0042407;32;0.4070167;1.5738648;0.028888889;0.36646378
GO BP;INOSITOL TRISPHOSPHATE METABOLIC PROCESS;GO:0032957;19;0.4635917;1.562563;0.03773585;0.38730684
GO BP;PROTEIN HETEROTETRAMERIZATION;GO:0051290;34;0.3812038;1.5466366;0.027149322;0.42372793
GO BP;RESPONSE TO FUNGUS;GO:0009620;18;0.45898178;1.5430108;0.052873563;0.4260329
GO BP;NEGATIVE REGULATION OF LIPID METABOLIC PROCESS;GO:0045833;52;0.35178566;1.5398792;0.012285012;0.42651397
GO BP;EXCRETION;GO:0007588;32;0.38751745;1.5382867;0.02877698;0.42247176
GO BP;POSITIVE REGULATION OF BIOMINERALIZATION;GO:0110151;28;0.40113628;1.519256;0.030660378;0.46960005
GO BP;AEROBIC ELECTRON TRANSPORT CHAIN;GO:0019646;17;0.45521855;1.5149785;0.059382424;0.473766
GO BP;POSITIVE REGULATION OF PROTEIN MATURATION;GO:1903319;18;0.44778156;1.5130371;0.06088993;0.47113308
GO BP;NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION;GO:0048662;27;0.3966676;1.5110052;0.025404157;0.46948376
GO BP;NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION;GO:0032715;16;0.47000706;1.5082656;0.057416268;0.4699752
GO BP;REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT;GO:0048641;30;0.38182902;1.5075891;0.043256998;0.46385872
GO BP;ORGANIC CATION TRANSPORT;GO:0015695;20;0.43994457;1.5028794;0.052380953;0.46972716
GO BP;POSITIVE REGULATION OF BONE MINERALIZATION;GO:0030501;24;0.41948512;1.498055;0.054176074;0.47630462
GO BP;GLUTATHIONE METABOLIC PROCESS;GO:0006749;35;0.36570778;1.4899596;0.027918782;0.49276856
GO BP;CYCLIC NUCLEOTIDE METABOLIC PROCESS;#N/A;21;0.44204068;1.4864378;0.05463183;0.49632087
GO BP;MONONUCLEAR CELL MIGRATION;GO:0071674;35;0.37039846;1.4857376;0.05172414;0.49061868
GO BP;NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS;#N/A;15;0.46875578;1.4839253;0.06320542;0.4884138
GO BP;PROTON TRANSMEMBRANE TRANSPORT;GO:1902600;118;0.28037265;1.4817173;0.005813954;0.48760638
GO BP;PROTEIN O LINKED GLYCOSYLATION;GO:0006493;76;0.30752245;1.4739277;0.021276595;0.5060699
GO BP;POSITIVE REGULATION OF REPRODUCTIVE PROCESS;#N/A;43;0.34949282;1.4666764;0.030162413;0.5226654
GO BP;REGULATION OF TRANSLATIONAL ELONGATION;GO:0006448;17;0.44737047;1.4666361;0.05479452;0.51508635
GO BP;DEFENSE RESPONSE TO BACTERIUM;GO:0042742;89;0.29463533;1.466077;0.008042895;0.5093523
GO BP;CYCLIC NUCLEOTIDE MEDIATED SIGNALING;#N/A;83;0.30248943;1.4651638;0.018918918;0.50503427
GO BP;VIRAL GENE EXPRESSION;#N/A;177;0.2620813;1.4600285;0.008720931;0.51532453
GO BP;SENSORY PERCEPTION;GO:0007600;240;0.25088766;1.4576913;0;0.5157862
GO BP;HOMOLOGOUS CHROMOSOME SEGREGATION;GO:0045143;41;0.34375808;1.4561529;0.054455444;0.51375973
GO BP;NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION;GO:0046636;21;0.4180043;1.4561245;0.07823961;0.50689524
GO BP;ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE;#N/A;16;0.44047126;1.4524844;0.055813953;0.5115107
GO BP;CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION;GO:0086019;19;0.41971;1.4507751;0.055421688;0.51020795
GO BP;CORNIFICATION;GO:0070268;40;0.34982646;1.4505581;0.033816423;0.5042463
GO BP;BROWN FAT CELL DIFFERENTIATION;GO:0050873;25;0.3932133;1.4485939;0.056234717;0.5041626
GO BP;CYTOPLASMIC TRANSLATION;GO:0002181;88;0.29025033;1.4453915;0.017156864;0.507892
GO BP;PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING;GO:0036151;16;0.4438967;1.4400069;0.07038835;0.51908803
GO BP;RESPONSE TO NICOTINE;GO:0035094;24;0.38408783;1.4259932;0.072115384;0.55935186
GO BP;ARACHIDONIC ACID SECRETION;GO:0050482;15;0.44622067;1.4256842;0.09953704;0.55345
GO BP;POSITIVE REGULATION OF ORGAN GROWTH;GO:0046622;28;0.3670024;1.4249601;0.055263158;0.549562
GO BP;RETINOL METABOLIC PROCESS;GO:0042572;16;0.4348997;1.4209051;0.08391608;0.55726045
GO BP;XENOBIOTIC METABOLIC PROCESS;GO:0006805;57;0.31478807;1.419708;0.038659792;0.5544808
GO BP;REGULATION OF VASCULAR SMOOTH MUSCLE CELL PROLIFERATION;#N/A;34;0.3557128;1.4077445;0.06714629;0.5895842
GO BP;IRON ION TRANSMEMBRANE TRANSPORT;GO:0034755;15;0.43921697;1.4061048;0.08928572;0.5886861
GO BP;VITAMIN BIOSYNTHETIC PROCESS;#N/A;15;0.4418608;1.4056227;0.10344828;0.583499
GO BP;RIBOSOMAL SMALL SUBUNIT ASSEMBLY;GO:0000028;15;0.4360274;1.4045118;0.08705882;0.5810157
GO BP;NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY;GO:2000272;27;0.37269115;1.4009073;0.0729927;0.58689445
GO BP;REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY;GO:0031664;17;0.42170912;1.3995378;0.10459184;0.5855711
GO BP;CHLORIDE TRANSPORT;GO:0006821;54;0.31173787;1.3872485;0.050251257;0.62472415
GO BP;SECOND MESSENGER MEDIATED SIGNALING;GO:0019932;194;0.24784443;1.3867023;0.005714286;0.62016594
GO BP;MONOCYTE CHEMOTAXIS;GO:0002548;20;0.40602356;1.3841138;0.11460674;0.6230342
GO BP;FOREBRAIN NEURON DIFFERENTIATION;GO:0021879;23;0.3882262;1.3832645;0.088785045;0.61952436
GO BP;MACROPHAGE CHEMOTAXIS;GO:0048246;20;0.3997121;1.3779522;0.09767442;0.6335145
GO BP;MONOVALENT INORGANIC ANION HOMEOSTASIS;#N/A;16;0.41922122;1.37635;0.1146789;0.6330574
GO BP;DETECTION OF VISIBLE LIGHT;GO:0009584;23;0.38340184;1.3708658;0.08705882;0.64730567
GO BP;NEGATIVE REGULATION OF CYTOKINE PRODUCTION;GO:0001818;154;0.25171387;1.367144;0.023188407;0.6554203
GO BP;HEART FORMATION;GO:0060914;21;0.3872981;1.3661848;0.10232558;0.652522
GO BP;PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY;GO:0007200;24;0.3800812;1.3655633;0.08830549;0.6482159
GO BP;RESPONSE TO BACTERIUM;GO:0009617;311;0.22886077;1.3635129;0.003058104;0.64979124
GO BP;SENSORY PERCEPTION OF MECHANICAL STIMULUS;GO:0050954;84;0.281123;1.3609836;0.05571031;0.65341234
GO BP;REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY;GO:1901385;19;0.4010805;1.3609791;0.10368664;0.64716434
GO BP;INORGANIC ANION TRANSPORT;GO:0015698;92;0.27265376;1.356788;0.05357143;0.6573952
GO BP;RETINA MORPHOGENESIS IN CAMERA TYPE EYE;GO:0060042;34;0.3375982;1.3563241;0.08229426;0.6529079
GO BP;REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA;#N/A;20;0.39091012;1.3543279;0.0952381;0.65448976
GO BP;GLYCOLIPID BIOSYNTHETIC PROCESS;GO:0009247;51;0.30213803;1.3530706;0.058080807;0.6531395
GO BP;DRUG TRANSPORT;#N/A;97;0.27155742;1.3516867;0.019021738;0.65240544
GO BP;EXOCRINE SYSTEM DEVELOPMENT;GO:0035272;30;0.35050753;1.3510462;0.09592326;0.6488288
GO BP;NERVE DEVELOPMENT;GO:0021675;43;0.3171281;1.3475645;0.075723834;0.6562531
GO BP;ISOPRENOID BIOSYNTHETIC PROCESS;GO:0008299;19;0.3957384;1.3442639;0.13219616;0.6628798
GO BP;FOREBRAIN NEURON DEVELOPMENT;GO:0021884;15;0.4129232;1.343678;0.12182741;0.65935373
GO BP;LEUKOCYTE CHEMOTAXIS;GO:0030595;99;0.26335946;1.3420827;0.02972973;0.65954465
GO BP;COFACTOR TRANSPORT;#N/A;33;0.34209672;1.3410522;0.09134615;0.6577978
GO BP;MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX IV ASSEMBLY;#N/A;20;0.38496798;1.3404316;0.11111111;0.65432227
GO BP;KERATINIZATION;GO:0031424;46;0.31050396;1.338819;0.0775;0.6548675
GO BP;PANCREAS DEVELOPMENT;GO:0031016;50;0.30779192;1.338379;0.092009686;0.65086126
GO BP;NEGATIVE REGULATION OF CHEMOTAXIS;GO:0050922;35;0.3274645;1.3365403;0.06619386;0.65231013
GO BP;RIBOSOME ASSEMBLY;GO:0042255;54;0.29860947;1.3323122;0.07371008;0.66268843
GO BP;GLANDULAR EPITHELIAL CELL DIFFERENTIATION;GO:0002067;30;0.33990818;1.3307662;0.10714286;0.6630241
GO BP;OLFACTORY LOBE DEVELOPMENT;GO:0021988;20;0.38202548;1.3266011;0.12756264;0.67337126
GO BP;REGULATION OF LIPID KINASE ACTIVITY;GO:0043550;44;0.31338704;1.3261526;0.114285715;0.6696853
GO BP;PRIMARY ALCOHOL METABOLIC PROCESS;#N/A;41;0.31730694;1.3260226;0.08796296;0.6647774
GO BP;L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT;GO:1902475;32;0.33223787;1.322913;0.11347517;0.6707879
GO BP;MESODERMAL CELL DIFFERENTIATION;GO:0048333;17;0.40051576;1.3215134;0.12723215;0.67105436
GO BP;PHOSPHATIDYLGLYCEROL METABOLIC PROCESS;GO:0046471;22;0.37377945;1.320706;0.09620253;0.66866773
GO BP;AMMONIUM TRANSPORT;GO:0015696;48;0.30261865;1.3206139;0.10075567;0.6637532
GO BP;POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT;GO:0048643;15;0.41258064;1.3122697;0.14761905;0.6905617
GO BP;POSITIVE REGULATION OF B CELL PROLIFERATION;GO:0030890;25;0.3610318;1.3106531;0.098557696;0.691494
GO BP;CELLULAR RESPONSE TO XENOBIOTIC STIMULUS;GO:0071466;99;0.2542688;1.3104905;0.05277778;0.68693227
GO BP;KERATAN SULFATE METABOLIC PROCESS;GO:0042339;24;0.35584295;1.3099381;0.13986014;0.68386906
GO BP;CELLULAR RESPIRATION;GO:0045333;163;0.23646149;1.3024784;0.036827195;0.7080944
GO BP;POSITIVE REGULATION OF STEROID METABOLIC PROCESS;#N/A;17;0.39741528;1.3010131;0.14932127;0.70898324
GO BP;B CELL MEDIATED IMMUNITY;GO:0019724;63;0.27707738;1.2969666;0.08486239;0.72
GO BP;REGULATION OF BONE MINERALIZATION;GO:0030500;42;0.31222197;1.295277;0.10659899;0.7210654
GO BP;KILLING OF CELLS OF OTHER ORGANISM;GO:0031640;17;0.3908919;1.2919523;0.17061612;0.7296039
GO BP;TYPE 2 IMMUNE RESPONSE;GO:0042092;17;0.39518785;1.2916253;0.1485849;0.7256751
GO BP;ENDOCRINE PANCREAS DEVELOPMENT;GO:0031018;29;0.33691487;1.2913574;0.15121952;0.7216117
GO BP;REGULATION OF HORMONE BIOSYNTHETIC PROCESS;GO:0046885;17;0.39128566;1.2895598;0.13439636;0.7238326
GO BP;POSITIVE REGULATION OF B CELL ACTIVATION;GO:0050871;49;0.30181995;1.2834858;0.11662531;0.74314874
GO BP;NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE;GO:0002820;21;0.36530745;1.2816455;0.13970588;0.74529785
GO BP;C21 STEROID HORMONE BIOSYNTHETIC PROCESS;GO:0006700;19;0.3785014;1.2774221;0.13808464;0.7578762
GO BP;REGULATION OF HUMORAL IMMUNE RESPONSE;#N/A;26;0.34336984;1.2772242;0.14386792;0.7534325
GO BP;ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY;GO:0007189;43;0.30226734;1.2753751;0.10576923;0.7558771
GO BP;INORGANIC ANION TRANSMEMBRANE TRANSPORT;#N/A;63;0.2771244;1.2730212;0.0961039;0.7603611
GO BP;NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS;GO:1903671;19;0.37300944;1.272292;0.17590362;0.75840086
GO BP;REPLACEMENT OSSIFICATION;#N/A;18;0.38338804;1.2685825;0.15801354;0.76851434
GO BP;ENERGY HOMEOSTASIS;GO:0097009;24;0.34103337;1.2593486;0.16953316;0.8030757
GO BP;MYELOID LEUKOCYTE MIGRATION;#N/A;90;0.25414696;1.2588863;0.10306407;0.7998583
GO BP;RESPONSE TO IRON ION;GO:0010039;25;0.34358782;1.258309;0.14663461;0.79680794
GO BP;REGULATION OF NERVOUS SYSTEM PROCESS;GO:0031644;66;0.27396515;1.2578657;0.10955711;0.7934838
GO BP;GLUTAMATE METABOLIC PROCESS;GO:0006536;24;0.34561652;1.2569449;0.17718446;0.7923449
GO BP;POTASSIUM ION HOMEOSTASIS;GO:0055075;18;0.37014055;1.2562101;0.15962441;0.7902088
GO BP;HETEROTYPIC CELL CELL ADHESION;GO:0034113;40;0.29995978;1.2549819;0.13447432;0.7904368
GO BP;SKELETAL MUSCLE CELL DIFFERENTIATION;GO:0035914;41;0.29478967;1.2520818;0.14609572;0.79812676
GO BP;RESPONSE TO MINERALOCORTICOID;#N/A;16;0.38925081;1.2517517;0.16853933;0.7943518
GO BP;MONOVALENT INORGANIC CATION TRANSPORT;GO:0015672;281;0.21290219;1.2515486;0.020710059;0.7901881
GO BP;NEGATIVE REGULATION OF INFLAMMATORY RESPONSE;GO:0050728;77;0.26048875;1.2514023;0.10372341;0.78591305
GO BP;ANION TRANSPORT;GO:0006820;384;0.20445085;1.2499334;0.023569023;0.78729624
GO BP;HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES;GO:0007156;50;0.2871654;1.247257;0.11282051;0.79402083
GO BP;SENSORY PERCEPTION OF CHEMICAL STIMULUS;GO:0007606;38;0.30477515;1.2458068;0.15167095;0.7953865
GO BP;REGULATION OF HORMONE METABOLIC PROCESS;GO:0032350;23;0.34308845;1.2410339;0.18333334;0.8111415
GO BP;IRON ION TRANSPORT;GO:0006826;60;0.26873565;1.2408032;0.11510792;0.80722165
GO BP;L AMINO ACID TRANSPORT;GO:0015807;38;0.30838194;1.2406802;0.14250614;0.8027813
GO BP;IRON ION HOMEOSTASIS;GO:0055072;63;0.26868045;1.2400177;0.109947644;0.80068326
GO BP;PROTEIN KINASE C SIGNALING;GO:0070528;17;0.3769886;1.2399693;0.18138425;0.7960862
GO BP;CYTOKINE SECRETION;GO:0050663;111;0.24092011;1.2398248;0.087403595;0.7919637
GO BP;ALPHA BETA T CELL ACTIVATION;GO:0046631;73;0.26011592;1.2386937;0.09819122;0.79193443
GO BP;SARCOMERE ORGANIZATION;GO:0045214;24;0.33594584;1.2385532;0.16780046;0.78783447
GO BP;NEGATIVE REGULATION OF LIPID LOCALIZATION;#N/A;30;0.31885487;1.2379109;0.13853905;0.78584075
GO BP;NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION;GO:0051250;78;0.2573847;1.2365221;0.12801932;0.78719413
GO BP;MITOCHONDRIAL TRANSMEMBRANE TRANSPORT;GO:1990542;82;0.25313365;1.2347685;0.10344828;0.79002154
GO BP;DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM;GO:0050829;22;0.348625;1.2335145;0.19090909;0.79078615
GO BP;PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS;GO:0010499;18;0.36546057;1.2332548;0.19294117;0.7874046
GO BP;GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS;#N/A;32;0.31110558;1.2331915;0.15898618;0.7832415
GO BP;REGULATION OF INFLAMMATORY RESPONSE;GO:0050727;178;0.22351816;1.2331322;0.07479224;0.77908826
GO BP;INTERFERON GAMMA PRODUCTION;GO:0032609;41;0.29771265;1.2328633;0.14420804;0.7758289
GO BP;PEPTIDYL ARGININE MODIFICATION;#N/A;20;0.36020726;1.2323716;0.20689656;0.7735124
GO BP;EXTRACELLULAR STRUCTURE ORGANIZATION;#N/A;234;0.21414189;1.2318592;0.049535602;0.7710422
GO BP;NEGATIVE REGULATION OF LIPID TRANSPORT;GO:0032369;20;0.3473953;1.2292504;0.2027027;0.7778363
GO BP;TYPE B PANCREATIC CELL DEVELOPMENT;GO:0003323;15;0.3837556;1.2292464;0.21461187;0.7735866
GO BP;ORGANIC ACID TRANSPORT;#N/A;200;0.21940967;1.2284013;0.044444446;0.7728194
GO BP;CALCIUM MEDIATED SIGNALING;GO:0019722;108;0.2398316;1.2273023;0.11581921;0.77324986
GO BP;GLANDULAR EPITHELIAL CELL DEVELOPMENT;GO:0002068;18;0.36154568;1.2265397;0.2043956;0.7724268
GO BP;PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS;GO:0006213;22;0.34294957;1.2265148;0.17444718;0.76836294
GO BP;POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION;#N/A;69;0.2646897;1.2264467;0.13471502;0.76452374
GO BP;POSITIVE REGULATION OF T CELL PROLIFERATION;GO:0042102;44;0.28755125;1.2261273;0.14136125;0.76162565
GO BP;REGULATION OF MACROPHAGE CHEMOTAXIS;GO:0010758;15;0.38038066;1.2252402;0.18957347;0.7609694
GO BP;BONE MINERALIZATION;GO:0030282;70;0.2628202;1.2237189;0.12222222;0.76307213
GO BP;REGULATION OF BIOMINERALIZATION;#N/A;52;0.28038004;1.2227767;0.16010499;0.7628516
GO BP;NEGATIVE REGULATION OF STEROID METABOLIC PROCESS;#N/A;15;0.38562748;1.2221397;0.20547946;0.76157254
GO BP;NERVOUS SYSTEM PROCESS;GO:0050877;492;0.19454701;1.220783;0.016447369;0.76322997
GO BP;ANION HOMEOSTASIS;#N/A;39;0.28995407;1.2188745;0.17026378;0.76678157
GO BP;REGULATION OF BLOOD CIRCULATION;GO:1903522;135;0.22744846;1.2165112;0.10429448;0.7724384
GO BP;VASCULAR PROCESS IN CIRCULATORY SYSTEM;#N/A;84;0.24895197;1.2163256;0.13259669;0.7692876
GO BP;EAR DEVELOPMENT;GO:0043583;122;0.23145132;1.2160145;0.09289618;0.76662725
GO BP;FATTY ACID DERIVATIVE TRANSPORT;#N/A;23;0.3491478;1.2139131;0.18577981;0.77146083
GO BP;B CELL RECEPTOR SIGNALING PATHWAY;GO:0050853;35;0.30389583;1.2131612;0.17539863;0.7705076
GO BP;NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS;GO:0051055;34;0.3037983;1.21294;0.15738499;0.7675276
GO BP;POSITIVE REGULATION OF FAT CELL DIFFERENTIATION;GO:0045600;43;0.2868588;1.2123556;0.1557789;0.7659909
GO BP;GLYCOPROTEIN CATABOLIC PROCESS;GO:0006516;19;0.35037953;1.2086643;0.20803782;0.777525
GO BP;ISOPRENOID METABOLIC PROCESS;GO:0006720;76;0.25103304;1.2036608;0.1498708;0.79494625
GO BP;REGULATION OF LEUKOCYTE PROLIFERATION;GO:0070663;120;0.22963531;1.2022359;0.10969388;0.79718405
GO BP;ORGANIC ANION TRANSPORT;GO:0015711;307;0.20261537;1.2002612;0.06312292;0.8017364
GO BP;LIPOSACCHARIDE METABOLIC PROCESS;#N/A;88;0.24254043;1.2002138;0.15561225;0.79803497
GO BP;PIGMENT GRANULE ORGANIZATION;GO:0048753;21;0.34309918;1.1999341;0.22696629;0.79544985
GO BP;ENDOCHONDRAL BONE MORPHOGENESIS;GO:0060350;47;0.27898642;1.1988374;0.18734178;0.79632205
GO BP;BICARBONATE TRANSPORT;GO:0015701;24;0.32728997;1.19864;0.18944845;0.7933955
GO BP;NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION;GO:1903556;28;0.32196945;1.1982523;0.21190476;0.791163
GO BP;PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX;GO:0030150;16;0.3755211;1.1981264;0.20512821;0.7879445
GO BP;CELLULAR RESPONSE TO ALKALOID;GO:0071312;21;0.34253854;1.1975706;0.19545455;0.7863828
GO BP;CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION;GO:0086065;34;0.29692343;1.1949204;0.2044335;0.79335755
GO BP;TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION;#N/A;81;0.24856555;1.1944747;0.15989847;0.79140097
GO BP;NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS;#N/A;216;0.21186705;1.1943779;0.089020774;0.78815544
GO BP;NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS;GO:0000956;187;0.21088344;1.1940086;0.102564104;0.786095
GO BP;SMOOTH MUSCLE CELL DIFFERENTIATION;GO:0051145;36;0.29932836;1.1935364;0.20403023;0.7844792
GO BP;POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION;GO:0031954;16;0.36766022;1.1931574;0.20779221;0.7824122
GO BP;POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION;GO:0014911;27;0.31270215;1.1931496;0.21323529;0.7788955
GO BP;HORMONE BIOSYNTHETIC PROCESS;GO:0042446;49;0.27925792;1.1915643;0.19954129;0.78215325
GO BP;REGULATION OF B CELL PROLIFERATION;GO:0030888;37;0.2902149;1.189978;0.18944845;0.7849174
GO BP;ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE;GO:0002251;19;0.34369087;1.1893119;0.23515439;0.784136
GO BP;TELOMERE CAPPING;GO:0016233;45;0.28484577;1.188688;0.19095477;0.78318584
GO BP;REGULATION OF MONONUCLEAR CELL MIGRATION;#N/A;26;0.31808427;1.1879663;0.21342926;0.7825406
GO BP;POSITIVE REGULATION OF CELL ACTIVATION;#N/A;178;0.21535982;1.1876898;0.121875;0.78017616
GO BP;MEMBRANE DEPOLARIZATION;GO:0051899;48;0.27090383;1.1872486;0.17874396;0.7783919
GO BP;POSITIVE CHEMOTAXIS;GO:0050918;25;0.32570547;1.1872482;0.20833333;0.77496284
GO BP;CHEMOKINE PRODUCTION;GO:0032602;46;0.2782581;1.1871377;0.19069767;0.772007
GO BP;NEUROTRANSMITTER METABOLIC PROCESS;GO:0042133;81;0.2443539;1.1858227;0.13861386;0.77387404
GO BP;LIVER REGENERATION;GO:0097421;24;0.32375097;1.1838212;0.20544554;0.7786726
GO BP;OSTEOBLAST PROLIFERATION;GO:0033687;19;0.34680438;1.183748;0.20608899;0.775567
GO BP;NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS;#N/A;85;0.24046412;1.1832886;0.15844156;0.7740811
GO BP;PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION;GO:0060389;40;0.28212738;1.182641;0.22864321;0.773191
GO BP;CELLULAR RESPONSE TO CADMIUM ION;GO:0071276;22;0.3315626;1.1811892;0.23167849;0.77561927
GO BP;REGULATION OF B CELL MEDIATED IMMUNITY;#N/A;27;0.31830758;1.181185;0.23006834;0.77233726
GO BP;POSITIVE REGULATION OF BLOOD PRESSURE;GO:0045777;16;0.353662;1.1773902;0.23893805;0.7836186
GO BP;CELLULAR RESPONSE TO ESTRADIOL STIMULUS;GO:0071392;21;0.33845872;1.1717359;0.23167849;0.8036991
GO BP;NEUROTRANSMITTER BIOSYNTHETIC PROCESS;GO:0042136;54;0.26640671;1.171114;0.18987341;0.80278057
GO BP;PROSTATE GLAND MORPHOGENESIS;GO:0060512;16;0.35741034;1.1701324;0.24568966;0.8034231
GO BP;INFLAMMATORY RESPONSE;GO:0006954;351;0.19477384;1.1642529;0.09904154;0.82399535
GO BP;POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN;GO:0042531;28;0.30989316;1.1639371;0.23664123;0.82180256
GO BP;ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE;GO:0090150;274;0.19630341;1.1617875;0.11;0.82775605
GO BP;POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA;GO:0090200;26;0.3167764;1.1614617;0.24711317;0.82564604
GO BP;SENSORY PERCEPTION OF TASTE;GO:0050909;16;0.35794887;1.1602795;0.2562929;0.8271643
GO BP;SULFUR COMPOUND TRANSPORT;#N/A;33;0.2872665;1.1589204;0.26666668;0.82962185
GO BP;APOPTOTIC CELL CLEARANCE;GO:0043277;26;0.3127199;1.1571023;0.22991072;0.8337375
GO BP;SPERMATID DIFFERENTIATION;GO:0048515;91;0.23300184;1.1570898;0.20199502;0.83042914
GO BP;ANION TRANSMEMBRANE TRANSPORT;GO:0098656;183;0.210515;1.1568531;0.14005603;0.8281428
GO BP;ADAPTIVE IMMUNE RESPONSE;GO:0002250;193;0.20539363;1.1537702;0.1461318;0.8381104
GO BP;GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS;GO:0006688;17;0.3586931;1.1520556;0.26968974;0.8421805
GO BP;REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA;GO:0090199;39;0.28182453;1.1518031;0.2370892;0.8399567
GO BP;NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS;GO:0009142;61;0.25049186;1.1504164;0.26804122;0.84261113
GO BP;SMOOTH MUSCLE CELL MIGRATION;GO:0014909;53;0.2608702;1.1503968;0.23267327;0.83937716
GO BP;ACUTE INFLAMMATORY RESPONSE;GO:0002526;43;0.28041902;1.1500725;0.20812182;0.8375046
GO BP;POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION;GO:0010862;27;0.30642718;1.1496322;0.24761905;0.8360665
GO BP;POSITIVE REGULATION OF CHEMOKINE PRODUCTION;GO:0032722;33;0.29258066;1.1476488;0.23076923;0.8412443
GO BP;RESPONSE TO INTERLEUKIN 1;GO:0070555;134;0.21377175;1.1463474;0.15804598;0.8436247
GO BP;ORGANIC ACID TRANSMEMBRANE TRANSPORT;GO:1903825;92;0.2287597;1.1435742;0.17195767;0.8519052
GO BP;DETECTION OF MECHANICAL STIMULUS;GO:0050982;19;0.33113596;1.1435689;0.25386313;0.848633
GO BP;ANIMAL ORGAN FORMATION;GO:0048645;40;0.27398854;1.143373;0.24009901;0.84631103
GO BP;NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS;GO:0043524;95;0.22758152;1.1427041;0.21717171;0.84578514
GO BP;MONOVALENT INORGANIC CATION HOMEOSTASIS;#N/A;102;0.22328058;1.1425328;0.18133333;0.84331584
GO BP;POSITIVE REGULATION OF HEART GROWTH;GO:0060421;23;0.31492496;1.1412754;0.2647059;0.8455405
GO BP;APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT;GO:1902742;18;0.34177426;1.1401674;0.29864255;0.84691197
GO BP;INTERLEUKIN 8 PRODUCTION;GO:0032637;41;0.27421448;1.1397958;0.26244345;0.84533304
GO BP;RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS;#N/A;53;0.25822878;1.1392648;0.22891566;0.84450483
GO BP;REGULATION OF SIGNALING RECEPTOR ACTIVITY;GO:0010469;87;0.2318067;1.1384343;0.20731707;0.8449103
GO BP;RESPONSE TO MOLECULE OF BACTERIAL ORIGIN;GO:0002237;189;0.2043852;1.1358942;0.1488764;0.8523858
GO BP;HOMOTYPIC CELL CELL ADHESION;GO:0034109;57;0.25152138;1.1348666;0.22365038;0.85355604
GO BP;RESPONSE TO MECHANICAL STIMULUS;GO:0009612;138;0.21518181;1.1343749;0.1974026;0.8525029
GO BP;POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION;GO:1903055;15;0.35318726;1.1333789;0.25892857;0.85377896
GO BP;G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY;GO:0007186;346;0.18672039;1.1318932;0.12420382;0.8569053
GO BP;POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS;#N/A;85;0.23144755;1.1310428;0.24020888;0.85728115
GO BP;CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS;GO:0006575;126;0.21578614;1.130739;0.21065375;0.85539186
GO BP;REGULATION OF T CELL APOPTOTIC PROCESS;#N/A;19;0.3389277;1.1300945;0.30361447;0.8550793
GO BP;GLYCOPROTEIN BIOSYNTHETIC PROCESS;GO:0009101;231;0.19403061;1.1294245;0.16722408;0.8548469
GO BP;VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY;GO:0038084;24;0.3097425;1.1289576;0.296875;0.853898
GO BP;REGULATION OF CARTILAGE DEVELOPMENT;GO:0061035;40;0.2772951;1.128378;0.2631579;0.8532208
GO BP;REGULATION OF PLATELET ACTIVATION;GO:0010543;19;0.3305639;1.1265497;0.2973568;0.8580847
GO BP;NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY;GO:1904030;25;0.31049258;1.1259601;0.29116946;0.8574035
GO BP;POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT;GO:1904894;38;0.27541125;1.1251162;0.26894864;0.85791767
GO BP;MALE MEIOTIC NUCLEAR DIVISION;GO:0007140;33;0.2804688;1.123576;0.2825;0.8613617
GO BP;MODIFIED AMINO ACID TRANSPORT;#N/A;18;0.33228296;1.1215421;0.29512194;0.866924
GO BP;CIRCULATORY SYSTEM PROCESS;#N/A;281;0.18829045;1.121312;0.14195584;0.8647415
GO BP;AORTIC VALVE DEVELOPMENT;GO:0003176;22;0.31424874;1.1198316;0.28440368;0.8680665
GO BP;RRNA CATABOLIC PROCESS;GO:0016075;15;0.3516367;1.1189903;0.27906978;0.86868984
GO BP;NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION;GO:0043537;20;0.32765907;1.1185905;0.30714285;0.86734366
GO BP;REGULATION OF HEART RATE;GO:0002027;45;0.25492537;1.1184864;0.2583732;0.86480296
GO BP;POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY;#N/A;25;0.30768234;1.1179397;0.3265306;0.86416197
GO BP;NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION;GO:0045662;17;0.34312537;1.1175628;0.31590414;0.86271816
GO BP;NEGATIVE REGULATION OF IMMUNE RESPONSE;GO:0050777;74;0.23576103;1.1171411;0.26463103;0.861489
GO BP;RHYTHMIC BEHAVIOR;GO:0007622;25;0.31086844;1.1171383;0.31220657;0.8585511
GO BP;POSITIVE REGULATION OF SODIUM ION TRANSPORT;GO:0010765;27;0.29854655;1.1170913;0.27688786;0.8558515
GO BP;RESPONSE TO PURINE CONTAINING COMPOUND;#N/A;91;0.22281158;1.1155115;0.22316384;0.8597204
GO BP;TERPENOID METABOLIC PROCESS;#N/A;60;0.23841928;1.115298;0.26302084;0.8577124
GO BP;REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS;#N/A;84;0.22727126;1.1149619;0.23664123;0.85618407
GO BP;POSITIVE REGULATION OF INFLAMMATORY RESPONSE;GO:0050729;65;0.23827624;1.1148196;0.27272728;0.85394466
GO BP;REGULATION OF PROTON TRANSPORT;GO:0010155;17;0.33035034;1.114437;0.30361447;0.8527096
GO BP;REGULATION OF PROTEIN MATURATION;#N/A;48;0.25520304;1.1135232;0.2923077;0.8536363
GO BP;REGULATION OF B CELL ACTIVATION;GO:0050864;75;0.231129;1.1114919;0.26785713;0.859223
GO BP;RELEASE OF CYTOCHROME C FROM MITOCHONDRIA;GO:0001836;47;0.2564454;1.1113974;0.2715736;0.8567822
GO BP;PLATELET AGGREGATION;GO:0070527;44;0.27022466;1.1110339;0.2693267;0.855472
GO BP;POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY;GO:0010518;27;0.29409885;1.1108314;0.29032257;0.853508
GO BP;POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE;GO:0070304;119;0.21444684;1.1106756;0.23966943;0.85132116
GO BP;REGULATION OF ACUTE INFLAMMATORY RESPONSE;GO:0002673;15;0.34691623;1.1089586;0.3067633;0.85571015
GO BP;CELL COMMUNICATION BY ELECTRICAL COUPLING;GO:0010644;19;0.31617048;1.1082127;0.3189066;0.85599405
GO BP;AMINO ACID TRANSPORT;GO:0006865;83;0.22709577;1.1050476;0.2857143;0.8663165
GO BP;EAR MORPHOGENESIS;GO:0042471;62;0.24477454;1.1047736;0.28316328;0.86464536
GO BP;NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION;GO:0010633;45;0.25804344;1.1047444;0.2887828;0.8619691
GO BP;FAT CELL DIFFERENTIATION;GO:0045444;143;0.20409012;1.1042154;0.23690774;0.8613945
GO BP;REGULATION OF CELL ACTIVATION;GO:0050865;308;0.18445425;1.1028502;0.16171618;0.8644323
GO BP;SODIUM ION TRANSPORT;GO:0006814;123;0.21270737;1.1027758;0.25067386;0.8619323
GO BP;BLOOD VESSEL REMODELING;GO:0001974;20;0.315344;1.1009133;0.31516588;0.8668067
GO BP;REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS;GO:0070228;33;0.27336535;1.1006376;0.2883117;0.86518925
GO BP;REGULATION OF SYSTEM PROCESS;#N/A;297;0.18587032;1.1004953;0.17627119;0.8630577
GO BP;PROSTANOID BIOSYNTHETIC PROCESS;#N/A;17;0.3345935;1.0984077;0.32634032;0.868829
GO BP;CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS;#N/A;37;0.2654026;1.0983603;0.30266345;0.8663059
GO BP;ATP BIOSYNTHETIC PROCESS;GO:0006754;41;0.26239312;1.0971421;0.3010204;0.86864054
GO BP;MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY;GO:0002755;23;0.30580592;1.0969788;0.2997763;0.8665924
GO BP;RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC;GO:0090502;63;0.23711738;1.0967867;0.30081302;0.8647071
GO BP;SPROUTING ANGIOGENESIS;GO:0002040;77;0.22604789;1.0965807;0.2958115;0.86280215
GO BP;INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS;GO:0032958;27;0.28880078;1.0965044;0.27817747;0.86042404
GO BP;ONE CARBON METABOLIC PROCESS;GO:0006730;21;0.31101033;1.0960113;0.33486238;0.85967696
GO BP;NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS;#N/A;59;0.23784813;1.0949868;0.27790973;0.8611757
GO BP;G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER;GO:0007187;74;0.22949052;1.0947292;0.28877005;0.8595062
GO BP;LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY;GO:0031663;38;0.26568025;1.0943178;0.33012047;0.8585403
GO BP;POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS;#N/A;31;0.2786036;1.0941898;0.32142857;0.8564592
GO BP;NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION;GO:0014912;18;0.32267335;1.0934669;0.32954547;0.8568925
GO BP;NEGATIVE REGULATION OF CELL ACTIVATION;GO:0050866;105;0.21040748;1.0933242;0.2650273;0.85486084
GO BP;REGULATION OF INTERLEUKIN 1 SECRETION;#N/A;19;0.3177643;1.0927128;0.3255814;0.85474086
GO BP;SALIVARY GLAND DEVELOPMENT;GO:0007431;22;0.30640122;1.0920811;0.3372093;0.8547105
GO BP;C4 DICARBOXYLATE TRANSPORT;#N/A;16;0.34077182;1.0920374;0.3426724;0.8523092
GO BP;POSITIVE REGULATION OF OSSIFICATION;GO:0045778;57;0.24419808;1.0910157;0.302799;0.8539116
GO BP;POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT;GO:1901863;43;0.26083747;1.090497;0.33415842;0.85336447
GO BP;AMINO ACID TRANSMEMBRANE TRANSPORT;GO:0003333;50;0.24706836;1.0904425;0.28442436;0.85102856
GO BP;INTERLEUKIN 1 SECRETION;#N/A;24;0.30205306;1.0900444;0.3053613;0.8501482
GO BP;VITAMIN TRANSPORT;GO:0051180;26;0.28219116;1.0897304;0.33012047;0.8489122
GO BP;REGULATION OF PHOSPHOLIPID METABOLIC PROCESS;GO:1903725;60;0.23647174;1.0891021;0.2939759;0.8489928
GO BP;MESODERM MORPHOGENESIS;GO:0048332;44;0.2570994;1.0879525;0.3207547;0.8513568
GO BP;NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY;GO:0034122;23;0.30318943;1.0868508;0.32779098;0.85337067
GO BP;DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM;GO:0050830;34;0.27245995;1.0866618;0.32142857;0.8516322
GO BP;DNA REPLICATION DEPENDENT NUCLEOSOME ORGANIZATION;#N/A;21;0.3078715;1.0854685;0.33793104;0.8539568
GO BP;CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION;GO:0086064;16;0.32736993;1.0854672;0.35147393;0.85147345
GO BP;BONE MORPHOGENESIS;GO:0060349;71;0.22611403;1.0850766;0.26395938;0.85067594
GO BP;REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR;GO:0043516;31;0.27739286;1.0848961;0.30806845;0.8489185
GO BP;VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION;GO:1904738;16;0.33882248;1.084771;0.34557235;0.8469717
GO BP;INTERLEUKIN 6 PRODUCTION;GO:0032635;70;0.22945465;1.0835458;0.32467532;0.8494807
GO BP;CGMP MEDIATED SIGNALING;GO:0019934;18;0.31849462;1.0825378;0.33411765;0.85110736
GO BP;ARACHIDONIC ACID METABOLIC PROCESS;GO:0019369;24;0.2955755;1.0820252;0.32265446;0.8508176
GO BP;INTERLEUKIN 10 PRODUCTION;GO:0032613;24;0.300605;1.081917;0.3382353;0.8488804
GO BP;CELLULAR IRON ION HOMEOSTASIS;GO:0006879;50;0.24705797;1.0797688;0.30870712;0.85505635
GO BP;MYOTUBE CELL DEVELOPMENT;GO:0014904;21;0.30524015;1.07976;0.34474885;0.8526621
GO BP;LEUKOCYTE MIGRATION;GO:0050900;224;0.18801475;1.0790448;0.27272728;0.85311496
GO BP;INTERLEUKIN 6 SECRETION;#N/A;21;0.30828592;1.0789187;0.34085777;0.8511987
GO BP;NEGATIVE REGULATION OF CYTOKINE SECRETION;GO:0050710;30;0.27411243;1.0785812;0.30379745;0.8501846
GO BP;HEART PROCESS;GO:0003015;145;0.20192769;1.0784602;0.25071225;0.8482253
GO BP;POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION;GO:0045669;42;0.25633392;1.0783682;0.33171913;0.8462401
GO BP;CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT;#N/A;20;0.30896178;1.0779948;0.35321102;0.84535486
GO BP;ADRENAL GLAND DEVELOPMENT;GO:0030325;16;0.33287898;1.0779182;0.3317757;0.8432894
GO BP;NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS;GO:0045922;17;0.31848076;1.0773059;0.35224587;0.8433152
GO BP;AROMATIC AMINO ACID FAMILY METABOLIC PROCESS;GO:0009072;28;0.28409904;1.0765653;0.36104512;0.8439472
GO BP;REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE;#N/A;83;0.21818678;1.076435;0.30649352;0.842131
GO BP;POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR;GO:1901798;20;0.31208146;1.0754292;0.33819953;0.84372795
GO BP;TRANSMISSION OF NERVE IMPULSE;GO:0019226;25;0.29159817;1.0751656;0.35371178;0.8425113
GO BP;NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS;GO:1903845;55;0.23314418;1.074999;0.33816424;0.84088546
GO BP;STRIATED MUSCLE CONTRACTION;GO:0006941;99;0.21325225;1.0748801;0.30952382;0.8390888
GO BP;REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS;#N/A;53;0.23647219;1.0732555;0.29081634;0.8432214
GO BP;DICARBOXYLIC ACID METABOLIC PROCESS;#N/A;76;0.22203551;1.0728043;0.31592688;0.8427388
GO BP;CD4 POSITIVE ALPHA BETA T CELL ACTIVATION;GO:0035710;46;0.2494057;1.0721011;0.3510101;0.8433342
GO BP;REGULATION OF MYOBLAST DIFFERENTIATION;GO:0045661;30;0.27907583;1.0720232;0.33106577;0.8413378
GO BP;GLYCOSYLATION;GO:0070085;190;0.1906566;1.070349;0.27793697;0.8456652
GO BP;PROTEIN TARGETING;GO:0006605;368;0.17451498;1.0702639;0.2551724;0.84372616
GO BP;POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS;#N/A;39;0.2588834;1.0697863;0.342233;0.84330696
GO BP;POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION;GO:0032729;21;0.30375266;1.069655;0.32360098;0.8416259
GO BP;REGULATION OF ADAPTIVE IMMUNE RESPONSE;GO:0002819;80;0.22305024;1.0684869;0.33333334;0.84378827
GO BP;MODULATION BY HOST OF VIRAL PROCESS;GO:0044788;20;0.3079186;1.0677966;0.34606206;0.8441375
GO BP;POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION;GO:0002639;22;0.29218653;1.0665118;0.3846154;0.84694266
GO BP;DETECTION OF ABIOTIC STIMULUS;#N/A;52;0.24193959;1.0658597;0.3178484;0.8472572
GO BP;NEGATIVE REGULATION OF DEFENSE RESPONSE;#N/A;120;0.20350736;1.065625;0.30708662;0.8459227
GO BP;REGULATION OF LYMPHOCYTE ACTIVATION;GO:0051249;238;0.18289989;1.064872;0.2508591;0.8466523
GO BP;GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY;GO:0007214;17;0.3210161;1.0643612;0.35903615;0.84647554
GO BP;SKELETAL MUSCLE ORGAN DEVELOPMENT;GO:0060538;99;0.21164906;1.061536;0.34586465;0.8554949
GO BP;VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION;#N/A;18;0.31672847;1.06006;0.3764706;0.8590101
GO BP;LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT;GO:0060716;15;0.3268317;1.0570611;0.36222222;0.8683828
GO BP;NEUROPEPTIDE SIGNALING PATHWAY;GO:0007218;26;0.278052;1.056645;0.3647343;0.8677888
GO BP;ERYTHROCYTE DEVELOPMENT;GO:0048821;24;0.2877185;1.0564235;0.35152838;0.8663989
GO BP;REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY;GO:1901019;48;0.24225399;1.0547864;0.3625304;0.87076503
GO BP;MULTICELLULAR ORGANISMAL SIGNALING;#N/A;89;0.2118367;1.0540842;0.34848484;0.87132716
GO BP;MESONEPHROS DEVELOPMENT;GO:0001823;58;0.2276119;1.0537559;0.3525;0.8703443
GO BP;RESPIRATORY CHAIN COMPLEX IV ASSEMBLY;GO:0008535;24;0.28829858;1.0530388;0.36829838;0.87106246
GO BP;REGULATION OF STEROID BIOSYNTHETIC PROCESS;GO:0050810;69;0.22174285;1.0525122;0.37467018;0.8709176
GO BP;COBALAMIN METABOLIC PROCESS;GO:0009235;15;0.32659993;1.0500035;0.39770114;0.8785191
GO BP;POSITIVE REGULATION OF LYMPHOCYTE MIGRATION;GO:2000403;22;0.2956405;1.0471386;0.40603247;0.8879743
GO BP;REGULATION OF BONE REMODELING;GO:0046850;27;0.27870944;1.046939;0.37592137;0.8865412
GO BP;CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS;GO:0035924;35;0.25805154;1.0462097;0.36430317;0.8873285
GO BP;REGULATION OF STEROID METABOLIC PROCESS;GO:0019218;88;0.21228501;1.0453327;0.36147758;0.8887168
GO BP;MEMBRANE REPOLARIZATION;GO:0086009;22;0.29536092;1.045141;0.39583334;0.8872795
GO BP;CELL CHEMOTAXIS;GO:0060326;135;0.19455239;1.0439477;0.35135135;0.88982743
GO BP;REGULATION OF LEUKOCYTE CHEMOTAXIS;GO:0002688;56;0.23237655;1.0430837;0.3736842;0.8910767
GO BP;DETECTION OF LIGHT STIMULUS;GO:0009583;28;0.2756227;1.0412894;0.39407745;0.89605546
GO BP;NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS;GO:0042036;16;0.32039177;1.0408547;0.3838631;0.89560014
GO BP;REGULATION OF OSSIFICATION;GO:0030278;117;0.2026507;1.0405886;0.32240438;0.8945192
GO BP;PHOTORECEPTOR CELL MAINTENANCE;GO:0045494;25;0.2762268;1.0398889;0.38679245;0.8951695
GO BP;C21 STEROID HORMONE METABOLIC PROCESS;GO:0008207;24;0.28448713;1.0395192;0.3939394;0.894489
GO BP;POSITIVE REGULATION OF ANION TRANSPORT;#N/A;24;0.27971962;1.0390579;0.35824743;0.8940865
GO BP;REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL;GO:0051881;56;0.23134951;1.0384271;0.38848922;0.8944372
GO BP;NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS;GO:0002683;257;0.17891996;1.0373397;0.3659306;0.89675635
GO BP;ACID SECRETION;GO:0046717;57;0.22762616;1.0372707;0.38802084;0.89480686
GO BP;CELLULAR METABOLIC COMPOUND SALVAGE;#N/A;26;0.2816239;1.0370953;0.39179954;0.8933097
GO BP;NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE;#N/A;17;0.30996618;1.0364965;0.3705463;0.89365304
GO BP;MUSCLE CELL MIGRATION;#N/A;62;0.2260574;1.0350899;0.3881748;0.89711994
GO BP;RENAL TUBULE DEVELOPMENT;GO:0061326;53;0.23273033;1.0339485;0.37209302;0.89955336
GO BP;P38MAPK CASCADE;GO:0038066;34;0.25633934;1.0334353;0.3975;0.89950407
GO BP;COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT;GO:0002066;37;0.2513244;1.032561;0.39328536;0.90078324
GO BP;ACTIVATION OF JUN KINASE ACTIVITY;GO:0007257;32;0.2615426;1.0324109;0.39302325;0.89921606
GO BP;RESPONSE TO VITAMIN D;GO:0033280;22;0.29147243;1.0312243;0.39318183;0.9018805
GO BP;ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS;GO:0002460;127;0.1976076;1.030869;0.37709498;0.9012343
GO BP;EPIDERMIS MORPHOGENESIS;GO:0048730;16;0.322002;1.0301439;0.4079254;0.902059
GO BP;NEURON PROJECTION ARBORIZATION;GO:0140058;19;0.30357426;1.0300142;0.40184757;0.9003924
GO BP;REGULATION OF FAT CELL DIFFERENTIATION;GO:0045598;84;0.20926206;1.0293252;0.40054497;0.90092933
GO BP;PHOTOTRANSDUCTION;GO:0007602;23;0.2867898;1.0285338;0.42465752;0.90193784
GO BP;INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS;GO:0070059;52;0.231673;1.0266094;0.39479905;0.90745884
GO BP;REGULATION OF ISOTYPE SWITCHING;GO:0045191;22;0.28642383;1.0255798;0.423445;0.90936154
GO BP;REGULATION OF MEMBRANE POTENTIAL;GO:0042391;211;0.18073118;1.0228897;0.38253012;0.91813195
GO BP;NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION;GO:0045620;31;0.26163518;1.022675;0.39423078;0.9167817
GO BP;NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION;GO:0001937;21;0.29573223;1.0224425;0.39529413;0.91557413
GO BP;NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY;#N/A;15;0.32424793;1.021703;0.4401914;0.91641647
GO BP;SENSORY PERCEPTION OF SMELL;GO:0007608;21;0.29001817;1.0211428;0.42388758;0.91651857
GO BP;INNER EAR MORPHOGENESIS;GO:0042472;50;0.23248062;1.0209017;0.42014742;0.9153393
GO BP;SKIN DEVELOPMENT;GO:0043588;185;0.1816067;1.020679;0.37345678;0.91415834
GO BP;DOPAMINE METABOLIC PROCESS;GO:0042417;17;0.31692985;1.0193223;0.40182647;0.91742885
GO BP;CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE;GO:0071243;18;0.30408484;1.0188473;0.38202247;0.9172643
GO BP;RESPONSE TO FATTY ACID;GO:0070542;49;0.23311108;1.018684;0.42676768;0.9157994
GO BP;CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION;GO:0086002;29;0.26824176;1.0186481;0.43087557;0.9138298
GO BP;REGULATION OF MUSCLE CONTRACTION;GO:0006937;90;0.20493862;1.0183543;0.40782124;0.912849
GO BP;POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST;GO:0002230;17;0.30485195;1.0167078;0.41666666;0.9175641
GO BP;REGULATION OF SPROUTING ANGIOGENESIS;GO:1903670;45;0.23927958;1.0154402;0.40189126;0.9204896
GO BP;REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY;GO:0050855;16;0.31563464;1.0154179;0.41036716;0.9184814
GO BP;POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS;#N/A;51;0.2337328;1.0150206;0.41836736;0.91798913
GO BP;KIDNEY EPITHELIUM DEVELOPMENT;GO:0072073;79;0.20688982;1.0149785;0.421875;0.9160746
GO BP;ATP METABOLIC PROCESS;GO:0046034;249;0.17425767;1.0147873;0.4200627;0.91474056
GO BP;PROTEIN PROCESSING;GO:0016485;155;0.18378091;1.0143182;0.4114114;0.9146
GO BP;TUMOR NECROSIS FACTOR SECRETION;GO:1990774;16;0.3097936;1.0137984;0.42307693;0.9146226
GO BP;RESPIRATORY BURST;GO:0045730;15;0.31914106;1.0130955;0.42042756;0.9153873
GO BP;CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION;#N/A;18;0.3053661;1.0128616;0.42997542;0.9142916
GO BP;INOSITOL PHOSPHATE METABOLIC PROCESS;GO:0043647;54;0.23050621;1.0124083;0.42168674;0.9140421
GO BP;SMOOTH MUSCLE CELL PROLIFERATION;GO:0048659;92;0.20131332;1.0113821;0.43979058;0.9159413
GO BP;RESPONSE TO RETINOIC ACID;GO:0032526;76;0.21108425;1.0113735;0.43703705;0.913924
GO BP;PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE;#N/A;15;0.31950492;1.0111799;0.43267107;0.912669
GO BP;REGULATION OF HOMOTYPIC CELL CELL ADHESION;#N/A;18;0.30518135;1.009322;0.4494382;0.9179113
GO BP;NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY;#N/A;19;0.29342365;1.0075192;0.4236902;0.92300487
GO BP;HORMONE METABOLIC PROCESS;GO:0042445;120;0.19264972;1.0064716;0.47297296;0.9251134
GO BP;CELL MATURATION;GO:0048469;95;0.19993263;1.0062519;0.42857143;0.92393285
GO BP;GLYCOPROTEIN METABOLIC PROCESS;GO:0009100;288;0.17343335;1.0058398;0.43887147;0.92356753
GO BP;METANEPHRIC NEPHRON DEVELOPMENT;GO:0072210;18;0.29807383;1.004389;0.42666668;0.92729545
GO BP;CELLULAR RESPONSE TO NUTRIENT;GO:0031670;45;0.23337746;1.0042167;0.44963145;0.92595714
GO BP;NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS;GO:1900077;24;0.27576724;1.0026035;0.4608295;0.9302128
GO BP;AUTOPHAGOSOME MATURATION;GO:0097352;30;0.25789592;1.0023454;0.44152746;0.9292034
GO BP;ICOSANOID METABOLIC PROCESS;GO:0006690;56;0.22521126;1.0023198;0.46024096;0.9272921
GO BP;SYNAPTIC VESICLE ENDOCYTOSIS;GO:0048488;42;0.2367982;1.002115;0.4256927;0.92608625
GO BP;REGULATION OF PHAGOCYTOSIS;GO:0050764;50;0.22750455;1.0005091;0.43358395;0.9304094
GO BP;REGULATION OF SMOOTH MUSCLE CONTRACTION;GO:0006940;30;0.25906223;1.0002717;0.44235295;0.92937446
GO BP;NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING;GO:0051898;34;0.25246868;0.9989502;0.46004844;0.93242246
GO BP;RESPONSE TO ORGANOPHOSPHORUS;GO:0046683;80;0.20758785;0.99883306;0.44152746;0.93086207
GO BP;NEGATIVE REGULATION OF AXON GUIDANCE;#N/A;21;0.2871102;0.99808675;0.46952596;0.93170303
GO BP;NEGATIVE REGULATION OF GENE SILENCING;#N/A;29;0.26223648;0.99624324;0.44393593;0.93695694
GO BP;ACTIVATION OF MAPK ACTIVITY;GO:0000187;109;0.19393094;0.9948311;0.45405406;0.94062054
GO BP;ION HOMEOSTASIS;GO:0050801;459;0.15745278;0.99459213;0.5019763;0.9395661
GO BP;MALE MEIOSIS I;GO:0007141;16;0.3048142;0.9930263;0.4707207;0.94369006
GO BP;MACROPHAGE MIGRATION;GO:1905517;27;0.26444682;0.99294406;0.45873785;0.94200444
GO BP;DETECTION OF STIMULUS;GO:0051606;121;0.1888431;0.9905774;0.46778712;0.9491616
GO BP;EXTRACELLULAR MATRIX ASSEMBLY;GO:0085029;28;0.25364897;0.98997146;0.45107397;0.9495267
GO BP;LAMELLIPODIUM ASSEMBLY;GO:0030032;43;0.23338898;0.9884008;0.4596577;0.9537027
GO BP;CARDIAC MUSCLE CELL CONTRACTION;GO:0086003;41;0.23544893;0.98804295;0.4549763;0.9531153
GO BP;POSITIVE REGULATION OF SPROUTING ANGIOGENESIS;GO:1903672;24;0.27430275;0.9879121;0.4439141;0.9516624
GO BP;PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA;#N/A;46;0.22951901;0.98790884;0.46329114;0.9496677
GO BP;OLIGOSACCHARIDE METABOLIC PROCESS;GO:0009311;31;0.25034484;0.9873527;0.47710842;0.9498292
GO BP;NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY;GO:1901185;48;0.2242996;0.98543483;0.4398977;0.9553719
GO BP;REGULATION OF PEPTIDE SECRETION;#N/A;278;0.1663919;0.9853022;0.48064515;0.95388466
GO BP;POSITIVE REGULATION OF T CELL MIGRATION;GO:2000406;19;0.2856476;0.9852792;0.4391408;0.9519831
GO BP;CELLULAR RESPONSE TO BIOTIC STIMULUS;#N/A;136;0.18592274;0.9848861;0.4815864;0.9515816
GO BP;POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION;#N/A;84;0.20353763;0.9847673;0.5013405;0.950026
GO BP;EPIDERMIS DEVELOPMENT;GO:0008544;205;0.17316239;0.98468643;0.49291784;0.9484049
GO BP;REGULATION OF LIPID TRANSPORT;#N/A;64;0.2125592;0.98461556;0.45049506;0.9467216
GO BP;GLYCOSYL COMPOUND CATABOLIC PROCESS;#N/A;28;0.25741735;0.98461074;0.49756098;0.9447874
GO BP;CELLULAR HORMONE METABOLIC PROCESS;#N/A;65;0.21387829;0.98449564;0.47341773;0.9432639
GO BP;SYNAPTIC VESICLE LOCALIZATION;#N/A;42;0.23239577;0.98346335;0.49881798;0.9452452
GO BP;REGULATION OF LEUKOCYTE APOPTOTIC PROCESS;#N/A;48;0.22610079;0.9830044;0.4617284;0.945108
GO BP;REGULATION OF REPRODUCTIVE PROCESS;#N/A;92;0.19780138;0.9807564;0.5093333;0.9517039
GO BP;T CELL PROLIFERATION;GO:0042098;103;0.1942162;0.9801185;0.47619048;0.95224535
GO BP;FERTILIZATION;GO:0009566;86;0.19419746;0.97894275;0.5012987;0.954947
GO BP;CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION;GO:0043367;36;0.23579226;0.97850615;0.51392406;0.9546941
GO BP;REGULATION OF COLLAGEN METABOLIC PROCESS;#N/A;27;0.2588224;0.9774265;0.52098763;0.95680815
GO BP;MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL;GO:0086010;20;0.2837696;0.97655565;0.4686775;0.95811856
GO BP;SIGNAL RELEASE;GO:0023061;270;0.16609979;0.9763611;0.51038575;0.9569166
GO BP;POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS;GO:0010907;30;0.25312096;0.97563636;0.5087282;0.95773214
GO BP;NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION;GO:1903038;63;0.21273877;0.9755594;0.5012987;0.95611954
GO BP;POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS;#N/A;18;0.28867725;0.97511125;0.4814815;0.9559923
GO BP;CARDIAC CONDUCTION;GO:0061337;67;0.2050738;0.9735693;0.53984576;0.95990866
GO BP;AMINOGLYCAN BIOSYNTHETIC PROCESS;#N/A;72;0.20760964;0.9734151;0.53493977;0.9586165
GO BP;RESPONSE TO ACTIVITY;GO:0014823;45;0.22555225;0.97314805;0.47654322;0.9577179
GO BP;SENSORY PERCEPTION OF LIGHT STIMULUS;GO:0050953;93;0.19236584;0.97297084;0.49866667;0.956472
GO BP;REGULATION OF CHONDROCYTE DIFFERENTIATION;GO:0032330;27;0.25747877;0.9722366;0.48564592;0.95732456
GO BP;LIPID TRANSLOCATION;GO:0034204;26;0.2678825;0.9718675;0.5082353;0.95681787
GO BP;KETONE BIOSYNTHETIC PROCESS;#N/A;32;0.2427937;0.97183603;0.5084746;0.9550517
GO BP;ORGANOPHOSPHATE CATABOLIC PROCESS;GO:0046434;106;0.18723048;0.9711331;0.5157068;0.9557597
GO BP;ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS;#N/A;185;0.17342876;0.9701077;0.538874;0.9578669
GO BP;CEREBELLAR CORTEX FORMATION;GO:0021697;16;0.29978648;0.9696584;0.47785547;0.9577208
GO BP;RESPIRATORY SYSTEM PROCESS;GO:0003016;19;0.28641522;0.96936363;0.48873875;0.95691866
GO BP;NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS;GO:0060761;38;0.24041817;0.96915513;0.48372093;0.9557886
GO BP;GLYCOSPHINGOLIPID METABOLIC PROCESS;GO:0006687;51;0.22038408;0.9680458;0.5239295;0.95804536
GO BP;CHROMATIN SILENCING AT RDNA;#N/A;28;0.25293323;0.9670773;0.52098763;0.95972645
GO BP;BIOMINERALIZATION;#N/A;97;0.19319035;0.9649328;0.524173;0.9659392
GO BP;MITOCHONDRION ORGANIZATION;GO:0007005;449;0.15406738;0.9647037;0.615942;0.96493524
GO BP;CARTILAGE DEVELOPMENT;GO:0051216;113;0.18760745;0.96456623;0.49415204;0.9635726
GO BP;PROTEIN KINASE A SIGNALING;GO:0010737;18;0.28902218;0.9644489;0.50238097;0.96213275
GO BP;TOLL LIKE RECEPTOR SIGNALING PATHWAY;GO:0002224;99;0.18986759;0.9642249;0.53351206;0.961089
GO BP;NEPHRON EPITHELIUM DEVELOPMENT;#N/A;58;0.21381116;0.96412385;0.5093897;0.9596006
GO BP;CELLULAR PROTEIN COMPLEX DISASSEMBLY;#N/A;186;0.17311999;0.9638918;0.54651165;0.9585474
GO BP;REGULATION OF IMMUNE EFFECTOR PROCESS;#N/A;220;0.16815527;0.9636088;0.5240793;0.95779103
GO BP;POSITIVE REGULATION OF LIPID METABOLIC PROCESS;GO:0045834;91;0.19172314;0.96277815;0.5037594;0.9590408
GO BP;PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE;GO:0002532;36;0.23624928;0.96121764;0.51707315;0.9629744
GO BP;RNA 5 END PROCESSING;#N/A;18;0.28646263;0.9611161;0.50344825;0.961491
GO BP;RESPONSE TO BMP;#N/A;110;0.18793061;0.96105003;0.50793654;0.9598798
GO BP;NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY;GO:0090101;78;0.19965705;0.9602242;0.5203252;0.9610684
GO BP;RESPONSE TO ACID CHEMICAL;#N/A;230;0.16518547;0.95803875;0.5986622;0.9671043
GO BP;POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION;#N/A;20;0.2711802;0.9576926;0.53101736;0.9665865
GO BP;GLAND MORPHOGENESIS;GO:0022612;75;0.19752677;0.95750064;0.5321337;0.9654538
GO BP;RESPONSE TO ELECTRICAL STIMULUS;GO:0051602;25;0.25956845;0.95695966;0.5322581;0.96566266
GO BP;RESPONSE TO ARSENIC CONTAINING SUBSTANCE;GO:0046685;31;0.24334368;0.9566263;0.52369076;0.9649971
GO BP;CARDIAC MUSCLE CELL ACTION POTENTIAL;GO:0086001;40;0.22590484;0.9562603;0.51843315;0.9644438
GO BP;RESPIRATORY SYSTEM DEVELOPMENT;GO:0060541;136;0.1772079;0.9562512;0.5588235;0.9626689
GO BP;COLLAGEN CATABOLIC PROCESS;GO:0030574;22;0.26622397;0.9536069;0.5331808;0.9703977
GO BP;SPERM MOTILITY;#N/A;46;0.21820153;0.9533491;0.5552941;0.96954876
GO BP;METANEPHROS MORPHOGENESIS;GO:0003338;16;0.29340285;0.9526529;0.5083933;0.97036535
GO BP;CARDIAC SEPTUM MORPHOGENESIS;GO:0060411;53;0.2140555;0.95261973;0.5447942;0.96868885
GO BP;REGULATION OF RENAL SYSTEM PROCESS;#N/A;15;0.30095416;0.95256585;0.5288889;0.967072
GO BP;ERBB2 SIGNALING PATHWAY;GO:0038128;27;0.25719857;0.9519174;0.53255814;0.96768546
GO BP;PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS;#N/A;18;0.28006122;0.95182365;0.49884528;0.9662368
GO BP;REGULATION OF NUCLEASE ACTIVITY;#N/A;17;0.29171753;0.9514758;0.5229358;0.96574616
GO BP;REGULATION OF CAMP MEDIATED SIGNALING;GO:0043949;22;0.26189113;0.95017594;0.5550122;0.9686301
GO BP;REGULATION OF OSTEOBLAST DIFFERENTIATION;GO:0045667;74;0.19635595;0.94979125;0.5425;0.9681477
GO BP;TISSUE HOMEOSTASIS;GO:0001894;130;0.17862844;0.94859964;0.5989011;0.97063583
GO BP;RESPONSE TO OXYGEN RADICAL;#N/A;18;0.28498533;0.94841987;0.5116823;0.9694598
GO BP;CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY;#N/A;62;0.20840542;0.94767475;0.55256724;0.97032315
GO BP;POSITIVE REGULATION OF PEPTIDE SECRETION;#N/A;152;0.1736844;0.9471322;0.59887004;0.9705235
GO BP;NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS;GO:0010656;28;0.24925268;0.9468932;0.5479115;0.9696135
GO BP;NEGATIVE REGULATION OF B CELL ACTIVATION;GO:0050869;19;0.27563733;0.9467851;0.5466378;0.9682349
GO BP;LYMPHOCYTE APOPTOTIC PROCESS;#N/A;47;0.22057226;0.9467244;0.5703704;0.96667665
GO BP;CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS;GO:0003413;20;0.27971646;0.9459533;0.5321782;0.96765697
GO BP;AORTA MORPHOGENESIS;GO:0035909;21;0.2718506;0.9459137;0.5344418;0.9660605
GO BP;POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY;GO:0045880;29;0.24531817;0.9457344;0.5514223;0.9649188
GO BP;B CELL PROLIFERATION;GO:0042100;46;0.22017883;0.94491833;0.5531401;0.96601516
GO BP;ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS;#N/A;228;0.16411662;0.9440751;0.6477987;0.9672372
GO BP;POSITIVE REGULATION OF LIPID KINASE ACTIVITY;GO:0090218;23;0.26064807;0.9427912;0.53968257;0.9699169
GO BP;RIBOSOMAL LARGE SUBUNIT ASSEMBLY;GO:0000027;26;0.25342202;0.94247544;0.54228854;0.96928614
GO BP;REGULATION OF NEUROTRANSMITTER LEVELS;GO:0001505;197;0.16671482;0.9410389;0.63126844;0.9725061
GO BP;CARBOHYDRATE PHOSPHORYLATION;GO:0046835;22;0.2682337;0.9386861;0.55841124;0.9790012
GO BP;LYMPH VESSEL DEVELOPMENT;GO:0001945;16;0.2918722;0.9381166;0.52248394;0.97925675
GO BP;PEPTIDE SECRETION;GO:0002790;356;0.15479246;0.93769264;0.7020548;0.9790387
GO BP;LONG CHAIN FATTY ACID TRANSPORT;GO:0015909;48;0.21461189;0.9368349;0.5563725;0.9802581
GO BP;POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION;GO:0045621;53;0.21124871;0.93658537;0.55990785;0.979422
GO BP;NEURAL RETINA DEVELOPMENT;GO:0003407;37;0.22708617;0.9362581;0.5872236;0.978842
GO BP;POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY;GO:2001056;100;0.18524253;0.9359872;0.6270718;0.97804654
GO BP;BONE RESORPTION;GO:0045453;40;0.22442958;0.9359846;0.575179;0.9763293
GO BP;PLASMINOGEN ACTIVATION;GO:0031639;19;0.2715545;0.934919;0.56057006;0.97834665
GO BP;LEUKOCYTE PROLIFERATION;GO:0070661;158;0.17355455;0.93470097;0.6336898;0.9773956
GO BP;TYROSINE PHOSPHORYLATION OF STAT PROTEIN;GO:0007260;36;0.22762528;0.9339296;0.5430622;0.9783291
GO BP;ICOSANOID BIOSYNTHETIC PROCESS;GO:0046456;29;0.24138598;0.933718;0.5196305;0.9773285
GO BP;DICARBOXYLIC ACID TRANSPORT;GO:0006835;57;0.20850681;0.9329651;0.6015424;0.9781772
GO BP;POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION;GO:0010800;20;0.27026936;0.93277025;0.56492025;0.97708166
GO BP;FOREBRAIN GENERATION OF NEURONS;GO:0021872;32;0.23500042;0.93239766;0.5249406;0.97668874
GO BP;POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION;GO:0048661;61;0.20611009;0.9312199;0.6069652;0.97895116
GO BP;GENERATION OF PRECURSOR METABOLITES AND ENERGY;GO:0006091;427;0.14980757;0.93082577;0.76241136;0.97859466
GO BP;REACTIVE NITROGEN SPECIES METABOLIC PROCESS;#N/A;44;0.22028908;0.92928725;0.5539568;0.9820395
GO BP;METAL ION HOMEOSTASIS;GO:0055065;346;0.15406613;0.92913586;0.7307692;0.98081666
GO BP;POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT;GO:0040019;26;0.25468707;0.9289342;0.56435645;0.97981596
GO BP;POSITIVE REGULATION OF HEART CONTRACTION;GO:0045823;22;0.26208788;0.9288653;0.5771812;0.9783448
GO BP;PROTEIN KINASE B SIGNALING;GO:0043491;152;0.17330278;0.9287744;0.6737805;0.9770003
GO BP;MYOBLAST DIFFERENTIATION;GO:0045445;54;0.21089856;0.9287714;0.5954198;0.97532445
GO BP;POSITIVE REGULATION OF PHAGOCYTOSIS;GO:0050766;37;0.22868618;0.92860544;0.5595238;0.97419864
GO BP;IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE;GO:0002381;34;0.2298978;0.9285018;0.56296295;0.9729107
GO BP;NEGATIVE REGULATION OF SECRETION;GO:0051048;116;0.18209377;0.9272351;0.6582633;0.9755268
GO BP;MITOCHONDRIAL TRANSCRIPTION;GO:0006390;15;0.28956276;0.9269689;0.55632186;0.97473025
GO BP;RESPONSE TO XENOBIOTIC STIMULUS;GO:0009410;158;0.1700155;0.92686397;0.6516854;0.97340006
GO BP;REGULATION OF CATION CHANNEL ACTIVITY;#N/A;74;0.19436793;0.92600775;0.6240209;0.97452915
GO BP;REGULATION OF HORMONE LEVELS;GO:0010817;286;0.1561;0.9250752;0.7313916;0.9759759
GO BP;REGULATION OF LEUKOCYTE MIGRATION;GO:0002685;100;0.18280183;0.9234082;0.6315789;0.97978455
GO BP;ENDOCARDIAL CUSHION FORMATION;GO:0003272;15;0.29227662;0.92325217;0.55902004;0.97865343
GO BP;TETRAPYRROLE METABOLIC PROCESS;#N/A;46;0.213941;0.9228659;0.5819861;0.9782494
GO BP;ORGANOPHOSPHATE ESTER TRANSPORT;#N/A;84;0.18513608;0.922789;0.63309354;0.9768182
GO BP;PIGMENTATION;GO:0043473;71;0.19266154;0.92273045;0.625;0.9753579
GO BP;AMINOGLYCAN METABOLIC PROCESS;#N/A;104;0.18247887;0.92271346;0.62247837;0.9737638
GO BP;ESTABLISHMENT OF MITOCHONDRION LOCALIZATION;GO:0051654;22;0.2546559;0.92244875;0.5717822;0.9730718
GO BP;PROTEIN MATURATION;GO:0051604;217;0.16178428;0.9221565;0.685879;0.97239435
GO BP;MEMORY;GO:0007613;62;0.19979385;0.9216319;0.6136364;0.9724988
GO BP;CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS;GO:0042219;17;0.27810034;0.9214103;0.5670588;0.9716086
GO BP;RESPONSE TO CADMIUM ION;GO:0046686;43;0.2196853;0.9208903;0.56650245;0.9716808
GO BP;MEIOSIS I CELL CYCLE PROCESS;#N/A;89;0.18676431;0.92074865;0.6446281;0.9704766
GO BP;MECHANORECEPTOR DIFFERENTIATION;GO:0042490;41;0.2194216;0.9205108;0.57042253;0.9695671
GO BP;HORMONE TRANSPORT;#N/A;183;0.16561367;0.9201365;0.6790451;0.96918005
GO BP;POSITIVE REGULATION OF VASCULAR SMOOTH MUSCLE CELL PROLIFERATION;#N/A;23;0.24881332;0.91899747;0.6;0.9712361
GO BP;REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY;#N/A;63;0.19653448;0.91683614;0.622108;0.9765921
GO BP;MESODERM DEVELOPMENT;GO:0007498;77;0.18759486;0.9167465;0.63254595;0.97527707
GO BP;POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING;GO:2000679;16;0.2796845;0.91572684;0.5638051;0.97699994
GO BP;NEGATIVE REGULATION OF PROTEIN MATURATION;#N/A;22;0.24794939;0.9130404;0.5866051;0.98397064
GO BP;POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION;GO:0032755;42;0.21695152;0.9127998;0.58900523;0.98308295
GO BP;POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION;GO:0002763;31;0.23146649;0.910937;0.58597285;0.9873917
GO BP;CELLULAR PIGMENTATION;GO:0033059;41;0.21839558;0.9099588;0.6120482;0.9888908
GO BP;REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS;GO:1902041;44;0.21162492;0.9092545;0.62650603;0.98946404
GO BP;POSITIVE REGULATION OF LEUKOCYTE MIGRATION;GO:0002687;69;0.19427247;0.90742743;0.62560385;0.99344254
GO BP;PHOSPHATE ION TRANSPORT;GO:0006817;17;0.27447817;0.90713906;0.5962877;0.9926763
GO BP;POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY;#N/A;17;0.27297434;0.90712833;0.5794621;0.99108887
GO BP;REGULATION OF SECRETION;GO:0051046;456;0.14566804;0.9068562;0.8375451;0.99035066
GO BP;PEPTIDE HORMONE SECRETION;GO:0030072;151;0.16468818;0.90641195;0.6979472;0.9900849
GO BP;CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS;GO:0002042;39;0.21760654;0.9062885;0.5819071;0.98885477
GO BP;ACYLGLYCEROL HOMEOSTASIS;GO:0055090;21;0.25495163;0.9059052;0.62217194;0.98840356
GO BP;PROTEIN TETRAMERIZATION;GO:0051262;107;0.17970608;0.90574247;0.6775068;0.9872858
GO BP;NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION;GO:0032480;33;0.2285068;0.9052651;0.61633664;0.9871495
GO BP;MUSCLE CELL PROLIFERATION;GO:0033002;122;0.17321973;0.904783;0.6775148;0.9871555
GO BP;GLYCOSYLCERAMIDE METABOLIC PROCESS;GO:0006677;15;0.28502673;0.9040409;0.5769231;0.987826
GO BP;NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS;GO:1902042;27;0.24338435;0.9037281;0.60487807;0.98720527
GO BP;REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS;GO:0045428;32;0.22167116;0.90283895;0.6155718;0.988319
GO BP;RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM;GO:0007585;32;0.22731481;0.9023845;0.6456311;0.9881268
GO BP;REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS;GO:0090049;27;0.23808812;0.90213674;0.6212871;0.98732716
GO BP;POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION;#N/A;42;0.21076775;0.901092;0.6070529;0.98902386
GO BP;POSITIVE REGULATION OF MUSCLE CONTRACTION;#N/A;22;0.2534749;0.90070766;0.5881007;0.9885631
GO BP;POSITIVE REGULATION OF MEIOTIC CELL CYCLE;#N/A;16;0.27192456;0.90028447;0.5945946;0.98823506
GO BP;CELL FATE DETERMINATION;GO:0001709;20;0.26130757;0.9002366;0.603912;0.9868202
GO BP;REGULATION OF CARDIAC CONDUCTION;GO:1903779;39;0.21662655;0.90017277;0.6220657;0.9854347
GO BP;NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION;GO:0046639;15;0.2831416;0.899857;0.56621003;0.98484087
GO BP;CELLULAR RESPONSE TO HYDROGEN PEROXIDE;GO:0070301;68;0.1936891;0.8970647;0.6281407;0.9915577
GO BP;REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY;GO:2000116;163;0.16232398;0.8970549;0.7827381;0.9900207
GO BP;LYMPHOCYTE MEDIATED IMMUNITY;#N/A;120;0.17110634;0.8969783;0.72303206;0.98866904
GO BP;TETRAHYDROFOLATE METABOLIC PROCESS;GO:0046653;15;0.28004485;0.8965472;0.5995575;0.98836654
GO BP;CHOLESTEROL EFFLUX;GO:0033344;32;0.22828054;0.8956825;0.62142855;0.9894196
GO BP;REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY;GO:0007176;22;0.24876086;0.8950654;0.60794044;0.98967683
GO BP;ALPHA BETA T CELL PROLIFERATION;GO:0046633;18;0.2655944;0.89482385;0.6052632;0.9888729
GO BP;RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM;GO:1903514;16;0.27530324;0.8942117;0.6060606;0.9891675
GO BP;BONE REMODELING;GO:0046849;56;0.1989852;0.8940794;0.6691542;0.9879914
GO BP;NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS;#N/A;103;0.17534077;0.89303243;0.7058824;0.98956764
GO BP;HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES;GO:0007157;20;0.26222935;0.892827;0.6092233;0.988612
GO BP;EXECUTION PHASE OF APOPTOSIS;GO:0097194;55;0.20232838;0.892783;0.6650124;0.9871972
GO BP;COCHLEA DEVELOPMENT;GO:0090102;28;0.2334364;0.8926728;0.5871122;0.9859902
GO BP;MONOCARBOXYLIC ACID TRANSPORT;GO:0015718;98;0.17946817;0.8924434;0.699187;0.9851583
GO BP;POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING;GO:0043123;134;0.16847551;0.89001775;0.72677594;0.9907233
GO BP;DRUG METABOLIC PROCESS;GO:0017144;375;0.14368087;0.889978;0.8245614;0.98931533
GO BP;ENDOCRINE SYSTEM DEVELOPMENT;GO:0035270;66;0.18838295;0.8893302;0.67788464;0.9896286
GO BP;PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY;GO:0002221;131;0.16750273;0.8888761;0.734375;0.9893875
GO BP;REGULATION OF ANIMAL ORGAN FORMATION;GO:0003156;19;0.25761518;0.8888383;0.61928934;0.98796475
GO BP;REGULATION OF IMMUNOGLOBULIN PRODUCTION;GO:0002637;37;0.22143082;0.88875836;0.6744186;0.98668844
GO BP;LEUKOCYTE APOPTOTIC PROCESS;#N/A;66;0.19186468;0.8887148;0.67792207;0.9853089
GO BP;NEUROTRANSMITTER SECRETION;GO:0007269;96;0.17806742;0.888597;0.7153846;0.9841529
GO BP;REGULATION OF HEART RATE BY CARDIAC CONDUCTION;GO:0086091;20;0.26093128;0.8882974;0.5876777;0.9835189
GO BP;GPI ANCHOR METABOLIC PROCESS;GO:0006505;29;0.23094992;0.8863117;0.6666667;0.9876673
GO BP;NEUTRAL LIPID CATABOLIC PROCESS;#N/A;29;0.22780429;0.88622445;0.6238938;0.9864129
GO BP;NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS;GO:2000107;26;0.2406567;0.8861687;0.63529414;0.9850504
GO BP;STEROID HORMONE BIOSYNTHETIC PROCESS;#N/A;40;0.21263021;0.885636;0.6412777;0.98508006
GO BP;RESPONSE TO COPPER ION;GO:0046688;23;0.2459375;0.8851525;0.63116884;0.98497564
GO BP;REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION;GO:0051480;148;0.16463949;0.8846477;0.77453583;0.9848102
GO BP;NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS;GO:1901292;59;0.19994068;0.8836337;0.6870229;0.98620015
GO BP;SEMI LUNAR VALVE DEVELOPMENT;GO:1905314;25;0.24416406;0.88339466;0.63265306;0.98538476
GO BP;NEPHRON MORPHOGENESIS;GO:0072028;42;0.2123762;0.8812701;0.6447059;0.9897015
GO BP;ENDOCARDIAL CUSHION DEVELOPMENT;GO:0003197;27;0.23446849;0.8798882;0.6453901;0.99193007
GO BP;NEGATIVE REGULATION OF HORMONE SECRETION;GO:0046888;32;0.22110203;0.8775106;0.66019416;0.9970461
GO BP;POSITIVE REGULATION OF FIBROBLAST PROLIFERATION;GO:0048146;38;0.21233737;0.8770341;0.65686274;0.9968466
GO BP;ANIMAL ORGAN REGENERATION;GO:0031100;51;0.20085305;0.87669104;0.67368424;0.9962612
GO BP;POSITIVE REGULATION OF CYTOKINE SECRETION;GO:0050715;56;0.19836748;0.8757156;0.7009346;0.99743485
GO BP;MITOCHONDRIAL TRANSPORT;GO:0006839;218;0.15196593;0.87521785;0.8220339;0.9972685
GO BP;POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION;GO:0002053;16;0.26430345;0.8750906;0.6321839;0.99614006
GO BP;NEGATIVE REGULATION OF OSSIFICATION;GO:0030279;42;0.20285253;0.87458134;0.68613136;0.99605155
GO BP;SUBSTRATE DEPENDENT CELL MIGRATION;GO:0006929;18;0.2608052;0.87451875;0.60470587;0.99473315
GO BP;SYNAPTIC VESICLE TRANSPORT;GO:0048489;35;0.2157932;0.8735633;0.66824645;0.9958546
GO BP;REGULATION OF GLUCONEOGENESIS;GO:0006111;35;0.21429627;0.87265956;0.63065326;0.99685943
GO BP;NEGATIVE REGULATION OF HEMOPOIESIS;GO:1903707;91;0.17239937;0.87240726;0.742268;0.99604654
GO BP;RELAXATION OF MUSCLE;GO:0090075;18;0.25488836;0.8711356;0.65110564;0.99799764
GO BP;REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE;GO:0060688;31;0.22636533;0.8700334;0.6819222;0.99950886
GO BP;OUTFLOW TRACT SEPTUM MORPHOGENESIS;GO:0003148;18;0.25928995;0.8699819;0.64705884;0.9981803
GO BP;TRANSFERRIN TRANSPORT;GO:0033572;32;0.2214539;0.86932516;0.6959459;0.99844044
GO BP;RENAL SYSTEM VASCULATURE DEVELOPMENT;#N/A;18;0.2573718;0.86909187;0.6225;0.9976036
GO BP;REGULATION OF HETEROTYPIC CELL CELL ADHESION;#N/A;18;0.25599086;0.8680085;0.6805556;0.99901277
GO BP;T CELL HOMEOSTASIS;GO:0043029;24;0.23889104;0.8677105;0.6403712;0.99834234
GO BP;NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION;#N/A;26;0.22972518;0.8671864;0.6580796;0.9982277
GO BP;STEROID BIOSYNTHETIC PROCESS;GO:0006694;143;0.15968718;0.8668621;0.8069164;0.99764985
GO BP;CARDIAC CHAMBER MORPHOGENESIS;#N/A;90;0.17292543;0.8658557;0.7638191;0.99876314
GO BP;OSSIFICATION;GO:0001503;248;0.14800248;0.86396116;0.8622754;1
GO BP;PHOSPHOLIPID CATABOLIC PROCESS;GO:0009395;31;0.22102031;0.8634801;0.6832918;1
GO BP;REGULATION OF HORMONE SECRETION;GO:0046883;148;0.1623031;0.86267966;0.78457445;1
GO BP;NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION;GO:0050680;87;0.17479134;0.8620147;0.7758621;1
GO BP;CERAMIDE BIOSYNTHETIC PROCESS;GO:0046513;50;0.19534934;0.86178845;0.7444717;1
GO BP;REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING;GO:0010882;16;0.26744646;0.86066806;0.67076164;1
GO BP;GLUTAMATE RECEPTOR SIGNALING PATHWAY;GO:0007215;41;0.20832784;0.8586174;0.70558375;1
GO BP;RETINA HOMEOSTASIS;GO:0001895;40;0.20478459;0.8584932;0.68321514;1
GO BP;OVULATION CYCLE PROCESS;GO:0022602;27;0.22860512;0.8581653;0.6875;1
GO BP;RESPONSE TO TUMOR NECROSIS FACTOR;GO:0034612;191;0.15336958;0.8579043;0.8738462;1
GO BP;CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE;GO:0002534;22;0.23928764;0.8574198;0.65617436;1
GO BP;CELLULAR RESPONSE TO FATTY ACID;GO:0071398;30;0.22330476;0.85703737;0.6879271;1
GO BP;CELLULAR ION HOMEOSTASIS;GO:0006873;363;0.13974786;0.8569105;0.9501661;1
GO BP;NEGATIVE REGULATION OF COAGULATION;GO:0050819;33;0.21602805;0.8561107;0.7124183;1
GO BP;PROTEIN HETEROOLIGOMERIZATION;GO:0051291;75;0.17876689;0.8558272;0.7401575;1
GO BP;LAMELLIPODIUM ORGANIZATION;GO:0097581;59;0.1887786;0.8553307;0.7330097;1
GO BP;PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS;#N/A;44;0.2060405;0.8536974;0.69647056;1
GO BP;REGULATION OF ORGAN GROWTH;GO:0046620;61;0.18905467;0.85350686;0.7304786;1
GO BP;PHOSPHOLIPID TRANSPORT;GO:0015914;60;0.18950118;0.85336035;0.720403;1
GO BP;ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS;#N/A;39;0.20538995;0.8531724;0.7040573;1
GO BP;RESPONSE TO PROGESTERONE;GO:0032570;30;0.22066765;0.852324;0.6968326;1
GO BP;CILIUM MOVEMENT;GO:0003341;40;0.20234321;0.8504492;0.72680414;1
GO BP;REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS;#N/A;66;0.18381114;0.8503247;0.78215224;1
GO BP;CELLULAR RESPONSE TO VITAMIN;#N/A;17;0.2611633;0.84995365;0.66997516;1
GO BP;REGULATION OF PEPTIDE HORMONE SECRETION;GO:0090276;125;0.15992475;0.84691817;0.8492063;1
GO BP;PEPTIDYL SERINE DEPHOSPHORYLATION;GO:0070262;15;0.2666839;0.84619266;0.678487;1
GO BP;EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS;GO:0008625;68;0.17933953;0.84617335;0.7684729;1
GO BP;REGULATION OF MEMBRANE LIPID DISTRIBUTION;GO:0097035;31;0.21814114;0.84608245;0.7328767;1
GO BP;LEUKOCYTE HOMEOSTASIS;GO:0001776;52;0.19214843;0.8450507;0.74216866;1
GO BP;REGULATION OF TISSUE REMODELING;GO:0034103;42;0.19797343;0.84488326;0.7327189;1
GO BP;MITOTIC G2 DNA DAMAGE CHECKPOINT;GO:0007095;18;0.25018364;0.8442996;0.69789225;1
GO BP;EXPORT ACROSS PLASMA MEMBRANE;GO:0140115;25;0.23093897;0.84387267;0.6864608;1
GO BP;MULTICELLULAR ORGANISMAL RESPONSE TO STRESS;GO:0033555;32;0.21517083;0.8436668;0.7058824;1
GO BP;MULTI ORGANISM CELLULAR PROCESS;#N/A;32;0.21111958;0.84354;0.69518715;1
GO BP;POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE;GO:0002821;47;0.19478956;0.8429744;0.74418604;1
GO BP;REGULATION OF CHEMOTAXIS;GO:0050920;112;0.1657577;0.84240484;0.82188296;1
GO BP;EPIDERMAL CELL DIFFERENTIATION;GO:0009913;142;0.15913454;0.8417714;0.85755813;1
GO BP;NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION;GO:0045599;32;0.21182892;0.84121835;0.7270642;1
GO BP;REGULATION OF BLOOD PRESSURE;GO:0008217;88;0.17161055;0.84086907;0.77835053;1
GO BP;CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS;#N/A;76;0.17552686;0.8407983;0.76962024;1
GO BP;REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE;GO:0002718;48;0.19346601;0.8402698;0.7639903;1
GO BP;INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION;GO:0042491;22;0.23872265;0.8382686;0.69423556;1
GO BP;ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS;GO:0006919;58;0.18406864;0.83810097;0.74634147;1
GO BP;NEGATIVE REGULATION OF NEURON DEATH;GO:1901215;137;0.15885489;0.8375711;0.8452722;1
GO BP;PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS;#N/A;26;0.22645314;0.8374959;0.74285716;1
GO BP;PROTEIN O LINKED MANNOSYLATION;GO:0035269;18;0.24883641;0.8370163;0.7004505;1
GO BP;NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE;#N/A;23;0.23505606;0.8369104;0.7146172;1
GO BP;INTERMEDIATE FILAMENT ORGANIZATION;GO:0045109;15;0.26801193;0.83676654;0.6720554;1
GO BP;PROTEIN MANNOSYLATION;GO:0035268;22;0.23285024;0.8365226;0.7111111;0.9998065
GO BP;AMELOGENESIS;GO:0097186;15;0.2554035;0.8354688;0.6873449;1
GO BP;REGULATION OF TUBE SIZE;GO:0035150;67;0.18078554;0.8344126;0.81038964;1
GO BP;BILE ACID METABOLIC PROCESS;GO:0008206;35;0.20856953;0.8342984;0.7487923;1
GO BP;NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER;GO:0097756;36;0.20402221;0.833956;0.7567568;1
GO BP;ENDOCARDIAL CUSHION MORPHOGENESIS;GO:0003203;20;0.24592268;0.83068925;0.71990174;1
GO BP;CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE;GO:0070192;51;0.19251642;0.83061355;0.7647059;1
GO BP;B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE;GO:0002312;47;0.19121765;0.8299365;0.79036146;1
GO BP;NEGATIVE REGULATION OF BMP SIGNALING PATHWAY;GO:0030514;30;0.2144109;0.82855046;0.74811083;1
GO BP;NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS;#N/A;65;0.1810414;0.82748795;0.7889688;1
GO BP;REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS;GO:2000369;15;0.25494066;0.8268523;0.6982379;1
GO BP;MEMBRANE LIPID METABOLIC PROCESS;GO:0006643;161;0.1496912;0.82665753;0.9197708;1
GO BP;POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION;GO:0035025;17;0.24644753;0.8263065;0.73255813;1
GO BP;VITAMIN METABOLIC PROCESS;GO:0006766;91;0.16643961;0.82630306;0.8097826;1
GO BP;LYMPHOCYTE HOMEOSTASIS;GO:0002260;40;0.19618237;0.8251475;0.7823961;1
GO BP;MITOCHONDRIAL MEMBRANE ORGANIZATION;GO:0007006;113;0.15962684;0.8244712;0.8763441;1
GO BP;GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS;#N/A;15;0.26440266;0.8234768;0.7025761;1
GO BP;AEROBIC RESPIRATION;GO:0009060;79;0.16924493;0.8226548;0.8374656;1
GO BP;DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION;#N/A;17;0.2470921;0.8224277;0.72439027;1
GO BP;REGULATION OF PHOSPHOLIPASE ACTIVITY;#N/A;36;0.20714681;0.8219565;0.7839806;1
GO BP;SUPEROXIDE ANION GENERATION;GO:0042554;21;0.23710029;0.8216984;0.7494253;1
GO BP;NEGATIVE REGULATION OF WOUND HEALING;GO:0061045;47;0.19034676;0.82128054;0.7848101;1
GO BP;AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS;GO:0009074;22;0.23007146;0.8209436;0.7480916;1
GO BP;CELLULAR COMPONENT MAINTENANCE;GO:0043954;42;0.19491987;0.8203601;0.76811594;1
GO BP;KIDNEY MORPHOGENESIS;GO:0060993;50;0.18818395;0.8197543;0.78516626;1
GO BP;POSITIVE REGULATION OF LIPID STORAGE;GO:0010884;15;0.2552135;0.8188931;0.7268171;1
GO BP;POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS;GO:1904407;21;0.23464538;0.8187147;0.7432432;1
GO BP;MITOCHONDRIAL DEPOLARIZATION;GO:0051882;16;0.25121328;0.81864834;0.6976744;1
GO BP;RESPONSE TO ESTROGEN;GO:0043627;52;0.18412496;0.8185613;0.77751195;0.9997413
GO BP;CELLULAR RESPONSE TO MECHANICAL STIMULUS;GO:0071260;59;0.18194757;0.81763357;0.7832168;1
GO BP;CELLULAR RESPONSE TO RETINOIC ACID;GO:0071300;40;0.20038955;0.8171276;0.7620192;0.9999512
GO BP;STRIATED MUSCLE ADAPTATION;#N/A;30;0.21229258;0.8169305;0.7619048;0.99901426
GO BP;ZYMOGEN ACTIVATION;GO:0031638;40;0.19629858;0.8163808;0.77017117;0.998784
GO BP;POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS;GO:0002690;44;0.19203125;0.8157738;0.7826087;0.9986917
GO BP;POSITIVE REGULATION OF BLOOD CIRCULATION;#N/A;35;0.20078619;0.8153153;0.7889688;0.99820846
GO BP;POLYOL BIOSYNTHETIC PROCESS;#N/A;52;0.17991626;0.8138713;0.79577464;0.99961215
GO BP;SNRNA 3 END PROCESSING;#N/A;18;0.23634802;0.81307214;0.7222222;0.9997811
GO BP;NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY;#N/A;17;0.25371742;0.8127435;0.7315271;0.9990993
GO BP;REGULATION OF COAGULATION;#N/A;52;0.18333842;0.8119188;0.7938144;0.99935895
GO BP;POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT;GO:0055025;28;0.21323854;0.8114854;0.790404;0.9988999
GO BP;REGULATION OF HEART GROWTH;GO:0060420;40;0.19519915;0.8113161;0.7935323;0.9979346
GO BP;POSITIVE REGULATION OF LIPID TRANSPORT;GO:0032370;33;0.19913232;0.8097157;0.7763819;0.99957025
GO BP;ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION;#N/A;19;0.23285697;0.8089128;0.76540285;0.99977446
GO BP;LIPID IMPORT INTO CELL;#N/A;15;0.25459185;0.80875355;0.713964;0.9988038
GO BP;POSITIVE REGULATION OF FILOPODIUM ASSEMBLY;GO:0051491;24;0.22037072;0.80317205;0.7624703;1
GO BP;REGULATION OF GLYCOPROTEIN METABOLIC PROCESS;#N/A;31;0.20474415;0.80228204;0.7914692;1
GO BP;NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS;GO:0048261;15;0.25445327;0.8000969;0.7565012;1
GO BP;NEURAL CREST CELL DIFFERENTIATION;GO:0014033;55;0.17926843;0.7994372;0.84517765;1
GO BP;POLYOL METABOLIC PROCESS;#N/A;92;0.15912275;0.7988959;0.8901099;1
GO BP;MEMBRANE LIPID BIOSYNTHETIC PROCESS;#N/A;118;0.15304792;0.7960945;0.92183286;1
GO BP;INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY;GO:0070498;79;0.16802146;0.79520506;0.8982188;1
GO BP;PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS;#N/A;16;0.24024536;0.7951065;0.76334107;1
GO BP;POSITIVE REGULATION OF PEPTIDASE ACTIVITY;GO:0010952;133;0.14999159;0.7946472;0.9247312;1
GO BP;IMPORT ACROSS PLASMA MEMBRANE;GO:0098739;66;0.17183825;0.7943489;0.848;1
GO BP;TRABECULA FORMATION;#N/A;17;0.23993173;0.7934976;0.76537585;1
GO BP;HAIR CELL DIFFERENTIATION;GO:0035315;27;0.21110973;0.79288435;0.76303315;1
GO BP;NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION;#N/A;24;0.21681935;0.79246676;0.7777778;1
GO BP;NEURON PROJECTION REGENERATION;GO:0031102;40;0.18721786;0.7920247;0.8062201;1
GO BP;NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION;GO:0045638;55;0.17461704;0.7892391;0.84343433;1
GO BP;POSITIVE REGULATION OF CHEMOTAXIS;GO:0050921;66;0.17112033;0.7891194;0.85422;1
GO BP;LUNG EPITHELIUM DEVELOPMENT;GO:0060428;21;0.22108771;0.78774977;0.7757009;1
GO BP;INNER EAR RECEPTOR CELL DEVELOPMENT;GO:0060119;29;0.20614001;0.7871915;0.80985916;1
GO BP;CELLULAR SENESCENCE;GO:0090398;52;0.17889865;0.785214;0.86198545;1
GO BP;NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION;GO:0032692;16;0.2333507;0.7823763;0.7808219;1
GO BP;INTERLEUKIN 1 PRODUCTION;GO:0032612;42;0.18852146;0.7817479;0.8484849;1
GO BP;POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY;GO:2001244;48;0.18271576;0.7816723;0.83698297;1
GO BP;MATING;#N/A;17;0.23149855;0.7808548;0.7591743;1
GO BP;POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION;GO:0032732;17;0.23609605;0.78026557;0.74130434;1
GO BP;POSITIVE REGULATION OF LIPID LOCALIZATION;#N/A;47;0.17951699;0.78011656;0.85148513;1
GO BP;RESPONSE TO MUSCLE ACTIVITY;GO:0014850;16;0.23509145;0.7792052;0.7668269;1
GO BP;ALDITOL METABOLIC PROCESS;#N/A;16;0.2387289;0.77671814;0.7806005;1
GO BP;T CELL APOPTOTIC PROCESS;GO:0070231;31;0.19826624;0.77624977;0.8428571;1
GO BP;REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION;#N/A;18;0.23445898;0.77546275;0.781106;1
GO BP;ORGAN GROWTH;GO:0035265;112;0.14955018;0.7748536;0.9338843;1
GO BP;CELLULAR TRANSITION METAL ION HOMEOSTASIS;#N/A;79;0.15956326;0.7743269;0.88409704;1
GO BP;OSTEOBLAST DIFFERENTIATION;GO:0001649;144;0.14338584;0.7720213;0.9369627;1
GO BP;POSITIVE REGULATION OF CELL KILLING;#N/A;21;0.21623632;0.7707451;0.80222225;1
GO BP;INTERLEUKIN 12 PRODUCTION;GO:0032615;28;0.19996399;0.7700762;0.8248848;1
GO BP;POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY;GO:0045747;34;0.19664907;0.7678733;0.8425;1
GO BP;REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE;GO:0003073;41;0.184782;0.76716954;0.8649289;1
GO BP;CELLULAR DETOXIFICATION;GO:1990748;68;0.1634571;0.7661485;0.87281793;1
GO BP;POSITIVE REGULATION OF LIPASE ACTIVITY;#N/A;35;0.19281675;0.76578015;0.85106385;1
GO BP;SINGLE FERTILIZATION;GO:0007338;64;0.1629077;0.76493233;0.8756219;1
GO BP;MANNOSYLATION;GO:0097502;31;0.19558752;0.76475966;0.8286385;1
GO BP;REGULATION OF STEROL TRANSPORT;#N/A;32;0.19214265;0.76395804;0.8627451;1
GO BP;MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION;GO:0097345;45;0.17589527;0.7624843;0.86141306;1
GO BP;PROTEIN HOMOTRIMERIZATION;GO:0070207;20;0.22250615;0.7618421;0.7977528;1
GO BP;FILOPODIUM ASSEMBLY;GO:0046847;48;0.17494293;0.76026565;0.85974026;1
GO BP;HINDLIMB MORPHOGENESIS;GO:0035137;24;0.21087745;0.75931937;0.8356807;1
GO BP;LUNG ALVEOLUS DEVELOPMENT;GO:0048286;28;0.19839467;0.7587798;0.8333333;1
GO BP;CARDIAC MUSCLE CELL PROLIFERATION;GO:0060038;29;0.19885182;0.7586562;0.86570746;1
GO BP;NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY;#N/A;18;0.22604291;0.75734746;0.8021739;1
GO BP;ATRIOVENTRICULAR VALVE DEVELOPMENT;GO:0003171;19;0.2217342;0.7572899;0.8025;1
GO BP;PROTEIN INSERTION INTO MEMBRANE;GO:0051205;50;0.17339681;0.7559636;0.8933649;1
GO BP;TRANSPOSITION;#N/A;15;0.23909025;0.75533026;0.78850573;1
GO BP;POSITIVE REGULATION OF ISOTYPE SWITCHING;GO:0045830;15;0.23869334;0.75260407;0.7991266;1
GO BP;POSITIVE REGULATION OF BLOOD VESSEL DIAMETER;GO:0097755;31;0.1922789;0.75244343;0.8671679;1
GO BP;PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE;#N/A;39;0.17798924;0.7503017;0.87009805;1
GO BP;NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS;GO:2000352;18;0.22189106;0.75022995;0.82983685;1
GO BP;NEGATIVE CHEMOTAXIS;GO:0050919;29;0.19695847;0.74987686;0.84345794;1
GO BP;REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY;GO:1904666;19;0.21720108;0.7495799;0.8321513;1
GO BP;REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY;GO:1902235;28;0.19597587;0.7488207;0.8598575;1
GO BP;HEART TRABECULA MORPHOGENESIS;GO:0061384;23;0.20955436;0.74731314;0.82425743;1
GO BP;TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY;GO:0034162;15;0.23585182;0.74730825;0.81276596;1
GO BP;PROSTANOID METABOLIC PROCESS;#N/A;27;0.19463582;0.74612904;0.8425926;1
GO BP;B CELL APOPTOTIC PROCESS;GO:0001783;21;0.21060008;0.7455256;0.84825873;1
GO BP;AMMONIUM ION METABOLIC PROCESS;#N/A;133;0.13967936;0.73953414;0.9717514;1
GO BP;NEGATIVE REGULATION OF PEPTIDE SECRETION;#N/A;70;0.1591353;0.73758996;0.9262087;1
GO BP;MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY;GO:0002756;24;0.20419107;0.73758453;0.87810946;1
GO BP;GLYCOLIPID CATABOLIC PROCESS;GO:0019377;15;0.23383267;0.73685557;0.8384798;1
GO BP;WATER SOLUBLE VITAMIN METABOLIC PROCESS;#N/A;69;0.15766959;0.736799;0.9411765;1
GO BP;RESPONSE TO COLD;GO:0009409;35;0.18377197;0.7344899;0.88687783;1
GO BP;REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS;GO:1902108;48;0.16877356;0.73405534;0.9060914;1
GO BP;BILE ACID BIOSYNTHETIC PROCESS;GO:0006699;27;0.19681808;0.7326799;0.8668224;1
GO BP;ACROSOME REACTION;GO:0007340;15;0.22818;0.7325265;0.8321513;1
GO BP;NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY;GO:0032088;52;0.16309144;0.7324873;0.91884816;1
GO BP;NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH;#N/A;69;0.15540113;0.7321469;0.9389313;1
GO BP;REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS;#N/A;64;0.15809357;0.72851694;0.9402299;1
GO BP;DETOXIFICATION;#N/A;78;0.15327746;0.7272825;0.96029776;1
GO BP;REGULATION OF FILOPODIUM ASSEMBLY;GO:0051489;39;0.17553072;0.72603565;0.90358746;1
GO BP;CERAMIDE METABOLIC PROCESS;GO:0006672;69;0.1573687;0.72547007;0.9230769;1
GO BP;PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING;GO:0036152;15;0.23053247;0.72401416;0.8277512;1
GO BP;NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS;GO:2000279;30;0.18536846;0.72393143;0.88915664;1
GO BP;FIBRINOLYSIS;GO:0042730;18;0.21404484;0.72338164;0.85411763;1
GO BP;RIBOSOMAL LARGE SUBUNIT BIOGENESIS;GO:0042273;65;0.15359293;0.72255635;0.95571095;1
GO BP;NEGATIVE REGULATION OF LEUKOCYTE MIGRATION;GO:0002686;17;0.22417031;0.7221407;0.83524024;1
GO BP;NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION;GO:1904950;110;0.1415529;0.72185826;0.96649486;1
GO BP;MEIOTIC CHROMOSOME SEGREGATION;GO:0045132;69;0.15477026;0.7201119;0.93877554;1
GO BP;PH REDUCTION;GO:0045851;42;0.16965275;0.71964777;0.9313984;1
GO BP;MUSCLE CELL APOPTOTIC PROCESS;#N/A;48;0.166632;0.7194553;0.937046;1
GO BP;POSITIVE REGULATION OF CARTILAGE DEVELOPMENT;GO:0061036;20;0.20759542;0.71937335;0.8958838;1
GO BP;REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST;GO:0050691;25;0.19670568;0.7189678;0.87009805;1
GO BP;PEPTIDE HORMONE PROCESSING;GO:0016486;20;0.20278116;0.71657926;0.8802817;1
GO BP;PIGMENT CELL DIFFERENTIATION;#N/A;24;0.19796123;0.7152142;0.88235295;1
GO BP;REGULATION OF MACROPHAGE MIGRATION;GO:1905521;21;0.20342734;0.71496624;0.90799034;1
GO BP;NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS;#N/A;19;0.21090493;0.7136977;0.86191535;1
GO BP;NUCLEOTIDE TRANSPORT;GO:0006862;18;0.21298364;0.7132233;0.8659341;1
GO BP;TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY;GO:0034142;24;0.19571358;0.71297544;0.89330024;1
GO BP;RNA INTERFERENCE;GO:0016246;16;0.21984148;0.71174943;0.8597701;1
GO BP;MELANOCYTE DIFFERENTIATION;GO:0030318;16;0.220031;0.7108035;0.8443936;1
GO BP;REGULATION OF GLIAL CELL PROLIFERATION;#N/A;22;0.2002263;0.7106959;0.8808989;1
GO BP;CELLULAR BIOGENIC AMINE METABOLIC PROCESS;GO:0006576;31;0.18080452;0.70995593;0.89908254;1
GO BP;POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS;GO:1903428;26;0.19604392;0.70675224;0.8752834;1
GO BP;REGULATION OF MEIOTIC NUCLEAR DIVISION;GO:0040020;17;0.21329899;0.70574546;0.84988964;1
GO BP;NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT;GO:1903170;17;0.22020935;0.7053216;0.87628865;1
GO BP;NEGATIVE REGULATION OF RESPONSE TO WOUNDING;#N/A;57;0.15842013;0.7042802;0.9516129;1
GO BP;PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS;#N/A;18;0.21351336;0.7030373;0.86966294;1
GO BP;MIRNA METABOLIC PROCESS;GO:0010586;30;0.18511711;0.7026654;0.8961353;1
GO BP;OVARIAN FOLLICLE DEVELOPMENT;GO:0001541;28;0.17829475;0.7008741;0.9398148;1
GO BP;NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY;#N/A;19;0.20781799;0.6998342;0.8808989;1
GO BP;PIGMENT GRANULE LOCALIZATION;GO:0051875;21;0.19644497;0.6972571;0.89376444;1
GO BP;REGULATION OF TELOMERASE ACTIVITY;GO:0051972;42;0.16710007;0.69539654;0.9505618;1
GO BP;REGULATION OF PH;GO:0006885;73;0.14567481;0.6873905;0.9647059;1
GO BP;FEAR RESPONSE;GO:0042596;18;0.20690335;0.6853403;0.88247865;1
GO BP;TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY;GO:0034138;16;0.21173158;0.6821322;0.88135594;1
GO BP;DENDRITIC SPINE MAINTENANCE;GO:0097062;15;0.21216224;0.68099004;0.88105726;1
GO BP;NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION;GO:0010823;45;0.15945247;0.6808999;0.9587629;1
GO BP;THYMOCYTE APOPTOTIC PROCESS;GO:0070242;15;0.21199343;0.6801487;0.8965517;1
GO BP;MESONEPHRIC TUBULE MORPHOGENESIS;#N/A;35;0.16790012;0.67981106;0.94814813;1
GO BP;AXIS ELONGATION;GO:0003401;22;0.19020112;0.6773302;0.9073276;1
GO BP;DEVELOPMENTAL PIGMENTATION;GO:0048066;30;0.17534873;0.67712325;0.94158876;1
GO BP;NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION;GO:0045668;27;0.18079513;0.67669034;0.9304556;1
GO BP;HEART GROWTH;#N/A;53;0.15452798;0.6765599;0.95843524;1
GO BP;SUPEROXIDE METABOLIC PROCESS;GO:0006801;43;0.15971966;0.67411846;0.94778067;1
GO BP;REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY;GO:2000479;16;0.20689523;0.6739315;0.90293455;1
GO BP;CELLULAR ALDEHYDE METABOLIC PROCESS;GO:0006081;41;0.15697797;0.6701078;0.9611651;1
GO BP;POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS;GO:2000379;61;0.14730377;0.66986144;0.97317076;1
GO BP;FOLIC ACID METABOLIC PROCESS;GO:0046655;16;0.2099527;0.6690482;0.91709846;1
GO BP;PHOTOPERIODISM;#N/A;21;0.19455756;0.6687958;0.89631337;1
GO BP;PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS;#N/A;17;0.20042785;0.66802067;0.9212963;1
GO BP;CATECHOLAMINE METABOLIC PROCESS;GO:0006584;24;0.1830559;0.6622185;0.9259259;1
GO BP;NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE;#N/A;26;0.18138902;0.6601968;0.94859815;1
GO BP;ANDROGEN METABOLIC PROCESS;GO:0008209;16;0.20729955;0.6576238;0.9341826;1
GO BP;REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY;GO:2000050;19;0.19063811;0.6555447;0.9481132;1
GO BP;T CELL MEDIATED CYTOTOXICITY;GO:0001913;17;0.20084392;0.6552521;0.9139073;1
GO BP;RESPONSE TO THYROID HORMONE;GO:0097066;17;0.19992068;0.6543099;0.9160998;1
GO BP;VENTRICULAR SEPTUM MORPHOGENESIS;GO:0060412;29;0.17209798;0.654297;0.9489051;1
GO BP;POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY;GO:0051443;26;0.17314745;0.6515813;0.9238095;1
GO BP;ENTRAINMENT OF CIRCADIAN CLOCK;GO:0009649;23;0.1781025;0.651146;0.93643034;1
GO BP;REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS;#N/A;16;0.19570836;0.6500898;0.9137931;1
GO BP;MACROPHAGE DIFFERENTIATION;GO:0030225;28;0.17361867;0.6497713;0.9484305;1
GO BP;FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS;GO:0006760;23;0.178602;0.6491611;0.9448621;1
GO BP;ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT;#N/A;26;0.17727897;0.6467282;0.9549763;1
GO BP;POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS;GO:2000108;16;0.19905342;0.64325285;0.9147465;1
GO BP;MYELOID LEUKOCYTE CYTOKINE PRODUCTION;#N/A;24;0.17285404;0.63671;0.95085996;1
GO BP;POSITIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY;#N/A;16;0.19954345;0.63414913;0.9254808;1
GO BP;REGULATION OF T CELL MEDIATED IMMUNITY;#N/A;29;0.16142048;0.63186425;0.9625;1
GO BP;PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS;GO:0046337;17;0.18917602;0.62871486;0.9314421;1
GO BP;REGULATION OF CELL AGING;#N/A;38;0.15351252;0.62606376;0.96829265;1
GO BP;RESPONSE TO AMPHETAMINE;GO:0001975;15;0.19700691;0.61640227;0.9482353;1
GO BP;REGULATION OF HEART MORPHOGENESIS;GO:2000826;25;0.17128627;0.612671;0.94170403;1
GO BP;PLACENTA BLOOD VESSEL DEVELOPMENT;GO:0060674;24;0.17085716;0.61089754;0.9655963;1
GO BP;RESPONSE TO AMINE;#N/A;23;0.16999298;0.6084451;0.9688249;1
GO BP;SPERM EGG RECOGNITION;GO:0035036;23;0.16635929;0.6078895;0.94390243;1
GO BP;TERMINATION OF RNA POLYMERASE I TRANSCRIPTION;GO:0006363;30;0.15776514;0.6041433;0.9693396;1
GO BP;CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION;GO:0060317;20;0.17297219;0.6026437;0.9647059;1
GO BP;CELL KILLING;GO:0001906;63;0.12983468;0.5989424;0.99760765;1
GO BP;TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER;GO:0006362;28;0.1533681;0.597274;0.96926713;1
GO BP;REGULATION OF CELLULAR AMINE METABOLIC PROCESS;#N/A;58;0.13190521;0.595844;0.9975186;1
GO BP;RESPONSE TO ATP;GO:0033198;16;0.18571272;0.5952226;0.96355355;1
GO BP;MEMBRANE DISASSEMBLY;#N/A;15;0.19136997;0.5929463;0.95862067;1
GO BP;BONE GROWTH;GO:0098868;29;0.15489304;0.5899412;0.97572815;1
GO BP;LENS MORPHOGENESIS IN CAMERA TYPE EYE;GO:0002089;17;0.17652646;0.5876398;0.96452326;1
GO BP;STRIATED MUSCLE CELL PROLIFERATION;#N/A;38;0.14039673;0.57911295;0.9954128;1
GO BP;POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION;GO:0032757;27;0.15430728;0.57474095;0.9850374;1
GO BP;POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY;GO:1904874;15;0.17560218;0.57236844;0.95936793;1
GO BP;RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION;#N/A;16;0.17448089;0.5719009;0.97447795;1
GO BP;BINDING OF SPERM TO ZONA PELLUCIDA;GO:0007339;16;0.17350744;0.5715699;0.97744364;1
GO BP;REGULATION OF POLYSACCHARIDE METABOLIC PROCESS;#N/A;33;0.14440183;0.56646955;0.9784689;1
GO BP;NEGATIVE REGULATION OF AXON EXTENSION;GO:0030517;28;0.14625728;0.56179106;0.982716;1
GO BP;MEMBRANE LIPID CATABOLIC PROCESS;GO:0046466;28;0.14799148;0.56100464;0.98540145;1
GO BP;PROTEIN HOMOTETRAMERIZATION;GO:0051289;61;0.11906687;0.5513981;1;1
GO BP;NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION;GO:0010719;18;0.163713;0.54697204;0.9742991;1
GO BP;SYNAPSE MATURATION;GO:0060074;16;0.16589668;0.5451681;0.96829265;1
GO BP;NEGATIVE REGULATION OF CELL AGING;GO:0090344;19;0.1587798;0.54291517;0.9868132;1
GO BP;REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS;GO:0006521;48;0.12344646;0.538701;1;1
GO BP;NEURAL CREST CELL MIGRATION;GO:0001755;31;0.13678534;0.5277017;0.9929245;1
GO BP;PHOSPHATIDYLSERINE METABOLIC PROCESS;GO:0006658;22;0.14894173;0.5261376;0.98507464;1
GO BP;REGULATION OF B CELL APOPTOTIC PROCESS;GO:0002902;15;0.1639703;0.5202445;0.99327356;1
GO BP;MYELOID CELL APOPTOTIC PROCESS;GO:0033028;20;0.1436702;0.49129087;0.9878049;1
GO BP;INOSITOL PHOSPHATE CATABOLIC PROCESS;#N/A;15;0.15651375;0.47991312;0.9929078;1
GO BP;REGULATION OF MITOCHONDRIAL GENE EXPRESSION;#N/A;28;0.123584986;0.4650126;0.99759614;1
GO BP;PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS;GO:0042558;29;0.11745202;0.4571967;0.9951691;0.99998605
GO BP;AMINE METABOLIC PROCESS;GO:0009308;86;0.090982996;0.44105318;1;0.9993612
KEGG;RIBOSOME;;80;0.678503;3.3103414;0;0
KEGG;INTESTINAL IMMUNE NETWORK FOR IGA PRODUCTION;;15;0.65452135;2.108535;0;0.001564804
KEGG;OXIDATIVE PHOSPHORYLATION;;112;0.40701857;2.0903418;0;0.001043202
KEGG;PARKINSONS DISEASE;;108;0.39582062;2.0220761;0;0.00250858
KEGG;SYSTEMIC LUPUS ERYTHEMATOSUS;;70;0.42524067;2.0086653;0;0.003617988
KEGG;METABOLISM OF XENOBIOTICS BY CYTOCHROME P450;;18;0.505257;1.6888428;0.024444444;0.06177872
KEGG;CYTOKINE CYTOKINE RECEPTOR INTERACTION;;80;0.3502032;1.6875389;0.002525253;0.05407545
KEGG;ALZHEIMERS DISEASE;;132;0.31184754;1.657319;0;0.059812482
KEGG;COMPLEMENT AND COAGULATION CASCADES;;30;0.41226313;1.5822232;0.02293578;0.09225754
KEGG;HEMATOPOIETIC CELL LINEAGE;;34;0.37485242;1.5031915;0.031100478;0.14425391
KEGG;GLYCOSPHINGOLIPID BIOSYNTHESIS LACTO AND NEOLACTO SERIES;;15;0.45654103;1.4429259;0.06802721;0.19641462
KEGG;CARDIAC MUSCLE CONTRACTION;;47;0.32379982;1.3883009;0.03968254;0.24910164
KEGG;DRUG METABOLISM OTHER ENZYMES;;20;0.38696223;1.3124509;0.12064965;0.3590836
KEGG;REGULATION OF AUTOPHAGY;;18;0.37184492;1.2578073;0.1908046;0.44948235
KEGG;GNRH SIGNALING PATHWAY;;67;0.26755625;1.2552031;0.09798995;0.42506307
KEGG;DRUG METABOLISM CYTOCHROME P450;;19;0.365639;1.2395597;0.17889908;0.4351406
KEGG;HUNTINGTONS DISEASE;;147;0.22816423;1.2216488;0.08963586;0.45207623
KEGG;RETINOL METABOLISM;;15;0.38229716;1.2069016;0.21307506;0.4619262
KEGG;STEROID HORMONE BIOSYNTHESIS;;16;0.37395278;1.1831639;0.24619289;0.49328884
KEGG;NEUROACTIVE LIGAND RECEPTOR INTERACTION;;61;0.25730026;1.1830893;0.17857143;0.4687835
KEGG;O GLYCAN BIOSYNTHESIS;;16;0.36548102;1.166897;0.27166277;0.4852833
KEGG;PHOSPHATIDYLINOSITOL SIGNALING SYSTEM;;62;0.24980712;1.156231;0.20481928;0.48996857
KEGG;TYPE II DIABETES MELLITUS;;30;0.29093266;1.1420729;0.22327791;0.5017556
KEGG;TYROSINE METABOLISM;;21;0.32123098;1.1335825;0.28761062;0.5016974
KEGG;ALDOSTERONE REGULATED SODIUM REABSORPTION;;31;0.27560648;1.1016021;0.30403802;0.5592018
KEGG;STEROID BIOSYNTHESIS;;16;0.3239973;1.0611244;0.35779816;0.64177233
KEGG;GLUTATHIONE METABOLISM;;38;0.2539574;1.0358677;0.36720553;0.69051874
KEGG;P53 SIGNALING PATHWAY;;60;0.22426224;1.0141835;0.42857143;0.72870976
KEGG;CALCIUM SIGNALING PATHWAY;;75;0.20599401;0.9941637;0.45363408;0.76232517
KEGG;HISTIDINE METABOLISM;;19;0.2788287;0.9585678;0.495283;0.8401853
KEGG;ARACHIDONIC ACID METABOLISM;;29;0.24908389;0.9422797;0.5152225;0.86278766
KEGG;AMYOTROPHIC LATERAL SCLEROSIS ALS;;40;0.22222671;0.92434937;0.5764411;0.8876851
KEGG;EPITHELIAL CELL SIGNALING IN HELICOBACTER PYLORI INFECTION;;56;0.20328702;0.91689336;0.5979644;0.88205665
KEGG;ECM RECEPTOR INTERACTION;;54;0.20759165;0.9095712;0.61042184;0.87491626
KEGG;PRIMARY IMMUNODEFICIENCY;;16;0.2771548;0.90065616;0.597561;0.8746736
KEGG;GLYCOSYLPHOSPHATIDYLINOSITOL GPI ANCHOR BIOSYNTHESIS;;22;0.2538201;0.8996639;0.5985577;0.8533683
KEGG;CYTOSOLIC DNA SENSING PATHWAY;;32;0.22349022;0.87576574;0.68585134;0.8873911
KEGG;ARGININE AND PROLINE METABOLISM;;39;0.20574258;0.86895627;0.68085104;0.88106406
KEGG;PURINE METABOLISM;;118;0.1670298;0.8598725;0.8189655;0.87954766
KEGG;APOPTOSIS;;61;0.187478;0.85979736;0.7302799;0.85778534
KEGG;GAP JUNCTION;;59;0.18115486;0.82549995;0.81578946;0.9046687
KEGG;GLYCEROPHOSPHOLIPID METABOLISM;;61;0.1754593;0.8090233;0.85316455;0.9137119
KEGG;OLFACTORY TRANSDUCTION;;18;0.24165973;0.80784744;0.7076566;0.8945855
KEGG;ABC TRANSPORTERS;;30;0.20498385;0.79938984;0.7684729;0.88794774
KEGG;LONG TERM DEPRESSION;;44;0.18664265;0.7884809;0.8271605;0.88554364
KEGG;B CELL RECEPTOR SIGNALING PATHWAY;;60;0.16959427;0.75736237;0.89168763;0.90877557
KEGG;RIG I LIKE RECEPTOR SIGNALING PATHWAY;;47;0.17247742;0.7445858;0.91079813;0.90603685
KEGG;ETHER LIPID METABOLISM;;22;0.20457238;0.722594;0.86619717;0.90945745
KEGG;THYROID CANCER;;23;-0.5998275;-2.0249658;0;0.017159106
KEGG;UBIQUITIN MEDIATED PROTEOLYSIS;;123;-0.41132924;-2.021674;0;0.008579553
KEGG;ADHERENS JUNCTION;;62;-0.43659586;-1.9016712;0;0.025987536
KEGG;RNA DEGRADATION;;54;-0.4460405;-1.8453605;0;0.036287457
KEGG;WNT SIGNALING PATHWAY;;103;-0.38680744;-1.8362088;0;0.031756613
KEGG;FOCAL ADHESION;;145;-0.36258784;-1.8222369;0;0.02970365
KEGG;AMINOACYL TRNA BIOSYNTHESIS;;39;-0.4581217;-1.7822938;0;0.04192305
KEGG;LEUKOCYTE TRANSENDOTHELIAL MIGRATION;;75;-0.39945138;-1.7815107;0.001610306;0.036958434
KEGG;VALINE LEUCINE AND ISOLEUCINE DEGRADATION;;38;-0.44765246;-1.7403028;0.004983389;0.048502576
KEGG;REGULATION OF ACTIN CYTOSKELETON;;156;-0.33678076;-1.7255586;0;0.05135661
KEGG;HEDGEHOG SIGNALING PATHWAY;;32;-0.4536467;-1.6991936;0.008650519;0.05856243
KEGG;RENAL CELL CARCINOMA;;58;-0.3891793;-1.6718694;0.005366726;0.069450535
KEGG;ENDOMETRIAL CANCER;;45;-0.41046128;-1.6553379;0.007029877;0.07313536
KEGG;PATHOGENIC ESCHERICHIA COLI INFECTION;;44;-0.40227202;-1.6138759;0.016207455;0.09854267
KEGG;PATHWAYS IN CANCER;;237;-0.29448172;-1.5979326;0;0.104687974
KEGG;ACUTE MYELOID LEUKEMIA;;51;-0.38786843;-1.5913675;0.005084746;0.103424616
KEGG;INSULIN SIGNALING PATHWAY;;106;-0.32757777;-1.570128;0.006568145;0.116414815
KEGG;TIGHT JUNCTION;;102;-0.3295542;-1.5677855;0.006144393;0.11195226
KEGG;PROGESTERONE MEDIATED OOCYTE MATURATION;;69;-0.3469765;-1.5397238;0.011182109;0.13052674
KEGG;FRUCTOSE AND MANNOSE METABOLISM;;30;-0.4133583;-1.5339584;0.023333333;0.12976511
KEGG;AMINO SUGAR AND NUCLEOTIDE SUGAR METABOLISM;;38;-0.39041966;-1.5329189;0.02550091;0.12505692
KEGG;VASOPRESSIN REGULATED WATER REABSORPTION;;35;-0.39777464;-1.5130869;0.035958905;0.13941349
KEGG;BASAL CELL CARCINOMA;;33;-0.38523883;-1.446035;0.058020476;0.2121915
KEGG;COLORECTAL CANCER;;52;-0.34676015;-1.4342221;0.034201954;0.21969223
KEGG;HOMOLOGOUS RECOMBINATION;;26;-0.39849856;-1.4090931;0.06491228;0.25072783
KEGG;ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY ARVC;;44;-0.35307974;-1.4081978;0.05794702;0.24220712
KEGG;NEUROTROPHIN SIGNALING PATHWAY;;100;-0.29593274;-1.4025944;0.02866779;0.24129832
KEGG;PANCREATIC CANCER;;58;-0.32447916;-1.4012011;0.055837564;0.23494022
KEGG;LYSINE DEGRADATION;;39;-0.35341462;-1.3944798;0.072758034;0.23682562
KEGG;MTOR SIGNALING PATHWAY;;42;-0.33685726;-1.381331;0.07239057;0.24919716
KEGG;CITRATE CYCLE TCA CYCLE;;29;-0.37938398;-1.3793564;0.07192983;0.24392799
KEGG;OOCYTE MEIOSIS;;88;-0.28766263;-1.3656433;0.04347826;0.25809002
KEGG;CYSTEINE AND METHIONINE METABOLISM;;26;-0.38272575;-1.3515439;0.099303134;0.2717226
KEGG;LONG TERM POTENTIATION;;47;-0.3274386;-1.3429192;0.07833333;0.2771688
KEGG;CELL CYCLE;;116;-0.27311224;-1.3254441;0.057877813;0.29769453
KEGG;PROSTATE CANCER;;76;-0.2927344;-1.3185833;0.07960199;0.30258563
KEGG;TRYPTOPHAN METABOLISM;;23;-0.39302346;-1.3162142;0.12998267;0.29882723
KEGG;AXON GUIDANCE;;90;-0.28147465;-1.3109103;0.07120253;0.299685
KEGG;SPLICEOSOME;;121;-0.26035526;-1.2943071;0.07166124;0.32141688
KEGG;SELENOAMINO ACID METABOLISM;;20;-0.38812524;-1.2915599;0.16869566;0.31865764
KEGG;GLYCOLYSIS GLUCONEOGENESIS;;41;-0.3297263;-1.2858402;0.11876076;0.3206071
KEGG;CHRONIC MYELOID LEUKEMIA;;63;-0.2910146;-1.2725059;0.10837439;0.33575314
KEGG;ERBB SIGNALING PATHWAY;;72;-0.28263685;-1.2594928;0.11129032;0.35233015
KEGG;MISMATCH REPAIR;;22;-0.37748364;-1.2585698;0.16354345;0.34600523
KEGG;TGF BETA SIGNALING PATHWAY;;57;-0.2903102;-1.2319363;0.14700855;0.39015794
KEGG;NOTCH SIGNALING PATHWAY;;38;-0.3097835;-1.2168001;0.2030981;0.41456103
KEGG;CHEMOKINE SIGNALING PATHWAY;;101;-0.25711313;-1.2150769;0.14992025;0.4090799
KEGG;PEROXISOME;;70;-0.2744534;-1.2085661;0.163606;0.41393828
KEGG;DNA REPLICATION;;34;-0.31640983;-1.2052486;0.20364238;0.4121298
KEGG;MELANOGENESIS;;58;-0.27732682;-1.1994921;0.16917923;0.41565442
KEGG;BIOSYNTHESIS OF UNSATURATED FATTY ACIDS;;18;-0.37902144;-1.198987;0.23725834;0.4085478
KEGG;N GLYCAN BIOSYNTHESIS;;41;-0.3041;-1.1868044;0.20512821;0.42584145
KEGG;STARCH AND SUCROSE METABOLISM;;22;-0.3515709;-1.1831169;0.24090122;0.42530203
KEGG;ENDOCYTOSIS;;145;-0.23562826;-1.1813962;0.14583333;0.42079267
KEGG;FC GAMMA R MEDIATED PHAGOCYTOSIS;;74;-0.2644616;-1.1810395;0.1889632;0.41375676
KEGG;T CELL RECEPTOR SIGNALING PATHWAY;;75;-0.26607928;-1.1702223;0.20547946;0.4286444
KEGG;GLYCEROLIPID METABOLISM;;39;-0.29941723;-1.1644095;0.22827938;0.43371165
KEGG;PROPANOATE METABOLISM;;28;-0.31835538;-1.1584494;0.24369748;0.43806913
KEGG;VIBRIO CHOLERAE INFECTION;;44;-0.28770202;-1.1530157;0.24414715;0.4420065
KEGG;HYPERTROPHIC CARDIOMYOPATHY HCM;;50;-0.2739782;-1.13043;0.27538726;0.481798
KEGG;LYSOSOME;;108;-0.2299417;-1.1139029;0.2449923;0.51011586
KEGG;JAK STAT SIGNALING PATHWAY;;77;-0.25005636;-1.1046121;0.29502574;0.5220101
KEGG;NATURAL KILLER CELL MEDIATED CYTOTOXICITY;;60;-0.25644282;-1.094469;0.3183391;0.5369474
KEGG;GLIOMA;;50;-0.26108104;-1.0915908;0.31153184;0.5355658
KEGG;VEGF SIGNALING PATHWAY;;55;-0.25743407;-1.0899427;0.3062606;0.5307996
KEGG;CELL ADHESION MOLECULES CAMS;;58;-0.25273755;-1.0766878;0.33830845;0.5516876
KEGG;SNARE INTERACTIONS IN VESICULAR TRANSPORT;;35;-0.27826738;-1.0516173;0.38898757;0.60143334
KEGG;NICOTINATE AND NICOTINAMIDE METABOLISM;;21;-0.31495008;-1.0404439;0.41843972;0.6196376
KEGG;DORSO VENTRAL AXIS FORMATION;;19;-0.32335353;-1.0370907;0.39783;0.61885315
KEGG;PENTOSE PHOSPHATE PATHWAY;;23;-0.3051802;-1.0364174;0.40104166;0.61143905
KEGG;NUCLEOTIDE EXCISION REPAIR;;41;-0.26370025;-1.0338477;0.3911672;0.60876465
KEGG;ALANINE ASPARTATE AND GLUTAMATE METABOLISM;;20;-0.30857557;-1.0297115;0.4072165;0.6091712
KEGG;VIRAL MYOCARDITIS;;36;-0.26809245;-1.0149;0.43193278;0.63565606
KEGG;PRION DISEASES;;21;-0.30000523;-1.0107031;0.42348754;0.6364468
KEGG;PROTEIN EXPORT;;22;-0.29869145;-1.0089965;0.432247;0.6322312
KEGG;PYRUVATE METABOLISM;;33;-0.2656118;-1.0041546;0.44781145;0.63506436
KEGG;DILATED CARDIOMYOPATHY;;50;-0.24029295;-0.99216586;0.459854;0.6532529
KEGG;MELANOMA;;45;-0.24610758;-0.9889049;0.46349746;0.6527448
KEGG;NON SMALL CELL LUNG CANCER;;47;-0.24530287;-0.9881986;0.48045602;0.6460972
KEGG;NITROGEN METABOLISM;;15;-0.31961808;-0.9856717;0.4638219;0.6439713
KEGG;BLADDER CANCER;;36;-0.25704888;-0.9817903;0.4972973;0.6449809
KEGG;BASE EXCISION REPAIR;;32;-0.26638168;-0.9621873;0.5159129;0.6806786
KEGG;ADIPOCYTOKINE SIGNALING PATHWAY;;50;-0.23099;-0.9453972;0.55407655;0.7113143
KEGG;SMALL CELL LUNG CANCER;;71;-0.19981682;-0.88882977;0.65723795;0.83317965
KEGG;GLYCOSAMINOGLYCAN BIOSYNTHESIS HEPARAN SULFATE;;15;-0.28816614;-0.8868535;0.60553634;0.82828975
KEGG;MAPK SIGNALING PATHWAY;;183;-0.16919002;-0.87984776;0.75292397;0.83411306
KEGG;NOD LIKE RECEPTOR SIGNALING PATHWAY;;36;-0.22993554;-0.87421423;0.67269737;0.8365879
KEGG;PANTOTHENATE AND COA BIOSYNTHESIS;;15;-0.2856047;-0.8550378;0.65292096;0.8684193
KEGG;PORPHYRIN AND CHLOROPHYLL METABOLISM;;21;-0.25328368;-0.84724224;0.6736111;0.8753483
KEGG;SPHINGOLIPID METABOLISM;;34;-0.21969797;-0.82959116;0.7113402;0.90169716
KEGG;PPAR SIGNALING PATHWAY;;50;-0.19681022;-0.82136613;0.7707317;0.90783703
KEGG;VASCULAR SMOOTH MUSCLE CONTRACTION;;65;-0.18756361;-0.80969876;0.80223286;0.91925395
KEGG;BUTANOATE METABOLISM;;23;-0.22947913;-0.789263;0.7959559;0.94570535
KEGG;INOSITOL PHOSPHATE METABOLISM;;49;-0.19002265;-0.77557963;0.83418804;0.95934874
KEGG;BASAL TRANSCRIPTION FACTORS;;28;-0.21267043;-0.76713425;0.79334503;0.9618833
KEGG;RNA POLYMERASE;;25;-0.21016316;-0.74989927;0.8369748;0.9772378
KEGG;GALACTOSE METABOLISM;;20;-0.22493204;-0.74636096;0.8277027;0.97157836
KEGG;PYRIMIDINE METABOLISM;;82;-0.16334991;-0.74589646;0.9251592;0.9622651
KEGG;ANTIGEN PROCESSING AND PRESENTATION;;37;-0.19262628;-0.7416432;0.86971235;0.95771253
KEGG;LEISHMANIA INFECTION;;41;-0.1897087;-0.7324918;0.88305086;0.9592597
KEGG;BETA ALANINE METABOLISM;;18;-0.22438432;-0.7296964;0.8420108;0.9531142
KEGG;FC EPSILON RI SIGNALING PATHWAY;;54;-0.17200735;-0.7289126;0.9020537;0.9446486
KEGG;ONE CARBON POOL BY FOLATE;;15;-0.23656344;-0.70641226;0.87341774;0.9590412
KEGG;GLYCINE SERINE AND THREONINE METABOLISM;;21;-0.20915598;-0.68891984;0.88659793;0.9650972
KEGG;TOLL LIKE RECEPTOR SIGNALING PATHWAY;;63;-0.14197166;-0.61944497;0.9882747;0.9985165
KEGG;PROTEASOME;;36;-0.13599621;-0.5153006;0.99829644;1
KEGG;FATTY ACID METABOLISM;;31;-0.13326105;-0.49106765;0.99656355;1
KEGG;GLYCOSAMINOGLYCAN DEGRADATION;;16;-0.1341732;-0.4001547;1;0.99970025